| NCT07108270 | A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Chinese Participants With Primary Advanced or Recurrent Endometrial Cancer (EC) | NOT_YET_RECRUITING | PHASE2 | 2025-11-30 | 2030-03-31 | 2030-03-31 |
| NCT07177339 | eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation | NOT_YET_RECRUITING | PHASE3 | 2025-10-20 | 2029-12-14 | 2029-10-19 |
| NCT07204964 | A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above | NOT_YET_RECRUITING | PHASE2 | 2025-10-10 | 2026-09-18 | 2026-09-18 |
| NCT07213609 | A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors | NOT_YET_RECRUITING | PHASE1, PHASE2 | 2025-10-10 | 2028-10-27 | 2028-09-28 |
| NCT07201051 | A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis | NOT_YET_RECRUITING | PHASE2 | 2025-09-26 | 2027-11-08 | 2027-03-15 |
| NCT07168356 | A Study to Evaluate Blood Levels of Bepirovirsen in Adult Participants With Severe or Moderate Kidney Disease | NOT_YET_RECRUITING | PHASE1 | 2025-09-16 | 2026-08-18 | 2026-04-28 |
| NCT07121192 | A Study to Assess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and Older | NOT_YET_RECRUITING | PHASE2 | 2025-09-01 | 2026-05-15 | 2025-11-20 |
| NCT07105709 | Open-label Extension Study in Participants With Early Alzheimer's Disease | RECRUITING | PHASE2 | 2025-08-14 | 2028-11-24 | 2028-09-01 |
| NCT07105722 | A Trial to Evaluate the Safety and Immune Response of an Investigational Pneumococcal Vaccine in Adults 50 To 64 Years of Age | RECRUITING | PHASE1 | 2025-08-12 | 2026-06-18 | 2026-06-18 |
| NCT07099898 | A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) | RECRUITING | PHASE3 | 2025-08-11 | 2028-09-11 | 2026-09-02 |
| NCT07092865 | A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following Revaccination in Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant | RECRUITING | PHASE2 | 2025-08-06 | 2027-07-16 | 2027-01-12 |
| NCT07036159 | A Study to Assess the Safety and Immunogenicity of a Vaccine Against Malaria in Healthy Children Aged 5-60 Months | RECRUITING | PHASE2 | 2025-08-06 | 2027-04-23 | 2027-04-23 |
| NCT07085702 | A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of the GSK 4-component Strep A Vaccine With Aluminum Hydroxide (Alum) or AS37 in Healthy Young Adults | RECRUITING | PHASE1 | 2025-07-31 | 2026-11-30 | 2026-11-30 |
| NCT06897527 | A Study to Evaluate the Safety of Dostarlimab in Adult Participants in India With Recurrent or Advanced Endometrial Cancer (EC) | NOT_YET_RECRUITING | PHASE4 | 2025-07-15 | 2027-01-13 | 2027-01-13 |
| NCT06995430 | A Phase 3 Study to Assess the Immune Response And Safety Of Rmenb+Omv Nz In Primed Healthy Participants (10 To 20 Years Old) | RECRUITING | PHASE3 | 2025-07-07 | 2025-12-10 | 2025-12-10 |
| NCT06405230 | Evaluation of Programmed Death Ligand 1 (PDL1) Response to Treatment in Extracellular Vesicles (EVs), Patient-derived Organoid (PDOs)s and Immune-marker Positron Emission Tomography (PET) Scanning in Non-small Cell Lung Cancer (NSCLC) | NOT_YET_RECRUITING | PHASE1, PHASE2 | 2025-06-27 | 2029-06-27 | 2028-04-24 |
| NCT06961214 | Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2) | RECRUITING | PHASE3 | 2025-06-23 | 2029-08-21 | 2029-08-21 |
| NCT06959095 | Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1) | RECRUITING | PHASE3 | 2025-06-20 | 2029-08-20 | 2029-08-20 |
| NCT06990880 | A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer | RECRUITING | PHASE1, PHASE2 | 2025-06-12 | 2028-08-09 | 2027-10-26 |
| NCT06885034 | A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed | RECRUITING | PHASE1, PHASE2 | 2025-06-11 | 2028-06-23 | 2027-11-11 |
| NCT06847867 | A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome | RECRUITING | PHASE2 | 2025-06-05 | 2029-03-06 | 2027-06-03 |
| NCT06979323 | Depemokimab Asthma Imaging and Bronchoscopy Sub-Study | RECRUITING | PHASE3 | 2025-06-03 | 2028-02-11 | 2028-02-11 |
| NCT06979518 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GSK3862995B Administered as a Single Dose to Healthy Participants of Chinese, Japanese, and European Ancestry | NOT_YET_RECRUITING | PHASE1 | 2025-05-20 | 2026-04-27 | 2025-11-25 |
| NCT06806137 | A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3 Months After a First Dose at 12 to 15 Months of Age | RECRUITING | PHASE3 | 2025-05-15 | 2027-04-02 | 2026-12-14 |
| NCT06887933 | A Trial to Evaluate the Safety of Niraparib Tablets in Adult Female Participants With Advanced or Relapsed Epithelial Ovarian Cancer | NOT_YET_RECRUITING | PHASE4 | 2025-04-22 | 2026-07-08 | 2026-03-20 |
| NCT06855160 | A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age | RECRUITING | PHASE3 | 2025-04-17 | 2026-12-24 | 2026-08-03 |
| NCT06702462 | A Study to Assess the Potential for Airway Sensitivity Reactions With Propellants HFA-152a (Test) and HFA-134a (Reference) Administered Via Pressurized Inhalers in Adults With Mild Asthma | COMPLETED | PHASE1 | 2025-03-11 | 2025-06-04 | 2025-06-04 |
| NCT06521567 | A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer | ACTIVE_NOT_RECRUITING | PHASE1, PHASE2 | 2025-03-06 | 2032-01-02 | 2032-01-02 |
| NCT06796907 | A Study of GSK5733584 in Combination With Anti-cancer Therapies for Advanced Solid Tumors | RECRUITING | PHASE1, PHASE2 | 2025-03-04 | 2028-04-05 | 2027-12-17 |
| NCT06517875 | Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis | RECRUITING | PHASE2 | 2025-02-28 | 2026-11-13 | 2026-10-14 |
| NCT06567782 | A Study of Neoadjuvant Dostarlimab Plus Capecitabine Plus Oxaliplatin (CAPEOX) Vs CAPEOX With Previously Untreated T4N0 or Stage III Mismatch Repair Proficient (MMRp)/Microsatellite Stable (MSS) Colon Cancer | RECRUITING | PHASE2 | 2025-02-17 | 2028-06-15 | 2026-07-06 |
| NCT06748053 | A Dose Finding Study With an Anti-TSLP Antibody (GSK5784283) in Adults Aged 18 to 75 Years of Age With Uncontrolled Asthma | RECRUITING | PHASE2 | 2025-02-10 | 2027-01-14 | 2026-07-15 |
| NCT06740630 | A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age | RECRUITING | PHASE3 | 2025-01-10 | 2027-05-13 | 2026-12-25 |
| NCT06679101 | A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM) | RECRUITING | PHASE3 | 2024-12-27 | 2032-04-06 | 2030-12-23 |
| NCT06710847 | A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Effectiveness of GSK4418959 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors | RECRUITING | PHASE1, PHASE2 | 2024-12-13 | 2028-06-16 | 2027-02-16 |
| NCT06716606 | A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease | RECRUITING | PHASE3 | 2024-12-12 | 2030-01-08 | 2028-07-19 |
| NCT06734234 | A Study to Evaluate the Safety, Tolerability, and Effects on Blood and Urine Markers of Single Ascending Dose of GSK4771261 in Healthy Participants and Participants With Autosomal Dominant Polycystic Kidney Disease | RECRUITING | PHASE1 | 2024-12-11 | 2026-09-04 | 2026-09-04 |
| NCT06693895 | A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age | RECRUITING | PHASE3 | 2024-11-26 | 2026-11-23 | 2026-07-01 |
| NCT06702449 | A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age | RECRUITING | PHASE1, PHASE2 | 2024-11-19 | 2027-05-31 | 2027-05-31 |
| NCT06681181 | A First-time in Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Target Engagement of GSK4528287 in Healthy Participants | RECRUITING | PHASE1 | 2024-11-18 | 2026-09-09 | 2025-10-23 |
| NCT06663436 | A Study on the Immune Response and Safety of a Multicomponent Shigella Vaccine in Preventing Shigellosis in Infants | ACTIVE_NOT_RECRUITING | PHASE2 | 2024-11-13 | 2025-10-16 | 2025-10-16 |
| NCT06666491 | An Interventional Study to Compare the Efficacy and Safety of Tafenoquine (TQ) and Primaquine (PQ) When Either Are Taken Together With Chloroquine (CQ) for the Treatment of P. Vivax Malaria in Indian Participants Aged 2 Years and Older | RECRUITING | PHASE3 | 2024-11-13 | 2026-05-25 | 2026-05-25 |
| NCT06680375 | A Study of an Investigational Flu Seasonal/SARS-CoV-2 Combination Vaccine in Adults | COMPLETED | PHASE1 | 2024-11-11 | 2025-06-09 | 2025-06-09 |
| NCT06537414 | A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB) | ACTIVE_NOT_RECRUITING | PHASE2 | 2024-11-11 | 2027-05-31 | 2027-05-31 |
| NCT06640049 | A Study of Dostarlimab in Participants With Untreated Locally Advanced Rectal Cancer in China | RECRUITING | PHASE2 | 2024-10-17 | 2031-04-15 | 2027-10-24 |
| NCT06625489 | A Study to Evaluate the Safety, Tolerability and Blood Levels of GSK3915393 Administered to Healthy Participants of Chinese, Japanese and European Ancestry and to Assess Effects of GSK3915393 on Nintedanib | COMPLETED | PHASE1 | 2024-10-07 | 2024-11-25 | 2024-11-25 |
| NCT06597344 | A Study in Adolescent and Adult Female Participants to Evaluate Clinical Symptom Improvement and the Safety of Gepotidacin During Treatment of Uncomplicated Urinary Tract Infections (Acute Cystitis) | COMPLETED | PHASE3 | 2024-10-02 | 2025-03-10 | 2025-03-10 |
| NCT06614725 | A Study in India on the Immune Response and Safety of a Respiratory Syncytial Virus (RSV) Older Adults (OA) Vaccine When Given to Older Adults 60 Years of Age and Above and Adults 50-59 Years of Age at Increased Risk (AIR) of Respiratory Syncytial Virus Lower Respiratory Tract Disease (RSV-LRTD) | ACTIVE_NOT_RECRUITING | PHASE3 | 2024-10-01 | 2025-11-24 | 2025-06-03 |
| NCT06573281 | A Study on the Safety and Immune Response to an mRNA-based RSV Investigational Vaccine in Healthy Adults Aged 18-45 Years | ACTIVE_NOT_RECRUITING | PHASE1 | 2024-09-30 | 2026-04-13 | 2026-04-13 |
| NCT06551142 | A Study of GSK5764227 in Participants With Advanced Solid Tumors | RECRUITING | PHASE1 | 2024-09-30 | 2027-03-19 | 2026-07-27 |
| NCT06597500 | A Study to Evaluate the Effect of Itraconazole on the Concentration of GSK3923868 in the Blood in Healthy Participants | COMPLETED | PHASE1 | 2024-09-30 | 2024-12-23 | 2024-12-16 |
| NCT06613698 | A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 65 Years With Alcohol-related Liver Disease | RECRUITING | PHASE2 | 2024-09-27 | 2027-08-23 | 2026-12-08 |
| NCT06497504 | Study of Bepirovirsen in Participants Living With Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection (B-Focus) | RECRUITING | PHASE2 | 2024-09-17 | 2027-04-27 | 2027-01-20 |
| NCT06572384 | A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease | RECRUITING | PHASE3 | 2024-09-11 | 2028-12-13 | 2028-10-18 |
| NCT06576271 | A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants and Healthy Chinese and Japanese Participants | RECRUITING | PHASE1 | 2024-09-02 | 2027-06-01 | 2027-06-01 |
| NCT06577597 | Safety, Tolerability and Blood Sampling of GSK3923868 Administered Via Dry Powder Inhaler to Healthy Participants of Chinese, Japanese and European Ancestry | COMPLETED | PHASE1 | 2024-09-02 | 2024-11-01 | 2024-11-01 |
| NCT06433921 | A Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics Aged 18 to 65 Inclusive | RECRUITING | PHASE1 | 2024-08-14 | 2026-08-14 | 2026-08-14 |
| NCT06551181 | A Study on the Immune Response, Safety and the Occurrence of Respiratory Syncytial Virus (RSV)-Associated Respiratory Tract Illness After Administration of RSV OA Vaccine in Adults 60 Years and Older | ACTIVE_NOT_RECRUITING | PHASE3 | 2024-08-05 | 2025-11-19 | 2025-04-24 |
| NCT06534892 | An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study | RECRUITING | PHASE3 | 2024-08-01 | 2026-09-30 | 2026-09-30 |
| NCT06506266 | Study of the Effect of HFA-152a and HFA-134a Propellants on Mucociliary Clearance in Healthy Participants | COMPLETED | PHASE1 | 2024-07-29 | 2024-10-24 | 2024-10-24 |
| NCT06422767 | Study to Evaluate the Effect of Bepirovirsen on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy Volunteers | COMPLETED | PHASE1 | 2024-07-18 | 2025-04-28 | 2025-04-28 |
| NCT06497517 | A Study to Investigate the Effect of Food on Camlipixant Concentrations in Healthy Participants | COMPLETED | PHASE1 | 2024-07-09 | 2024-08-26 | 2024-08-22 |
| NCT06431594 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Participants With Advanced Solid Tumors | RECRUITING | PHASE1 | 2024-07-02 | 2027-09-20 | 2027-02-01 |
| NCT06472076 | A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC) | ACTIVE_NOT_RECRUITING | PHASE3 | 2024-06-10 | 2027-02-02 | 2027-02-02 |
| NCT06411249 | A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE) | RECRUITING | PHASE4 | 2024-06-06 | 2029-05-29 | 2027-05-31 |
| NCT06447506 | Long-Term Study (AtDvance) to Evaluate GSK1070806 in Atopic Dermatitis. | ACTIVE_NOT_RECRUITING | PHASE2 | 2024-06-05 | 2025-07-29 | 2025-07-29 |
| NCT06433908 | A Study to Compare the Pharmacokinetics (PK) of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152A (Test) or HFA-134A (Reference) in Healthy Participants Aged 18 to 55 Inclusive | COMPLETED | PHASE1 | 2024-06-04 | 2024-10-22 | 2024-10-17 |
| NCT06413511 | A Study to Investigate the Safety and Pharmacological Effect of a Single Intravenous Infusion of Belantamab in Male and Female Participants Aged 18 to 75 With Autoimmune Disease | WITHDRAWN | PHASE1 | 2024-06-03 | 2025-07-08 | 2025-07-08 |
| NCT06261957 | A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants ≥ 18 Years of Age With Asthma | ACTIVE_NOT_RECRUITING | PHASE3 | 2024-05-31 | 2025-09-05 | 2025-09-05 |
| NCT06431607 | A Study to Find the Dose and Assess the Immune Response and Safety of a Vaccine Against Influenza in Healthy Younger and Older Adults | COMPLETED | PHASE2 | 2024-05-23 | 2025-06-04 | 2024-11-21 |
| NCT06317311 | A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Japanese Participants With Primary Advanced or Recurrent Endometrial Cancer | ACTIVE_NOT_RECRUITING | PHASE2 | 2024-05-07 | 2027-08-31 | 2026-07-15 |
| NCT06389487 | A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus (RSV) Given to Adults 18 to 49 Years of Age at Increased Risk for Respiratory Syncytial Virus Disease, Compared to Older Adults 60 Years of Age and Above | COMPLETED | PHASE3 | 2024-04-29 | 2025-03-18 | 2024-07-29 |
| NCT06374394 | A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a COVID-19 mRNA Vaccine in Adults Aged 50 Years and Above | COMPLETED | PHASE3 | 2024-04-29 | 2025-03-31 | 2024-11-01 |
| NCT06382311 | A Study to Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy Younger and Older Adults | RECRUITING | PHASE1, PHASE2 | 2024-04-18 | 2026-01-16 | 2025-08-25 |
| NCT06372496 | Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Participants With Uncontrolled Asthma | ACTIVE_NOT_RECRUITING | PHASE4 | 2024-04-16 | 2026-03-11 | 2025-09-01 |
| NCT06354257 | A Study to Investigate the Pharmacokinetics of a Combined Oral Contraceptive When Given Alone and in Combination With GSK3036656 in Female Participants of Non-childbearing Potential Aged 18 to 65 Years of Age | COMPLETED | PHASE1 | 2024-04-05 | 2024-07-01 | 2024-07-01 |
| NCT06317285 | A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF) | ACTIVE_NOT_RECRUITING | PHASE2 | 2024-04-04 | 2025-10-01 | 2025-10-01 |
| NCT06331156 | A Study on the Immune Response and Safety of Inactivated Poliovirus Vaccine (IPV) When Co-administered With Human Rotavirus (HRV) Porcine Circovirus (PCV)-Free Vaccine in Healthy Chinese Infants | COMPLETED | PHASE3 | 2024-03-22 | 2024-10-22 | 2024-10-22 |
| NCT06256588 | A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma | RECRUITING | PHASE3 | 2024-03-21 | 2029-10-26 | 2028-06-30 |
| NCT06041386 | REIMAGINE - Real World EvaluatIon of Mepolizumab in Severe Asthma achievinG on Treatment clinIcal remissioN, a prospEctive Study | ACTIVE_NOT_RECRUITING | PHASE4 | 2024-03-20 | 2028-06-14 | 2025-01-31 |
| NCT06222892 | A Study of Camlipixant in Male and Female Healthy Participants and Participants With Hepatic Impairment Aged 18-75 Years of Age | COMPLETED | PHASE1 | 2024-02-02 | 2024-12-30 | 2024-12-17 |
| NCT06104319 | Dose Exploration Study of GSK4532990 in. Participants With NASH or Suspected NASH | ACTIVE_NOT_RECRUITING | PHASE2 | 2024-01-22 | 2025-09-23 | 2025-09-23 |
| NCT06213506 | A Study on the Safety, Reactogenicity, and Immune Response to the GVGH iNTS-GMMA Vaccine Against Invasive Nontyphoidal Salmonella in Adults, Children, and Infants | RECRUITING | PHASE2 | 2024-01-15 | 2026-04-27 | 2026-04-27 |
| NCT06188507 | A First Time in Human Study to Evaluate the Safety and Tolerability of GSK3996401 Following Dosing With GSK4347859 in Healthy Participants | SUSPENDED | PHASE1 | 2024-01-12 | 2026-07-14 | 2026-07-14 |
| NCT05648357 | A Study to Assess the Safety and Immune Response of Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) in Participants Aged 65 Years and Older in India | COMPLETED | PHASE4 | 2023-12-14 | 2024-02-26 | 2024-02-26 |
| NCT06171113 | A Study to Investigate the Safety of GSK4024484 in Healthy Adult Participants | RECRUITING | PHASE1 | 2023-12-12 | 2025-08-14 | 2025-08-14 |
| NCT06154837 | A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease | RECRUITING | PHASE1 | 2023-11-27 | 2027-03-31 | 2027-03-31 |
| NCT05999799 | A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis | ACTIVE_NOT_RECRUITING | PHASE2 | 2023-11-16 | 2025-07-24 | 2025-07-24 |
| NCT06062420 | A Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck- GALAXIES H&N-202 | RECRUITING | PHASE2 | 2023-11-14 | 2027-05-14 | 2027-05-14 |
| NCT06113198 | A Study on the Immune Response and Safety of a Vaccine Against N. Meningitidis Serogroup B Infection in Healthy Infants From 2 Months of Age | RECRUITING | PHASE4 | 2023-11-10 | 2027-07-30 | 2027-02-23 |
| NCT05999708 | A First Time in Human Study to Evaluate the Safety and Tolerability of GSK4381406 in Healthy Participants | WITHDRAWN | PHASE1 | 2023-10-31 | 2024-12-05 | 2024-12-05 |
| NCT06077877 | A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Anticancer Activity of GSK4524101 Alone or With Niraparib in Participants With Solid Tumors | RECRUITING | PHASE1, PHASE2 | 2023-10-24 | 2027-06-29 | 2027-06-29 |
| NCT06079190 | Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease | ACTIVE_NOT_RECRUITING | PHASE2 | 2023-10-20 | 2026-11-23 | 2026-11-23 |
| NCT05340257 | A Pharmacokinetics and Safety Study of Augmentin ES-600 in Children With CAP and ABRS | WITHDRAWN | PHASE2 | 2023-10-14 | 2024-07-08 | 2024-07-08 |
| NCT06058390 | A Study to Evaluate the Relative Bioavailability of Subcutaneous Bepirovirsen When Delivered From a Vial or Prefilled Syringe Fitted With a Safety Syringe Device in Healthy Adult Participants | COMPLETED | PHASE1 | 2023-10-04 | 2024-05-03 | 2024-05-03 |
| NCT06065735 | Concentration-QT Study of Paroxetine in Healthy Adults | COMPLETED | PHASE1 | 2023-10-02 | 2024-01-08 | 2024-01-08 |
| NCT05838755 | A Study to Evaluate Efficacy and Safety of GSK3858279 in Diabetic Peripheral Neuropathic Pain | TERMINATED | PHASE2 | 2023-09-20 | 2025-02-17 | 2024-10-14 |
| NCT05878717 | A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease | RECRUITING | PHASE2, PHASE3 | 2023-09-13 | 2027-07-12 | 2027-05-17 |
| NCT05838742 | A Dose-Finding Study to Evaluate the Efficacy and Safety of GSK3858279 in Adults With Knee Osteoarthritis (OA) Pain | TERMINATED | PHASE2 | 2023-09-13 | 2024-12-03 | 2024-08-12 |
| NCT05682326 | Anemia Studies in CKD: Erythropoiesis Via a Novel PHI Daprodustat - Pediatric (ASCEND-P) | COMPLETED | PHASE3 | 2023-09-06 | 2025-03-17 | 2025-03-17 |
| NCT06025695 | Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix Porcine Circovirus (PCV)-Free Liquid Compared to Rotarix Liquid Given in 2-doses in Healthy Chinese Infants Starting at Age 6-16 Weeks | COMPLETED | PHASE3 | 2023-09-01 | 2024-10-23 | 2024-05-28 |
| NCT05660265 | A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Oral GSK4172239D Compared With Placebo in Sickle Cell Disease Participants Aged 18 to 50 Years | RECRUITING | PHASE1 | 2023-08-26 | 2026-02-27 | 2026-02-27 |
| NCT06201559 | Bioequivalence Study Between Two Albendazole 400 mg Tablets in Healthy Adult Participants Under Fed Conditions | COMPLETED | PHASE1 | 2023-08-21 | 2023-09-12 | 2023-09-12 |
| NCT05989672 | A Study on the Reactogenicity, Safety and Immune Response of a Targeted Immunotherapy Against HSV in Healthy Japanese Participants Aged 18-40 Years | COMPLETED | PHASE1 | 2023-08-08 | 2024-04-24 | 2023-11-29 |
| NCT05972993 | A Safety and Immune Response Study to Evaluate Varying Doses of an mRNA Vaccine Against Coronavirus Disease 2019 (COVID-19) in Healthy Adults | COMPLETED | PHASE1 | 2023-08-07 | 2024-10-14 | 2024-05-09 |
| NCT05975840 | Safety and Immunogenicity of Different Formulations of Monovalent Influenza A/Astrakhan/3212/2020 Like (H5N8) Virus Vaccine With AS03 Adjuvant System in Medically Stable Adults | COMPLETED | PHASE1, PHASE2 | 2023-08-03 | 2024-09-19 | 2024-05-21 |
| NCT05855200 | Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer | RECRUITING | PHASE3 | 2023-08-01 | 2031-03-27 | 2029-03-19 |
| NCT05960097 | A Study on the Safety and Immune Response of Investigational COVID-19 mRNA Vaccines in Healthy Adults | COMPLETED | PHASE2 | 2023-08-01 | 2024-08-30 | 2024-08-30 |
| NCT05921903 | A Study on the Immune Response and Safety of an RSV Vaccine When Given to Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant and Are at an Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease and Compared to Healthy Adults 50 Years of Age and Above | COMPLETED | PHASE2 | 2023-07-28 | 2025-05-16 | 2024-06-25 |
| NCT05966090 | A Study on Safety and Immune Response of Investigational RSV OA Vaccine in Combination With Herpes Zoster Vaccine in Healthy Adults | COMPLETED | PHASE3 | 2023-07-28 | 2024-07-29 | 2024-02-19 |
| NCT05959447 | Evaluation of the Potential Drug-drug Interactions Between Gemfibrozil or Dabigatran Etexilate and Camlipixant | COMPLETED | PHASE1 | 2023-07-26 | 2023-10-13 | 2023-10-13 |
| NCT05917288 | A Study of Belimumab in Chinese Pediatric Participants With Systemic Lupus Erythematosus | COMPLETED | PHASE1 | 2023-07-07 | 2024-10-30 | 2024-10-30 |
| NCT05899829 | Evaluation of the Effect of Rifampin and Rabeprazole on the Pharmacokinetics of Camlipixant | COMPLETED | PHASE1 | 2023-06-21 | 2023-08-08 | 2023-08-08 |
| NCT05714839 | A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments | RECRUITING | PHASE1 | 2023-06-14 | 2029-12-03 | 2029-12-03 |
| NCT04923347 | A Study to Evaluate the Safety and Efficacy of Fluticasone Furoate (FF)/Umeclidinium(UMEC)/Vilanterol (VI) in Participants With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE4 | 2023-06-06 | 2024-03-14 | 2024-03-14 |
| NCT05879107 | Study to Assess the Immune Response, the Safety and the Reactogenicity of Respiratory Syncytial Virus (RSV) Prefusion Protein 3 Older Adult (OA) (RSVPreF3 OA) Investigational Vaccine When co Administered With PCV20 in Older Adults | COMPLETED | PHASE3 | 2023-05-26 | 2024-05-07 | 2023-12-06 |
| NCT05823974 | A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults | COMPLETED | PHASE1, PHASE2 | 2023-04-27 | 2024-12-18 | 2024-07-02 |
| NCT05757102 | A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma | RECRUITING | PHASE3 | 2023-04-25 | 2027-01-15 | 2027-01-15 |
| NCT05760261 | Drug Interaction Assessment of GSK3882347 in Healthy Participants Aged 18 to 65 Years | COMPLETED | PHASE1 | 2023-04-11 | 2024-08-20 | 2024-08-13 |
| NCT05723562 | A Study of Dostarlimab in Untreated dMMR/MSI-H Locally Advanced Rectal Cancer | ACTIVE_NOT_RECRUITING | PHASE2 | 2023-04-03 | 2029-10-11 | 2026-11-02 |
| NCT05791565 | Green (Sustainable) VENTOLIN - Pharmacokinetics (PK) Study in Healthy Participants | COMPLETED | PHASE1 | 2023-04-03 | 2023-05-21 | 2023-05-21 |
| NCT05304130 | A Study in Healthy Japanese Participants to Evaluate the Safety and Pharmacokinetics of Otilimab | WITHDRAWN | PHASE1 | 2023-02-08 | 2023-05-04 | 2023-05-04 |
| NCT05705440 | A Follow-up Study to Describe the Safety of Study Participants Who Received RSVPreF3 Maternal Vaccination (Any Dose) or Controls From Previous RSV MAT Studies During Any Pregnancy Conceived Post Vaccination/Control | COMPLETED | PHASE3 | 2023-02-07 | 2025-01-15 | 2025-01-15 |
| NCT05677347 | Phase 1, Single and Repeat Dose Study to Assess Safety, Tolerability, and Pharmacokinetics (PK) of GSK3923868 in Participants With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE1 | 2023-01-23 | 2023-07-20 | 2023-07-20 |
| NCT05630833 | A Study to Investigate the Efficacy and Safety With Gepotidacin in Japanese Female Participants With Uncomplicated Urinary Tract Infection (Acute Cystitis) | COMPLETED | PHASE3 | 2023-01-11 | 2024-02-02 | 2024-02-02 |
| NCT05583344 | Phase 2b Study of GSK4532990 in Adults With NASH | ACTIVE_NOT_RECRUITING | PHASE2 | 2023-01-02 | 2027-04-05 | 2026-01-26 |
| NCT05630846 | A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age | COMPLETED | PHASE2 | 2022-12-14 | 2024-10-14 | 2024-06-07 |
| NCT05602025 | A Study to Compare the Pharmacokinetics (PK) of Depemokimab When Delivered With a Safety Syringe Device (SSD) or an Autoinjector in Healthy Adult Participants | COMPLETED | PHASE1 | 2022-12-13 | 2023-10-23 | 2023-10-23 |
| NCT05630807 | Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 1) | ACTIVE_NOT_RECRUITING | PHASE3 | 2022-12-07 | 2026-05-08 | 2025-11-12 |
| NCT05630820 | Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2) | ACTIVE_NOT_RECRUITING | PHASE3 | 2022-12-06 | 2026-05-08 | 2025-11-13 |
| NCT05600777 | A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough | RECRUITING | PHASE3 | 2022-12-05 | 2027-03-23 | 2026-06-17 |
| NCT05630859 | Safety and Efficacy of GSK Neisseria Gonorrhoeae GMMA (NgG) Investigational Vaccine When Administered to Healthy Adults 18 to 50 Years of Age. | COMPLETED | PHASE1, PHASE2 | 2022-11-28 | 2025-05-22 | 2025-05-22 |
| NCT05613205 | Safety and Immunogenicity of a Novel Conjugate Vaccine Against Salmonella Typhi and Salmonella Paratyphi A in Healthy Adults | COMPLETED | PHASE1 | 2022-11-28 | 2024-04-02 | 2023-12-06 |
| NCT04494412 | An Intravenous (IV) Zanamivir Pharmacokinetics (PK) Study in Hospitalized Neonates and Infants With Influenza Infection | RECRUITING | PHASE2 | 2022-11-21 | 2026-04-30 | 2026-04-30 |
| NCT04420221 | Safety, Immunogenicity and Efficacy of GSK S. Aureus Candidate Vaccine (GSK3878858A) When Administered to Healthy Adults (Dose-escalation) and to Adults 18 to 64 Years of Age With a Recent S. Aureus Skin and Soft Tissue Infection (SSTI) | COMPLETED | PHASE2 | 2022-11-16 | 2024-03-12 | 2024-03-12 |
| NCT05590338 | A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic of GSK1070806 After a Single Intravenous Dose in Healthy Male and Female Caucasian, Chinese and Japanese Participants Aged 18 to 65 Years of Age Inclusive | COMPLETED | PHASE1 | 2022-11-04 | 2023-12-28 | 2023-07-12 |
| NCT05590403 | A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 50-59 Years of Age, Including Adults at Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease, Compared to Older Adults 60 Years of Age and Above | COMPLETED | PHASE3 | 2022-10-28 | 2024-02-12 | 2023-03-13 |
| NCT05599191 | A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough | ACTIVE_NOT_RECRUITING | PHASE3 | 2022-10-25 | 2026-05-28 | 2025-12-18 |
| NCT05559476 | A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 65 Years and Above | COMPLETED | PHASE3 | 2022-10-20 | 2023-08-15 | 2023-03-07 |
| NCT05565378 | A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung Cancer | ACTIVE_NOT_RECRUITING | PHASE2 | 2022-10-14 | 2027-02-26 | 2027-02-26 |
| NCT05568797 | A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone or Co-administered With an Adjuvanted Vaccine Against Influenza in Adults Aged 65 Years and Above | COMPLETED | PHASE3 | 2022-10-14 | 2023-07-17 | 2023-02-17 |
| NCT05535972 | To Evaluate Real-World Effectiveness of Fluticasone Furoate/Umeclidinium Bromide/Vilanterol (FF/UMEC/VI) in a Single Inhaler (Trelegy Ellipta) in Participants With Symptomatic COPD | COMPLETED | PHASE4 | 2022-10-14 | 2023-09-25 | 2023-09-25 |
| NCT05570539 | Assessment of the Pharmacokinetics of BLU-5937 Extended Release Prototypes and a BLU-5937 Immediate Release Reference Formulation | COMPLETED | PHASE1 | 2022-10-07 | 2024-07-01 | 2024-05-02 |
| NCT05561673 | A Study on the Safety and Immune Response of AS37 Together With Hepatitis B Antigen in Adults Aged 18-45 Years | COMPLETED | PHASE1, PHASE2 | 2022-10-04 | 2024-11-29 | 2024-11-29 |
| NCT05424380 | A Phase 1, Open Label Study of Intravenous GSK3745417 to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Determine RP2D & Schedule in Participants With Relapsed or Refractory Myeloid Malignancies Including AML and HR MDS | TERMINATED | PHASE1 | 2022-09-20 | 2024-03-04 | 2024-03-04 |
| NCT05480800 | A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella and Typhoid Fever | RECRUITING | PHASE1, PHASE2 | 2022-09-13 | 2024-12-18 | 2024-12-18 |
| NCT05334368 | Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial | RECRUITING | PHASE3 | 2022-09-06 | 2026-11-30 | 2026-11-02 |
| NCT07150104 | Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Nirogacestat, Pomalidomide, and Dexamethasone in Participants With RRMM | ACTIVE_NOT_RECRUITING | PHASE1, PHASE2 | 2022-08-31 | 2027-03-11 | 2025-04-17 |
| NCT05496231 | A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age | COMPLETED | PHASE1, PHASE2 | 2022-08-22 | 2024-02-25 | 2024-02-23 |
| NCT05477186 | Safety and Immunogenicity Study of a Booster Dose of the Investigational CV0501 mRNA COVID-19 Vaccine in Adults at Least 18 Years Old | COMPLETED | PHASE1 | 2022-08-12 | 2023-08-18 | 2023-08-18 |
| NCT05435170 | Food Effect Study of Linerixibat Tablets in Healthy Adult Participants | COMPLETED | PHASE1 | 2022-08-11 | 2022-10-10 | 2022-10-10 |
| NCT05371080 | A Study on the Long-term Efficacy, Safety and Persistence of Immune Response of a Vaccine Against Herpes Zoster in Older Adults | ACTIVE_NOT_RECRUITING | PHASE3 | 2022-08-10 | 2027-08-23 | 2027-08-23 |
| NCT05446740 | A Study on the Safety, Reactogenicity and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults | COMPLETED | PHASE1 | 2022-08-09 | 2024-03-26 | 2024-03-26 |
| NCT05489237 | First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors | RECRUITING | PHASE1 | 2022-08-03 | 2027-11-03 | 2027-03-10 |
| NCT05382312 | Early Bactericidal Activity, Safety & Tolerability of Oral GSK3036656 in a Dual Combination With Novel and Established Antitubercular Agents, or Standard of Care in Adults With Rifampicin Susceptible Pulmonary Tuberculosis | COMPLETED | PHASE2 | 2022-07-26 | 2025-05-27 | 2025-05-27 |
| NCT07150091 | Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat, Lenalidomide, and Dexamethasone in Participants With RRMM | ACTIVE_NOT_RECRUITING | PHASE1, PHASE2 | 2022-07-19 | 2027-03-11 | 2025-04-17 |
| NCT05393076 | Phase I Study of Linerixibat in Adults With Moderate Hepatic Impairment and Healthy Controls | COMPLETED | PHASE1 | 2022-07-19 | 2022-12-06 | 2022-12-06 |
| NCT05263934 | Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA) | RECRUITING | PHASE3 | 2022-07-14 | 2026-11-24 | 2026-10-27 |
| NCT04965636 | Study in Pediatrics With HypEREosinophilic Syndrome (SPHERE) | ACTIVE_NOT_RECRUITING | PHASE3 | 2022-07-11 | 2025-10-09 | 2025-10-09 |
| NCT05305651 | Study to Monitor the Occurrence of Viral Variants in Patients With Compromised Immune Systems Being Treated for COVID-19 | COMPLETED | PHASE4 | 2022-07-01 | 2023-07-17 | 2023-07-17 |
| NCT05412030 | A Phase 2 Study to Evaluate the Safety, Tolerability, and Immune Response of AFX3772 Vaccine in Healthy Infants | ACTIVE_NOT_RECRUITING | PHASE2 | 2022-06-16 | 2026-07-23 | 2026-07-23 |
| NCT05398198 | Efficacy and Safety of GSK3923868 Inhalation Powder, During Experimental Human Rhinovirus Infection in Participants With Mild Asthma | COMPLETED | PHASE1 | 2022-06-09 | 2024-04-09 | 2024-04-09 |
| NCT05138822 | Safety, Tolerability, Pharmacokinetic and Microbiological Investigation of GSK3882347 in Female Participants With Urinary Tract Infections | COMPLETED | PHASE1 | 2022-05-18 | 2024-12-03 | 2024-12-03 |
| NCT04600752 | Study to Evaluate the Safety and Clinical Efficacy of Augmentin® Extra Strength-600 in Children With Acute Otitis Media in India | COMPLETED | PHASE4 | 2022-05-07 | 2022-11-12 | 2022-11-12 |
| NCT05274750 | Efficacy and Safety of Depemokimab (GSK3511294) in Participants With Chronic Rhinosinusitis With Nasal Polyps | COMPLETED | PHASE3 | 2022-04-22 | 2024-08-27 | 2024-07-30 |
| NCT04964050 | A Bioequivalence Study Between Capozide Versus ACE-Hemmer-ratiopharm in Healthy Adult Participants Under Fasting Conditions | WITHDRAWN | PHASE1 | 2022-04-21 | 2022-05-26 | 2022-05-26 |
| NCT05281523 | Efficacy and Safety of Depemokimab (GSK3511294) in Participants With Chronic Rhinosinusitis With Nasal Polyps (ANCHOR-2) | COMPLETED | PHASE3 | 2022-04-18 | 2024-08-06 | 2024-07-12 |
| NCT05330455 | Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B Infection | ACTIVE_NOT_RECRUITING | PHASE1, PHASE2 | 2022-04-14 | 2026-04-03 | 2025-05-19 |
| NCT05260437 | Safety, Reactogenicity, and Immunogenicity Trial of CV2CoV mRNA Vaccine Against SARS-CoV-2 in Seropositive Adult Participants | COMPLETED | PHASE1 | 2022-03-24 | 2023-03-07 | 2023-03-07 |
| NCT05276297 | A Study on the Safety, Efficacy and Immune Response Following Sequential Treatment With an Anti-sense Oligonucleotide Against Chronic Hepatitis B (CHB) and Chronic Hepatitis B Targeted Immunotherapy (CHB-TI) in CHB Patients Receiving Nucleos(t)Ide Analogue (NA) Therapy | ACTIVE_NOT_RECRUITING | PHASE2 | 2022-03-22 | 2025-08-11 | 2025-08-11 |
| NCT05277051 | First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors | RECRUITING | PHASE1 | 2022-03-22 | 2028-09-12 | 2028-09-12 |
| NCT05229068 | A Study of Safety, Reactogenicity and Immune Response of the Repeat Vaccination Against RSV When Given to Female Participants of 18-49 Years of Age During Their Subsequent Uncomplicated Pregnancy | WITHDRAWN | PHASE3 | 2022-03-11 | 2024-10-24 | 2023-11-06 |
| NCT05298254 | A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent Genital Herpes | COMPLETED | PHASE1, PHASE2 | 2022-03-07 | 2025-06-12 | 2025-06-12 |
| NCT05064358 | Study to Investigate Alternative Dosing Regimens of Belantamab Mafodotin in Participants With Relapsed or Refractory Multiple Myeloma | ACTIVE_NOT_RECRUITING | PHASE2 | 2022-03-03 | 2026-01-30 | 2024-08-19 |
| NCT05243680 | An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103) | ACTIVE_NOT_RECRUITING | PHASE3 | 2022-03-01 | 2025-05-19 | 2025-05-19 |
| NCT05271799 | A Study to Evaluate Pharmacokinetic, Safety, Tolerability and Relative Bioavailability of Gepotidacin in Healthy Adult Male and Female Participants | COMPLETED | PHASE1 | 2022-03-01 | 2022-04-22 | 2022-04-22 |
| NCT05174013 | Safety, Tolerability, Pharmacokinetics and Target Engagement of GSK3858279 in Healthy Caucasian, Chinese and Japanese Participants | COMPLETED | PHASE1 | 2022-02-14 | 2023-04-17 | 2023-02-10 |
| NCT04878315 | Bioequivalence Study Between Capoten Versus Captopril Reference Product in Healthy Adult Participants Under Fasting Conditions | WITHDRAWN | PHASE1 | 2022-02-13 | 2022-03-25 | 2022-03-25 |
| NCT06956170 | All Japanese Population: Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple Myeloma | ACTIVE_NOT_RECRUITING | PHASE3 | 2022-02-10 | 2029-11-30 | 2024-05-27 |
| NCT05084508 | A Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compared With a Marketed Chickenpox Vaccine, Given to Healthy Children 12 to 15 Months of Age | COMPLETED | PHASE2 | 2022-02-03 | 2024-06-13 | 2024-02-09 |
| NCT05219253 | A Study on the Immune Response and Safety of a Vaccine Against Herpes Zoster in Adults Aged 50 Years and Older in India | COMPLETED | PHASE3 | 2022-02-02 | 2022-12-12 | 2022-10-11 |
| NCT05169905 | A Study to Evaluate the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine in Healthy Non-pregnant Females From 9 to 49 Years of Age | COMPLETED | PHASE3 | 2022-02-02 | 2022-08-03 | 2022-08-03 |
| NCT06926673 | Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 3 | COMPLETED | PHASE2 | 2021-12-23 | 2024-05-02 | 2024-05-02 |
| NCT05124210 | Pharmacokinetics, Pharmacodynamics, and Safety of Single-dose Sotrovimab in High-risk Pediatric Participants With Mild to Moderate COVID-19 | TERMINATED | PHASE2 | 2021-12-16 | 2023-06-14 | 2023-06-14 |
| NCT05100316 | Screening Protocol for Preliminary Eligibility Determination for Adoptive Cell Therapy Trials | TERMINATED | PHASE2 | 2021-12-16 | 2022-10-04 | 2022-10-04 |
| NCT04954859 | Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure) | RECRUITING | PHASE2 | 2021-12-14 | 2029-02-08 | 2029-02-08 |
| NCT05140200 | Study of GSK3511294 in Healthy Chinese Participants | COMPLETED | PHASE1 | 2021-12-10 | 2022-12-23 | 2022-12-23 |
| NCT05082285 | A Study on the Safety, Tolerability and Immune Response of Meningococcal Combined ABCWY Vaccine in Healthy Infants | COMPLETED | PHASE2 | 2021-11-29 | 2025-03-31 | 2025-03-31 |
| NCT05133830 | Linerixibat and Obeticholic Acid Drug Interaction Study in Healthy Adult Participants | COMPLETED | PHASE1 | 2021-11-23 | 2022-05-31 | 2022-05-31 |
| NCT04975438 | Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis | COMPLETED | PHASE1 | 2021-11-18 | 2023-03-13 | 2022-12-19 |
| NCT05087056 | Safety, Tolerability, and Immunogenicity of MenABCWY Administered on Different Dosing Schedules in Healthy Adolescents | ACTIVE_NOT_RECRUITING | PHASE2 | 2021-11-18 | 2027-02-05 | 2027-02-05 |
| NCT05131971 | A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics (PD) of GSK3888130B in Healthy Participants | COMPLETED | PHASE1 | 2021-11-01 | 2023-10-12 | 2023-10-12 |
| NCT05045144 | A Phase III Study to Assess the Lot-to-lot Consistency of GSK's Investigational RSV Maternal Vaccine and the Immune Response and Safety of RSV Maternal Vaccine When Given Alone or Co-administered With GSK's Influenza D-QIV Vaccine in Healthy Non-pregnant Women. | COMPLETED | PHASE3 | 2021-10-26 | 2022-06-06 | 2022-06-06 |
| NCT04908865 | Open-label Study of Belimumab Plus Standard Therapy in Chinese Pediatric Participants With Active Systemic Lupus Erythematosus (SLE) | COMPLETED | PHASE4 | 2021-10-21 | 2024-08-13 | 2024-05-23 |
| NCT05089630 | A Study of Safety and Immune Response to Different Doses of a Cytomegalovirus Vaccine in Healthy Adults | COMPLETED | PHASE1 | 2021-10-14 | 2025-04-02 | 2025-04-02 |
| NCT05047770 | A Study on the Immune Response and Safety of the Shingles Vaccine and the Influenza Vaccine When Either is Given to Healthy Adults at the Same Time or Following a COVID-19 Booster Vaccine | COMPLETED | PHASE3 | 2021-10-07 | 2022-08-31 | 2022-08-29 |
| NCT05073003 | A Study on the Safety and Immune Responses to the GVGH altSonflex1-2-3 Vaccine Against Shigellosis in Adults, Children, and Infants | ACTIVE_NOT_RECRUITING | PHASE1 | 2021-10-06 | 2025-07-04 | 2025-07-04 |
| NCT05059301 | A Study of 3 Lots of an Investigational Vaccine Against Respiratory Syncytial Virus (RSV) in Adults Aged 60 Years and Above | COMPLETED | PHASE3 | 2021-10-01 | 2022-06-30 | 2022-01-24 |
| NCT05044325 | A First Time in Human (FTIH) Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GSK3884464 in Healthy Participants | TERMINATED | PHASE1 | 2021-09-20 | 2022-08-05 | 2022-08-05 |
| NCT04971928 | Phase 1 Study of GSK3228836 Pharmacokinetics in Participants With Hepatic Impairment | COMPLETED | PHASE1 | 2021-09-07 | 2022-05-12 | 2022-05-12 |
| NCT04950127 | Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN) | COMPLETED | PHASE3 | 2021-08-27 | 2024-12-20 | 2024-10-28 |
| NCT06179537 | Evaluation of the Pharmacokinetics and Safety of BLU-5937 in Healthy Adult Japanese and Caucasian Subjects | COMPLETED | PHASE1 | 2021-08-06 | 2021-11-21 | 2021-10-22 |
| NCT04980391 | A Study on the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine, in High Risk Pregnant Women Aged 15 to 49 Years and Infants Born to the Vaccinated Mothers | TERMINATED | PHASE3 | 2021-08-03 | 2023-05-30 | 2023-05-30 |
| NCT04937387 | Efficacy and Safety of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) in Chinese Participants With Inadequately Controlled Asthma | COMPLETED | PHASE3 | 2021-07-29 | 2024-08-05 | 2024-08-05 |
| NCT06868667 | Japan Expansion Cohort: Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma | ACTIVE_NOT_RECRUITING | PHASE3 | 2021-07-28 | 2026-06-19 | 2024-04-03 |
| NCT06868654 | China Subpopulation: Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma | ACTIVE_NOT_RECRUITING | PHASE3 | 2021-07-28 | 2026-06-19 | 2024-04-03 |
| NCT04544995 | Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid Tumors (SCOOP) | TERMINATED | PHASE1 | 2021-07-19 | 2025-04-23 | 2025-04-23 |
| NCT04276233 | Efficacy and Safety Study of Mepolizumab 100 Milligram (mg) Subcutaneous (SC) in Indian Participants Aged Greater Than or Equal to (>=) 18 Years With Severe Eosinophilic Asthma | COMPLETED | PHASE4 | 2021-06-29 | 2023-10-28 | 2023-10-28 |
| NCT04915755 | Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular Disease | ACTIVE_NOT_RECRUITING | PHASE3 | 2021-06-28 | 2025-12-31 | 2024-06-28 |
| NCT04886154 | A Study on the Safety, Effectiveness and Immune Response of Meningococcal Combined ABCWY Vaccine in Healthy Adolescents and Adults | COMPLETED | PHASE1, PHASE2 | 2021-06-14 | 2024-02-02 | 2024-02-02 |
| NCT04535037 | A Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and Toddlers | COMPLETED | PHASE4 | 2021-05-26 | 2022-07-25 | 2022-07-25 |
| NCT04886596 | Efficacy Study of GSK's Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above | COMPLETED | PHASE3 | 2021-05-25 | 2024-05-31 | 2022-04-11 |
| NCT04772053 | Molecular Disease Characterization Initiative (MDCI) | TERMINATED | PHASE2 | 2021-05-25 | 2022-11-15 | 2022-11-15 |
| NCT04869982 | Efficacy, Immunogenicity and Safety Study of GSKs Recombinant Zoster Vaccine Shingrix (GSK1437173A) in Chinese Adults Aged ≥50 Years | COMPLETED | PHASE4 | 2021-05-14 | 2023-04-20 | 2023-04-20 |
| NCT04841577 | A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 60 Years and Above | COMPLETED | PHASE3 | 2021-04-27 | 2022-02-08 | 2021-09-22 |
| NCT04607005 | Efficacy and Safety of Mepolizumab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)/ Eosinophilic Chronic Rhinosinusitis (ECRS) | COMPLETED | PHASE3 | 2021-04-22 | 2023-04-12 | 2023-04-12 |
| NCT04398680 | A Study of Belantamab Mafodotin in Multiple Myeloma Participants With Normal and Impaired Hepatic Function | RECRUITING | PHASE1 | 2021-04-20 | 2025-10-13 | 2025-10-13 |
| NCT04641247 | A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study | RECRUITING | PHASE2 | 2021-04-16 | 2026-11-13 | 2026-11-13 |
| NCT04813354 | A Comparison of Critical Errors, Overall Errors, Training/Teaching Time, and Preference Attributes of the ELLIPTA Versus BREEZHALER Dry Powder Inhalers (DPIs) in Adult Participants With Asthma | COMPLETED | PHASE4 | 2021-04-14 | 2021-07-08 | 2021-07-08 |
| NCT04151225 | Study to Evaluate Safety, Tolerability and Efficacy of GSK2330811 in Crohn's Disease | WITHDRAWN | PHASE2 | 2021-04-05 | 2025-05-26 | 2024-04-22 |
| NCT04719832 | Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype | COMPLETED | PHASE3 | 2021-03-17 | 2023-11-21 | 2023-11-21 |
| NCT04789577 | A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine GSK3206641A Administered in Adults 18 to 64 Years of Age and 65 Years of Age and Older | COMPLETED | PHASE2 | 2021-03-16 | 2022-09-12 | 2022-09-12 |
| NCT06655818 | Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Dostarlimab (GSK4057190) in Participants With RRMM | TERMINATED | PHASE1, PHASE2 | 2021-03-09 | 2024-02-14 | 2024-02-14 |
| NCT06790303 | Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 2 | TERMINATED | PHASE2 | 2021-03-04 | 2021-09-23 | 2021-09-23 |
| NCT04749459 | Sun Protection Factor (SPF) Determination of Two Sunscreen-Containing Lip Balms | COMPLETED | NA | 2021-03-03 | 2021-03-31 | 2021-03-31 |
| NCT04676763 | Substance P Challenge in Healthy Participants | COMPLETED | NA | 2021-03-02 | 2021-07-21 | 2021-07-21 |
| NCT04762511 | A Study on the Reactogenicity, Safety and Immune Response of a Vaccine Against Herpes Simplex Virus (HSV)-2 in Healthy Participants Aged 18-40 Years | TERMINATED | PHASE1 | 2021-03-02 | 2021-05-26 | 2021-05-26 |
| NCT04758962 | A Study of the Safety of and Immune Response to Varying Doses of a Vaccine Against COVID-19 in Healthy Adults | COMPLETED | PHASE1 | 2021-02-15 | 2022-04-19 | 2021-06-04 |
| NCT04732871 | Immunogenicity, Safety, Reactogenicity and Persistence of an Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above | ACTIVE_NOT_RECRUITING | PHASE3 | 2021-02-15 | 2026-05-25 | 2022-06-06 |
| NCT04737538 | A Proof-of-principle Clinical Study Investigating the Efficacy of an Experimental Dentifrice Containing Sodium Bicarbonate and Sodium Hyaluronate on Gingivitis | COMPLETED | PHASE2 | 2021-02-10 | 2021-07-28 | 2021-07-28 |
| NCT04718103 | A Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype | COMPLETED | PHASE3 | 2021-02-04 | 2024-04-11 | 2024-04-11 |
| NCT04676724 | Study of Sequential GSK3228836 and Peginterferon Treatment in Participants With Chronic Hepatitis B (CHB) | COMPLETED | PHASE2 | 2021-01-28 | 2023-02-17 | 2023-02-17 |
| NCT04718389 | A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype | ACTIVE_NOT_RECRUITING | PHASE3 | 2021-01-26 | 2025-09-15 | 2025-09-15 |
| NCT04707391 | Immunogenicity and Safety Study of GSK's MenABCWY Vaccine in Healthy Adolescents and Adults Previously Primed With MenACWY Vaccine | COMPLETED | PHASE3 | 2021-01-25 | 2023-09-29 | 2023-05-03 |
| NCT04549363 | Characterization of Corneal Epithelial Changes in Participants Treated With Belantamab Mafodotin | TERMINATED | PHASE3 | 2020-12-21 | 2022-11-21 | 2022-11-21 |
| NCT04640311 | Comparison of Daprodustat Formulations Produced by Two Methods of Manufacture for Bioequivalence and Dissolution in Healthy Participants | COMPLETED | PHASE1 | 2020-12-18 | 2021-05-18 | 2021-05-18 |
| NCT04693195 | A Multiple-Dose Study of BLU-5937 in Chronic Pruritus Associated With Atopic Dermatitis | COMPLETED | PHASE2 | 2020-12-09 | 2021-10-12 | 2021-10-04 |
| NCT04657198 | Extension Study to Evaluate the Safety and Immunogenicity of a Revaccination Dose of the RSVPreF3 OA Investigational Vaccine in Adults 60 Years and Older Who Participated in the RSV OA=ADJ-002 Study | COMPLETED | PHASE2 | 2020-12-09 | 2021-10-25 | 2021-06-03 |
| NCT04311463 | Bioequivalence Study of Paroxetine and PAXIL Under Fasting Conditions in Healthy Mexican Participants | COMPLETED | PHASE1 | 2020-12-09 | 2021-01-02 | 2021-01-02 |
| NCT04655976 | Efficacy Comparison of Cobolimab + Dostarlimab + Docetaxel to Dostarlimab + Docetaxel to Docetaxel Alone in Participants With Advanced Non-small Cell Lung Cancer Who Have Progressed on Prior Anti-PD-(L)1 Therapy and Chemotherapy | ACTIVE_NOT_RECRUITING | PHASE3 | 2020-12-08 | 2027-03-30 | 2025-06-05 |
| NCT04678206 | Evaluation of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough | COMPLETED | PHASE2 | 2020-12-07 | 2021-11-02 | 2021-10-21 |
| NCT04605159 | A Phase III, Double-blind Study to Assess Safety and Efficacy of an RSV Maternal Unadjuvanted Vaccine, in Pregnant Women and Infants Born to Vaccinated Mothers | TERMINATED | PHASE3 | 2020-11-20 | 2023-06-14 | 2023-06-14 |
| NCT04581824 | Efficacy Comparison of Dostarlimab Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy in Participants With Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) | TERMINATED | PHASE2 | 2020-11-19 | 2024-09-10 | 2022-08-04 |
| NCT04604795 | Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GSK3915393 in Healthy Participants and to Evaluate the Interaction Between GSK3915393 and Grapefruit Juice and Itraconazole | COMPLETED | PHASE1 | 2020-11-04 | 2021-06-29 | 2021-06-29 |
| NCT04472897 | A Study to Evaluate Safety, Tolerability and Pharmacokinetics of GSK2556286 in Healthy Adult Participants | TERMINATED | PHASE1 | 2020-10-30 | 2024-11-06 | 2024-11-06 |
| NCT04475939 | Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-Small Cell Lung Cancer | ACTIVE_NOT_RECRUITING | PHASE3 | 2020-10-26 | 2026-02-06 | 2025-02-26 |
| NCT04349280 | A Study to Evaluate the Efficacy and Safety of Bintrafusp Alfa (M7824) Monotherapy in Metastatic or Locally Advanced Urothelial Cancer | TERMINATED | PHASE1 | 2020-10-15 | 2022-08-15 | 2022-08-15 |
| NCT04585009 | Safety, Tolerability and Pharmacokinetics of GSK3923868 Inhalation Powder in Healthy Participants and Stable Asthmatics | COMPLETED | PHASE1 | 2020-10-12 | 2022-06-16 | 2022-06-16 |
| NCT04557371 | A Study to Assess the Local Cutaneous and Ocular Tolerance of Three Developmental Facial Skin-care Formulations. | COMPLETED | NA | 2020-10-12 | 2020-12-22 | 2020-12-22 |
| NCT04398745 | A Study of Belantamab Mafodotin Monotherapy in Multiple Myeloma Participants With Normal and Varying Degree of Impaired Renal Function | ACTIVE_NOT_RECRUITING | PHASE1 | 2020-10-09 | 2025-12-31 | 2025-04-21 |
| NCT04544956 | A Mechanistic Study of GSK3228836 With Fine Needle Aspiration (FNA) in Participants With Chronic Hepatitis B | COMPLETED | PHASE2 | 2020-10-06 | 2023-11-30 | 2023-11-30 |
| NCT04473521 | A Clinical Study to Assess Force Required to Dislodge Upper Denture With and Without Use of a Novel Denture Adhesive | WITHDRAWN | PHASE3 | 2020-10-04 | 2021-01-10 | 2021-01-10 |
| NCT04484623 | Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple Myeloma | ACTIVE_NOT_RECRUITING | PHASE3 | 2020-10-01 | 2029-10-25 | 2024-01-29 |
| NCT04504435 | Safety, Tolerability and Pharmacokinetics (PK) Investigation of GSK3494245 in Healthy Participants | COMPLETED | PHASE1 | 2020-09-29 | 2024-01-11 | 2024-01-11 |
| NCT04316585 | A Study to Evaluate the Benefit and Safety of GSK2982772 in Moderate to Severe Psoriasis Participants | COMPLETED | PHASE1 | 2020-09-28 | 2021-10-12 | 2021-09-13 |
| NCT04292912 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Participants With Diabetic Macular Edema | TERMINATED | PHASE1 | 2020-09-07 | 2022-04-11 | 2022-04-11 |
| NCT04318548 | Study to Assess the Safety and Immunogenicity of GSK Meningococcal Group B Vaccine When Administered Concomitantly With GSK Meningococcal MenACWY Conjugate Vaccine in Healthy Subjects of 16-18 Years of Age | COMPLETED | PHASE3 | 2020-08-25 | 2023-11-21 | 2023-11-21 |
| NCT05244759 | Mass Balance Recovery, Absorption, Metabolism and Excretion of [14C]-BLU-5937 | COMPLETED | PHASE1 | 2020-08-25 | 2021-03-02 | 2020-09-23 |
| NCT04488770 | Safety, Tolerability and Pharmacokinetic Investigation of GSK3882347 in Healthy Participants. | COMPLETED | PHASE1 | 2020-08-24 | 2021-05-14 | 2021-05-14 |
| NCT04502693 | Effectiveness of GlaxoSmithKline Biologicals S.A's Meningococcal Group B and Combined ABCWY Vaccines in Healthy Adolescents and Young Adults | COMPLETED | PHASE3 | 2020-08-14 | 2022-09-13 | 2022-09-13 |
| NCT04493931 | Drug-drug Interaction Study of Gepotidacin | COMPLETED | PHASE1 | 2020-08-14 | 2020-12-21 | 2020-12-21 |
| NCT04428333 | Study of GSK3359609 With Pembrolizumab and 5-fluorouracil (5-FU)-Platinum Chemotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma | TERMINATED | PHASE3 | 2020-08-12 | 2023-09-19 | 2021-04-27 |
| NCT04449029 | A Study of GSK3228836 in Participants With Chronic Hepatitis B (CHB) | COMPLETED | PHASE2 | 2020-07-27 | 2022-03-18 | 2022-03-18 |
| NCT04366349 | A Study to Evaluate the Safety and Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Melrilimab (GSK3772847) in Healthy Participants | COMPLETED | PHASE1 | 2020-07-21 | 2020-12-21 | 2020-12-21 |
| NCT04167358 | Linerixibat Long-term Safety, and Tolerability Study | ACTIVE_NOT_RECRUITING | PHASE3 | 2020-07-14 | 2027-08-31 | 2027-08-31 |
| NCT04446351 | Study of the Safety and Effectiveness of GSK6097608 in Participants With Advanced Solid Tumors | ACTIVE_NOT_RECRUITING | PHASE1 | 2020-06-25 | 2025-12-31 | 2025-12-31 |
| NCT07084896 | Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat in Participants With RRMM | ACTIVE_NOT_RECRUITING | PHASE1, PHASE2 | 2020-06-08 | 2027-03-11 | 2025-04-17 |
| NCT04376684 | Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease | COMPLETED | PHASE2 | 2020-05-28 | 2021-08-16 | 2021-07-15 |
| NCT04333147 | Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA) | TERMINATED | PHASE3 | 2020-05-12 | 2023-02-24 | 2023-02-24 |
| NCT04246047 | Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma | ACTIVE_NOT_RECRUITING | PHASE3 | 2020-05-07 | 2026-06-19 | 2023-10-02 |
| NCT04187144 | Comparative Study to Evaluate Efficacy and Safety of Gepotidacin to Nitrofurantoin in Treatment of Uncomplicated Urinary Tract Infection (UTI) | COMPLETED | PHASE3 | 2020-04-23 | 2022-12-01 | 2022-12-01 |
| NCT04162210 | Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) | ACTIVE_NOT_RECRUITING | PHASE3 | 2020-04-02 | 2026-07-01 | 2022-09-12 |
| NCT04173494 | A Study of Momelotinib Versus Danazol in Symptomatic and Anemic Myelofibrosis Participants (MOMENTUM) | COMPLETED | PHASE3 | 2020-02-07 | 2022-12-29 | 2021-12-03 |
| NCT04318535 | Bioequivalence (BE) Study of Test Griseofulvin 500 Milligram (mg) Tablets Versus Reference and Dose Proportionality Study of Test Griseofulvin 250 mg and 500 mg Tablets Under Fed Conditions | COMPLETED | PHASE1 | 2020-01-13 | 2020-02-06 | 2020-01-13 |
| NCT04091126 | Study of Belantamab Mafodotin Plus Standard of Care (SoC) in Newly Diagnosed Multiple Myeloma | ACTIVE_NOT_RECRUITING | PHASE1 | 2019-12-18 | 2026-12-31 | 2025-06-02 |
| NCT04176939 | A Study to Test GlaxoSmithKline's (GSK) Herpes Zoster (HZ) Subunit Vaccine's Long-term Immune Response in Previously Vaccinated Kidney Transplant Adults and Then to Test if 2 Additional Doses of the Vaccine Are Safe and Able to Generate an Immune Response | COMPLETED | PHASE3 | 2019-12-09 | 2024-06-27 | 2022-08-12 |
| NCT04177823 | A Study of Belantamab Mafodotin to Investigate Safety, Tolerability, Pharmacokinetics, Immunogenicity and Clinical Activity in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) | COMPLETED | PHASE1 | 2019-12-09 | 2021-12-30 | 2021-12-30 |
| NCT04138043 | Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of GSK2330811 in Healthy Japanese Participants | COMPLETED | PHASE1 | 2019-12-05 | 2020-05-28 | 2020-05-28 |
| NCT04179032 | Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE) | ACTIVE_NOT_RECRUITING | PHASE2 | 2019-11-28 | 2027-04-23 | 2023-01-16 |
| NCT04128696 | Study of GSK3359609 and Pembrolizumab in Programmed Death Receptor 1-ligand 1 (PD-L1) Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma | TERMINATED | PHASE3 | 2019-11-21 | 2023-06-20 | 2021-04-27 |
| NCT04138056 | A Study of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Diphtheria, Pertussis and Tetanus (Tdap) Viruses Followed by a 2nd Dose of the RSV Vaccine to Healthy Non-Pregnant Women | COMPLETED | PHASE2 | 2019-11-05 | 2021-11-22 | 2020-02-25 |
| NCT04126213 | Study of Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline's (GSK)Respiratory Syncytial Virus (RSV)Maternal Unadjuvanted Vaccine in Healthy Pregnant Women (Aged 18 to 40 Years) and Their Infants | COMPLETED | PHASE2 | 2019-11-05 | 2021-05-14 | 2020-07-23 |
| NCT04134728 | Efficacy and Safety of GSK3196165 (Otilimab) Versus Placebo and Sarilumab in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological Disease-modifying Antirheumatic Drug (DMARDs) and/or Janus Kinase (JAK) Inhibitors | COMPLETED | PHASE3 | 2019-10-31 | 2022-02-01 | 2021-09-15 |
| NCT04133909 | Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level | COMPLETED | PHASE3 | 2019-10-30 | 2024-08-08 | 2024-08-08 |
| NCT04136145 | Single Dose Study to Investigate the Pharmacokinetics (PK) and Safety of Belimumab 200 Milligrams (mg) Intravenous and 200 mg Subcutaneous Via Auto-injector in Chinese Healthy Subjects | COMPLETED | PHASE1 | 2019-10-28 | 2020-01-14 | 2020-01-14 |
| NCT04006808 | A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney Transplant | RECRUITING | PHASE1, PHASE2 | 2019-10-25 | 2027-03-31 | 2026-02-16 |
| NCT04052620 | Voltaren Emulgel 2% Acute Ankle Sprain Non Inferiority Study | COMPLETED | PHASE3 | 2019-10-24 | 2020-11-12 | 2020-11-12 |
| NCT04010539 | A Study Evaluating Efficacy and Safety of Gepotidacin Compared With Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea | COMPLETED | PHASE3 | 2019-10-21 | 2023-10-10 | 2023-10-10 |
| NCT04020341 | A Study to Evaluate Efficacy and Safety of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection (UTI) | COMPLETED | PHASE3 | 2019-10-17 | 2022-11-30 | 2022-11-30 |
| NCT04114656 | Effects of Intravenous GSK3858279 on a Battery of Evoked Pain Tests in Healthy Volunteers | TERMINATED | PHASE1 | 2019-10-15 | 2021-09-16 | 2021-09-16 |
| NCT04126200 | Platform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) | ACTIVE_NOT_RECRUITING | PHASE2 | 2019-10-07 | 2029-02-12 | 2029-02-12 |
| NCT06160609 | Platform Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With aOX40 (GSK3174998) in Participants With RRMM | TERMINATED | PHASE1, PHASE2 | 2019-10-07 | 2023-01-09 | 2023-01-09 |
| NCT04050722 | A Clinical Study Investigating the Efficacy of a Stannous Fluoride Dentifrice in Improving Gingival Health After Twice Daily Use for 3 Weeks | COMPLETED | PHASE4 | 2019-10-07 | 2019-11-13 | 2019-11-13 |
| NCT04025684 | Efficacy of Manual Toothbrushes in Removing Dental Plaque | COMPLETED | NA | 2019-09-30 | 2019-12-10 | 2019-12-10 |
| NCT04095286 | Relative Bioavailability Study of Marketed and Lower Dose Ambrisentan in Healthy Adult Participants | COMPLETED | PHASE1 | 2019-09-30 | 2019-12-17 | 2019-12-17 |
| NCT02964507 | Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Participants With Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Advanced or Metastatic Breast Cancer | TERMINATED | PHASE1 | 2019-09-26 | 2021-07-19 | 2020-09-29 |
| NCT04090658 | A Study to Test GlaxoSmithKline's (GSK) Respiratory Syncytial Virus RSV Candidate Vaccine's Safety and Immune Response in Japanese Older Adults | COMPLETED | PHASE1 | 2019-09-25 | 2020-12-11 | 2020-01-10 |
| NCT04091451 | Safety and Immunogenicity Study of GlaxoSmithKline's Herpes Zoster Subunit Vaccine (HZ/su) When Given on a Two-dose Schedule to Adults at Least 50 Years of Age (YOA) With a Prior Episode of Herpes Zoster | COMPLETED | PHASE3 | 2019-09-17 | 2024-02-15 | 2024-02-15 |
| NCT04079790 | Pharmacokinetics of Gepotidacin Tablets in Adults and Adolescents Subjects | COMPLETED | PHASE1 | 2019-09-04 | 2019-11-25 | 2019-11-25 |
| NCT04007159 | To Evaluate Skin Irritation and Skin Sensitisation of Developmental Cosmetic Facial Products | COMPLETED | NA | 2019-08-30 | 2019-11-29 | 2019-11-29 |
| NCT04006795 | A Photoxicity and Photoallergy Study of a Developmental Face Cream, Serum and Lotion | COMPLETED | NA | 2019-08-28 | 2019-10-11 | 2019-10-11 |
| NCT04053023 | Linerixibat and Obeticholic Acid Drug Interaction Study in Healthy Subjects | COMPLETED | PHASE1 | 2019-08-27 | 2019-11-25 | 2019-11-25 |
| NCT04062669 | A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Experimental Rabies Vaccine in Healthy Adults | COMPLETED | PHASE1 | 2019-08-13 | 2022-07-01 | 2021-07-28 |
| NCT04026009 | Safety and Immunogenicity Study of GSK's Clostridium Difficile Vaccine 2904545A When Administered in Healthy Adults Aged 18-45 Years and 50-70 Years | COMPLETED | PHASE1 | 2019-08-05 | 2022-05-10 | 2022-05-10 |
| NCT03457701 | Anemia Studies in CKD: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat- Iron (ASCEND: Fe) | COMPLETED | PHASE2 | 2019-07-30 | 2022-07-05 | 2022-07-05 |
| NCT03954743 | Safety Study of 2 Formulations of GSK's Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks | COMPLETED | PHASE3 | 2019-07-19 | 2020-11-30 | 2020-11-30 |
| NCT03979638 | A Dose Escalation Study of BLU-5937 in Unexplained or Refractory Chronic Cough | TERMINATED | PHASE2 | 2019-07-10 | 2020-04-23 | 2020-04-23 |
| NCT03809910 | Dental Plaque Removal Ability of Prototype Power Toothbrush Versus a Manual Toothbrush in Healthy Participants | COMPLETED | PHASE2 | 2019-07-08 | 2019-08-09 | 2019-08-09 |
| NCT03992014 | Pharmacokinetics (PKs) and Metabolism of Radiolabelled Linerixibat | COMPLETED | PHASE1 | 2019-07-08 | 2019-08-26 | 2019-08-26 |
| NCT03949842 | Legend: TRELEGY Real World Chronic Obstructive Pulmonary Disease (COPD) Effectiveness Study | WITHDRAWN | PHASE4 | 2019-06-27 | 2022-11-30 | 2022-11-30 |
| NCT03965533 | Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2831781 After an Intravenous (IV) Dose in Healthy Japanese and Caucasian Subjects, and a Subcutaneous (SC) Dose in Healthy Caucasian Subjects | COMPLETED | PHASE1 | 2019-06-10 | 2019-12-10 | 2019-12-10 |
| NCT03970837 | Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs) | TERMINATED | PHASE3 | 2019-06-05 | 2023-01-18 | 2021-10-29 |
| NCT03614676 | A Study of Outcomes and Events of Interest in Pregnant Women, Neonates and Infants and of RSV Surveillance | COMPLETED | NA | 2019-05-30 | 2021-07-27 | 2021-07-27 |
| NCT03980483 | Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate | COMPLETED | PHASE3 | 2019-05-16 | 2022-08-16 | 2021-09-15 |
| NCT03943095 | Study to Characterize the Efficacy of a Dual Active Dentifrice for the Relief of Dentin Hypersensitivity | COMPLETED | PHASE2 | 2019-05-13 | 2019-08-28 | 2019-08-28 |
| NCT03893565 | Safety, Tolerability, Efficacy and Dose-response of GSK2831781 in Ulcerative Colitis | TERMINATED | PHASE2 | 2019-05-06 | 2021-05-17 | 2021-05-17 |
| NCT03874234 | Safety, Tolerability and Pharmacokinetics (PKs) Investigation of GSK3186899 in Healthy Subjects | TERMINATED | PHASE1 | 2019-04-30 | 2019-10-17 | 2019-10-17 |
| NCT03894969 | Study to Assess the Immunogenicity and Safety of GSK's Investigational Vaccine (GSK3277511A) When Given to Healthy Smokers and Ex-smokers After Administration of Shingrix Vaccine | COMPLETED | PHASE2 | 2019-04-23 | 2021-08-13 | 2020-08-31 |
| NCT03636906 | Respiratory Syncytial Virus (RSV) Investigational Vaccine in Infants Aged 6 and 7 Months Likely to be Unexposed to RSV | COMPLETED | PHASE1, PHASE2 | 2019-04-08 | 2021-07-22 | 2020-01-16 |
| NCT03866187 | Safety, Efficacy, Immunogenicity Study of GSK Biologicals' HBV Viral Vector and Adjuvanted Proteins Vaccine (GSK3528869A) in Adult Patients With Chronic Hepatitis B Infection | TERMINATED | PHASE1, PHASE2 | 2019-03-28 | 2024-10-07 | 2024-10-07 |
| NCT03557281 | An Early Bactericidal Activity, Safety and Tolerability of GSK3036656 in Subjects With Drug-sensitive Pulmonary Tuberculosis | COMPLETED | PHASE2 | 2019-03-22 | 2021-12-14 | 2021-12-03 |
| NCT03828292 | An Open-label, Dose Escalation Study in Japanese Participants With Relapsed/Refractory Multiple Myeloma Who Have Failed Prior Anti Myeloma Treatments | COMPLETED | PHASE1 | 2019-03-14 | 2024-09-05 | 2023-04-06 |
| NCT03848845 | Study Evaluating Safety, Tolerability and Clinical Activity of GSK2857916 in Combination With Pembrolizumab in Subjects With Relapsed/Refractory Multiple Myeloma (RRMM) | COMPLETED | PHASE1, PHASE2 | 2019-03-14 | 2023-06-14 | 2021-10-18 |
| NCT03843359 | A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With Advanced Solid Tumors | ACTIVE_NOT_RECRUITING | PHASE1 | 2019-03-12 | 2025-03-31 | 2024-04-05 |
| NCT03697824 | Clinical Trial of Safety, Tolerability and Antitumor Activity of Genetically Engineered T Cells in Combination With Anti-Cancer Agents in Relapsed and Refractory Synovial Sarcoma Expressing New York Esophageal Antigen-1 (NY-ESO-1) and/or LAGE-1a | WITHDRAWN | PHASE2 | 2019-02-25 | 2022-07-18 | 2022-07-18 |
| NCT02141204 | Immunogenicity, Reactogenicity and Safety Study of Two Different Formulations of GSK Biologicals' Human Rotavirus Vaccine, Rotarix, in Healthy Infants | COMPLETED | PHASE3 | 2019-02-20 | 2019-12-28 | 2019-12-28 |
| NCT03824236 | A Study to Evaluate the Efficacy, Immunogenicity and Safety in a Sporozoite Challenge Model of a Fractional Booster Dose of GSK Biologicals' Candidate Malaria Vaccine Administered to Previously Vaccinated Healthy Malaria-naïve Adults | COMPLETED | PHASE2 | 2019-02-05 | 2019-09-26 | 2019-04-30 |
| NCT03807700 | To Evaluate Oral Health and Quality of Life Associated With Use of a Denture Adhesive | COMPLETED | PHASE3 | 2019-02-04 | 2019-05-04 | 2019-05-04 |
| NCT03739710 | Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) | COMPLETED | PHASE2 | 2019-01-24 | 2024-05-02 | 2024-05-02 |
| NCT03803202 | A Single Ascending Dose Study in Adults (Stage 1) and Single Ascending Dose-Finding Study (Stage 2) in Elderly Subjects With ASP3772, A Pneumococcal Vaccine | COMPLETED | PHASE1, PHASE2 | 2019-01-24 | 2020-09-28 | 2020-09-28 |
| NCT05553808 | Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 1 | COMPLETED | PHASE2 | 2019-01-24 | 2021-09-23 | 2021-09-23 |
| NCT03804710 | To Evaluate the Effect of Moisturizing Creams on Skin Barrier Function | COMPLETED | NA | 2019-01-22 | 2019-04-16 | 2019-04-16 |
| NCT03814590 | A Study to Assess the Safety, Reactogenicity and Immune Response of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3844766A) in Older Adults | COMPLETED | PHASE1, PHASE2 | 2019-01-21 | 2020-11-30 | 2019-12-12 |
| NCT03707678 | A Safety and Efficacy Study of Intranasal GSK2245035 in Adults With Allergic Asthma | WITHDRAWN | PHASE2 | 2019-01-21 | 2019-12-23 | 2019-12-23 |
| NCT03376932 | Effectiveness of Fluticasone Furoate/ Umeclidinium/ Vilanterol (FF/UMEC/VI) Using the Connected Inhaler System (CIS) as Compared With Fluticasone Proprionate/ Salmeterol (FP/SAL) Plus Tiotropium (TIO) in Inadequately Controlled Asthma | WITHDRAWN | PHASE3 | 2019-01-18 | 2021-02-03 | 2021-02-03 |
| NCT03446612 | Anemia Study in Chronic Kidney Disease (CKD) : Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat -Forearm Blood Flow (ASCEND-FBF) | TERMINATED | PHASE2 | 2019-01-10 | 2019-05-29 | 2019-05-29 |
| NCT03709810 | A Study to Investigate Food Occlusion Efficacy of a Denture Adhesive in Denture Wearers | COMPLETED | PHASE4 | 2019-01-07 | 2019-01-24 | 2019-01-24 |
| NCT03709706 | Pilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel, GSK3377794)T-cells in New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1)/ LAGE-1a-positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With Pembrolizumab | TERMINATED | PHASE1, PHASE2 | 2018-12-31 | 2022-11-04 | 2022-06-27 |
| NCT03693612 | GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors | COMPLETED | PHASE1, PHASE2 | 2018-11-26 | 2021-09-16 | 2021-06-25 |
| NCT03681951 | First-time-in-human (FTIH) Study of GSK3145095 Alone and in Combination With Other Anticancer Agents in Adults With Advanced Solid Tumors | TERMINATED | PHASE2 | 2018-11-16 | 2019-08-13 | 2019-08-13 |
| NCT03674177 | A Study to Evaluate Different Dose Levels of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3888550A), Based on the Vaccine Safety and the Antibodies (Body Defences) Produced Following Vaccine Administration, When Given to Healthy Non-pregnant Women | COMPLETED | PHASE1 | 2018-10-30 | 2019-09-02 | 2019-04-16 |
| NCT03666988 | First Time in Humans (FTIH) Study of GSK3368715 in Participants With Solid Tumors and Diffuse Large B-cell Lymphoma (DLBCL) | TERMINATED | PHASE1 | 2018-10-22 | 2021-03-04 | 2021-03-04 |
| NCT03614728 | Study to Investigate the Safety and Clinical Activity of GSK3326595 and Other Agents to Treat Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) | TERMINATED | PHASE1, PHASE2 | 2018-10-16 | 2022-01-11 | 2022-01-11 |
| NCT03640832 | A Clinical Study to Investigate the Dermal and Ocular Tolerance of a Developmental Cosmetic Facial Serum Formulation in Healthy Females With Sensitive Skin | COMPLETED | NA | 2018-10-15 | 2018-11-13 | 2018-11-13 |
| NCT03688620 | Enhanced Safety Surveillance of GlaxoSmithKline's (GSK's) Quadrivalent Seasonal Influenza Vaccines During the 2018/19 Influenza Season | COMPLETED | PHASE4 | 2018-10-05 | 2019-01-04 | 2019-01-04 |
| NCT03361774 | A Clinical Method Development Study to Characterise The Efficacy of a Dentifrice For The Relief Of Dentin Hypersensitivity | WITHDRAWN | PHASE2 | 2018-10-01 | 2018-12-03 | 2018-12-03 |
| NCT03649412 | A Study to Investigate the Pharmacokinetics (PK) of Modified Release (MR) Prototype Coated Tablet Formulations of GSK2982772 | COMPLETED | PHASE1 | 2018-09-26 | 2019-05-07 | 2019-05-07 |
| NCT03544281 | To Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-drug Conjugate, GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or in Combination With Bortezomib Plus Dexamethasone (Arm B) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) | COMPLETED | PHASE1, PHASE2 | 2018-09-20 | 2024-02-28 | 2023-02-28 |
| NCT03652610 | A Study to Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) Administered to Healthy Adults 18 to 40 Years of Age | COMPLETED | PHASE2 | 2018-09-07 | 2019-06-11 | 2019-01-17 |
| NCT03400033 | Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Three-times Weekly Dosing in Dialysis (ASCEND-TD) | COMPLETED | PHASE3 | 2018-09-05 | 2020-06-19 | 2020-06-19 |
| NCT03433482 | A Study to Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) Administered to Healthy Adolescents and Young Adults 10 to 40 Years of Age | COMPLETED | PHASE2 | 2018-08-30 | 2019-12-17 | 2019-07-26 |
| NCT03627494 | First Time in Human (FTIH) Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single and Repeat Doses of GSK3439171A in Healthy Subjects and to Assess Food Effect | COMPLETED | PHASE1 | 2018-08-30 | 2019-08-26 | 2019-08-26 |
| NCT03562195 | A Safety and Efficacy Study of Mepolizumab in Subjects With Severe Asthma | COMPLETED | PHASE3 | 2018-08-29 | 2022-09-07 | 2022-09-07 |
| NCT03527173 | A Study to Evaluate the Efficacy, Safety and Immunogenicity of a Vaccine Designed to Protect Against Infection With Shigella Sonnei in Healthy Adults | COMPLETED | PHASE2 | 2018-08-29 | 2019-11-11 | 2019-05-08 |
| NCT03629886 | Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study | COMPLETED | PHASE4 | 2018-08-22 | 2020-02-28 | 2020-02-28 |
| NCT03621670 | Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants | COMPLETED | PHASE3 | 2018-07-27 | 2024-12-27 | 2024-12-27 |
| NCT03568942 | Pharmacokinetic Study of Oral Gepotidacin (GSK2140944) in Subjects With Uncomplicated Urinary Tract Infection (Acute Cystitis) | COMPLETED | PHASE2 | 2018-07-23 | 2019-01-07 | 2019-01-07 |
| NCT03590613 | Phase I Study of GSK2982772 in Japanese Healthy Male Participants | COMPLETED | PHASE1 | 2018-07-19 | 2018-09-26 | 2018-09-21 |
| NCT03497039 | A Study to Characterize Diclofenac's Plasma and Knee Exposure After Application of Diclofenac Gel to the Knee of Subjects With Osteoarthritis That Have a Scheduled Arthroplasty | COMPLETED | PHASE1 | 2018-07-19 | 2019-03-01 | 2019-03-01 |
| NCT03567499 | Pro-arrhythmic Potential of GSK3039294 in Healthy Subjects | WITHDRAWN | PHASE1 | 2018-07-12 | 2019-05-03 | 2019-05-03 |
| NCT03587207 | Study to Assess Potential Immune Interference When GlaxoSmithKline (GSK) Biologicals' MenABCWY Vaccine is Administered to Healthy Subjects Aged 10-25 Years | COMPLETED | PHASE2 | 2018-07-09 | 2018-12-19 | 2018-12-19 |
| NCT03638180 | BLU-5937: First-in-Human, Single and Multiple Doses Escalation, Safety, Tolerability, Pharmacokinetics and Food Effect | COMPLETED | PHASE1 | 2018-07-09 | 2018-10-25 | 2018-10-25 |
| NCT03511105 | Effects of GSK2798745 on Alveolar Barrier Disruption in a Segmental Lipopolysaccharide (LPS) Challenge Model | TERMINATED | PHASE1 | 2018-06-25 | 2018-12-18 | 2018-12-18 |
| NCT03478696 | A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE4 | 2018-06-25 | 2019-03-18 | 2019-03-18 |
| NCT03478683 | A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE4 | 2018-06-25 | 2019-03-14 | 2019-03-14 |
| NCT03525678 | A Study to Investigate the Efficacy and Safety of Two Doses of GSK2857916 in Participants With Multiple Myeloma Who Have Failed Prior Treatment With an Anti-CD38 Antibody | COMPLETED | PHASE2 | 2018-06-18 | 2024-09-12 | 2019-06-21 |
| NCT03478657 | An Open-label Study to Evaluate Correct Use and Ease of Use of the ELLIPTA DPI in Pediatric Subjects With Asthma | COMPLETED | PHASE4 | 2018-06-18 | 2018-12-07 | 2018-12-07 |
| NCT03541044 | A Bioequivalence Study of Two Nicotine Lozenges in Fasting Conditions in Healthy Smokers | COMPLETED | PHASE1 | 2018-06-18 | 2019-03-24 | 2019-03-24 |
| NCT03543137 | To Assess the Bioequivalence of the 4mg Prototype Mini Nicotine Lozenge to the Reference Product (Nicorette) in Healthy Smokers | COMPLETED | PHASE1 | 2018-06-18 | 2018-11-12 | 2018-11-12 |
| NCT03562117 | Pharmacokinetics (PK) Study of Gepotidacin (GSK2140944) in Adult Subjects With Varying Degrees of Hepatic Impairment and in Matched Control Subjects With Normal Hepatic Function | COMPLETED | PHASE1 | 2018-06-14 | 2018-12-26 | 2018-12-26 |
| NCT03212690 | Study of Renin-angiotensin System in Mechanically Ventilated Subjects | TERMINATED | NA | 2018-06-11 | 2019-07-08 | 2019-07-08 |
| NCT02671188 | A Study to Evaluate the Safety, Mode of Action and Clinical Efficacy of GSK3050002 in Subjects With Psoriatic Arthritis | WITHDRAWN | PHASE1 | 2018-06-01 | 2019-08-09 | 2019-08-09 |
| NCT03329573 | Bioequivalence Study of Paroxetine Immediate Release (IR) Tablets Manufactured in GlaxoSmithKline Tianjin (GSKT) and Mississauga Sites in Healthy Chinese Subjects | COMPLETED | PHASE1 | 2018-05-30 | 2018-08-03 | 2018-08-03 |
| NCT03188458 | Immunogenicity of a Single Dose of GSK Biologicals' Boostrix™ in Infants Prior to Primary Pertussis Vaccination, When Administered to Pregnant Women as Per Routine Practice in Bogota, Colombia | TERMINATED | PHASE4 | 2018-05-29 | 2018-10-22 | 2018-10-22 |
| NCT03555890 | Bioequivalence Study Between Levocetirizine Oral Disintegrating Tablet (ODT) and Levocetirizine Immediate Release Tablet (IRT) | COMPLETED | PHASE1 | 2018-05-18 | 2018-09-17 | 2018-09-17 |
| NCT03485365 | A Safety, Tolerability, Pharmacokinetics (PK) and Target Engagement (TE) Study of GSK3858279 in Healthy Participants and Evaluation of the Efficacy of Repeat Doses in Participants With Osteoarthritis (OA) | COMPLETED | PHASE1 | 2018-05-17 | 2022-09-12 | 2022-09-12 |
| NCT03183492 | Immunogenicity and Persistence of GlaxoSmithKline (GSK) Biologicals' Havrix® in Healthy Adult Subjects Vaccinated at Infancy Under the Hepatitis A Universal Mass Vaccination (UMV) Program in Israel | WITHDRAWN | PHASE4 | 2018-05-07 | 2019-01-28 | 2019-01-28 |
| NCT03441113 | Extended Access of Momelotinib in Adults With Myelofibrosis | ACTIVE_NOT_RECRUITING | PHASE2 | 2018-05-03 | 2026-12-31 | 2026-12-31 |
| NCT03493386 | Daprodustat Bioequivalence and Food Effect Study | COMPLETED | PHASE1 | 2018-04-24 | 2018-06-09 | 2018-06-09 |
| NCT03393806 | Repeat Dose Study of GSK3772847 in Participants With Moderate to Severe Asthma With Allergic Fungal Airway Disease (AFAD) | TERMINATED | PHASE2 | 2018-04-18 | 2020-01-06 | 2019-10-09 |
| NCT03439657 | Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With Prevenar13 in Adults Aged 50 Years and Older | COMPLETED | PHASE3 | 2018-04-12 | 2020-03-03 | 2019-05-06 |
| NCT03467425 | INTREPID: Investigation of TRELEGY Effectiveness: Usual Practice Design | COMPLETED | PHASE4 | 2018-04-11 | 2019-10-10 | 2019-10-10 |
| NCT02802501 | Efficacy and Safety Study of Tafenoquine (TQ) Co-administered With Dihydroartemisinin-piperaquine (DHA-PQP) for the Radical Cure of Plasmodium Vivax (P. Vivax) Malaria | COMPLETED | PHASE3 | 2018-04-08 | 2019-08-19 | 2019-08-19 |
| NCT03417830 | Biodistribution of 89Zirconium-labelled GSK2398852 Using PET Imaging | TERMINATED | PHASE1 | 2018-04-06 | 2018-07-20 | 2018-07-20 |
| NCT03372603 | A Study to Assess the Effectiveness and Side Effects of GSK2798745 in Participants With Chronic Cough | TERMINATED | PHASE1, PHASE2 | 2018-04-05 | 2018-10-08 | 2018-10-08 |
| NCT03474081 | A Comparative Study Between Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy Versus Tiotropium Monotherapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE4 | 2018-03-29 | 2019-07-17 | 2019-07-17 |
| NCT03447314 | Study of a Combination of GSK1795091 and Immunotherapies in Subjects With Advanced Solid Tumors | COMPLETED | PHASE1 | 2018-03-26 | 2022-03-11 | 2020-07-01 |
| NCT03443427 | A Study to Test if a Third Dose of the Vaccine is Safe in Current and Former Smokers Aged 40 to 80 Years Old and to Gather Information on the Immune Response Following the Third Dose of the Vaccine | COMPLETED | PHASE2 | 2018-03-20 | 2020-09-23 | 2019-12-31 |
| NCT02899026 | Efficacy and Safety Study of Sirukumab in Subjects With Polymyalgia Rheumatica | WITHDRAWN | PHASE3 | 2018-03-15 | 2021-08-26 | 2020-08-26 |
| NCT03426995 | First-time-in-Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single (in Both Fed and Fasted States) or Repeat Doses of GSK3358699 | TERMINATED | PHASE1 | 2018-03-13 | 2019-05-02 | 2019-05-02 |
| NCT03493919 | A Sourcing Study to Collect Human Blood Samples From Healthy Adults | COMPLETED | PHASE4 | 2018-03-08 | 2022-05-27 | 2022-05-27 |
| NCT03457727 | GSK1325756 Relative Bioavailability Study in Healthy Elderly Subjects | COMPLETED | PHASE1 | 2018-03-07 | 2018-07-25 | 2018-07-25 |
| NCT03363191 | The Efficacy of Fluticasone Furoate/Vilanterol Versus (vs) Fluticasone Furoate on Asthma | WITHDRAWN | PHASE4 | 2018-03-07 | 2019-05-29 | 2019-05-29 |
| NCT03409107 | Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ) | COMPLETED | PHASE3 | 2018-03-05 | 2020-10-07 | 2020-10-07 |
| NCT03312907 | A Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE) - BLISS-BELIEVE | COMPLETED | PHASE3 | 2018-03-01 | 2021-07-07 | 2020-05-29 |
| NCT03415243 | To Investigate the Gastrointestinal Behaviour of Two Triple Combination Products in Healthy Male Volunteers | COMPLETED | PHASE1 | 2018-03-01 | 2018-03-29 | 2018-03-29 |
| NCT03355820 | A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in Healthy Chinese Female Subjects Who Received Three Doses of the Vaccine in the HPV-058 Study | COMPLETED | PHASE3 | 2018-02-28 | 2018-06-29 | 2018-06-29 |
| NCT03359473 | Study to Evaluate the Safety and Efficacy of 13 Weeks of the Selective Androgen Receptor Modulator (SARM) GSK2881078 in Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE2 | 2018-02-28 | 2019-11-19 | 2019-11-19 |
| NCT03177603 | A Dose-escalation Study in Subjects With Pulmonary Arterial Hypertension (PAH) | COMPLETED | PHASE2 | 2018-02-21 | 2019-05-07 | 2019-05-07 |
| NCT03192371 | A Study to Evaluate the One Year Long-term Persistence of Immune Responses Following Two Different Rabies Vaccine Post-exposure Regimens in Chinese Children | WITHDRAWN | PHASE4 | 2018-02-15 | 2019-05-12 | 2019-05-12 |
| NCT03408392 | Bioequivalence Study Between SKF101804 Cefixime 200 Milligram (mg)/5 Milliliter (mL) Suspension Versus Cefixime 200 mg/5 mL Suspension Reference Product in Healthy Adult Subjects Under Fasting Conditions | COMPLETED | PHASE1 | 2018-02-06 | 2018-03-13 | 2018-03-13 |
| NCT03380429 | A Clinical Study to Evaluate the Effect of the Connected Inhaler System (CIS) on Adherence to Maintenance Therapy in Poorly Controlled Asthmatic Subjects | COMPLETED | PHASE4 | 2018-01-31 | 2019-01-24 | 2019-01-24 |
| NCT03242434 | Investigation of Thermal Injury on Intestinal Permeability in Both Thermal Injury and Healthy Participants | TERMINATED | PHASE1 | 2018-01-29 | 2018-03-26 | 2018-03-26 |
| NCT03311659 | Evaluation of Immunogenicity, Safety and Reactogenicity of GSK Biologicals' Boostrix Vaccine Administered as a Booster Dose in Healthy Russian Subjects | COMPLETED | PHASE3 | 2018-01-26 | 2018-08-31 | 2018-08-31 |
| NCT03202004 | GSK2894512 Vehicle-Controlled Study for Adult Plaque Psoriasis | WITHDRAWN | PHASE3 | 2018-01-22 | 2018-09-28 | 2018-09-28 |
| NCT03398421 | A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics (PK) of Nemiralisib | COMPLETED | PHASE1 | 2018-01-17 | 2018-03-12 | 2018-03-12 |
| NCT03358407 | GSK2983559 First Time in Human Study | TERMINATED | PHASE1 | 2018-01-11 | 2019-02-19 | 2019-02-19 |
| NCT03329547 | A Bioequivalence Study of SKF101804 Cefixime Versus Cefixime Reference Formulation in Healthy Adults Under Fasting Conditions | WITHDRAWN | PHASE1 | 2018-01-11 | 2018-02-02 | 2018-02-02 |
| NCT03368053 | Long-term Immunogenicity of the HIV gp120-NefTat/AS01B Vaccine (GSK SB732461) | COMPLETED | PHASE1 | 2017-12-14 | 2018-01-30 | 2018-01-30 |
| NCT03201978 | A Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of GSK2894512 in Healthy Adult Subjects | WITHDRAWN | PHASE1 | 2017-12-14 | 2018-05-15 | 2018-05-15 |
| NCT03128489 | Evaluation of Immunogenicity and Safety of DTPa-IPV/Hib Conjugate Vaccine (Infanrix™-IPV/Hib) Administered at 6, 10 and 14 Weeks in Healthy Indian Infants | WITHDRAWN | PHASE3 | 2017-12-01 | 2018-08-01 | 2018-08-01 |
| NCT03345407 | Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) | TERMINATED | PHASE2 | 2017-11-28 | 2019-01-10 | 2019-01-10 |
| NCT03281876 | A Study to Test if the Vaccine is Working Well in Chronic Obstructive Pulmonary Disease (COPD) Patients Aged 40 to 80 Years Old to Reduce Episodes of Worsening Symptoms and to Gather Further Information on Safety and Immune Response. | COMPLETED | PHASE2 | 2017-11-27 | 2020-03-26 | 2020-03-26 |
| NCT03266159 | A Dose Escalation Study to Investigate the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD), and Clinical Activity of GSK525762 Plus Trametinib in Subjects With Solid Tumors | WITHDRAWN | PHASE2 | 2017-11-27 | 2020-08-19 | 2020-08-19 |
| NCT03345108 | A Study to Investigate a Method to Measure Food Occlusion by Denture Adhesives in Denture Wearers | COMPLETED | NA | 2017-11-20 | 2017-12-15 | 2017-12-15 |
| NCT03310268 | A Clinical Study to Evaluate a Stannous Fluoride Toothpaste for the Relief of Dentinal Hypersensitivity | COMPLETED | NA | 2017-11-18 | 2018-02-02 | 2018-02-02 |
| NCT03250689 | Randomized Study Evaluating the Effect of Danirixin on Neutrophil Extracellular Traps (NETs) in Chronic Obstructive Pulmonary Disease (COPD) | TERMINATED | PHASE2 | 2017-11-15 | 2018-10-08 | 2018-10-08 |
| NCT03315559 | Absorption & Elimination of Radiolabelled GSK2269557 | COMPLETED | PHASE1 | 2017-11-14 | 2017-12-22 | 2017-12-22 |
| NCT03296072 | In Situ Erosion Study to Investigate the Effectiveness of an Experimental Toothpaste | COMPLETED | PHASE3 | 2017-11-13 | 2018-01-16 | 2018-01-16 |
| NCT03306043 | A Multi-center, Open-label Extension, Safety Study of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES) From Study 200622 | COMPLETED | PHASE3 | 2017-11-13 | 2019-12-30 | 2019-12-30 |
| NCT03248128 | Safety and Efficacy Study of Fluticasone Furoate/Vilanterol (FF/VI) Fixed Dose Combination (FDC) Compared to FF Alone in Subjects With Asthma | COMPLETED | PHASE3 | 2017-10-20 | 2022-03-21 | 2022-03-21 |
| NCT03287310 | First Time in Human (FTIH) Study to Evaluate Safety, Tolerability, Immunogenicity, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK3511294 Administered Subcutaneously (SC) in Subjects With Mild to Moderate Asthma | COMPLETED | PHASE1 | 2017-10-17 | 2019-07-31 | 2019-07-31 |
| NCT03170232 | A Pilot Study of Danirixin for Disease Progression in Chronic Obstructive Pulmonary Disease (COPD) | TERMINATED | PHASE2 | 2017-10-16 | 2018-11-15 | 2018-11-15 |
| NCT03305419 | A Safety and Pharmacokinetic (PK) Study of GSK2982772 in Healthy Subjects | COMPLETED | PHASE1 | 2017-10-11 | 2018-10-15 | 2018-10-15 |
| NCT03239522 | Absorption and Elimination of Radiolabeled Daprodustat | COMPLETED | PHASE1 | 2017-10-10 | 2017-11-28 | 2017-11-28 |
| NCT03294135 | The Aim of This Study is to Investigate the Persistence of Antibody Response in Adults up to 15 Years After One Booster Dose of GlaxoSmithKline (GSK) Biologicals' Encepur Adults Vaccine | COMPLETED | PHASE4 | 2017-10-05 | 2021-10-25 | 2021-10-25 |
| NCT03258710 | A Study of Switching From Entecavir to Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B | COMPLETED | PHASE4 | 2017-10-02 | 2019-11-25 | 2018-12-28 |
| NCT02130661 | Study to Determine the Effect of Itraconazole on the Pharmacokinetics of Rilapladib (SB659032) in Healthy Volunteers | WITHDRAWN | PHASE1 | 2017-10 | 2018-01 | 2018-01 |
| NCT03276962 | Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Schedules With or Without Fractional Doses, Early Dose 4 and Yearly Doses, in Children 5-17 Months of Age | COMPLETED | PHASE2 | 2017-09-28 | 2022-11-14 | 2019-11-04 |
| NCT03266172 | A Study to Compare the Pharmacokinetics (PK) of GSK2982772 Following Administration of Different Modified Release (MR) Formulations in Capsule and MR Tablet Formulations Relative to an Immediate Release (IR) Tablet Formulation and to Check the PK of MR Formulation in Capsule Following Repeat Doses | COMPLETED | PHASE1 | 2017-09-27 | 2018-11-21 | 2018-11-21 |
| NCT03258762 | Phase I Study of Pyrimethamine in Healthy Japanese and Caucasian Subjects | COMPLETED | PHASE1 | 2017-09-25 | 2017-11-19 | 2017-11-19 |
| NCT03267511 | A Study to Investigate the Stain and Plaque Removal Capability of Two Experimental Potassium Nitrate Dentifrices | COMPLETED | PHASE2 | 2017-09-25 | 2017-12-02 | 2017-12-02 |
| NCT03227445 | Comparative Study of ELLIPTA Dry Powder Inhaler (DPI) Versus DISKUS DPI Used With HandiHaler DPI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE4 | 2017-09-20 | 2018-01-04 | 2018-01-04 |
| NCT02937636 | To Investigate the Gingivitis Efficacy of a Stannous Fluoride Dentifrice in a Chinese Population | COMPLETED | NA | 2017-09-19 | 2017-12-22 | 2017-12-22 |
| NCT03239600 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Proof of Mechanism of GSK2618960 in Primary Sjögren's Syndrome (pSS) | WITHDRAWN | PHASE2 | 2017-09-19 | 2017-10-12 | 2017-10-12 |
| NCT03207750 | This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine | COMPLETED | PHASE3 | 2017-09-14 | 2019-03-01 | 2018-10-09 |
| NCT03207243 | Efficacy and Safety Study of GSK3772847 in Subjects With Moderately Severe Asthma | COMPLETED | PHASE2 | 2017-09-14 | 2019-05-15 | 2019-02-15 |
| NCT03275389 | A Study to Evaluate the Reactogenicity, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Supra-seasonal Universal Influenza Vaccines - Inactivated (SUIVs) (GSK3816302A) in Healthy Adults Aged 18 to 39 Years | COMPLETED | PHASE1 | 2017-09-08 | 2020-03-26 | 2020-03-26 |
| NCT03151395 | Occurrence of Potential Bacterial and Viral Pathogens in Stable Chronic Obstructive Pulmonary Disease and During Acute Exacerbations of the Disease, in Asia Pacific | COMPLETED | NA | 2017-08-25 | 2020-04-06 | 2020-04-06 |
| NCT03245619 | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Investigation of GSK3335065 Intravenous (IV) Infusion in Healthy Adults | TERMINATED | PHASE1 | 2017-08-22 | 2018-05-19 | 2018-05-19 |
| NCT03168438 | Letetresgene Autoleucel Engineered T Cells Alone and in Combination With Pembrolizumab in NY-ESO-1 Positive Multiple Myeloma | TERMINATED | PHASE1 | 2017-08-18 | 2020-11-05 | 2020-07-13 |
| NCT03015519 | A Study to Evaluate Pharmacokinetics, Safety and Efficacy of Albiglutide in Pediatric Subjects With Type 2 Diabetes Mellitus | WITHDRAWN | PHASE3 | 2017-08-14 | 2020-04-20 | 2020-04-20 |
| NCT03306589 | Lipopolysaccharide (LPS) or Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Challenge Study on Healthy Subjects | COMPLETED | PHASE1 | 2017-08-11 | 2018-06-20 | 2018-01-03 |
| NCT03238352 | A Study to Assess Efficacy of an Experimental Oral Rinse in Providing Long Term Relief From Dentinal Hypersensitivity | COMPLETED | PHASE2 | 2017-08-07 | 2017-10-27 | 2017-10-27 |
| NCT03234036 | A Two-part Study to Compare a Tablet and Capsule Formulation of GSK2838232 With and Without Food, and to Assess the Safety and Drug Levels of Repeated Once-daily Doses of GSK2838232 Without Ritonavir | COMPLETED | PHASE1 | 2017-08-02 | 2017-11-10 | 2017-11-10 |
| NCT03261167 | A Phase III Study to Evaluate the Efficacy and Safety of GSK1358820 in Subjects With Post-stroke Upper Limb Spasticity | COMPLETED | PHASE3 | 2017-08-02 | 2019-01-10 | 2018-03-20 |
| NCT03150082 | Bioequivalence Study Between GR37547 500 Milligrams (mg) Tablet Versus Ciprofloxacin 500 mg Tablet Reference Product in Healthy Adult Subjects | COMPLETED | PHASE1 | 2017-08-01 | 2017-08-28 | 2017-08-28 |
| NCT02929498 | Safety, Clinical Activity, Pharmacokinetics (PK) and Pharmacodynamics Study of GSK2879552, Alone or With Azacitidine, in Subjects With High Risk Myelodysplastic Syndromes (MDS) | TERMINATED | PHASE1, PHASE2 | 2017-07-31 | 2018-01-31 | 2018-01-31 |
| NCT03029247 | Anemia Study in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Blood Pressure (ASCEND-BP) | COMPLETED | PHASE2 | 2017-07-27 | 2020-07-09 | 2020-07-09 |
| NCT02542865 | A Study to Investigate the Impact of Fortified Malt Based on Immunity Outcomes in School Children | COMPLETED | NA | 2017-07-24 | 2018-07-06 | 2018-07-06 |
| NCT03223337 | Daprodustat Hepatic Impairment Study | COMPLETED | PHASE1 | 2017-07-24 | 2018-08-20 | 2018-08-20 |
| NCT03150056 | Dose Escalation and Dose Expansion Study of GSK525762 in Combination With Androgen Deprivation Therapy in Participants With Castrate-resistant Prostate Cancer | TERMINATED | PHASE1 | 2017-07-18 | 2021-06-22 | 2020-07-31 |
| NCT03197883 | Assessment of the Cosmetic Benefit of a Skin Cream in Healthy Females With Mild to Advanced Photo-damaged Facial Skin Who Have Undergone a Glycolic Acid Facial Peel Procedure | COMPLETED | NA | 2017-07-17 | 2017-10-31 | 2017-10-31 |
| NCT03235726 | Study of Safety and Drug Levels of CCI15106 Inhalation Powder in Healthy Adults and Adults With Moderate Chronic Obstructive Pulmonary Disease. Study of CCI15106 Levels in People Standing Near the Person Inhaling the Drug | COMPLETED | PHASE1 | 2017-07-13 | 2018-06-19 | 2018-06-19 |
| NCT03191383 | A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the GlaxoSmithKline (GSK) Biologicals' Respiratory Syncytial Virus (RSV) Investigational Vaccine (GSK3003891A) in Healthy Pregnant Women and Infants Born to Vaccinated Mothers | WITHDRAWN | PHASE2 | 2017-07-11 | 2017-07-14 | 2017-07-14 |
| NCT02889809 | Effects of a Orally Inhaled Fluticasone Furoate on Growth Velocity in Prepubertal, Paediatric Subjects With Asthma Over a Year | COMPLETED | PHASE4 | 2017-07-10 | 2021-06-04 | 2021-04-09 |
| NCT03044353 | Multiple Treatment Session Study to Assess GSK2398852 Administered Following and Along With GSK2315698 | TERMINATED | PHASE2 | 2017-07-10 | 2019-01-03 | 2019-01-03 |
| NCT03160703 | Study to Investigate the Stain Control of Two Stannous Fluoride Dentifrices | COMPLETED | NA | 2017-07-10 | 2017-08-25 | 2017-08-25 |
| NCT03201211 | A Long Term Follow-up Study up to 4 Years After Study Vaccination to Assess Immunogenicity and Safety of the Investigational Vaccine in Adults | COMPLETED | PHASE1 | 2017-06-22 | 2020-03-19 | 2020-03-19 |
| NCT03184987 | A Long-term Safety Study of Fixed Dose Combination Therapy Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate in Japanese Subjects With Asthma | COMPLETED | PHASE3 | 2017-06-22 | 2019-06-25 | 2019-06-25 |
| NCT03157583 | A Study to Measure the Sun Protection Factor (SPF) and Ultraviolet-A Protection Factor (UVAPF) of Four Developmental Sunscreen Formulations | COMPLETED | NA | 2017-06-21 | 2017-07-07 | 2017-07-07 |
| NCT03034915 | A 24-week Study to Compare Umeclidinium/Vilanterol (UMEC/VI), UMEC and Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE4 | 2017-06-16 | 2018-06-18 | 2018-06-18 |
| NCT03189589 | Safety, Tolerability and Pharmacokinetics (PK) Study of GSK2269557 in Healthy Subjects | COMPLETED | PHASE1 | 2017-06-15 | 2017-07-24 | 2017-07-24 |
| NCT03069989 | Single Doses of GSK3008348 in Idiopathic Pulmonary Fibrosis (IPF) Participants Using Positron Emission Tomography (PET) Imaging | TERMINATED | PHASE1 | 2017-06-13 | 2018-07-18 | 2018-07-04 |
| NCT03172364 | To Investigate the Cutaneous and Ocular Local Tolerance of Two Cosmetic Facial Cleanser in Healthy Females With Sensitive Skin | COMPLETED | NA | 2017-06-12 | 2017-07-13 | 2017-07-13 |
| NCT03041025 | Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis | COMPLETED | PHASE2 | 2017-06-05 | 2020-07-07 | 2020-07-07 |
| NCT03136107 | Determination of the Sun Protection Factor (SPF) of a Cosmetic Daily De-fence Skin Cream | COMPLETED | NA | 2017-05-30 | 2017-06-30 | 2017-06-30 |
| NCT03085797 | Effect of Mepolizumab in Severe Bilateral Nasal Polyps | COMPLETED | PHASE3 | 2017-05-25 | 2019-12-11 | 2019-12-11 |
| NCT03155269 | To Investigate the Impact of a Nutritional Supplement on Bone Turnover Markers in Indian Healthy Premenopausal Women (25- 45 Years) After 6 Months of Intervention | COMPLETED | NA | 2017-05-25 | 2018-01-16 | 2018-01-16 |
| NCT03162614 | Efficacy, Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Evaluating Different Dose Schedules in a Sporozoite Challenge Model in Healthy Malaria-naïve Adults | COMPLETED | PHASE2 | 2017-05-24 | 2018-09-24 | 2018-07-09 |
| NCT03233009 | To Investigate Primary Irritation Potential of Four Skin Serum Products on Human Subjects Assessed by 24 Hour Patch Test | COMPLETED | NA | 2017-05-22 | 2017-05-26 | 2017-05-26 |
| NCT03000686 | Study of GSK2586881 on Acute Hypoxia and Exercise | TERMINATED | PHASE1 | 2017-05-17 | 2019-01-04 | 2019-01-04 |
| NCT03154086 | A Phase 1, First Time in Human (FTIH) Study to Evaluate GSK3352589, a REarranged During Transfection (RET) Growth Factor Receptor Tyrosine Kinase Inhibitor, in Healthy Volunteers | COMPLETED | PHASE1 | 2017-05-17 | 2018-03-05 | 2018-03-05 |
| NCT03029208 | Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-in Incident Dialysis (ASCEND-ID) | COMPLETED | PHASE3 | 2017-05-11 | 2020-09-24 | 2020-09-24 |
| NCT02699099 | Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine. | COMPLETED | PHASE3 | 2017-05-10 | 2020-10-07 | 2018-03-14 |
| NCT03103906 | Evaluation of the Cosmetic Benefit of a Skin Cream in Healthy Females With Mild to Advanced Photo-damaged Facial Skin Who Have Undergone a Glycolic Acid Facial Peel Procedure | COMPLETED | NA | 2017-05-10 | 2017-07-19 | 2017-07-19 |
| NCT03136380 | Study of Danirixin in Japanese Healthy Elderly Male Subjects | COMPLETED | PHASE1 | 2017-05-10 | 2017-07-31 | 2017-07-31 |
| NCT03119688 | To Assess the Mildness of a Cosmetic Cleanser in Healthy Participants Using the Forearm-Controlled Application Technique (FCAT) | COMPLETED | NA | 2017-05-08 | 2017-05-26 | 2017-05-26 |
| NCT03099096 | Study of Mepolizumab Autoinjector in Asthmatics | COMPLETED | PHASE3 | 2017-05-04 | 2017-11-30 | 2017-11-30 |
| NCT02939846 | Pharmacokinetics of Single and Repeat Oral Doses of Trametinib in Chinese Subjects With Solid Tumours | WITHDRAWN | PHASE1 | 2017-05 | 2018-12 | 2018-08 |
| NCT02447939 | Pharmacokinetics of Repeat Oral Doses of Dabrafenib and the Combination of Dabrafenib and Trametinib in Chinese Subjects With Melanoma | WITHDRAWN | PHASE1 | 2017-05 | 2018-12 | 2018-10 |
| NCT03034967 | Danirixin Dose Ranging Study in Participants With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE2 | 2017-04-25 | 2018-10-05 | 2018-10-05 |
| NCT03093181 | A Study to Evaluate of Cosmetic Benefit of a Moisturising Cream in People With Blemish Prone Skin | COMPLETED | NA | 2017-04-04 | 2017-08-28 | 2017-08-28 |
| NCT03075410 | First Time in Human (FTIH) Safety and Pharmacokinetics (PK) Study of GSK3036656 in Healthy Subjects | COMPLETED | PHASE1 | 2017-04-02 | 2017-08-04 | 2017-08-04 |
| NCT03175562 | To Assess the Cutaneous Irritation and Sensitization Potential of a Cosmetic Facial Product Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Participants | COMPLETED | NA | 2017-03-27 | 2017-05-19 | 2017-05-19 |
| NCT03183518 | To Assess the Photosensitisation and Photoallergy Potential of a Cosmetic Facial Product in Healthy Participants | COMPLETED | NA | 2017-03-27 | 2017-05-19 | 2017-05-19 |
| NCT03055195 | Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic Dermatitis | TERMINATED | PHASE2 | 2017-03-21 | 2017-12-06 | 2017-12-06 |
| NCT03180645 | Proof of Concept Anti-ageing Clinical Study in Healthy Subjects | COMPLETED | NA | 2017-03-20 | 2017-04-21 | 2017-04-21 |
| NCT03031496 | Bioequivalence Study Between GSK3542503 Hydrochlorothiazide + Amiloride Hydrochloride 50 mg: 5 mg Tablets and Reference Product in Healthy Adult Participants Under Fasting Conditions | COMPLETED | PHASE1 | 2017-03-17 | 2017-04-10 | 2017-04-10 |
| NCT03045861 | Safety and Efficacy Study of GSK2838232 in Human Immunodeficiency Virus (HIV)-1 Infected Adults | COMPLETED | PHASE2 | 2017-03-17 | 2018-04-23 | 2018-04-23 |
| NCT03089879 | A Study to Evaluate Safety and Immunogenicity of 1 Booster Dose of 1790GAHB Vaccine in Healthy Adults Primed With 3 Doses of 1790GAHB Vaccine in Study H03_01TP Compared to 1 Vaccination of 1790GAHB in Either Subjects Who Received Placebo in the Same Study or naïve Subjects Not Part of H03_01TP Study | COMPLETED | PHASE1 | 2017-03-16 | 2017-08-31 | 2017-08-31 |
| NCT02836496 | Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES) | COMPLETED | PHASE3 | 2017-03-07 | 2019-08-08 | 2019-08-08 |
| NCT02937870 | A Bite Force Study Comparing Two New Test Adhesives With Currently Marketed Denture Adhesive | COMPLETED | NA | 2017-03-07 | 2017-04-05 | 2017-04-05 |
| NCT02981602 | Safety, Tolerability, Pharmacokinetics and Antiviral Activity of IONIS-HBVRx in Treatment-Naïve Patients With Chronic HBV Infection | COMPLETED | PHASE2 | 2017-02-24 | 2019-12-26 | 2019-12-18 |
| NCT03216265 | A Proof of Concept Clinical Study to Investigate the Effects of an Experimental Cosmetic Moisturiser on the Barrier Function of Human Skin on the Face and Forearm | COMPLETED | NA | 2017-02-23 | 2017-04-24 | 2017-04-19 |
| NCT03020745 | A Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK3389404 in Chronic Hepatitis B (CHB) Subjects | COMPLETED | PHASE2 | 2017-02-14 | 2019-11-06 | 2019-01-28 |
| NCT03004846 | A Study of GSK2981278 Ointment in Subjects With Plaque Psoriasis | COMPLETED | PHASE1, PHASE2 | 2017-02-13 | 2017-05-05 | 2017-05-05 |
| NCT03037307 | A Clinical Bite Force Study of Two Marketed Adhesives Against no Adhesive | COMPLETED | NA | 2017-02-13 | 2017-05-04 | 2017-05-04 |
| NCT02991859 | Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects | COMPLETED | PHASE2 | 2017-02-09 | 2018-12-20 | 2018-12-20 |
| NCT02563496 | A Pharmacokinetics, Safety and Efficacy Study of Tafenoquine (TQ) in Pediatric Subjects With Plasmodium Vivax (P. Vivax) Malaria | COMPLETED | PHASE2 | 2017-02-06 | 2020-02-17 | 2019-12-15 |
| NCT03045887 | Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of GSK2292767 in Healthy Participants Who Smoke Cigarettes | COMPLETED | PHASE1 | 2017-02-06 | 2017-08-16 | 2017-08-11 |
| NCT03021304 | Study of Mepolizumab Safety Syringe in Asthmatics | COMPLETED | PHASE3 | 2017-02-01 | 2017-08-08 | 2017-08-08 |
| NCT02678234 | An Efficacy and Safety Study of Theraflu Day Powder as Oral Solution for Cold and Flu | WITHDRAWN | PHASE3 | 2017-02-01 | 2017-04-01 | 2017-04-01 |
| NCT02730364 | An Efficacy and Safety Study of Theraflu Night Powder as Oral Solution for Cold and Flu | WITHDRAWN | PHASE3 | 2017-02-01 | 2017-04-01 | 2017-04-01 |
| NCT03012061 | Phase IIb Study of Umeclidinium (UMEC) Bromide Versus Placebo in Subjects With Asthma | COMPLETED | PHASE2 | 2017-01-25 | 2018-05-30 | 2018-05-30 |
| NCT03028467 | Evaluation of Pharmacokinetics and Safety of GSK3196165 in Combination With Methotrexate in Japanese Subjects With Rheumatoid Arthritis | COMPLETED | PHASE1, PHASE2 | 2017-01-24 | 2017-12-20 | 2017-12-20 |
| NCT02880852 | Belimumab Phase I Study in Chinese Subjects With Systemic Lupus Erythematosus | COMPLETED | PHASE1 | 2017-01-23 | 2017-09-08 | 2017-09-08 |
| NCT02927431 | Study to Evaluate the Efficacy and Safety of Danirixin Co-administered With Oseltamivir in the Treatment of Adults Hospitalized With Influenza | TERMINATED | PHASE2 | 2017-01-19 | 2017-05-24 | 2017-05-24 |
| NCT02979639 | Study to Evaluate the Impact of Reactogenicity on Quality of Life (QoL), After Administration of GlaxoSmithKline (GSK) Biologicals' Candidate Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 50 Years of Age | COMPLETED | PHASE3 | 2017-01-16 | 2018-05-24 | 2017-04-12 |
| NCT02927457 | Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of GSK2646264 in Cutaneous Lupus Erythematosus Subjects | COMPLETED | PHASE1 | 2017-01-13 | 2018-06-12 | 2018-06-12 |
| NCT02927873 | A Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in RSV-seropositive Infants | COMPLETED | PHASE1, PHASE2 | 2017-01-11 | 2020-11-26 | 2019-02-19 |
| NCT02966834 | Dose Response Study of GSK2330672 for the Treatment of Pruritus in Participants With Primary Biliary Cholangitis | COMPLETED | PHASE2 | 2017-01-11 | 2020-04-15 | 2020-04-15 |
| NCT02798978 | A Phase I, 2-part (Part 1 Being a Single Dose Escalation and Part 2, a Parallel Group) Study of Toll-like Receptor (TLR4) Agonist (GSK1795091) in Healthy Subjects | COMPLETED | PHASE1 | 2017-01-10 | 2017-10-13 | 2017-10-13 |
| NCT03014674 | A Study to Compare the Pharmacokinetics of Mepolizumab as a Liquid Drug in a Safety Syringe or an Autoinjector Versus Lyophilised Drug | COMPLETED | PHASE3 | 2017-01-06 | 2017-08-11 | 2017-08-11 |
| NCT02982187 | A Clinical Study Assessing Critical Errors, Training/Teaching Time, and Preference Attributes of the ELLIPTA® Dry Powder Inhaler, in Comparison to Combinations of Dry Powder Inhalers Used to Provide Triple Therapy, in Patients With Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE4 | 2016-12-30 | 2017-06-19 | 2017-06-19 |
| NCT03005067 | To Evaluate the Efficacy and Safety of 1146A Nasal Spray in Adult Participants With Symptoms of Common Cold | COMPLETED | PHASE2 | 2016-12-29 | 2017-06-07 | 2017-06-07 |
| NCT02965599 | Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK3117391 in Subjects With Rheumatoid Arthritis | TERMINATED | PHASE2 | 2016-12-27 | 2017-11-14 | 2017-11-14 |
| NCT02992691 | Efficacy of Three Experimental Toothpastes to Remove Plaque | COMPLETED | NA | 2016-12-19 | 2017-02-02 | 2017-02-02 |
| NCT02991872 | A Study to Evaluate Persistence of Immune Responses After Post-exposure Prophylaxis of Rabipur® (Purified Chicken-embryo Cell Rabies Vaccine) in Chinese Children | COMPLETED | PHASE4 | 2016-12-16 | 2017-03-12 | 2017-03-12 |
| NCT02986854 | Study to Assess the Safety and Immunogenicity of a Single Dose of GlaxoSmithKline's (GSK) Meningococcal MenACWY-CRM Vaccine (Menveo), Administered to Subjects 15 Through 55 Years of Age, Approximately 4-6 Years After Primary ACWY Vaccination | COMPLETED | PHASE3 | 2016-12-08 | 2017-12-07 | 2017-07-17 |
| NCT02992743 | Letetresgene Autoleucel Engineered T Cells in NY-ESO-1 Positive Participants With Advanced Myxoid/ Round Cell Liposarcoma | COMPLETED | PHASE2 | 2016-12-06 | 2022-03-22 | 2021-11-01 |
| NCT02833974 | Effect of the GSK2245035 on the Allergen-induced Asthmatic Response | COMPLETED | PHASE2 | 2016-12-05 | 2018-05-04 | 2018-02-14 |
| NCT02999100 | Comparison of Inhaled Oxytocin (IH) With Intramuscular (IM) Oxytocin in Pregnant Women and With Intravenous (IV) Oxytocin in Healthy Non-pregnant Women | TERMINATED | PHASE1 | 2016-11-23 | 2019-03-04 | 2019-03-01 |
| NCT02969655 | A Study to Evaluate Efficacy and Safety of Daprodustat Compared to Darbepoetin Alfa in Japanese Hemodialysis (HD)-Dependent Subjects With Anemia Associated With Chronic Kidney Disease (CKD) | COMPLETED | PHASE3 | 2016-11-21 | 2018-07-02 | 2018-07-02 |
| NCT02937623 | To Evaluate the Efficacy of an Experimental Dissolvable Strip in Rapidly Relieving Dentinal Hypersensitivity (DH) | COMPLETED | NA | 2016-11-21 | 2016-12-22 | 2016-12-22 |
| NCT02899377 | A PH I Pilot Imaging Study to Evaluate Molecular Imaging Methods in HVs and pSS Pts | COMPLETED | NA | 2016-11-18 | 2018-07-12 | 2018-07-12 |
| NCT02903966 | GSK2982772 Study in Subjects With Ulcerative Colitis | COMPLETED | PHASE2 | 2016-11-15 | 2019-06-17 | 2019-06-17 |
| NCT02946385 | Study to Assess the Immunological Long-term Persistence of Antibodies (Abs) 2 Years After GlaxoSmithKline (GSK) Meningococcal ABCWY Vaccination in the V102_15 (NCT02212457) and Response to a Booster in Adolescents | COMPLETED | PHASE2 | 2016-11-15 | 2018-02-13 | 2018-02-13 |
| NCT02956837 | A Study to Rank Different Dosages of Antigen of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3003891A), Based on Their Immune Response and Safety, When Administered to Healthy Adult Women | COMPLETED | PHASE2 | 2016-11-10 | 2018-02-05 | 2017-08-30 |
| NCT02924350 | The Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity (DH) | COMPLETED | NA | 2016-11-07 | 2017-03-17 | 2017-03-17 |
| NCT02953808 | Phase 1 Study of GSK2315698 in Healthy Japanese Subjects | COMPLETED | PHASE1 | 2016-11 | 2016-12 | 2016-12 |
| NCT02974114 | Exploratory Study to Investigate Cognition Function and Mobility in Individuals With Pain | TERMINATED | PHASE4 | 2016-10-31 | 2017-02-06 | 2017-02-06 |
| NCT02914184 | Evaluation of Immunogenicity and Safety of Two Formulations of GSK Biologicals' Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks | COMPLETED | PHASE3 | 2016-10-27 | 2018-11-26 | 2018-06-27 |
| NCT02858492 | Safety and Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy of Repeat Doses of GSK2982772 in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) | COMPLETED | PHASE2 | 2016-10-17 | 2018-10-22 | 2018-10-22 |
| NCT02924688 | A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled Asthma | COMPLETED | PHASE3 | 2016-10-13 | 2019-02-22 | 2019-02-22 |
| NCT02849418 | Efficacy and Safety Study of GSK1358820 in Japanese Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity | COMPLETED | PHASE3 | 2016-10-11 | 2018-12-20 | 2018-03-02 |
| NCT02901951 | Long-term Persistence of Immunity to Hepatitis B in Adults Vaccinated With GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine (HBV), Engerix-B | COMPLETED | PHASE4 | 2016-10-11 | 2017-05-01 | 2017-05-01 |
| NCT02923895 | To Investigate the Efficacy of an Occluding Dentifrice in Dentinal Hypersensitivity (DH) | COMPLETED | PHASE4 | 2016-10-11 | 2016-12-16 | 2016-12-16 |
| NCT03478644 | Oral and Dermal Tolerability Clinical Study of an Experimental Denture Wipe | COMPLETED | NA | 2016-10-10 | 2016-10-31 | 2016-10-31 |
| NCT02750930 | Extension to Study 200952 to Evaluate the Long-term Safety, Tolerability and Pharmacodynamics of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus Subjects | TERMINATED | PHASE4 | 2016-10-07 | 2017-03-21 | 2017-03-21 |
| NCT02972905 | Study to Evaluate Safety, Tolerability and Pharmacokinetics of GSK2269557 to Japanese Healthy Subjects | COMPLETED | PHASE1 | 2016-10 | 2016-12 | 2016-12 |
| NCT02925546 | A Phase I Study to Assess the Pharmacokinetics of GSK2798745 Tablets | COMPLETED | PHASE1 | 2016-10 | 2016-12 | 2016-12 |
| NCT02879305 | Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D) | COMPLETED | PHASE3 | 2016-09-28 | 2020-11-09 | 2020-11-09 |
| NCT02876835 | Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND) | COMPLETED | PHASE3 | 2016-09-27 | 2021-04-19 | 2021-04-19 |
| NCT02793154 | An Exploratory Study on the Effects of Repeat Doses of Albiglutide Compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Type 2 Diabetes Mellitus Subjects | TERMINATED | PHASE4 | 2016-09-26 | 2017-03-16 | 2017-03-16 |
| NCT02794519 | A Phase 2a Study to Evaluate the Effects of Sirukumab in Subjects With Severe Poorly Controlled Asthma | WITHDRAWN | PHASE2 | 2016-09-23 | 2016-10-04 | 2016-10-04 |
| NCT02861664 | Assessment of the Efficacy of an Experimental Occlusion Technology Dentifrice in Dentinal Hypersensitivity | COMPLETED | NA | 2016-09-21 | 2016-12-24 | 2016-12-01 |
| NCT02802514 | A Study Comparing the Effect of Albiglutide With Exenatide on Regional Brain Activity Related to Nausea in Healthy Subjects | TERMINATED | PHASE4 | 2016-09-20 | 2017-09-07 | 2017-08-10 |
| NCT02853929 | Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery | COMPLETED | PHASE4 | 2016-09-19 | 2019-03-19 | 2019-03-19 |
| NCT02907216 | Evaluation of Immunogenicity and Safety of the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus (DPT-IPV) Vaccine Squarekids Co-administered With GSK Biologicals' Human Rotavirus (HRV) Vaccine Rotarix (GSK444563) in Healthy Infants | COMPLETED | PHASE4 | 2016-09-16 | 2017-05-29 | 2017-05-29 |
| NCT02858440 | A Study to Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix-IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia | COMPLETED | PHASE3 | 2016-09-13 | 2018-11-13 | 2017-10-24 |
| NCT02837380 | A Phase I Pharmacokinetic Study of Fluticasone Furoate /Umeclidinium Bromide/Vilanterol (100/62.5/25 Microgram [mcg]) After Single and Repeat Dose Administration From a Dry Powder Inhaler in Healthy Chinese Subjects | COMPLETED | PHASE1 | 2016-09 | 2016-11 | 2016-11 |
| NCT03005041 | Consumer Perception of an Experimental Mouthwash After a Single Use in Dry Mouth Subjects | COMPLETED | NA | 2016-08-31 | 2016-10-19 | 2016-10-19 |
| NCT02783300 | An Open-label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK3326595 in Participants With Solid Tumors and Non-Hodgkin's Lymphoma | COMPLETED | PHASE1 | 2016-08-30 | 2023-08-30 | 2023-08-30 |
| NCT02776033 | Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Repeat Doses of GSK2982772 in Subjects With Psoriasis | COMPLETED | PHASE2 | 2016-08-30 | 2018-01-04 | 2018-01-04 |
| NCT02723786 | Efficacy, Safety, Tolerability and Pharmacokinetic (PK) Study of GSK1070806 for the Prevention of Delayed Graft Function (DGF) in Adult Subjects After Renal Transplantation | TERMINATED | PHASE2 | 2016-08-27 | 2018-03-06 | 2017-03-31 |
| NCT02868281 | Asthma Control Test Guided Treatment in Chinese Subjects | COMPLETED | PHASE4 | 2016-08-26 | 2019-08-09 | 2019-08-09 |
| NCT02798952 | A Study to Evaluate Persistence of Hepatitis B Antibodies, Immunogenicity and Safety of Engerix™-B Kinder Challenge Dose, in Adolescents Vaccinated With Four Doses of Infanrix™ Hexa During Infancy | COMPLETED | PHASE4 | 2016-08-23 | 2017-07-05 | 2017-07-05 |
| NCT02829307 | A Positron Emission Tomography (PET) Imaging Study to Investigate the Biodistribution and Clearance of an Albumin Binding Domain Antibody (AlbudAb) GSK3128349 in Healthy Male Subjects | COMPLETED | PHASE1 | 2016-08-23 | 2017-01-27 | 2017-01-27 |
| NCT02794480 | Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use | COMPLETED | PHASE4 | 2016-08-22 | 2016-12-15 | 2016-12-15 |
| NCT02820844 | Efficacy and Safety of GSK1358820 in Subjects With Overactive Bladder | COMPLETED | PHASE3 | 2016-08-10 | 2018-11-12 | 2018-03-06 |
| NCT02829320 | Efficacy and Safety Study of GSK1278863 in Japanese Hemodialysis Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Taking Erythropoiesis Stimulating Agents | COMPLETED | PHASE3 | 2016-08-08 | 2017-10-17 | 2017-05-16 |
| NCT02676895 | A Study of the Safety and Immune Response of 2 Doses of a New Shigella Vaccine in Kenyan Adults | COMPLETED | PHASE2 | 2016-08-08 | 2017-03-10 | 2017-03-10 |
| NCT02853435 | To Assess Bioavailability, Food Effect and Pharmacokinetics of Gepotidacin Tablets: A Phase I, Single-Dose, 2 Part Study in Healthy Subjects. | COMPLETED | PHASE1 | 2016-08-04 | 2017-10-17 | 2017-10-17 |
| NCT02928380 | Evaluation of a Experimental Denture Adhesive to Prevent Food Ingress | COMPLETED | NA | 2016-07-25 | 2016-09-16 | 2016-09-01 |
| NCT02801942 | Immune Profile in Subjects With New Onset Type 1 Diabetes | COMPLETED | NA | 2016-07-25 | 2017-12-21 | 2017-12-21 |
| NCT02593539 | Safety, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Repeat Doses of Inhaled Nemiralisib in Patients With APDS/PASLI | COMPLETED | PHASE2 | 2016-07-22 | 2020-06-04 | 2020-06-04 |
| NCT02766088 | This Study Will Describe the Burden of DENgue Fever Virus (DENV) Illness Among Household Members Aged 6 Months to 50 Years of Selected Communities in Latin America and Southeast Asia | TERMINATED | NA | 2016-07-14 | 2018-12-14 | 2018-12-14 |
| NCT02799784 | An Efficacy Study of Umeclidinium/Vilanterol With Tiotropium/Olodaterol in COPD Patients | COMPLETED | PHASE4 | 2016-07-14 | 2017-04-27 | 2017-04-27 |
| NCT02719743 | A Dose Ranging Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' GSK1557484A Vaccine in Children 6 to Less Than 36 Months of Age | COMPLETED | PHASE2 | 2016-07-07 | 2018-02-13 | 2018-02-13 |
| NCT02768194 | Dentine Tubule Occlusion Assessment in a Modified in Situ Model | COMPLETED | NA | 2016-07-06 | 2016-09-21 | 2016-09-01 |
| NCT02797964 | A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer | COMPLETED | PHASE1, PHASE2 | 2016-07 | 2019-10-28 | 2019-10-28 |
| NCT02797977 | A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer Subjects | COMPLETED | PHASE1, PHASE2 | 2016-07 | 2020-04-08 | 2020-04-08 |
| NCT02794467 | Placebo-controlled Proof of Concept Study of Epelsiban in Women With Adenomyosis | WITHDRAWN | PHASE2 | 2016-07 | 2016-10 | 2016-10 |
| NCT02729038 | Pharmacokinetic Study of Gepotidacin in Subjects With Varying Degrees of Renal Impairment and in Subjects With Normal Renal Function | COMPLETED | PHASE1 | 2016-06-29 | 2017-06-20 | 2017-06-20 |
| NCT02729051 | Comparative Study of Fluticasone Furoate(FF)/Umeclidinium Bromide (UMEC)/ Vilanterol (VI) Closed Therapy Versus FF/VI Plus UMEC Open Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2016-06-29 | 2017-05-23 | 2017-05-23 |
| NCT02723955 | Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1) | COMPLETED | PHASE1 | 2016-06-23 | 2023-07-05 | 2023-07-05 |
| NCT02786927 | Preference Attributes of ELLIPTA Dry Powder Inhaler (DPI) and HANDIHALER DPI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE4 | 2016-06-21 | 2016-10-04 | 2016-10-04 |
| NCT02780661 | Frequency of Denture Cleanser Use and Denture Cleanliness | COMPLETED | NA | 2016-06-20 | 2016-11-15 | 2016-11-15 |
| NCT02799472 | Mechanistic Study of GSK3196165 Plus Methotrexate (MTX) in Subjects With Active Rheumatoid Arthritis | COMPLETED | PHASE2 | 2016-06-15 | 2017-10-30 | 2017-10-30 |
| NCT02751424 | A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Ascending Intravenous Single Dose and Repeat Dose of GSK3342830 | TERMINATED | PHASE1 | 2016-06-13 | 2017-02-02 | 2017-02-02 |
| NCT02832362 | Local Nasal Tolerability and Safety Study of 1146A in Healthy Adult Participants | COMPLETED | PHASE1 | 2016-06-11 | 2016-07-18 | 2016-07-10 |
| NCT02791763 | Phase III Study of GSK1278863 in Japanese Non-dialysis (ND) and Peritoneal Dialysis (PD) Subjects With Renal Anemia | COMPLETED | PHASE3 | 2016-06-06 | 2018-10-26 | 2018-10-26 |
| NCT02570152 | A Cohort Study to Determine the Incidence of Dengue Fever and to Build Capacity for Dengue Vaccine Trials in Dengue-endemic Regions of South Asia | COMPLETED | NA | 2016-06-01 | 2019-06-28 | 2019-06-28 |
| NCT02712359 | This Study Will Evaluate the Persistence of Hepatitis A Antibodies, 8 Years and 10 Years Later, in Children Who Had Received Havrix at Selected Health Centres of Panama | COMPLETED | NA | 2016-06-01 | 2018-08-22 | 2018-08-22 |
| NCT02551627 | A Study to Investigate the Impact of a Multiple Micronutrient (MMN) Beverage Powder on Vaccine Response in School Children | WITHDRAWN | NA | 2016-06-01 | 2017-10-01 | 2017-10-01 |
| NCT02798991 | A Phase I, Randomized, Placebo-controlled, Double Blind, Repeat Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Gastrointestinal Transit Time and Pharmacodynamic Biomarkers of GSK3179106 in Normal Subjects | COMPLETED | PHASE1 | 2016-06 | 2016-11 | 2016-11 |
| NCT02801981 | Dose-escalation Study of GSK2330672 in Japanese Healthy Male Volunteers | COMPLETED | PHASE1 | 2016-06 | 2016-08 | 2016-08 |
| NCT02731846 | A Study Comparing the Closed Triple Therapy, Open Triple Therapy and a Dual Therapy for Effect on Lung Function in Subjects With Chronic Obstructive Pulmonary Disease (COPD) | WITHDRAWN | PHASE3 | 2016-06 | 2016-11 | 2016-11 |
| NCT02730351 | Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB) | COMPLETED | PHASE4 | 2016-05-25 | 2017-02-03 | 2017-02-03 |
| NCT02698553 | A Study to Evaluate Pharmacokinetics, Safety and Tolerability of Extended-release Bupropion Hydrochloride Tablets in Chinese Healthy Volunteers | COMPLETED | PHASE1 | 2016-05-23 | 2016-06-29 | 2016-06-29 |
| NCT02752958 | Impact of Long Term Management of Dentine Hypersensitivity (DH) With a Daily Use Anti-sensitivity Toothpaste on the Quality of Life Related to Oral Health | COMPLETED | NA | 2016-05-23 | 2017-02-03 | 2017-02-01 |
| NCT02839135 | A Comparative Bioavailability and Adhesion Performance Study, Comparing a New Scopolamine Transdermal Delivery System Formulation to the Currently Established Reference Transdermal Delivery System in Healthy Adult Participants. | COMPLETED | PHASE1 | 2016-05-13 | 2016-08-10 | 2016-08-01 |
| NCT02757963 | Benign Prostatic Hyperplasia (BPH) Screening Tool Case Finding Study in Subjects >=50 Years | COMPLETED | PHASE4 | 2016-05-12 | 2017-02-27 | 2017-02-27 |
| NCT02603172 | A Safety Study of GSK3039294 in Healthy Volunteers and Patients With Systemic Amyloidosis | TERMINATED | PHASE1 | 2016-05-12 | 2017-05-10 | 2017-05-10 |
| NCT02184611 | A 24 Week Efficacy Study of Inhaled Umeclidinium (UMEC) in Patients of Chronic Obstructive Pulmonary Disease (COPD) Using a Novel Dry Powder Inhaler (NDPI) | COMPLETED | PHASE3 | 2016-05-09 | 2017-11-08 | 2017-11-08 |
| NCT02706535 | A Cross-over Study to Evaluate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics (PK) of GSK525762 in Healthy Female Subjects of Non Child Bearing Potential | COMPLETED | PHASE1 | 2016-05-05 | 2017-01-06 | 2017-01-06 |
| NCT02751294 | A Study to Assess the Effects of Dissolution Profile on the Pharmacokinetics of Single Oral Doses of Tafenoquine Tablets and Tafenoquine Stable Isotope Labelled Solution | COMPLETED | PHASE1 | 2016-05 | 2016-08 | 2016-08 |
| NCT02705807 | Evaluation of a New Thermostable Formulation of FLOLAN in Japanese Subjects | COMPLETED | PHASE4 | 2016-05 | 2016-07 | 2016-07 |
| NCT02712047 | A Phase IIA FF/VI Study to Measure FeNO in Asthmatic Patients. | COMPLETED | PHASE2 | 2016-04-29 | 2017-02-21 | 2017-02-21 |
| NCT02630251 | Dose Escalation Study of GSK2820151 in Subjects With Advanced or Recurrent Solid Tumors | TERMINATED | PHASE1 | 2016-04-25 | 2018-12-13 | 2018-12-13 |
| NCT02737007 | A Microdose Study in Healthy Subjects to Describe Intravenous Pharmacokinetics of GSK3191607 | COMPLETED | PHASE1 | 2016-04-18 | 2016-05-12 | 2016-05-12 |
| NCT02723773 | A Long-term Follow-up Study (ZOE-LTFU) of Two Studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to Assess the Efficacy, Safety, and Immunogenicity Persistence of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine and Assessment of 1 or 2 Additional Doses in Two Subgroups of Older Adults | COMPLETED | PHASE3 | 2016-04-16 | 2023-06-28 | 2023-06-28 |
| NCT02497937 | A Study to Evaluate the Effect of the Transient Receptor Potential Vanilloid 4 (TRPV4) Channel Blocker, GSK2798745, on Pulmonary Gas Transfer and Respiration in Patients With Congestive Heart Failure | COMPLETED | PHASE2 | 2016-04-13 | 2017-08-21 | 2017-08-21 |
| NCT02735915 | Study to Evaluate Immunogenicity and Safety of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine at 9 and 10 Years After Vaccine Administration and Assessment of Re-vaccination With 2 Additional Doses at 10 Years After Initial Vaccination, in Healthy Subjects Aged 60 Years of Age(YOA) and Older | COMPLETED | PHASE3 | 2016-04-11 | 2018-10-08 | 2017-08-28 |
| NCT02753413 | Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3003891A) in Healthy Women | COMPLETED | PHASE2 | 2016-04-01 | 2016-06-28 | 2016-06-28 |
| NCT02731833 | Short Term Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity | COMPLETED | PHASE4 | 2016-04-01 | 2016-05-20 | 2016-05-01 |
| NCT02690181 | Extension Study to Evaluate the Immunogenicity and Safety of the Second Dose of GBS Trivalent Vaccine in Healthy Non-Pregnant Subjects. | COMPLETED | PHASE2 | 2016-03-29 | 2016-11-02 | 2016-11-02 |
| NCT02688387 | A Phase 1 Relative Bioavailability Study of Ambrisentan and Tadalfil Fixed Dose Combination Tablets in Healthy Subjects | COMPLETED | PHASE1 | 2016-03-18 | 2017-08-04 | 2017-08-04 |
| NCT02683785 | A Study to Investigate the Efficacy and Safety of GSK3196165 in Inflammatory Hand Osteoarthritis | COMPLETED | PHASE2 | 2016-03-17 | 2017-11-29 | 2017-11-29 |
| NCT02654145 | Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma Patients | COMPLETED | PHASE4 | 2016-03-17 | 2017-05-31 | 2017-05-31 |
| NCT02690207 | Cross-vaccination Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK 1437173A) in Subjects Who Previously Received Placebo in ZOSTER-006 (NCT01165177) and ZOSTER-022 (NCT01165229) Studies. | COMPLETED | PHASE3 | 2016-03-16 | 2019-03-15 | 2019-03-15 |
| NCT02683746 | Safety and Efficacy Study of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus | COMPLETED | PHASE3 | 2016-03-16 | 2017-05-15 | 2017-04-03 |
| NCT02742766 | Safety, Tolerability and Preliminary Pharmacokinetics (PK) and Pharmacodynamics (PD) of Single and Repeat Oral Doses of GSK3008356 in Healthy and Obese Subjects | COMPLETED | PHASE1 | 2016-03-14 | 2017-06-16 | 2017-06-16 |
| NCT02691325 | Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK2269557 Administered Via the ELLIPTA Dry Powder Inhaler to Healthy Subjects | COMPLETED | PHASE1 | 2016-03-14 | 2016-06-05 | 2016-06-05 |
| NCT02860169 | Motivation, Brain Function and Mood in Individuals With Cold and/or Flu | TERMINATED | NA | 2016-03-11 | 2016-11-24 | 2016-11-24 |
| NCT02688374 | A Bioequivalence Study of Three, 2 mg Nicotine Chewing Gums (Two Tests and One Reference) in Healthy Adult Smokers | COMPLETED | PHASE1 | 2016-03-11 | 2016-06-12 | 2016-06-12 |
| NCT02641912 | Potential of an Experimental Mouthwash Formulation to Reduce Dry Mouth Symptoms | COMPLETED | NA | 2016-03-09 | 2016-04-15 | 2016-04-15 |
| NCT02673619 | A Study to Evaluate Clinical Effect, Pharmacokinetics , Safety, and Tolerability of Umeclidinium in Palmar Hyperhidrosis Subjects | COMPLETED | PHASE2 | 2016-03-07 | 2016-12-08 | 2016-12-08 |
| NCT02639351 | Safety and Immunogenicity of an Aluminium Hydroxide/LHD153R Adjuvanted Meningococcal C-CRM197 Conjugate Vaccine | COMPLETED | PHASE1 | 2016-03-01 | 2017-08-31 | 2017-08-31 |
| NCT02400320 | Local Skin Safety Study of a Topical Pain Relief Spray Containing a Combination of Diclofenac, Methyl Salicylate, and Menthol | WITHDRAWN | PHASE4 | 2016-03-01 | 2016-06-30 | 2016-06-01 |
| NCT02832375 | Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity | COMPLETED | PHASE3 | 2016-03-01 | 2016-05-12 | 2016-05-01 |
| NCT02705716 | Study Investigating Efficacy of an Occluding Dentifrice for Dentine Hypersensitivity | COMPLETED | NA | 2016-03-01 | 2016-05-20 | 2016-05-20 |
| NCT02795754 | Single and Repeated Dose Escalation Study of GSK2838232 | COMPLETED | PHASE1 | 2016-03 | 2016-12 | 2016-12 |
| NCT02177734 | Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3277510A and GSK3277509A in Adults 18 to 60 Years of Age | WITHDRAWN | PHASE1 | 2016-03 | 2017-05 | 2016-06 |
| NCT02377466 | A Phase III Efficacy and Safety Study of Intravenous Retosiban Versus Placebo for Women in Spontaneous Preterm Labor | TERMINATED | PHASE3 | 2016-02-29 | 2017-07-24 | 2017-07-24 |
| NCT02688361 | A Bioequivalence Study of an Acetylcysteine 2% Oral Solution Versus a Reference Fluimucil 2% Oral Solution | COMPLETED | PHASE1 | 2016-02-22 | 2016-04-13 | 2016-04-13 |
| NCT02631538 | Safety and Efficacy Study of Subcutaneous Belimumab and Intravenous Rituximab Co-administration in Subjects With Primary Sjogren's Syndrome | COMPLETED | PHASE2 | 2016-02-17 | 2020-06-23 | 2020-06-23 |
| NCT02689206 | Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Three-times Weekly Dosing of GSK1278863 in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease Who Are Switched From a Stable Dose of an Erythropoiesis-stimulating Agent | COMPLETED | PHASE2 | 2016-02-17 | 2017-01-25 | 2017-01-25 |
| NCT03243760 | Dose Escalating Study of CCI15106 Inhalation Capsules in Healthy Subjects and Moderate Chronic Obstructive Pulmonary Disease (COPD) Patients | TERMINATED | PHASE1 | 2016-02-10 | 2016-08-20 | 2016-07-20 |
| NCT02658435 | Assessment of Any Potential Retinal Effects of Tafenoquine (TQ) | COMPLETED | PHASE1 | 2016-02-02 | 2017-09-14 | 2017-09-14 |
| NCT02588612 | Letetresgene Autoleucel Engineered T Cells in NY-ESO -1 Positive Advanced Non-Small Cell Lung Cancer (NSCLC) | COMPLETED | PHASE1 | 2016-02-01 | 2020-08-10 | 2020-08-10 |
| NCT02751320 | Efficacy of Three Toothpastes Using an in Situ Caries Model | COMPLETED | NA | 2016-02-01 | 2016-08-11 | 2016-07-01 |
| NCT02751450 | The Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity(DH) | COMPLETED | NA | 2016-02-01 | 2016-06-17 | 2016-05-01 |
| NCT02660736 | Bioequivalence Study of Two Albiglutide Drug Products in Healthy Adult Subjects | COMPLETED | PHASE1 | 2016-02 | 2016-08 | 2016-08 |
| NCT02822287 | Warming Sensation and Tolerability Study of Acetylcysteine 2% Oral Solution for Productive Cough | COMPLETED | PHASE3 | 2016-02 | 2016-03 | 2016-03 |
| NCT02292732 | A Pharmacokinetics (PK) and Safety Study to Determine the Effect of Repeat Dosing of Trametinib on Combined Oral Contraceptive (Norethindrone Plus Ethinyl Estradiol) in Female Subjects With Solid Tumors | WITHDRAWN | PHASE1 | 2016-02 | 2017-05 | 2017-05 |
| NCT02515630 | Momelotinib in Transfusion-Dependent Adults With Primary Myelofibrosis (PMF) or Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis (Post-PV/ET MF) | COMPLETED | PHASE2 | 2016-01-29 | 2017-08-15 | 2017-07-18 |
| NCT02666287 | GSK961081 Alone and With Fluticasone Furoate (FF), Phase 1 (Ph1), Single Dose Regimen (SD), Repeat Dose Regimen (RD), Pharmacokinetic (PK) Study in Healthy Volunteer (HV) | COMPLETED | PHASE1 | 2016-01-27 | 2016-06-03 | 2016-06-03 |
| NCT02422264 | Immunogenicity and Safety Study of Infanrix Hexa in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery | COMPLETED | PHASE4 | 2016-01-22 | 2018-03-07 | 2018-03-07 |
| NCT02555371 | Cessation Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma Patients | COMPLETED | PHASE3 | 2016-01-07 | 2019-07-24 | 2019-07-24 |
| NCT02651467 | A Study to Investigate Efficacy of Two Experimental Oral Rinses in Providing Long Term Relief From Pain Derived From Exposed Dentine in Response to Chemical, Thermal, Tactile, or Osmotic Stimuli. | COMPLETED | NA | 2016-01-04 | 2016-04-22 | 2016-04-01 |
| NCT02773758 | Study to Investigate the Efficacy of an Occluding Dentifrice in Providing Relief From Dentine Hypersensitivity | COMPLETED | PHASE4 | 2016-01-01 | 2016-03-11 | 2016-03-11 |
| NCT03083509 | A Physiological Profile of Recovery From Resistance, Endurance, and Mixed Exercise Types | COMPLETED | NA | 2016-01-01 | 2016-07-29 | 2016-07-29 |
| NCT02613910 | Long-Term Extension Study of Ofatumumab in Subjects With Pemphigus Vulgaris | TERMINATED | PHASE3 | 2015-12-23 | 2016-03-23 | 2016-03-23 |
| NCT02647281 | First Time in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of GSK3389404 in Healthy Subjects | COMPLETED | PHASE1 | 2015-12-17 | 2017-01-03 | 2017-01-03 |
| NCT02581410 | Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 65 Years of Age With and Without Zostavax® Vaccination at Least 5 Years Earlier | COMPLETED | PHASE3 | 2015-12-15 | 2017-08-01 | 2016-08-30 |
| NCT02612051 | First Time in Human (FTIH) Study of GSK3008348 in Healthy Volunteers and Idiopathic Pulmonary Fibrosis Patients | COMPLETED | PHASE1 | 2015-12-04 | 2016-06-02 | 2016-06-02 |
| NCT02573870 | Batefenterol/Fluticasone Furoate in Treatment of Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE2 | 2015-12-01 | 2016-07-05 | 2016-07-05 |
| NCT02564055 | A Dose-Finding Study of GSK2894512 Cream in Subjects With Atopic Dermatitis (AD) | COMPLETED | PHASE2 | 2015-12-01 | 2017-01-12 | 2017-01-01 |
| NCT02141230 | Risk Management Plan (RMP) Survey for Purchasers of Alli® (60 mg Orlistat) in the European Union. | WITHDRAWN | NA | 2015-12 | 2016-02 | 2016-02 |
| NCT02436473 | Clinical Efficacy of Fluoride Toothpastes Using an In Situ Caries Model | WITHDRAWN | NA | 2015-12 | 2016-11 | 2016-11 |
| NCT02727283 | A Phase 1, Randomized, Placebo-Controlled, Ascending Cohort, Dose Escalation Study in Normal Healthy Volunteers | COMPLETED | PHASE1 | 2015-11-26 | 2016-03-18 | 2016-03-18 |
| NCT02563899 | Pharmacokinetic, Safety, Tolerability, and Clinical Effect of Topical Umeclidinium in Primary Axillary Hyperhidrosis | COMPLETED | PHASE2 | 2015-11-23 | 2016-02-25 | 2016-02-25 |
| NCT02564042 | A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis | COMPLETED | PHASE2 | 2015-11-23 | 2016-10-05 | 2016-10-01 |
| NCT02551653 | Positron Emission Tomography (PET) Study to Evaluate Biodistribution of [11C]-GSK2256098 in Healthy Subjects and Idiopathic Pulmonary Arterial Hypertension (PAH) Patients | COMPLETED | PHASE1 | 2015-11-17 | 2017-03-14 | 2017-03-14 |
| NCT02446743 | Combined Study - Phase 3b MenB Long Term Persistence in Adolescents | COMPLETED | PHASE3 | 2015-11-17 | 2016-09-23 | 2016-09-23 |
| NCT02570126 | A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age. | COMPLETED | PHASE3 | 2015-11-13 | 2016-10-25 | 2016-10-25 |
| NCT02548078 | A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Children | COMPLETED | PHASE2 | 2015-11-09 | 2017-05-15 | 2017-05-15 |
| NCT02856880 | A Study to Investigate the Antimicrobial Activity of 2 Test Toothpastes | COMPLETED | NA | 2015-11-09 | 2015-12-11 | 2015-12-01 |
| NCT02570165 | Dose-Finding Study of Batefenterol (GSK961081) Via Dry Powder Inhaler in Patients With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE2 | 2015-11-06 | 2016-07-06 | 2016-07-06 |
| NCT02522299 | A Study to Evaluate the Safety, Efficacy and Changes in Induced Sputum and Blood Biomarkers Following Daily Repeat Doses of Inhaled GSK2269557 in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Acute Exacerbation | COMPLETED | PHASE2 | 2015-11-04 | 2018-06-22 | 2018-06-15 |
| NCT02612064 | The Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity | COMPLETED | NA | 2015-11-01 | 2016-06-03 | 2016-06-03 |
| NCT02750943 | Potential of Stannous Fluoride Toothpaste to Reduce Gum Disease | COMPLETED | NA | 2015-11-01 | 2016-03-04 | 2016-03-01 |
| NCT02637206 | Skin Irritation Study of GSK2894512 Cream | COMPLETED | PHASE1 | 2015-10-27 | 2015-12-02 | 2015-12-02 |
| NCT02548052 | Study of Safety and Efficacy of Topical GSK2981278 Ointment in Plaque Psoriasis | COMPLETED | PHASE1 | 2015-10-22 | 2016-02-19 | 2016-02-19 |
| NCT02531633 | Efficacy and Safety Study of Sirukumab in Patients With Giant Cell Arteritis | TERMINATED | PHASE3 | 2015-10-16 | 2018-03-21 | 2018-03-21 |
| NCT02377349 | Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Pregnant Women | COMPLETED | PHASE4 | 2015-10-14 | 2017-10-24 | 2017-08-14 |
| NCT02483975 | Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma | COMPLETED | PHASE3 | 2015-10-09 | 2016-06-21 | 2016-06-20 |
| NCT02557399 | DUAC® Early Onset Efficacy Study in Japanese Subjects | COMPLETED | PHASE4 | 2015-10-07 | 2016-02-17 | 2015-12-17 |
| NCT02545517 | A Phase 3 Clinical Trial to Evaluate Long-term Immunogenicity and Boostability of Purified Chick-Embryo Cell Rabies Vaccine in Adults Following Primary Series of Pre/Exposure Prophylaxis. | COMPLETED | PHASE3 | 2015-10-05 | 2022-12-23 | 2022-12-23 |
| NCT02567708 | A Study to Investigate the Efficacy, Safety, and Tolerability of Repeat Doses of Inhaled GSK2269557 in Adults With Persistent, Uncontrolled Asthma | COMPLETED | PHASE2 | 2015-10-01 | 2016-09-28 | 2016-09-21 |
| NCT02586506 | Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma | COMPLETED | PHASE4 | 2015-10-01 | 2016-02-04 | 2016-02-04 |
| NCT02586493 | Ease of Use and Correct Use Study of Placebo ELLIPTA® Inhaler in COPD Subjects | COMPLETED | PHASE4 | 2015-10-01 | 2016-03-15 | 2016-03-01 |
| NCT02533466 | In Vivo Investigation of Initial Stages of Enamel Erosion | COMPLETED | NA | 2015-10-01 | 2015-11-06 | 2015-11-06 |
| NCT02380313 | Dose-Finding Study of Afuresertib Administered in Combination With Either Enzalutamide or Aibraterone | WITHDRAWN | PHASE1 | 2015-10 | 2017-05 | 2017-05 |
| NCT02424539 | A Study to Compare the Efficacy and Safety of Fluticasone Furoate Nasal Sprays (FFNS) 55 Microgram (mcg) and 110 mcg in Chinese Pediatric Subjects With Allergic Rhinitis (AR) | COMPLETED | PHASE4 | 2015-09-30 | 2017-10-25 | 2017-10-25 |
| NCT02619357 | Method Validation Study to Explore the Sensitivity of SenseWear Armband Gecko for Measuring Physical Activity in Subjects With Chronic Obstructive Pulmonary Disease (COPD) & Asthma | COMPLETED | PHASE1 | 2015-09-21 | 2016-03-16 | 2016-03-16 |
| NCT02542813 | Safety, Tolerability and Pharmacokinetics (PK) Study of Oxytocin (GR121619) Administered Via an Inhaled Route in Healthy Female Volunteers | COMPLETED | PHASE1 | 2015-09-14 | 2015-12-16 | 2015-12-16 |
| NCT02528357 | GSK3174998 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors (ENGAGE-1) | COMPLETED | PHASE1 | 2015-09-11 | 2020-04-29 | 2020-04-29 |
| NCT02578953 | Bioequivalence Study of Dutasteride Capsules in Healthy Japanese Male Subjects | COMPLETED | PHASE1 | 2015-09-09 | 2015-12-15 | 2015-12-15 |
| NCT02753075 | A Study in Dentinal Hypersensitivity (DH) Participants to Assess the Efficacy of an Occluding Dentifrice. | COMPLETED | NA | 2015-09-08 | 2015-12-18 | 2015-12-01 |
| NCT02502734 | Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma | COMPLETED | PHASE3 | 2015-09-07 | 2015-12-21 | 2015-12-21 |
| NCT02513654 | Pharmacokinetics, Safety and Tolerability of Repeat Dosing Lamotrigine in Healthy Chinese Subjects | COMPLETED | PHASE1 | 2015-09-06 | 2015-11-11 | 2015-11-11 |
| NCT02502812 | Bioequivalence Study of Clopidogrel 75 mg in Two Tablet Formulations Relative to Reference Tablet in Healthy Subjects | COMPLETED | PHASE1 | 2015-09-04 | 2015-09-24 | 2015-09-24 |
| NCT02567773 | Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic Study of GSK2881078 and Study to Evaluate the Effect of CYP3A4 Inhibition on PK of GSK2881078 | COMPLETED | PHASE1 | 2015-09 | 2016-12 | 2016-12 |
| NCT02542943 | Efficacy of Two Experimental Oral Rinses in Providing Long Term Relief From Dentinal Hypersensitivity | COMPLETED | NA | 2015-09 | 2015-12 | 2015-12 |
| NCT02548156 | Intra Oral Kinetics of Fluoride Containing Dentifrices | COMPLETED | NA | 2015-09 | 2015-10 | 2015-10 |
| NCT02547974 | A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the Investigational GSK Biologicals' GSK3277511A Vaccine in Adults. | COMPLETED | PHASE1 | 2015-08-31 | 2017-03-31 | 2017-03-31 |
| NCT02377427 | Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Subcutaneously in Children | COMPLETED | PHASE2 | 2015-08-25 | 2018-01-31 | 2016-12-07 |
| NCT02658422 | Bioequivalence of GW483100 10 Milligram (mg) Tablets in Healthy Subjects Under Fasting Conditions | COMPLETED | PHASE1 | 2015-08-18 | 2015-09-21 | 2015-09-21 |
| NCT02350426 | A Study to Assess Inflammation in Rheumatoid Arthritis Using Molecular Imaging Techniques | TERMINATED | PHASE1 | 2015-08-12 | 2016-10-26 | 2016-10-26 |
| NCT02378038 | PNT2258 for Treatment of Patients With Richter's Transformation (Brighton) | TERMINATED | PHASE2 | 2015-08 | 2016-06 | 2016-06 |
| NCT02504775 | Bioequivalence Study for Mejoral 500 Product | COMPLETED | NA | 2015-08-01 | 2015-08-19 | 2015-08-01 |
| NCT02229240 | Albiglutide Versus Placebo Added-on to Basal-Bolus Insulin Therapy in Subjects With Type 2 Diabetes Mellitus | WITHDRAWN | PHASE3 | 2015-08 | 2015-12 | 2015-12 |
| NCT02509104 | Bioavailability Study of Fixed Dose Combination (FDC) Dutasteride and Tamsulosin Hydrochloride (HCl) Relative to One Dutasteride and One Tamsulosin HCl Tablet in Healthy Male Subjects | COMPLETED | PHASE1 | 2015-07-30 | 2015-10-10 | 2015-10-10 |
| NCT02504671 | Study to Evaluate the Efficacy and Safety of GSK3196165 Plus Methotrexate in Subjects With Active Moderate-Severe Rheumatoid Arthritis | COMPLETED | PHASE2 | 2015-07-23 | 2017-12-29 | 2017-12-22 |
| NCT02491463 | A Study to Assess the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' RSV Investigational Vaccine (ChAd155-RSV) (GSK3389245A) in Healthy Adults | COMPLETED | PHASE1 | 2015-07-23 | 2017-01-26 | 2016-04-08 |
| NCT02485301 | A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Adults | COMPLETED | PHASE2 | 2015-07-15 | 2016-12-23 | 2016-12-23 |
| NCT02446691 | Evaluation of Antibody Persistence Following 4 MenACWY Vaccinations | COMPLETED | PHASE4 | 2015-07-13 | 2017-12-28 | 2017-12-28 |
| NCT02703181 | Dose Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Epelsiban Administered in Repeat Doses in Healthy Women Volunteers | COMPLETED | PHASE1 | 2015-07-09 | 2015-09-10 | 2015-09-10 |
| NCT02446418 | A Study to Compare the Efficacy of Fluticasone Furoate/Vilanterol Inhalation Powder With Usual Inhaled Corticosteroids (ICS)/Long Acting Beta Agonists (LABA) in Persistent Asthma | COMPLETED | PHASE3 | 2015-07-09 | 2017-07-20 | 2017-07-20 |
| NCT02411162 | A Single Dose Phase I Exploratory Study in Healthy Volunteers With GSK2894512 Cream | COMPLETED | PHASE1 | 2015-07-07 | 2015-09-24 | 2015-09-24 |
| NCT02465515 | Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus | COMPLETED | PHASE4 | 2015-07-01 | 2018-03-14 | 2018-02-20 |
| NCT02451514 | A Study to Evaluate 4-year Antibody Persistence and Booster Response Following MenABCWY Vaccination in Healthy Adolescents and Young Adults Who Previously Participated in Studies V102_02 (NCT01210885) and V102_02E1 (NCT01367158) | COMPLETED | PHASE2 | 2015-06-30 | 2015-12-10 | 2015-11-14 |
| NCT02447952 | Exploratory Study of Biotelemetry in Amyotrophic Lateral Sclerosis | COMPLETED | NA | 2015-06-30 | 2017-06-01 | 2017-06-01 |
| NCT02446613 | Follow-up Study to Investigate the Effect of GSK2245035 on Nasal Allergic Reactivity in Subjects Completing Treatment in Study TL7116958 | COMPLETED | PHASE2 | 2015-06-22 | 2015-08-10 | 2015-08-10 |
| NCT02416180 | Study to Evaluate Handling Errors in Usage of SERETIDE® Metered Dose Inhaler (MDI) (EVOHALER®) by Adult Subjects Currently Using the SERETIDE DISKUS® Inhaler | COMPLETED | PHASE4 | 2015-06-18 | 2015-08-20 | 2015-08-20 |
| NCT02447432 | A Study to Compare the Immunogenicity of GSK Biologicals' 10Pn-PD-DiT 4-dose Presentation to the Licensed 1-dose Synflorix™ (10Pn-PD-DiT) Vaccine When Co-administered With DTPw-combination Vaccine in Healthy Infants | COMPLETED | PHASE3 | 2015-06-11 | 2016-05-22 | 2016-01-23 |
| NCT02496221 | A Study Evaluating the Effect of Albiglutide on Gallbladder Emptying in Healthy Subjects | COMPLETED | PHASE4 | 2015-06-11 | 2015-10-13 | 2015-10-13 |
| NCT02292784 | Follow up Study to Assess Long Term Safety and Outcomes in Infants and Children Born to Mothers Participating in Retosiban Treatment Studies | COMPLETED | PHASE3 | 2015-06-01 | 2019-09-02 | 2019-09-02 |
| NCT02469298 | Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza | COMPLETED | PHASE2 | 2015-06-01 | 2016-04-25 | 2016-04-25 |
| NCT02367651 | Study of Pazopanib Versus Placebo as Maintenance Therapy for Advanced Soft Tissue Sarcoma | WITHDRAWN | PHASE2 | 2015-06 | 2018-05 | 2018-05 |
| NCT02458599 | Efficacy Study of Protein Supplementation in Attenuating the Decline in Performance After Strenuous Concurrent Exercise | COMPLETED | NA | 2015-06 | 2016-02 | 2016-02 |
| NCT02792595 | In Vivo Sun Protection Factor Determination | COMPLETED | NA | 2015-06 | 2015-07 | 2015-07 |
| NCT02466152 | Pharmacokinetic Study of Topical GSK2894512 Cream | COMPLETED | PHASE1 | 2015-05-28 | 2015-10-27 | 2015-10-27 |
| NCT02428699 | Study Comparing Blood Levels of Fatty Acids After Consuming Two Forms of Cod Liver Oil | COMPLETED | NA | 2015-05-20 | 2015-07-15 | 2015-07-15 |
| NCT02453022 | A 5-Period, Single Dose, Phase 1 Study in Healthy Elderly Subjects to Assess Relative Bioavailability and Food Effect of Two Oral Formulations of GSK1325756 (Free Base vs HBr Salt) and Food Effect on the HBr Formulation When Given With Omeprazole | COMPLETED | PHASE1 | 2015-05-18 | 2015-07-31 | 2015-07-31 |
| NCT02428127 | Efficacy of a Carbohydrate Drink on Speed, Agility and Power in School Going Children | COMPLETED | NA | 2015-05-01 | 2015-05-30 | 2015-05-01 |
| NCT02424565 | Effect of Topical Application of Iodex® Balm on Local Surface Temperature | COMPLETED | PHASE4 | 2015-05 | 2015-06 | 2015-05 |
| NCT02124785 | Evaluation of the Long-term Persistence of Hepatitis A Antibodies in Healthy Adults Who Were Vaccinated 21-25 Years Earlier With GlaxoSmithKline (GSK) Biologicals' Hepatitis A Vaccine, Havrix® | WITHDRAWN | PHASE4 | 2015-05 | 2019-07 | 2019-07 |
| NCT02135666 | Evaluation of the Long-term Hepatitis A and B Antibody Persistence in Healthy Adult Subjects, Primed 16 to 20 Years Earlier With GSK Biologicals' Combined Hepatitis A and B Vaccine, Twinrix® (SB208127) in Study HAB-084 (208127/084) | WITHDRAWN | PHASE4 | 2015-05 | 2019-10 | 2019-10 |
| NCT02216123 | Study to Assess the Incidence of Hemolysis, Safety, and Efficacy of Tafenoquine (SB-252263, WR238605) Versus Primaquine in Subjects With Plasmodium Vivax Malaria | COMPLETED | PHASE3 | 2015-04-30 | 2016-11-04 | 2016-11-04 |
| NCT02369341 | Immunogenicity and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Split Virion Influenza Vaccine Fluarix Tetra (2015 Season Southern Hemisphere) in Adults 18 Years of Age and Above | COMPLETED | PHASE3 | 2015-04-29 | 2015-06-03 | 2015-06-03 |
| NCT02221037 | Study of GSK2862277 in Subjects Undergoing Oesophagectomy Surgery | TERMINATED | PHASE2 | 2015-04-28 | 2017-06-28 | 2017-06-28 |
| NCT02377401 | Pharmacokinetics of Zanamivir After Single and Repeated Dose Infusion Administration in Healthy Chinese Adults | COMPLETED | PHASE1 | 2015-04-28 | 2015-06-19 | 2015-06-19 |
| NCT02386436 | A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of GSK2330811 in Healthy Subjects | COMPLETED | PHASE1 | 2015-04-21 | 2016-04-11 | 2016-04-11 |
| NCT02294682 | A Dose-Ranging Study Evaluating the Efficacy, Safety, and Tolerability of GSK2140944 in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria Gonorrhoeae | COMPLETED | PHASE2 | 2015-04-15 | 2016-07-27 | 2016-07-01 |
| NCT03298061 | Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921 | COMPLETED | PHASE3 | 2015-04-14 | 2023-02-16 | 2023-02-16 |
| NCT02399163 | Evaluation of Oral Hygiene Products in an In Situ Caries Model | COMPLETED | NA | 2015-04 | 2015-08 | 2015-07 |
| NCT02294734 | An Efficacy Study of GSK2269557 Added to Standard Care in Subjects With an Acute Exacerbation of Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE2 | 2015-03-31 | 2016-04-25 | 2016-02-19 |
| NCT02397915 | Patient Preference Study of Fluticasone Furoate and Mometasone Furoate Nasal Sprays | COMPLETED | PHASE4 | 2015-03-26 | 2015-06-08 | 2015-06-08 |
| NCT02224456 | Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis | COMPLETED | PHASE4 | 2015-03-25 | 2020-12-04 | 2020-12-04 |
| NCT02360475 | Safety, Reactogenicity and Immunogenicity Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals' Investigational RSV Vaccine (GSK3003891A), in Healthy Women | COMPLETED | PHASE2 | 2015-03-20 | 2016-06-21 | 2015-07-02 |
| NCT02345174 | Immuno Positron Emission Tomography Study of GSK2849330 in Subjects With Human Epidermal Growth Factor Receptor 3-Positive Solid Tumors | COMPLETED | PHASE1 | 2015-03-19 | 2016-06-02 | 2016-06-02 |
| NCT02195518 | Tenofovir Disoproxil Fumarate (TDF) 300mg 3 Years RD Therapy Chinese Chronic Hepatitis B (CHN) CHB Multiple Nucleos(t)Ide Analogues (NAs) Failure Points Pts PH4 PMS Study | COMPLETED | PHASE4 | 2015-03-18 | 2018-08-14 | 2018-08-14 |
| NCT02551614 | Neutrophil Imaging in Healthy Subjects Following Lipopolysaccharide or Saline Challenge and in Subjects With Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE1 | 2015-03-17 | 2016-05-24 | 2016-05-24 |
| NCT02292771 | A Randomized Study Comparing the Efficacy and Safety of Retosiban Versus Atosiban for Women in Spontaneous Preterm Labour | TERMINATED | PHASE3 | 2015-03-16 | 2017-08-25 | 2017-08-25 |
| NCT02258607 | Efficacy and Safety of Momelotinib Combined With Trametinib in Adults With Metastatic KRAS-mutated Non-Small Cell Lung Cancer (NSCLC) Who Have Failed Platinum-Based Chemotherapy Preceded by a Dose-finding Lead-in Phase | TERMINATED | PHASE1 | 2015-03-11 | 2017-02-27 | 2016-07-19 |
| NCT02377414 | Study to Investigate the Pharmacokinetics (PK), Safety and Tolerability of Retosiban in Healthy Japanese Women | COMPLETED | PHASE1 | 2015-03-02 | 2015-04-17 | 2015-04-17 |
| NCT02301975 | An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol 100/25 Microgram (mcg) Inhalation Powder, Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Fluticasone Propionate 250 mcg Inhalation Powder in Adults and Adolescents With Persistent Asthma | COMPLETED | PHASE3 | 2015-03-01 | 2016-11-25 | 2016-11-01 |
| NCT02403999 | A Tolerability Assessment Study of Three Wash Products in Infants | COMPLETED | NA | 2015-03-01 | 2015-04-27 | 2015-04-27 |
| NCT02204371 | Evaluation of Pazopanib on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia | TERMINATED | PHASE2 | 2015-02-25 | 2016-02-10 | 2016-02-10 |
| NCT02322671 | Relative Bioavailability Study of Two Montelukast Sodium (GW483100) 5 Milligrams (mg) Chewable Tablets and One Reference Montelukast Sodium 5 mg Chewable Tablet in Healthy Adult Subjects | COMPLETED | PHASE1 | 2015-02-23 | 2015-04-20 | 2015-04-20 |
| NCT02082665 | Effects of Dabrafenib on the Single Dose Pharmacokinetics (PK) of Rosuvastatin and Midazolam | COMPLETED | PHASE1 | 2015-02-19 | 2016-08-01 | 2016-07-01 |
| NCT02371603 | Drug-drug Interaction Study of GSK1278863 With Pioglitazone, Rosuvastatin and Trimethoprim in Healthy Adult Volunteers | COMPLETED | PHASE1 | 2015-02-11 | 2015-08-12 | 2015-08-12 |
| NCT02191397 | Study to Evaluate the Efficacy, Safety and Tolerability of Bupropion Hydrochloride Extended-release Tablet, and Escitalopram Oxalate Capsule in Subjects With Major Depressive Disorder | COMPLETED | PHASE3 | 2015-02-10 | 2016-10-25 | 2016-10-10 |
| NCT02319668 | Antimicrobial Agent for Reducing Bacteria in Aerosols and Oral Cavity | COMPLETED | PHASE4 | 2015-02-01 | 2016-02-29 | 2015-06-01 |
| NCT02082639 | Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus Vaccine (Cervarix™) When Co-administered With GSK Biologicals' Hepatitis A Vaccine (Havrix®) in Healthy Female Adolescents Aged 9-14 Years | WITHDRAWN | PHASE3 | 2015-02 | 2015-11 | 2015-08 |
| NCT02275052 | A Study to Evaluate the Effect of the Combination of Umeclidinium (UMEC) and Vilanterol (VI) on Exercise Endurance Time (EET) in Participants With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE4 | 2015-01-23 | 2016-06-02 | 2016-06-02 |
| NCT02345161 | A Comparison Study Between the Fixed Dose Triple Combination of Fluticasone Furoate/ Umeclidinium/ Vilanterol Trifenatate (FF/UMEC/VI) With Budesonide/Formoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2015-01-23 | 2016-04-07 | 2016-04-01 |
| NCT02231190 | GSK1278863 Effects on Eccentric Exercise-Induced Muscle Damage | COMPLETED | PHASE1 | 2015-01-15 | 2015-06-12 | 2015-06-12 |
| NCT02262689 | To Evaluate Effects of GSK2256294 on Pulmonary Artery Pressure in Healthy Volunteers Under Normoxic and Hypoxic Conditions | COMPLETED | PHASE1 | 2015-01-08 | 2015-04-24 | 2015-04-24 |
| NCT02302404 | A Safety and Tolerability Study of GSK2982772, in Single (in Both Fed and Fasted States) and Repeat Oral Doses in Healthy Male Subjects | COMPLETED | PHASE1 | 2015-01-06 | 2016-03-05 | 2016-03-05 |
| NCT02302417 | Study Assessing Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE2 | 2015-01-01 | 2015-05-28 | 2015-05-01 |
| NCT02311881 | A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis | COMPLETED | PHASE3 | 2015-01 | 2016-02 | 2016-02 |
| NCT02246166 | The Effect of Paracetamol, Pseudoephedrine Hydrochloride, Dextromethorphan Hydrobromide and Chlorpheniramine Maleate Tablets Compared to Placebo in Subjects Suffering From the Common Cold or Influenza. | COMPLETED | PHASE4 | 2015-01 | 2015-02 | 2015-02 |
| NCT02100618 | Antibody Persistence for GlaxoSmithKline (GSK) Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) Administered in Healthy Adults and Adolescents, 6.5 Years After First Vaccination in the Primary Study | WITHDRAWN | PHASE3 | 2015-01 | 2015-04 | 2015-04 |
| NCT02298179 | A Study to Evaluate the Safety and Ability of the Vaccine to Induce Antibodies Against the Respiratory Syncytial Virus in Healthy Adults | COMPLETED | PHASE1 | 2014-12-19 | 2017-03-27 | 2017-03-27 |
| NCT02257359 | Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Epelsiban in Healthy Female Volunteers | COMPLETED | PHASE1 | 2014-12-18 | 2015-01-29 | 2015-01-29 |
| NCT02281318 | Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control | COMPLETED | PHASE3 | 2014-12-11 | 2016-06-10 | 2016-06-10 |
| NCT02299375 | Safety and Efficacy Study of Losmapimod (GW856553) in Frequently Exacerbating Participants With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE2 | 2014-12-09 | 2016-06-30 | 2016-06-30 |
| NCT02254447 | Relative Bioavailability Study of Candesartan Cilexetil Under Fasting Conditions | COMPLETED | PHASE1 | 2014-12-02 | 2015-01-08 | 2015-01-08 |
| NCT02226965 | PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine) | COMPLETED | PHASE2 | 2014-12 | 2018-08-22 | 2016-07-11 |
| NCT02285777 | Assessing the Effectiveness, Immunogenicity and Safety of Meningococcal ABCWY Vaccine Administered to Healthy Adolescents | COMPLETED | PHASE2 | 2014-12-01 | 2015-06-11 | 2015-03-26 |
| NCT02293265 | Cross-sectional Study for Identification and Description of Severe Asthma Patients | COMPLETED | PHASE3 | 2014-12 | 2015-05 | 2015-05 |
| NCT02229227 | Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus | COMPLETED | PHASE3 | 2014-11-21 | 2017-07-24 | 2017-07-24 |
| NCT02270944 | Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine | COMPLETED | PHASE2 | 2014-11-20 | 2015-09-22 | 2015-04-23 |
| NCT02289495 | A Repeat Dose Pharmacokinetic (PK) and Safety Study of GSK2838232 With and Without Ritonavir (RTV) Conducted in Healthy Subjects | TERMINATED | PHASE1 | 2014-11-18 | 2015-06-27 | 2015-06-27 |
| NCT02424799 | Study to Investigate Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of GSK2646264 | COMPLETED | PHASE1 | 2014-11-17 | 2017-11-10 | 2017-11-10 |
| NCT02293148 | Single Dose, Pharmacokinetic, Safety, Tolerability and QTc Study of GSK1278863 in Healthy Volunteers | COMPLETED | PHASE1 | 2014-11-17 | 2015-03-10 | 2015-03-10 |
| NCT02289482 | A Single Dose Pharmacokinetic (PK) and Safety Study of GSK2838232 With and Without Ritonavir (RTV) Conducted in Healthy Subjects | TERMINATED | PHASE1 | 2014-11-17 | 2015-03-10 | 2015-03-10 |
| NCT02233803 | A Non-inferiority Study to Evaluate Efficacy, Safety and Tolerability of NEUMOTEROL® 400 and SYMBICORT® Forte in Adults With Asthma | COMPLETED | PHASE4 | 2014-11-14 | 2015-12-11 | 2015-12-11 |
| NCT02215096 | Dose-finding Study of GSK2636771 When Administered in Combination With Enzalutamide in Male Subjects With Metastatic Castration-Resistant Prostate Cancer | COMPLETED | PHASE1 | 2014-11-13 | 2019-10-03 | 2019-10-03 |
| NCT02293161 | Single Ascending Doses Study of Anti- Interleukin-7 Receptor α Monoclonal Antibody (GSK2618960) in Healthy Volunteers | COMPLETED | PHASE1 | 2014-11-11 | 2015-09-01 | 2015-09-01 |
| NCT02244489 | Momelotinib Combined With Capecitabine and Oxaliplatin in Adults With Relapsed/Refractory Metastatic Pancreatic Ductal Adenocarcinoma | TERMINATED | PHASE1 | 2014-11-05 | 2017-04-05 | 2017-03-08 |
| NCT02281370 | Drug-drug Interaction Study of Eltrombopag and Cyclosporine in Healthy Subjects | COMPLETED | PHASE1 | 2014-11-05 | 2014-12-24 | 2014-12-24 |
| NCT03587428 | Effect of Two Toothpastes on Bacteria in Saliva | COMPLETED | NA | 2014-11-04 | 2014-11-27 | 2014-11-27 |
| NCT02195284 | To Study Device Attributes by Investigating Errors Made in Use, Ease of Use and Preference Among Different Inhalers in Subjects With Asthma | COMPLETED | PHASE4 | 2014-11 | 2015-05 | 2015-05 |
| NCT02218723 | Pharmacokinetic Profile of Four Formulations of Fluticasone Furoate (FF) Using Unit Dose Dry Powder Inhaler (UD-DPI) Compared With FF ELLIPTA® Presentation | COMPLETED | PHASE1 | 2014-10-28 | 2014-12-19 | 2014-12-19 |
| NCT02243306 | Study to Assess the Pharmacokinetics of GSK1278863 in Subjects With End Stage Renal Disease Undergoing Peritoneal Dialysis | COMPLETED | PHASE1 | 2014-10-24 | 2017-05-10 | 2017-05-10 |
| NCT02251704 | Epidemiology Study of Malaria Transmission Intensity in Sub-Saharan Africa | COMPLETED | PHASE4 | 2014-10-22 | 2024-07-06 | 2024-07-06 |
| NCT02206763 | Erlotinib and Momelotinib for the Treatment of Epidermal Growth Factor Receptor (EGFR) Mutated EGFR Tyrosine Kinase Inhibitor (TKI) Naive Metastatic Non-Small Cell Lung Cancer (NSCLC) | TERMINATED | PHASE1 | 2014-10-16 | 2017-02-16 | 2017-01-12 |
| NCT02257385 | Comparative Study of Umeclidinium/Vilanterol (UMEC/VI) in a Fixed Dose Combination With Indacaterol Plus Tiotropium | COMPLETED | PHASE3 | 2014-10-15 | 2015-05-04 | 2015-05-04 |
| NCT02284009 | Albiglutide Versus Placebo in Insulin-treated Subjects With New-onset Type 1 Diabetes Mellitus | COMPLETED | PHASE2 | 2014-10-10 | 2017-10-18 | 2017-10-18 |
| NCT02257398 | Placebo and Moxifloxacin Controlled Cardiac Conduction Study of GSK2140944 in Healthy Volunteers | COMPLETED | PHASE1 | 2014-10-06 | 2015-03-02 | 2015-03-02 |
| NCT02218697 | Evaluation of the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine Influsplit™ Tetra (Fluarix™ Tetra) (GSK2321138A) When Co-administered With Pneumovax™ 23 in Adults 50 Years of Age and Older | COMPLETED | PHASE3 | 2014-10-01 | 2015-05-04 | 2015-01-14 |
| NCT02201225 | A Methodology Study to Evaluate a Sitting Knee Measuring Device in Assessing Growth in Indian Children. | COMPLETED | PHASE1 | 2014-10-01 | 2015-03-13 | 2015-03-01 |
| NCT02242643 | Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine (GSK2282512A) Compared to Fluzone® Quadrivalent in Children 6 to 35 Months of Age | COMPLETED | PHASE3 | 2014-10-01 | 2015-06-23 | 2015-03-16 |
| NCT02201238 | Pharmacokinetics Study Comparing Topical Diclofenac/Menthol Gels With Voltaren Gel and Oral Diclofenac Sodium | COMPLETED | PHASE1 | 2014-10-01 | 2014-11-21 | 2014-11-21 |
| NCT02519751 | New Method Using Deuterium Labelled Creatine to Measure Total Body Skeletal Muscle Mass | COMPLETED | NA | 2014-10 | 2015-01 | 2015-01 |
| NCT02345187 | fMRI Study to Investigate Hemodynamic Changes in Brain Resulting From Supplementation of Bacopa Monnieri Extract and Multiple Micronutrient Supplementation. | COMPLETED | NA | 2014-10 | 2015-04 | 2015-04 |
| NCT02218762 | A Study in Patients With Moderate Asthma to Compare Pharmacokinetics and Pharmacodynamic Effects of Fluticasone Propionate and Salmeterol Delivered Via the ROTAHALER® Inhaler Relative to the DISKUS® Inhaler | WITHDRAWN | PHASE1 | 2014-10 | 2015-06 | 2015-06 |
| NCT02257372 | A Study to Evaluate the Effect of Umeclidinium (UMEC) as Combination Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE4 | 2014-09-30 | 2015-03-24 | 2015-03-24 |
| NCT02371616 | Clinical Study to Evaluate the Efficacy of Two Dentifrices for Dentine Hypersensitivity | COMPLETED | NA | 2014-09-29 | 2014-12-18 | 2014-12-18 |
| NCT02236611 | A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium 62.5 Microgram (mcg) Compared With Glycopyrronium 44 mcg in Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE4 | 2014-09-26 | 2015-06-02 | 2015-06-02 |
| NCT02207816 | An Extension to Study MALARIA-055 PRI (NCT00866619) to Evaluate the Long-term Efficacy, Safety and Immunogenicity of GSK Biologicals' Candidate Malaria Vaccine in Infants and Children in Africa | COMPLETED | PHASE3 | 2014-09-18 | 2017-01-31 | 2017-01-31 |
| NCT01899742 | The Purpose of the This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily Compared With Tiotropium 18mcg Once Daily Over a a 12-week Treatment Period in Subjects With COPD Who Continue to Have Symptoms on Tiotropium | COMPLETED | PHASE3 | 2014-09-15 | 2015-07-22 | 2015-07-22 |
| NCT02173704 | Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Meningococcal B Recombinant Vaccine When Administered Concomitantly With Routine Vaccines to Healthy Infants of 2 Months of Age and Older, in Taiwan. | COMPLETED | PHASE3 | 2014-09-11 | 2016-06-17 | 2015-12-25 |
| NCT02226562 | Clinical Study Investigating the Efficacy of a Mouthwash in Providing Long Term Relief From Dentinal Hypersensitivity | COMPLETED | PHASE2 | 2014-09-02 | 2014-12-05 | 2014-12-01 |
| NCT02207829 | A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium Compared With Tiotropium in Subjects With Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE3 | 2014-09-01 | 2015-06-15 | 2015-05-25 |
| NCT02152605 | A Phase IIIb Study to Evaluate the Efficacy of Umeclidinium/Vilanterol (UMEC/VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2014-09-01 | 2015-03-05 | 2015-03-01 |
| NCT02254434 | A Pharmacokinetic Study of Eltrombopag 50 Milligram (mg) in Healthy Volunteers Under Fasting Conditions | COMPLETED | PHASE1 | 2014-08-28 | 2014-09-08 | 2014-09-08 |
| NCT02213029 | A Study to Evaluate Pharmacokinetics, Pharmacodynamics and Tissue Concentrations of Epelsiban | TERMINATED | PHASE1 | 2014-08-28 | 2016-02-07 | 2016-02-07 |
| NCT02184624 | Study of Inhaler Device Attributes Investigating Critical and Overall Errors, Ease of Use, and Preference Between a Number of Inhaler Devices | COMPLETED | PHASE4 | 2014-08-28 | 2015-07-31 | 2015-07-31 |
| NCT02177812 | A Phase I Dose Escalation Study of GSK2879552 in Subjects With Acute Myeloid Leukemia (AML) | TERMINATED | PHASE1 | 2014-08-27 | 2017-12-08 | 2017-12-08 |
| NCT02210000 | A Study to Evaluate the Effect of Camicinal on Gastroparesis Symptoms in Type 1 and 2 Diabetic Subjects With Gastroparesis | COMPLETED | PHASE2 | 2014-08-27 | 2015-08-24 | 2015-08-24 |
| NCT02202161 | A Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 Administered With Metformin to Type 2 Diabetes Patients | COMPLETED | PHASE2 | 2014-08-27 | 2015-01-30 | 2015-01-30 |
| NCT02184572 | Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age | COMPLETED | PHASE3 | 2014-08-25 | 2015-12-22 | 2015-08-14 |
| NCT02207400 | To Evaluate Efficacy and Tolerability of Sodium Bicarbonate Toothpaste and Its Effect on Opportunistic or Resistant Organisms | COMPLETED | PHASE2 | 2014-08-25 | 2015-04-30 | 2015-02-01 |
| NCT02212457 | Trial to Assess Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Meningococcal ABCWY Vaccine as Compared to Meningococcal B Vaccine in Adolescents | COMPLETED | PHASE2 | 2014-08-21 | 2016-03-03 | 2015-05-22 |
| NCT01755598 | Study to Evaluate the Efficacy of GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine in Adults | COMPLETED | PHASE2 | 2014-08-19 | 2018-11-16 | 2018-11-16 |
| NCT02207413 | A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Candidate Vaccine (GSK2321138A) Manufactured Using a New Process in Adults and Children | COMPLETED | PHASE3 | 2014-08-18 | 2015-04-18 | 2015-04-18 |
| NCT02075515 | Consistency, Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults ≥ 50 Years of Age | COMPLETED | PHASE3 | 2014-08-13 | 2016-04-25 | 2015-04-29 |
| NCT02207907 | To Evaluate the Efficacy and Tolerability of Sodium Bicarbonate Toothpaste | COMPLETED | PHASE2 | 2014-08 | 2015-03 | 2015-02 |
| NCT01953809 | A Pharmacokinetics, Pharmacodynamics, and Safety Study of an Oral Contraceptive Containing Norethindrone and Ethinyl Estradiol When Co-administered With GSK1322322 in Healthy Adult Women | WITHDRAWN | PHASE1 | 2014-08 | 2015-03 | 2015-03 |
| NCT01803399 | A Study to Evaluate the Effect of GSK1322322 on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy Volunteers | WITHDRAWN | PHASE1 | 2014-08 | 2014-12 | 2014-12 |
| NCT02130635 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Dose-Response Relationship of Multiple Doses of GSK2269557 Administered as a Dry Powder to Chronic Obstructive Pulmonary Disease (COPD) Patients | COMPLETED | PHASE2 | 2014-07-31 | 2015-08-18 | 2015-08-18 |
| NCT02184637 | A Study to Evaluate the Pharmacokinetics of a Single Dose of Tafenoquine Co-administered With Either Artemether + Lumefantrine or Dihydroartemisinin + Piperaquine Tetraphosphate | COMPLETED | PHASE1 | 2014-07-31 | 2015-04-08 | 2015-04-08 |
| NCT02195349 | A First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Intravenous (IV) Dose of GSK2831781 in Healthy Volunteers and Patients With Plaque Psoriasis | COMPLETED | PHASE1 | 2014-07-30 | 2018-03-07 | 2018-03-07 |
| NCT02135861 | A Method Validation Study for Evaluation of Novel Treatments Limiting Pulmonary Oedema in Cardiac Failure | COMPLETED | PHASE1 | 2014-07-30 | 2017-02-22 | 2017-02-22 |
| NCT02064387 | Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Clinical Activity of GSK2857916 | COMPLETED | PHASE1 | 2014-07-29 | 2019-08-01 | 2018-08-31 |
| NCT02135640 | China HVT Safety, PK, PD | COMPLETED | PHASE1 | 2014-07-17 | 2015-02-17 | 2015-02-17 |
| NCT02184585 | Comparative Bioavailability of Two Fixed Dose Combination (FDC) Formulations of Dutasteride and Tamsulosin Hydrochloride Relative to Co-administration of Dutasteride With Tamsulosin Hydrochloride in Healthy Male Subjects Under Fed and Fasted States | COMPLETED | PHASE1 | 2014-07-10 | 2015-02-23 | 2015-02-23 |
| NCT02075541 | A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithkline (GSK) Biologicals' Investigational Vaccine GSK2838504A When Administered to Chronic Obstructive Pulmonary Disease (COPD) Patients With Persistent Airflow Obstruction. | COMPLETED | PHASE2 | 2014-07-08 | 2017-04-19 | 2017-04-19 |
| NCT02014584 | Sexual Function in Men Receiving Dutasteride for Androgenetic Alopecia | COMPLETED | PHASE3 | 2014-07-02 | 2016-03-19 | 2016-03-19 |
| NCT02058563 | Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older | COMPLETED | PHASE3 | 2014-07-01 | 2015-09-17 | 2015-05-24 |
| NCT02164539 | Evaluation of Umeclidinium Bromide in Combination With Fluticasone Furoate in COPD Subjects With an Asthmatic Component | COMPLETED | PHASE2 | 2014-07-01 | 2015-07-18 | 2015-07-01 |
| NCT02000440 | A Phase II, Repeat Dose, Proof of Mechanism Study of Losmapimod to Reduce Proteinuria in Patients With Focal Segmental Glomerulosclerosis (FSGS) | COMPLETED | PHASE2 | 2014-07-01 | 2016-05-11 | 2016-02-29 |
| NCT02416245 | Impact of Beverage Powder With Micronutrients and Brahmi Extract on Cognitive Variables in Indian School Children | COMPLETED | NA | 2014-07 | 2015-03 | 2015-01 |
| NCT02164513 | A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2014-06-30 | 2017-07-17 | 2017-07-17 |
| NCT02153346 | Indirect Cost of Illness Study of Moderate and Severe Asthma in Quebec | COMPLETED | NA | 2014-06-22 | 2016-04-22 | 2016-04-01 |
| NCT02177942 | A Clinical Trial to Study the Impact of a Nutritional Beverage on Tests of Memory in Healthy Preschool Age Children | COMPLETED | NA | 2014-06-20 | 2015-06-01 | 2015-06-01 |
| NCT02101268 | Efficacy of Momelotinib Versus Best Available Therapy in Anemic or Thrombocytopenic Subjects With Primary Myelofibrosis (MF), Post-polycythemia Vera MF, or Post-essential Thrombocythemia MF | COMPLETED | PHASE3 | 2014-06-19 | 2019-04-25 | 2016-07-28 |
| NCT02169583 | Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Escalating Doses of GSK1325756 Solution for Infusion, and Absolute Bioavailability Relative of an Oral Dose, in Healthy Adult Subjects | COMPLETED | PHASE1 | 2014-06-12 | 2014-08-28 | 2014-08-28 |
| NCT02119260 | A First Time in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Healthy Subjects and Stable Heart Failure Patients | COMPLETED | PHASE2 | 2014-06-09 | 2016-12-25 | 2016-12-25 |
| NCT02106390 | Safety and Immunogenicity of GlaxoSmithKline Biologicals Meningococcal Group B Vaccine When Administered Concomitantly With GlaxoSmithKline Biologicals MenACWY Conjugate Vaccine to Healthy Infants | COMPLETED | PHASE3 | 2014-06-05 | 2016-10-14 | 2016-10-14 |
| NCT02145468 | A Phase 3 Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting With Acute Coronary Syndrome Treated With Losmapimod Compared to Placebo (LATITUDE-TIMI 60) | COMPLETED | PHASE3 | 2014-06-03 | 2015-12-14 | 2015-12-14 |
| NCT02101021 | Gemcitabine and Nab-paclitaxel Combined With Momelotinib in Participants With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma | TERMINATED | PHASE3 | 2014-06-02 | 2017-04-10 | 2017-04-10 |
| NCT02169154 | A Safety Study to Investigate the Skin Irritancy Potential of Diclofenac-Menthol Gel | COMPLETED | PHASE1 | 2014-06-01 | 2014-07-01 | 2014-07-01 |
| NCT02075463 | Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With Anemia | TERMINATED | PHASE2 | 2014-06-01 | 2016-03-16 | 2016-03-01 |
| NCT02195583 | The Effect of Experimental Dentifrices on Remineralization of Caries Lesions In-situ | COMPLETED | NA | 2014-06 | 2014-08 | 2014-08 |
| NCT02135692 | A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects | COMPLETED | PHASE3 | 2014-05-29 | 2017-10-05 | 2017-10-05 |
| NCT02124798 | A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector | COMPLETED | PHASE2 | 2014-05-20 | 2015-04-13 | 2015-04-13 |
| NCT01943851 | A Dose Escalation Study to Investigate the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD) and Clinical Activity of GSK525762 in Subjects With Relapsed, Refractory Hematologic Malignancies | COMPLETED | PHASE2 | 2014-05-14 | 2020-04-30 | 2020-04-30 |
| NCT02119156 | Belimumab Treatment Holiday and Treatment Re-start Study in Lupus Patients | COMPLETED | PHASE3 | 2014-05-13 | 2018-12-14 | 2018-12-14 |
| NCT01962454 | A Study to Evaluate a Skeletal-muscle Microbiopsy Technique With Dynamic Proteomic Measurement in Healthy Male Volunteers | COMPLETED | PHASE1 | 2014-05-05 | 2015-03-20 | 2015-03-20 |
| NCT02113436 | Efficacy and Safety of Fluticasone Propionate(FP)/ Salmeterol Xinafoate (SLM) Hydro Fluoro Alkane (HFA) Metered Dose Inhaler (MDI) in Pediatric Patients With Bronchial Asthma | COMPLETED | PHASE4 | 2014-05-01 | 2016-10-01 | 2016-06-01 |
| NCT02106403 | A Study to Evaluate the Cooling Sensation and Consumer Liking of a Skin Disinfectant Spray | COMPLETED | NA | 2014-05 | 2014-06 | 2014-06 |
| NCT02124746 | Long-term Safety and Efficacy of Momelotinib in Subjects With Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Polycythemia Vera or Essential Thrombocythemia | COMPLETED | PHASE2 | 2014-04-30 | 2018-12-06 | 2018-12-06 |
| NCT02082977 | A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK2816126 in Subjects With Relapsed/Refractory Diffuse Large B Cell Lymphoma, Transformed Follicular Lymphoma, Other Non-Hodgkin's Lymphomas, Solid Tumors and Multiple Myeloma | TERMINATED | PHASE1 | 2014-04-24 | 2017-06-20 | 2017-06-20 |
| NCT02014519 | A Study to Determine the Seroprevalence of Bordetella Pertussis in Adults in Hungary | COMPLETED | NA | 2014-04-24 | 2015-04-24 | 2015-04-22 |
| NCT02105961 | Efficacy and Safety of Mepolizumab as an Add-on Treatment in Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2014-04-24 | 2017-01-16 | 2017-01-16 |
| NCT01376167 | Ph 2B/3 Tafenoquine (TFQ) Study in Prevention of Vivax Relapse | COMPLETED | PHASE2 | 2014-04-24 | 2016-11-18 | 2016-11-18 |
| NCT02065063 | A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Anti-Cancer Activity of Trametinib in Combination With Palbociclib in Subjects With Solid Tumors | COMPLETED | PHASE1 | 2014-04-22 | 2016-06-23 | 2016-06-23 |
| NCT02094924 | A Relative Bioavailability Study of a Fixed Dose Combination (FDC) Tablets of GSK587323 | COMPLETED | PHASE1 | 2014-04-17 | 2014-05-23 | 2014-05-23 |
| NCT02096263 | Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants | COMPLETED | PHASE3 | 2014-04-16 | 2015-11-13 | 2015-02-06 |
| NCT02105948 | Study to Evaluate Efficacy and Safety of Mepolizumab for Frequently Exacerbating Chronic Obstructive Pulmonary Disease (COPD) Patients | COMPLETED | PHASE3 | 2014-04-15 | 2017-01-17 | 2017-01-17 |
| NCT01978301 | Study to Evaluate Fractional Collagen Synthesis Within Keloid Scars and Identify Biomarkers of Keloid Scars | TERMINATED | PHASE1 | 2014-04-15 | 2015-02-05 | 2015-02-05 |
| NCT02100644 | Valproate Dose Reduction and Its Clinical Evaluation by Introducing Lamotrigine in Japanese Women With Epilepsy - Single Arm, Multicenter, and Open-label Study | COMPLETED | PHASE4 | 2014-04-12 | 2015-05-11 | 2015-05-11 |
| NCT01978236 | Dabrafenib/Trametinib, BRAF or BRAF AND MEK Pre-op With BRAF and MEK Post-op, Phase IIB, Melanoma With Brain Mets,Biomarkers and Metabolites | TERMINATED | PHASE2 | 2014-04-08 | 2017-04-26 | 2017-04-26 |
| NCT02105974 | Study Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Inhalation Powder (FF/VI) Compared With Vilanterol Inhalation Powder (VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2014-04-07 | 2015-07-08 | 2015-07-08 |
| NCT01934192 | Nutritional Adequacy Therapeutic Enhancement in the Critically Ill. The NUTRIATE Study | TERMINATED | PHASE2 | 2014-04-04 | 2016-07-08 | 2016-07-08 |
| NCT01812382 | Retapamulin Microdialysis Feasibility Study | COMPLETED | PHASE1 | 2014-04-02 | 2014-05-27 | 2014-05-27 |
| NCT02072525 | A Protocol to Collect Human Serum Samples From Healthy Adults for Use as Quality Controls Samples in GlaxoSmithKline (GSK) Biologicals' Assays | COMPLETED | PHASE4 | 2014-04-01 | 2015-06-02 | 2015-06-02 |
| NCT02192203 | A Safety Study to Investigate the Skin Sensitization Potential of MFC51123 | COMPLETED | PHASE1 | 2014-04-01 | 2014-07-15 | 2014-07-15 |
| NCT02034097 | A Study to Evaluate Foretinib in Subjects With Non-Small-Cell Lung Cancer | WITHDRAWN | PHASE2 | 2014-04 | 2016-12 | 2014-04 |
| NCT02446496 | A Bioequivalence Study of Cefadroxil Film Coated Tablets After A Single Oral Dose Administration to Healthy Subjects | COMPLETED | PHASE4 | 2014-03-31 | 2014-04-08 | 2014-04-08 |
| NCT02094937 | A Study to Compare the Efficacy and Safety of Fluticasone Furoate (FF) 100 mcg Once Daily With Fluticasone Propionate (FP) 250 mcg Twice Daily (BD) and FP 100 mcg BD in Well-controlled Asthmatic Japanese Subjects | COMPLETED | PHASE3 | 2014-03-27 | 2015-08-28 | 2015-08-28 |
| NCT02045797 | Dose-Ranging Study of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections | COMPLETED | PHASE2 | 2014-03-24 | 2015-06-29 | 2015-06-29 |
| NCT02075619 | Relative Bioavailability Study of One Amlodipine 10mg Tablet and One Rosuvastatin 20mg Tablet to Two Fixed Dose Combinations of Amlodipine (10mg) and Rosuvastatin (20mg) in Healthy Subjects Under Fasting Conditions | COMPLETED | PHASE1 | 2014-03-24 | 2014-07-11 | 2014-07-11 |
| NCT02605395 | Bioequivalence Study of Raperazole 20mg DR Tabs and PARIET® 20 mg DR Tabs Under Fed Conditions | COMPLETED | PHASE4 | 2014-03-22 | 2014-03-30 | 2014-03-30 |
| NCT02058589 | Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults 18 Years of Age or Older With Renal Transplant | COMPLETED | PHASE3 | 2014-03-20 | 2017-04-13 | 2016-05-11 |
| NCT02446483 | A Bioequivalence Study of Idiazole 20mg DR Tabs and PARIET® 20 mg DR Tabs After a Single Oral Dose Administration Under Fasting Conditions in Healthy Adults | COMPLETED | PHASE4 | 2014-03-19 | 2014-03-26 | 2014-03-26 |
| NCT02046148 | Safety and Immunogenicity of a Trivalent Group B Streptococcus Vaccine in Healthy Pregnant Women | COMPLETED | PHASE2 | 2014-03-18 | 2016-03-26 | 2015-12-30 |
| NCT02064465 | The Bioequivalence Study of Lamotrigine Dispersible/Chewable Tablets 100mg Compared With Compressed Tablet 100 mg | COMPLETED | PHASE1 | 2014-03-15 | 2014-07-08 | 2014-07-08 |
| NCT02000817 | Investigation of Otelixizumab in New-Onset, Autoimmune Type 1 Diabetes Mellitus Patients | COMPLETED | PHASE1, PHASE2 | 2014-03-12 | 2018-09-27 | 2018-09-27 |
| NCT01899703 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of Pruritus | COMPLETED | PHASE2 | 2014-03-10 | 2015-10-07 | 2015-10-07 |
| NCT02045836 | Study to Evaluate Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A When Co-administered With Pneumovax 23™ in Adults Aged 50 Years and Older | COMPLETED | PHASE3 | 2014-03-05 | 2016-06-17 | 2015-07-02 |
| NCT02034500 | Evaluate a New Shigella Sonnei Vaccine Administered Either by Intradermal, Intranasal or Intramuscular Route in Healthy Adults | COMPLETED | PHASE1 | 2014-03 | 2015-04 | 2015-04 |
| NCT02058641 | Effect of Darapladib on Cantharidin-Induced Inflammatory Blisters in Subjects With Type 2 Diabetes Mellitus (T2DM) | COMPLETED | PHASE1 | 2014-02-26 | 2014-08-18 | 2014-08-18 |
| NCT01988857 | Safety of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Healthy Vietnamese Children | COMPLETED | PHASE3 | 2014-02-22 | 2014-05-10 | 2014-05-10 |
| NCT02058628 | Comparison of the Efficacy and Safety of Clindamycin + Benzoyl Peroxide Formulation With Azelaic Acid Formulation in the Treatment of Acne Vulgaris | COMPLETED | PHASE4 | 2014-02-21 | 2014-09-08 | 2014-09-08 |
| NCT01998828 | Safety and Efficacy of Momelotinib in Subjects With Polycythemia Vera or Essential Thrombocythemia | TERMINATED | PHASE2 | 2014-02-19 | 2015-05-07 | 2015-03-17 |
| NCT02052713 | Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin Hydrochloride (HCL) Combination Capsule in Fasted State | COMPLETED | PHASE1 | 2014-02-19 | 2014-12-29 | 2014-12-29 |
| NCT02064504 | Study to Determine the Pharmacokinetics of GSK961081 and Fluticasone Furoate When Administered Alone or in Combination | COMPLETED | PHASE1 | 2014-02-19 | 2014-05-20 | 2014-05-20 |
| NCT01751139 | An Epidemiological Surveillance Study to Evaluate the Incidence of Dengue in Brazil | TERMINATED | NA | 2014-02-18 | 2018-12-20 | 2018-12-20 |
| NCT02052661 | This Study Aims to Determine the Long-term Persistence of Antibodies Against Hepatitis B and to Evaluate the Immunogenicity and Safety of Hepatitis B Vaccine in Adolescents Vaccinated in Infancy With Infanrix™ Hexa | COMPLETED | PHASE4 | 2014-02-18 | 2014-09-23 | 2014-09-23 |
| NCT02130193 | Investigation of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of Oral Danirixin in Symptomatic COPD Subjects With Mild to Moderate Airflow Limitation at Risk for Exacerbations | COMPLETED | PHASE2 | 2014-02-13 | 2016-08-29 | 2016-08-29 |
| NCT02058576 | Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin HCl Combination Capsule in Fed State | COMPLETED | PHASE1 | 2014-02-11 | 2015-01-02 | 2015-01-02 |
| NCT02058368 | Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic Hyperplasia | COMPLETED | PHASE3 | 2014-02-10 | 2017-03-03 | 2017-03-03 |
| NCT02052596 | Study to Assess the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) When Co-administered With GSK Biologicals' Diphtheria, Tetanus and Pertussis Vaccine (Boostrix®) in Adults Aged 50 Years and Older | COMPLETED | PHASE3 | 2014-02-07 | 2016-04-21 | 2015-06-16 |
| NCT02020889 | A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis | COMPLETED | PHASE3 | 2014-02-05 | 2016-09-05 | 2016-09-05 |
| NCT02040480 | Bioavailability and Food Effect Study of Gelatin Formulation and Immediate Release Tablet Formulation of Afuresertib | COMPLETED | PHASE1 | 2014-02-05 | 2014-04-04 | 2014-04-04 |
| NCT02034123 | Investigation of GSK2879552 in Subjects With Relapsed/Refractory Small Cell Lung Carcinoma | TERMINATED | PHASE1 | 2014-02-04 | 2017-04-18 | 2017-04-18 |
| NCT02201316 | A Pilot Study to Determine the Relative Bioavailability of Mosapride 5mg From Two Candidate Formulations of GR107719B Relative to One 5mg Tablet of Reference Mosapride Citrate (GASMOTIN™) in Healthy Adult Human Subjects Under Fasting Conditions | COMPLETED | PHASE1 | 2014-02-03 | 2014-03-18 | 2014-03-18 |
| NCT02017899 | A Phase 1, Dose Escalation Study, to Evaluate a New Shigella Sonnei Vaccine in Healthy Adults. | COMPLETED | PHASE1 | 2014-02 | 2015-03 | 2015-03 |
| NCT01978093 | Immunogenicity, Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Hib-MenCY-TT (MenHibrix®) Vaccine Compared to Merck & Co, Inc. PedvaxHIB Vaccine in Healthy Infants and Toddlers 12 to 15 Months of Age | COMPLETED | PHASE3 | 2014-02-01 | 2016-03-18 | 2016-03-18 |
| NCT02052752 | A Five Day Clinical Study to Examine the Effects of a Benzoyl Peroxide Treatment on Facial Acne Lesions | COMPLETED | PHASE4 | 2014-02 | 2014-05 | 2014-05 |
| NCT02006537 | A Study to Investigate the Safety and Pharmacokinetics of a Single Dose of GSK2256294 in Healthy Young Males and Elderly Subjects | COMPLETED | PHASE1 | 2014-01-31 | 2014-05-27 | 2014-05-27 |
| NCT02045953 | A Study to Assess the Systemic Exposure of FLIXOTIDE™ (Fluticasone Propionate) and SERETIDE™ (Fluticasone Propionate and Salmeterol) Given With VENTOLIN™ Mini-Spacer Compared to the Aerochamber Plus Spacer | COMPLETED | PHASE1 | 2014-01-29 | 2014-03-13 | 2014-03-13 |
| NCT01957150 | Study Evaluating the Effect of Fluticasone Furoate/ Vilanterol (FF/VI) Inhalation Powder Compared With Vilanterol (VI) Inhalation Powder on Bone Mineral Density (BMD) in Subjects With Chronic Obstructive Pulmonary Disease (COPD). | COMPLETED | PHASE4 | 2014-01-28 | 2018-03-26 | 2018-03-26 |
| NCT02058407 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Food Effect of Single or Repeat Doses of GSK2793660 in Healthy Subjects | TERMINATED | PHASE1 | 2014-01-28 | 2014-10-31 | 2014-10-31 |
| NCT02045849 | Relative Bioavailability, Safety, Tolerability, Pharmacokinetics (PK) and Food Effect Study of GSK2140944 in Healthy Subjects | COMPLETED | PHASE1 | 2014-01-28 | 2014-08-21 | 2014-08-21 |
| NCT02052297 | A Validation and Dosimetry Study of GSK2634673F PET Ligand | TERMINATED | PHASE1 | 2014-01-24 | 2016-04-21 | 2016-04-21 |
| NCT01894022 | A Open Label Study to Assess the Long-term Safety, Tolerability and Efficacy of Ambrisentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH) | TERMINATED | PHASE3 | 2014-01-23 | 2015-11-18 | 2015-11-18 |
| NCT02033668 | Pharmacokinetic (PK) Study of GSK933776 in Healthy Volunteers | COMPLETED | PHASE1 | 2014-01-22 | 2014-07-15 | 2014-07-15 |
| NCT02045940 | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of GSK2881078 in Single and Repeat Doses | COMPLETED | PHASE1 | 2014-01-20 | 2015-03-26 | 2015-03-26 |
| NCT02014662 | A Methodology Study to Assess Muscle Damage After Eccentric Exercise | COMPLETED | PHASE1 | 2014-01-14 | 2014-07-02 | 2014-07-02 |
| NCT02201303 | Evaluation of Danirixin (GSK1325756) Inhibition of CD11b Cell Surface Expression | COMPLETED | PHASE1 | 2014-01-13 | 2015-07-02 | 2015-07-02 |
| NCT01984047 | Single Dose Escalation Trial to Evaluate the Safety, Tolerability Pharmacokinetics and Pharmacodynamics of GSK3050002 | COMPLETED | PHASE1 | 2014-01-10 | 2015-02-23 | 2015-02-23 |
| NCT02014467 | Denosumab China Phase III Study | COMPLETED | PHASE3 | 2014-01 | 2015-08 | 2015-08 |
| NCT01916200 | Efficacy and Safety of Paroxetine Controlled Release for Major Depressive Disorder in Irritable Bowel Syndrome Patients | WITHDRAWN | PHASE4 | 2014-01 | 2014-09 | 2014-09 |
| NCT01890798 | Drisapersen Duchenne Muscular Dystrophy (DMD) Treatment Protocol | WITHDRAWN | PHASE3 | 2014-01 | 2015-07 | 2014-01 |
| NCT02014571 | Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of Repeat Doses of GSK2878175 in Subjects With Chronic Hepatitis C. | COMPLETED | PHASE1 | 2013-12-26 | 2015-01-15 | 2014-07-03 |
| NCT01915914 | A Randomized, Open-label, Comparative Study to Evaluate an Intermittent Dosing Regimen of Fluticasone Propionate 0.05% Cream (Twice Per Week) in Reducing the Risk of Relapse When Added to Regular Daily Moisturization Using PHYSIOGEL Lotion in Paediatric Subjects With Stabilized Atopic Dermatitis | COMPLETED | PHASE4 | 2013-12-23 | 2015-02-15 | 2015-02-15 |
| NCT02000453 | Safety and Tolerability Study of GSK2586184 in Patients With Moderate to Severely Active Ulcerative Colitis. | TERMINATED | PHASE1 | 2013-12-20 | 2014-08-08 | 2014-08-08 |
| NCT01954043 | A Pharmacokinetics (PK) Study of the Effects Rabeprazole and Rifampin on Dabrafenib in Subjects With BRAF V600 Mutation Positive Tumors | COMPLETED | PHASE1 | 2013-12-20 | 2016-02-29 | 2016-02-29 |
| NCT02006602 | Bioavailability Study of Candesartan Cilexetil 16mg Tablet Under Fasting Conditions | COMPLETED | PHASE1 | 2013-12-13 | 2014-01-22 | 2014-01-22 |
| NCT01995175 | A Prospective, Epidemiological Study to Assess the Disease Burden of Respiratory Syncytial Virus Associated, Suspected Lower Respiratory Tract Infections in Newborns, From 0 to 2 Years of Age and Risk of Development of Wheeze and Asthma From 0 to 6 Years of Age | COMPLETED | NA | 2013-12-12 | 2021-11-03 | 2017-10-03 |
| NCT01888471 | Feasibility Study for Identifying Anti Capsular Antibody Protection Against Invasive Group B Streptococcus (GBS) Disease in Newborns of 0-6 Days Age (Early Onset Disease [EOD]) as Well as Among Infants of 7-90 Days Age (Late Onset Disease [LOD]) | COMPLETED | NA | 2013-12-11 | 2014-07-14 | 2014-07-14 |
| NCT02006589 | Bioavailability Study of Candesartan Cilexetil 8mg Tablet Under Fasting Conditions | COMPLETED | PHASE1 | 2013-12-11 | 2014-01-22 | 2014-01-22 |
| NCT01969838 | Momelotinib Versus Ruxolitinib in Subjects With Myelofibrosis | COMPLETED | PHASE3 | 2013-12-06 | 2019-05-02 | 2016-09-12 |
| NCT02058602 | Inhalation Profiling of Idiopathic Pulmonary Fibrosis (IPF) Patients | COMPLETED | PHASE1 | 2013-12-03 | 2016-07-11 | 2016-07-11 |
| NCT02058654 | A Clinical Study to Investigate the Effects of Creatine Supplementation on Muscle Energetics and Cognitive Function in Young Healthy Male Athletes and an Ageing Population | COMPLETED | PHASE1 | 2013-12-01 | 2014-06-24 | 2014-06-01 |
| NCT02094781 | Effect of Using Whey Protein and Creatine Supplements on Muscular Strength in Weight-training Adult Males | COMPLETED | PHASE1 | 2013-12 | 2014-09 | 2014-09 |
| NCT01966445 | Dose Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of GSK2849330 in Subjects With Advanced Her3-Positive Solid Tumors | COMPLETED | PHASE1 | 2013-11-26 | 2017-09-18 | 2017-09-18 |
| NCT01999842 | Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3206641A and GSK3206640A Administered in Adults 18 to 64 Years of Age | COMPLETED | PHASE1 | 2013-11-25 | 2015-01-19 | 2014-02-01 |
| NCT01978327 | GSK2647544 RD, DDI in Healthy Young and Elderly Volunteers | TERMINATED | PHASE1 | 2013-11-22 | 2014-03-03 | 2014-03-03 |
| NCT01938443 | A Dose Escalation Study to Assess Safety of GSK2256098 (FAK Inhibitor) in Combination With Trametinib (MEK Inhibitor) in Subjects With Advanced Solid Tumors | COMPLETED | PHASE1 | 2013-11-18 | 2016-06-23 | 2016-06-23 |
| NCT01978145 | A Non-inferiority Study to Evaluate the Efficacy, Safety, and Tolerability of Fluticasone Propionate/Salmeterol (FSC) 250/50 Microgram (mcg) Through a Capsule-Based Inhaler and a Multi-Dose Inhaler Administered Twice Daily (BID) in Adults With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2013-11-14 | 2015-04-16 | 2015-04-16 |
| NCT02314143 | Phase II Biomarker Study Comparing the Combination of BRAF Inhibitor Dabrafenib With MEK Inhibitor Trametinib Versus the Combination After Monotherapy With Dabrafenib or Trametinib | TERMINATED | PHASE2 | 2013-11-13 | 2017-01-19 | 2017-01-19 |
| NCT02000765 | A Study to Investigate the Recovery, Excretion and Pharmacokinetics of [14C]-GSK2140944 Administered as a Single Intravenous and Single Oral Dose to Healthy Adult Male Subjects | COMPLETED | PHASE1 | 2013-11-08 | 2013-11-30 | 2013-11-30 |
| NCT01978119 | A Non-inferiority Study to Evaluate the Efficacy, Safety, and Tolerability of Combination Dry Powder of Fluticasone Propionate and Salmeterol (FSC) 250/50 Microgram (mcg) Twice Daily (BID) in Adults and Adolescents With Asthma | COMPLETED | PHASE3 | 2013-11-06 | 2015-01-28 | 2015-01-28 |
| NCT02019719 | Study to Evaluate the Safety, Efficacy and Pharmacokinetics of GSK1278863 in Japanese Hemodialysis-Dependent Subjects With Anemia Associated With Chronic Kidney Disease | COMPLETED | PHASE2 | 2013-11-05 | 2014-08-06 | 2014-08-06 |
| NCT01977482 | Evaluation of Dose Response Relationship, Safety and Efficacy of GSK1278863 in Hemodialysis-dependent Subjects With Chronic Kidney Disease Associated Anemia | COMPLETED | PHASE2 | 2013-11-01 | 2015-02-06 | 2015-02-01 |
| NCT02100670 | A Multicenter Efficacy Study of a Diclofenac+Menthol Gel in Subjects With Ankle Sprain | COMPLETED | PHASE3 | 2013-11-01 | 2015-03-22 | 2015-03-01 |
| NCT01899768 | GSK2339345 Hypertussive Challenge Study | COMPLETED | PHASE2 | 2013-11 | 2014-10 | 2014-10 |
| NCT02113449 | Market Potential of Carbon Dioxide Nasal Spray | COMPLETED | PHASE2 | 2013-11 | 2014-02 | 2014-02 |
| NCT01977573 | A Study to Evaluate Safety and Efficacy of GSK1278863 in Non-Dialysis Dependent (NDD) Subjects With Anemia Associated With Chronic Kidney Diseases (CKD) | COMPLETED | PHASE2 | 2013-10-31 | 2015-06-15 | 2015-05-01 |
| NCT01920594 | Study of GSK1278863 to Reduce Ischemic Events in Patients Undergoing Thoracic Aortic Aneurysm Repair | COMPLETED | PHASE2 | 2013-10-31 | 2014-10-08 | 2014-10-08 |
| NCT01938482 | Study to Evaluate the Safety, Tolerability and Pharmacokinetic of Single and 14 Day Repeat Topical Application of GSK1940029 | COMPLETED | PHASE1 | 2013-10-31 | 2015-02-17 | 2015-02-17 |
| NCT01984775 | A Study to Evaluate the Irritation Potential of GSK2894512 Cream on Skin in Healthy Subjects | COMPLETED | PHASE1 | 2013-10-30 | 2014-07-02 | 2014-07-02 |
| NCT01957189 | This Will be an Open-label, Three-period, Fixed-sequence Study to Evaluate the Drug-drug Interaction, Pharmacokinetics and Safety of Dutasteride and Tamsulosin When Administered Alone and In-combination in Chinese Healthy Male Volunteers. The Study Will Last Approximately Eleven Weeks. Blood Samples | COMPLETED | PHASE1 | 2013-10-25 | 2014-01-22 | 2014-01-22 |
| NCT02000804 | Darapladib China PK | COMPLETED | PHASE1 | 2013-10-23 | 2014-01-04 | 2014-01-04 |
| NCT01974895 | Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children From 6 to 35 Months of Age | COMPLETED | PHASE2 | 2013-10-23 | 2014-07-03 | 2014-02-27 |
| NCT01984086 | Study to Evaluate the Pharmacokinetic Profile of Salbutamol Delivered by Unit Dose Dry Powder Inhaler (UD-DPI) Compared to the Diskus and Metered Dose Inhaler (MDI) in Healthy Volunteers. | COMPLETED | PHASE1 | 2013-10-21 | 2014-05-26 | 2014-05-26 |
| NCT01837316 | A Study to Assess the Bronchodilator Effect of a Single Dose of Fluticasone Furoate (FF)/ Vilanterol (VI) 100/25 Micrograms (mcg) Combination When Administered in Adult Patients With Asthma | COMPLETED | PHASE1 | 2013-10-21 | 2014-08-08 | 2014-08-08 |
| NCT01954264 | Epidemiology Study of Malaria Transmission Intensity in Sub-Saharan Africa | COMPLETED | NA | 2013-10-19 | 2013-11-25 | 2013-11-22 |
| NCT01894360 | A Study to Estimate the Relative Bioavailability, Tolerability and Safety of a Single Dose of Belimumab Self-Administered Subcutaneously (SC) by Healthy Subjects | COMPLETED | PHASE1 | 2013-10-14 | 2014-05-13 | 2014-05-13 |
| NCT01984801 | Study to Investigate the Irritation Potential of GSK1940029 Gel | COMPLETED | PHASE1 | 2013-10-14 | 2015-04-10 | 2015-04-10 |
| NCT01962467 | A Relative Bioavailability Study of Fluticasone Furoate and Levocabastine | COMPLETED | PHASE1 | 2013-10-11 | 2014-02-27 | 2014-02-27 |
| NCT01868022 | Study to Evaluate GSK3052230 in Combination With Paclitaxel and Carboplatin, or Docetaxel or as Single Agent in Subjects With Solid Malignancies and Deregulated Fibroblast Growth Factor (FGF) Pathway Signaling | COMPLETED | PHASE1 | 2013-10-09 | 2017-10-24 | 2017-10-24 |
| NCT01953835 | A Two-part Study to Investigate the Interaction and Pharmacokinetics of GSK2586184 | COMPLETED | PHASE1 | 2013-10-04 | 2014-03-10 | 2014-03-10 |
| NCT01954251 | Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older | COMPLETED | PHASE3 | 2013-10-03 | 2015-03-20 | 2014-06-02 |
| NCT01957163 | Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2013-10-01 | 2014-04-01 | 2014-04-01 |
| NCT01949051 | A Study to Assess Intranasal Repeat Dose Effect of Levocabastine in the Subjects With Allergic Rhinitis | COMPLETED | PHASE2 | 2013-10-01 | 2014-02-04 | 2014-02-04 |
| NCT02119286 | Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2 | COMPLETED | PHASE3 | 2013-10 | 2014-04 | 2014-04 |
| NCT01957202 | A Proof of Concept Study to Assess Effect of Fluticasone Furoate (FF)/Levocabastine Fixed Dose Combination (FDC) Compared With Levocabastine and FF Alone in Subjects With Allergic Rhinitis (AR) | COMPLETED | PHASE2 | 2013-10 | 2014-02 | 2014-02 |
| NCT01957215 | Efficacy of Topical Indomethacin Patch Over Placebo in Ankle Sprain Pain Relief | COMPLETED | PHASE4 | 2013-10 | 2014-09 | 2014-09 |
| NCT01938456 | Safety and Tolerability of Trametinib in Combination With Docetaxel in Japanese Subjects With Non-small Cell Lung Cancer | WITHDRAWN | PHASE1 | 2013-10 | 2014-07 | 2014-07 |
| NCT01949090 | Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 65 Years of Age and Older | COMPLETED | PHASE2 | 2013-09-25 | 2014-10-23 | 2013-12-04 |
| NCT01934205 | To Evaluate Plasma and Pulmonary Pharmacokinetics of GSK2140944 | COMPLETED | PHASE1 | 2013-09-25 | 2013-12-21 | 2013-12-21 |
| NCT02838407 | Identification and Characterization of Bacteria in the Lungs of Children From 6 Months up to 6 Years Old, With Suspected Infection of the Lungs, in Spain. | COMPLETED | NA | 2013-09-23 | 2015-09-23 | 2015-09-23 |
| NCT01929330 | Bioequivalence Study of Dutasteride Five 0.1 mg and One 0.5 mg Soft Gelatin Capsules in Healthy Male Volunteers | COMPLETED | PHASE1 | 2013-09-23 | 2014-01-09 | 2014-01-09 |
| NCT01943864 | A Phase IIa Study of the MEK Inhibitor Trametinib Monotherapy in the Treatment of Biliary Tract Cancers | COMPLETED | PHASE2 | 2013-09-19 | 2016-02-01 | 2014-07-01 |
| NCT03494985 | A Clinical Study to Evaluate the Efficacy of Three Dry Mouth Relief Products Versus Water | COMPLETED | NA | 2013-09-17 | 2014-01-10 | 2014-01-10 |
| NCT01750931 | This Study is Randomised, Single Oral Dose Bioequivalence Study of Meloxicam GSK 15 MG Tablets. | COMPLETED | NA | 2013-09-12 | 2013-10-01 | 2013-10-01 |
| NCT01934153 | Characterization of Exposure From Topical Administration of [14C] Umeclidinium to Axilla or Palm of Healthy Male Subjects | COMPLETED | PHASE1 | 2013-09-02 | 2014-02-19 | 2014-02-19 |
| NCT01536379 | A Study of Belimumab in the Prevention of Kidney Transplant Rejection | COMPLETED | PHASE2 | 2013-09 | 2016-02 | 2016-02 |
| NCT01884675 | Ambrisentan for Inoperable Chronic Thromboembolic Pulmonary Hypertension. | TERMINATED | PHASE3 | 2013-09 | 2015-03 | 2015-03 |
| NCT02119325 | The Effect of a Nutritional Supplement on Post Prandial Glucose and Lipids in an Adult Population | COMPLETED | NA | 2013-09 | | 2013-10 |
| NCT01962493 | An Efficacy Study of Stain Control of a 67% Sodium Bicarbonate Containing Toothpaste on Chlorhexidine Tooth Staining | COMPLETED | PHASE4 | 2013-09 | 2013-11 | 2013-11 |
| NCT02076269 | Severe Chronic Obstructive Pulmonary Disease Inhalation Profiles Comparison | COMPLETED | PHASE1 | 2013-09 | 2014-02 | 2014-02 |
| NCT01934231 | Study to Assess the Efficacy and Safety of Potassium Clavulanate/Amoxicillin in Children With Acute Bacterial Rhinosinusitis | COMPLETED | PHASE3 | 2013-08-30 | 2013-11-07 | 2013-11-07 |
| NCT01929317 | A Study to Evaluate the Efficacy of 18 to 24mg/Day Ropinirole Controlled Release (CR) Tablets in Early and Advanced Parkinson's Disease (PD) Patients. | TERMINATED | PHASE3 | 2013-08-28 | 2015-06-09 | 2014-09-16 |
| NCT01934127 | Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 21 to 64 Years of Age | COMPLETED | PHASE1 | 2013-08-26 | 2014-10-20 | 2013-11-01 |
| NCT01924858 | A Positron Emission Tomography (PET) Study to Investigate the Brain Biodistribution of 18F GSK2647544 in Healthy Subjects to Determine Its Ability to Cross the Blood-brain-barrier. | TERMINATED | PHASE1 | 2013-08-19 | 2014-03-03 | 2014-03-03 |
| NCT01928940 | Japan PhI/II of GSK2118436 and GSK1120212 Combination in Subjects With BRAF V600E/K Mutation Positive Advanced Solid Tumors (Phase I Part) or Cutaneous Melanoma (Phase II Part) | COMPLETED | PHASE2 | 2013-08-15 | 2016-07-04 | 2014-09-18 |
| NCT01934101 | Phase 1 Dose Escalating Study to Assess Safety, Tolerability, Food Effect and PK of CHR-5154 in Healthy Male Volunteers | TERMINATED | PHASE1 | 2013-08-12 | 2014-05-28 | 2014-05-28 |
| NCT01818011 | A Three-part Study to Determine the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Volunteers and Healthy Male Japanese Subjects | TERMINATED | PHASE1 | 2013-08-07 | 2013-10-18 | 2013-10-18 |
| NCT01890863 | ROTAHALER Device Optimization Study | COMPLETED | PHASE1 | 2013-08-05 | 2013-09-30 | 2013-09-30 |
| NCT02275364 | Functional Magnetic Resonance Imaging (fMRI) Study of Nasal Strips in Nasal Congestion | COMPLETED | PHASE4 | 2013-08-05 | 2013-10-30 | 2013-10-30 |
| NCT01916226 | A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis | COMPLETED | PHASE4 | 2013-08-01 | 2013-10-17 | 2013-10-01 |
| NCT01929863 | Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 in Type 2 Diabetes Patients Taking Metformin | COMPLETED | PHASE2 | 2013-08-01 | 2013-11-21 | 2013-11-01 |
| NCT01920568 | A Study to Compare Denosumab With Zoledronic Acid in Subjects With Bone Metastases From Solid Tumors | COMPLETED | PHASE3 | 2013-08 | 2016-04 | 2015-02 |
| NCT01905215 | Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccines | COMPLETED | PHASE1 | 2013-07-22 | 2015-03-16 | 2014-04-09 |
| NCT01847430 | Evaluation of the Long-term Persistence of Immunity to Hepatitis B, in Adolescents Vaccinated in Infancy With Engerix™-B Kinder | COMPLETED | PHASE4 | 2013-07-19 | 2014-02-21 | 2014-02-21 |
| NCT01878825 | Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Trivalent Split Virion Influenza Vaccine Fluviral™ (2013-2014 Season) in Adults Aged 18 Years and Older | COMPLETED | PHASE3 | 2013-07-18 | 2013-08-09 | 2013-08-09 |
| NCT01894386 | Pharmacokinetic Study in Healthy Volunteers to Characterise the Exposure of Fluticasone Furoate (FF), Vilanterol (VI) and Umeclidinium (UMEC) at Two Different Doses | COMPLETED | PHASE1 | 2013-07-15 | 2013-09-26 | 2013-09-26 |
| NCT01878812 | Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine, Fluarix/Influsplit Tetra® (2013/2014 Season), in Adults 18 Years of Age and Older | COMPLETED | PHASE3 | 2013-07-11 | 2013-08-05 | 2013-08-05 |
| NCT01899755 | A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability, Immunogenicity, and Pharmacodynamics (PD) of GSK2800528 in Healthy Subjects. | COMPLETED | PHASE1 | 2013-07-10 | 2014-04-03 | 2014-04-03 |
| NCT01884519 | Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine, Fluarix®/Influsplit SSW® (2013/2014 Season), in Adults 18 Years of Age and Older | COMPLETED | PHASE3 | 2013-07-01 | 2013-08-02 | 2013-08-02 |
| NCT01873339 | Pharmacokinetic Interaction of Darapladib and CYP 3A4 in Healthy Subjects | COMPLETED | PHASE1 | 2013-06-19 | 2013-09-12 | 2013-09-12 |
| NCT01746108 | Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine (Synflorix™) When Administered to Children Who Are at an Increased Risk of Pneumococcal Infection | COMPLETED | PHASE3 | 2013-06-18 | 2015-06-29 | 2015-06-29 |
| NCT01831804 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single and Repeated Doses of Topical GSK1278863 | COMPLETED | PHASE1 | 2013-06-17 | 2017-02-10 | 2017-02-10 |
| NCT01777321 | Safety and Immunogenicity Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A When Administered Subcutaneously Intramuscularly in Adults Aged ≥50 Years | COMPLETED | PHASE3 | 2013-06-17 | 2014-11-11 | 2013-10-10 |
| NCT01879462 | A First Time in Human Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single & Repeat Escalating Doses of GSK2878175 in Healthy Subjects | COMPLETED | PHASE1 | 2013-06-14 | 2014-01-10 | 2014-01-10 |
| NCT01879410 | A Study to Compare the Efficacy and Safety of Umeclidinium/Vilanterol With Fluticasone Propionate/Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2013-06-13 | 2014-01-09 | 2014-01-01 |
| NCT01853878 | A Study to Demonstrate the Benefit of a New Kind of Anti-cancer Treatment [PReferentially Expressed Antigen of MElanoma (PRAME) Immunotherapy] for Patients With Non-Small Cell Lung Cancer (NSCLC), After Removal of Their Tumor | COMPLETED | PHASE2 | 2013-06-12 | 2016-08-24 | 2016-08-24 |
| NCT01867996 | A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Retosiban (GSK221149) When Dosed With Efavirenz (EFZ) | COMPLETED | PHASE1 | 2013-06-11 | 2013-09-26 | 2013-09-26 |
| NCT01827839 | Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A in Adults With a Prior Episode of Herpes Zoster | COMPLETED | PHASE3 | 2013-06-10 | 2014-11-25 | 2014-02-10 |
| NCT02498288 | A Study to Determine Bioequivalence of Isotretinoin in Healthy Male Subjects Under Fed Condition | COMPLETED | PHASE1 | 2013-05-31 | 2013-07-15 | 2013-07-15 |
| NCT04123665 | A Phase 3 Clinical Study Investigating the Gingivitis Efficacy of a Test Dentifrice Containing Stannous Fluoride | COMPLETED | PHASE3 | 2013-05-28 | 2013-12-11 | 2013-12-11 |
| NCT01827657 | Study to Evaluate the Pharmacokinetics and Safety of GSK2336805 in Subjects With Hepatic Impairment and Healthy Matched Control Subjects | COMPLETED | PHASE1 | 2013-05-28 | 2014-03-20 | 2014-03-20 |
| NCT01842607 | A Study to Determine Long-term Safety of Mepolizumab in Asthmatic Subjects | COMPLETED | PHASE3 | 2013-05-27 | 2015-03-13 | 2015-03-13 |
| NCT01827631 | Single and Repeat Dose Pharmacokinetic Study of GSK1605786 in Healthy Chinese Subjects | COMPLETED | PHASE1 | 2013-05-27 | 2013-06-25 | 2013-06-14 |
| NCT01797926 | Study to Determine the Bioequivalence of Two Fixed Dose Combination (FDC) Tablet Formulations of Amlodipine and Losartan FDC5/50 and FDC5/100 Under Fasting Conditions | COMPLETED | PHASE1 | 2013-05-23 | 2013-07-25 | 2013-07-25 |
| NCT01857869 | Efficacy, Safety and Immunogenicity Study of GlaxoSmithKline(GSK) Biologicals' Candidate Malaria Vaccine 257049 in the Sporozoite Challenge Model in Healthy Malaria-naïve Adults | COMPLETED | PHASE2 | 2013-05-20 | 2014-12-16 | 2014-03-24 |
| NCT01899638 | Pharmacokinetics Of Umeclidinium and Vilanterol in Healthy Chinese, a Randomized, Open Label, 3 Crossover Study. | COMPLETED | PHASE1 | 2013-05-20 | 2013-07-25 | 2013-07-25 |
| NCT01808261 | Proof of Concept (POC) in Patients With Ischaemic Stroke | TERMINATED | PHASE2 | 2013-05-18 | 2014-07-28 | 2014-07-28 |
| NCT01857895 | Feasibility Study of Exenatide by Continuous Subcutaneous Infusion | COMPLETED | PHASE1 | 2013-05-16 | 2013-11-01 | 2013-11-01 |
| NCT01847417 | Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of Acetylsalicylic Acid (ASA) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fed Conditions | COMPLETED | PHASE1 | 2013-05-16 | 2013-07-01 | 2013-07-01 |
| NCT01852565 | Study to Determine the Effect of Repeated Administration of Diltiazem on the Pharmacokinetics of Darapladib (Sb-480848). | COMPLETED | PHASE1 | 2013-05-14 | 2013-09-30 | 2013-09-30 |
| NCT01847404 | Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of ASA (Acetylsalicylic Acid) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fasting Conditions | COMPLETED | PHASE1 | 2013-05-14 | 2013-06-28 | 2013-06-28 |
| NCT01777243 | A Study to Evaluate the Safety of GSK2398852 When Co-administered With GSK2315698 in Patients With Systemic Amyloidosis | COMPLETED | PHASE1 | 2013-05-13 | 2015-12-22 | 2015-12-22 |
| NCT01777308 | Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' MenACWY-TT Vaccine Administered 6 Years Post-MenC Primary Vaccination in Healthy Subjects Who Were 12-18 Months at Primary Vaccination | COMPLETED | PHASE3 | 2013-05-03 | 2016-04-20 | 2014-07-03 |
| NCT01817777 | An Open Study to Evaluate Whether Pack Size Affects Compliance of Metformin Treatment in Subjects With Type II Diabetes | TERMINATED | PHASE4 | 2013-05 | 2014-02 | 2014-02 |
| NCT01847443 | Comparison of Pharmacokinetic Profiles of Two Nicotine Gum Formulations | COMPLETED | PHASE1 | 2013-05 | 2013-06 | 2013-06 |
| NCT01868009 | DISKUS vs. ELLIPTA Device Preference Study in Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2013-05 | 2013-07 | 2013-07 |
| NCT01938508 | Minocycline Bioequivalence Study | COMPLETED | PHASE1 | 2013-05 | 2013-06 | 2013-06 |
| NCT01879423 | The Bioequivalence Study of Lamotrigine Dispersible/Chewable Tablets 5mg×5 Compared With Lamotrigine Compressed Tablet 25mg in Chinese Healthy Male Subjects | COMPLETED | PHASE1 | 2013-04-28 | 2013-06-06 | 2013-06-06 |
| NCT01827644 | Bioavailability and Food Effect of the Original Gelatin Formulation and Two New Formulations of Afuresertib in Normal Healthy Volunteers | COMPLETED | PHASE1 | 2013-04-24 | 2013-07-12 | 2013-07-12 |
| NCT01831791 | A Long-term Study to Determine Safety and Efficacy of Dutasteride in Male Subjects With Androgenetic Alopecia | COMPLETED | PHASE3 | 2013-04-14 | 2014-07-19 | 2014-07-19 |
| NCT01777139 | A Long-term, Safety, Tolerability, and Efficacy Study of Retigabine Immediate-release (IR) in Asian Adults With Partial Onset Seizures | COMPLETED | PHASE3 | 2013-04-11 | 2017-09-13 | 2016-12-14 |
| NCT01822899 | A Study to Evaluate the Efficacy and Safety of Umeclidinium Bromide/Vilanterol Compared With Fluticasone Propionate/Salmeterol Over 12 Weeks in Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2013-04-04 | 2013-10-07 | 2013-10-01 |
| NCT01822639 | A Fixed Dose Combination Amlodipine + Enalapril Bioavailability Study | COMPLETED | PHASE1 | 2013-04-03 | 2013-05-24 | 2013-05-24 |
| NCT01842633 | Clinical Study to Evaluate Efficacy of New Paracetamol Formulation Compared to Ibuprofen in Headache | TERMINATED | PHASE3 | 2013-04-01 | 2015-03-31 | 2015-03-31 |
| NCT01762852 | Efficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous Nephropathy | WITHDRAWN | PHASE2 | 2013-04 | 2014-01 | 2014-01 |
| NCT01915732 | A Efficacy and Safety of Duac™Compared With Clindamycin Phosphate Gel in the Treatment of Mild to Moderate Acne Vulgaris | COMPLETED | PHASE3 | 2013-04 | 2014-04 | 2014-04 |
| NCT01480596 | The Evaluation of Belimumab in Myasthenia Gravis (MG) | COMPLETED | PHASE2 | 2013-04 | 2015-10 | 2015-08 |
| NCT01808326 | A Phase II, Open Label, Single Arm, Multicenter Study of Chlorambucil in Japanese Previously Untreated Patients With Chronic Lymphocytic Leukemia | COMPLETED | PHASE2 | 2013-04 | 2014-11 | 2014-11 |
| NCT01607346 | An Open Label Study to Evaluate the Effects of Ezogabine/Retigabine Added to Existing Anti-epileptic Drug(s) on Urinary Voiding Function in Subjects With Partial Onset Seizures | TERMINATED | PHASE4 | 2013-03-27 | 2016-11-16 | 2016-11-16 |
| NCT01788228 | Safety and Tolerability Study of GlaxoSmithKline (GSK)1557484A Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure | COMPLETED | PHASE3 | 2013-03-22 | 2015-02-25 | 2014-03-27 |
| NCT02141217 | AUGMENTIN™ in Dental Infections | COMPLETED | PHASE4 | 2013-03-21 | 2013-12-28 | 2013-12-28 |
| NCT01663623 | Belimumab in Remission of VASculitis | COMPLETED | PHASE3 | 2013-03-20 | 2017-02-06 | 2017-02-06 |
| NCT01766206 | Safety of One Dose of Meningococcal ACWY Conjugate Vaccine in Subjects From 2 Months to 55 Years of Age in the Republic of South Korea | COMPLETED | PHASE4 | 2013-03-15 | 2018-01-22 | 2018-01-22 |
| NCT01842620 | OXEMET™ 1000 mg Coated Tablets (Metformin Hydrochloride) Bioequivalence Study. OXEMET (TM) is a Trademark of the GlaxoSmithKline Group of Companies. GLAFORNIL(TM) is a Trademark of Merck. | COMPLETED | PHASE4 | 2013-03-13 | 2013-05-04 | 2013-05-04 |
| NCT01808482 | A First Time in Human Study Exploring Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2618960 in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis (RRMS) | TERMINATED | PHASE1 | 2013-03-13 | 2013-08-06 | 2013-08-06 |
| NCT01751165 | Safety and Immunogenicity of Different Dosing Schedules of GlaxoSmithkline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine in Adults 50 Years of Age or Older | COMPLETED | PHASE3 | 2013-03-12 | 2015-04-08 | 2014-05-22 |
| NCT01725139 | A Proof of Mechanism Study With GSK2126458 in Patients With Idiopathic Pulmonary Fibrosis (IPF) | COMPLETED | PHASE1 | 2013-03-08 | 2016-07-12 | 2016-07-12 |
| NCT01798056 | Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving Chemotherapy | COMPLETED | PHASE3 | 2013-03-06 | 2016-05-20 | 2015-06-18 |
| NCT01767467 | Study to Assess the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults Aged 18 Years and Older With Blood Cancers | COMPLETED | PHASE3 | 2013-03-01 | 2017-01-06 | 2016-01-07 |
| NCT01817764 | A Study to Compare the Efficacy and Safety of Umeclidinium/Vilanterol and Fluticasone Propionate/Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2013-03-01 | 2013-10-25 | 2013-10-01 |
| NCT01777256 | An Adaptive Phase II Study to Evaluate the Efficacy, Pharmacodynamics, Safety and Tolerability of GSK2586184 | TERMINATED | PHASE2 | 2013-03-01 | 2014-03-31 | 2014-03-01 |
| NCT01782664 | A Dose Ranging Study to Evaluate the Safety and Efficacy of GSK2586184 in Patients With Chronic Plaque Psoriasis | COMPLETED | PHASE2 | 2013-03-01 | 2014-03-24 | 2014-03-01 |
| NCT01808339 | To Investigate the Effects of Altering the Time of Day of Dosing (Morning or Evening) With Fluticasone Furoate 100 Micrograms Once Daily Administered Via a Dry Powder Inhaler in Subjects With Asthma | COMPLETED | PHASE2 | 2013-03 | 2014-03 | 2014-03 |
| NCT01055600 | Milk-only Lactation Study for Patients on Eltrombopag | WITHDRAWN | PHASE4 | 2013-03 | 2014-07 | 2014-07 |
| NCT01788813 | To Investigate the Safety, Pharmacodynamics and Effect on Allergic Reactivity of the Toll-like Receptor 7 (TLR7) Agonist GSK2245035 in Subjects With Respiratory Allergies | COMPLETED | PHASE2 | 2013-03 | 2014-08 | 2014-08 |
| NCT01440361 | A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia. | WITHDRAWN | PHASE2 | 2013-03 | 2015-04 | 2015-04 |
| NCT01777295 | Development of Read-outs in Healthy, Hepatitis B Virus Naive Adults Vaccinated With the Hepatitis B Surface Antigen (HBsAg) in Combination With a GlaxoSmithKline (GSK) Biologicals' Adjuvant System | COMPLETED | PHASE2 | 2013-02-25 | 2016-09-13 | 2016-05-17 |
| NCT01711749 | Rosuvastatin Calcium Bioequivalence Study - Fast | COMPLETED | PHASE1 | 2013-02-25 | 2013-03-13 | 2013-03-13 |
| NCT01777282 | A Study to Determine the Long Term Safety and Efficacy of Albiglutide in Combination With Oral Monotherapy Antihyperglycemic Medications in Japanese Patients With Type 2 Diabetes Mellitus | COMPLETED | PHASE3 | 2013-02-23 | 2015-01-27 | 2015-01-27 |
| NCT01910662 | Characterisation of T-cell Response to Keyhole Limpet Hemocyanin (KLH) and Tuberculin Purified Protein Derivative (PPD) | COMPLETED | PHASE1 | 2013-02-22 | 2013-11-26 | 2013-11-26 |
| NCT01818024 | A Study to Investigate the Safety Tolerability Pharmacokinetics, and Pharmacodynamics of Inhaled and Intravenous GSK2862277 in Healthy Volunteers | COMPLETED | PHASE1 | 2013-02-22 | 2013-10-25 | 2013-10-25 |
| NCT01632241 | Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE) | COMPLETED | PHASE4 | 2013-02-19 | 2019-01-28 | 2018-06-18 |
| NCT01777269 | Prospective Sexual Function Study for BPH Subjects | COMPLETED | PHASE4 | 2013-02-18 | 2016-04-05 | 2016-04-05 |
| NCT01802918 | Single Dose Escalation Study of GSK2838232 in Healthy Subjects | COMPLETED | PHASE1 | 2013-02-18 | 2013-11-21 | 2013-11-21 |
| NCT01767454 | Study of Dabrafenib +/- Trametinib in Combination With Ipilimumab for V600E/K Mutation Positive Metastatic or Unresectable Melanoma | COMPLETED | PHASE1 | 2013-02-12 | 2015-09-04 | 2015-09-04 |
| NCT01725126 | To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes | COMPLETED | PHASE2 | 2013-02-10 | 2013-09-12 | 2013-09-12 |
| NCT02254460 | Investigation of Iron Uptake From Micronutrient Fortified Powder Versus From Tailored Control in Milk | COMPLETED | NA | 2013-02-06 | 2013-03-08 | 2013-03-01 |
| NCT01725100 | A Study to Determine the Relative Bioavailability of the MEK Inhibitor, Trametinib, in Subjects With Solid Tumor Malignancies | COMPLETED | PHASE1 | 2013-02-05 | 2015-01-30 | 2015-01-30 |
| NCT01716533 | Evaluation of the Immune Response to Clostridium Difficile in Adults With Clostridium Difficile Infection (CDI) | COMPLETED | NA | 2013-02-02 | 2015-06-01 | 2015-06-01 |
| NCT02014480 | A Cross-Over Study to Evaluate Lung Function Response After Treatment With Umeclidinium (UMEC) 62.5 Micrograms (mcg), Vilanterol (VI) 25 mcg, and Umeclidinium/Vilanterol (UMEC/VI) 62.5/25 mcg Once-Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2013-02-01 | 2013-06-11 | 2013-06-01 |
| NCT01751113 | A 3 Way Cross-over Study Evaluating the Effects of ADOAIR Twice Daily Plus Tiotropium Bromide Once Daily Compared With the Individual Treatments of Japanese Subjects | COMPLETED | PHASE4 | 2013-02 | 2013-11 | 2013-11 |
| NCT01733758 | A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM) | COMPLETED | PHASE3 | 2013-02 | 2015-02 | 2014-06 |
| NCT01772199 | Study to Assess Whether GSK239512 Can Remyelinate Lesions in Subjects With Relapsing Remitting Multiple Sclerosis | COMPLETED | PHASE2 | 2013-02 | 2014-09 | 2014-09 |
| NCT01762800 | Evaluating the Control of COPD Symptoms in Patients Treated With Tiotropium Bromide 18mcg Once Daily Alone, ADOAIR 50/250mcg Twice Daily Alone or ADOAIR 50/250mcg Plus Tiotropium Bromide 18mcg | COMPLETED | PHASE4 | 2013-02 | 2015-09 | 2015-09 |
| NCT01827670 | Investigating the Efficacy of a Dentifrice in Providing Long Term Relief From Dentinal Hypersensitivity | COMPLETED | PHASE3 | 2013-02 | 2013-05 | 2013-05 |
| NCT01658605 | A Study to Investigate the Efficacy and Safety of GSK1605786 for Treatment of Patients With Active Ulcerative Colitis | WITHDRAWN | PHASE2 | 2013-02 | 2014-12 | 2013-02 |
| NCT01738477 | Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Previously Boosted Young Adults | COMPLETED | PHASE3 | 2013-01-31 | 2014-04-02 | 2014-04-02 |
| NCT01777334 | The Purpose of This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily Compared With Tiotriopium 18 mcg Once Daily Over a 24-week Treatment Period in Subjects With COPD | COMPLETED | PHASE3 | 2013-01-23 | 2013-09-24 | 2013-09-24 |
| NCT01738451 | A Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive Tumors | COMPLETED | PHASE1 | 2013-01-22 | 2014-11-28 | 2014-11-28 |
| NCT01762774 | A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of GSK2256294 in Healthy Volunteers, and Single and Repeat Doses of GSK2256294 in Adult Male Moderately Obese Smokers | COMPLETED | PHASE1 | 2013-01-16 | 2014-05-01 | 2014-05-01 |
| NCT01793870 | A Study in Healthy Volunteers to Evaluate the Application of Stable Isotope Approach to Reduce Number of Subjects Needed for PK Studies | COMPLETED | PHASE1 | 2013-01-15 | 2013-06-17 | 2013-06-17 |
| NCT01755689 | Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Vaccine With or Without Co-administration of Cervarix and Boostrix in Female Adolescents and Young Adults | COMPLETED | PHASE3 | 2013-01-11 | 2014-04-29 | 2014-04-29 |
| NCT01767376 | Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Conjugate Vaccine (GSK134612) When Co-administered With Boostrix® in Subjects Between 11 and 25 Years of Age | COMPLETED | PHASE3 | 2013-01-10 | 2014-01-16 | 2014-01-16 |
| NCT01756495 | A Study to Evaluate the Effect of Losmapimod on Cardiac Conduction as Compared to Placebo and Moxifloxacin | COMPLETED | PHASE1 | 2013-01-10 | 2013-04-23 | 2013-04-23 |
| NCT01762878 | A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of the Dry Powder Formulation of GSK2269557 in Healthy Subjects | COMPLETED | PHASE1 | 2013-01-09 | 2013-10-21 | 2013-10-21 |
| NCT01802931 | GSK239512 DDI Study | COMPLETED | PHASE1 | 2013-01-07 | 2013-04-15 | 2013-04-15 |
| NCT01772134 | Efficacy and Safety of the Addition of Fluticanse Propionate/Salmeterol (250/50mcg) Twice-daily to 2 Doses of Umeclidinium Bromide (62.5 or 125mcg) Once-daily Over 12 Weeks | COMPLETED | PHASE3 | 2013-01-01 | 2013-07-22 | 2013-07-01 |
| NCT01772147 | Efficacy and Safety of the Addition of Fluticasone Propionate/Salmeterol (250/50mcg) Twice-daily to 2 Doses of Umeclidinium Bromide Inhalation Powder (62.5 or 125mcg) Once-daily Over 12 Weeks. | COMPLETED | PHASE3 | 2013-01 | 2013-08 | 2013-08 |
| NCT01831817 | Exploratory Study to Evaluate the Efficacy of an Occlusion Based Dentifrice in Relief of Dentinal Hypersensitivity | COMPLETED | PHASE2 | 2013-01 | 2013-05 | 2013-05 |
| NCT01753076 | Study of Ozanezumab (GSK1223249) Versus Placebo in the Treatment of Amyotrophic Lateral Sclerosis | COMPLETED | PHASE2 | 2012-12-20 | 2015-01-22 | 2015-01-22 |
| NCT01721317 | Dose-Optimization, Adjunctive Treatment Study of Ezogabine/Retigabine Immediate Release in Partial-onset Seizures | TERMINATED | PHASE4 | 2012-12-19 | 2013-06-20 | 2013-06-20 |
| NCT01751074 | To Estimate the Potential Effects of Repeat Doses of Darapladib on the Pharmacokinetics (PK) of Rosuvastatin as Well as Evaluating Safety and Tolerability in Healthy Volunteers | COMPLETED | PHASE1 | 2012-12-17 | 2013-03-14 | 2013-03-14 |
| NCT01691547 | A Study to Assess the Systemic Exposure, Systemic Pharmacodynamics and Safety and Tolerability of FluticasoneFuroate, Umeclidinium and Vilanterol in Healthy Subjects | COMPLETED | PHASE1 | 2012-12-17 | 2013-03-08 | 2013-03-08 |
| NCT01738867 | To Evaluate the Influence of the A118G Polymorphism in the mu Opioid Receptor Gene (OPRM1) on Effects of GSK1521498 and Naltrexone on Physiological and Behavioural Markers of Brain Function in Healthy Social Drinkers | COMPLETED | PHASE1 | 2012-12-12 | 2014-05-27 | 2014-05-27 |
| NCT01577732 | Safety of GSK Biologicals' Infanrix-IPV+HibTM Vaccine in Healthy Vietnamese Toddlers | COMPLETED | PHASE3 | 2012-12-08 | 2013-04-09 | 2013-04-09 |
| NCT01711463 | Relovair PD PK in Chinese Healthy Subjects | COMPLETED | PHASE1 | 2012-12-05 | 2013-06-04 | 2013-06-04 |
| NCT01730378 | Immunogenicity and Safety of PrepandrixTM in Korean Subjects Aged 18 to 60 Years Old | COMPLETED | PHASE4 | 2012-12-05 | 2013-12-17 | 2013-12-17 |
| NCT01808313 | Efficacy Study of Ambrisentan in Chinese Patients With Pulmonary Arterial Hypertension (PAH) | COMPLETED | PHASE3 | 2012-12-01 | 2014-08-15 | 2014-08-15 |
| NCT01817790 | Assessment of Fluticasone Propionate on Ocular Allergy Symptoms | COMPLETED | PHASE3 | 2012-12 | 2013-02 | 2013-02 |
| NCT01705977 | Belimumab Assessment of Safety in SLE | COMPLETED | PHASE4 | 2012-11-27 | 2022-08-10 | 2018-07-30 |
| NCT01687296 | Nebulized Fluticasone Propionate VS Oral Prednisone in Chinese Pediatric and Adolescent Subjects With an Acute Exacerbation of Asthma | COMPLETED | PHASE3 | 2012-11-12 | 2013-06-21 | 2013-06-01 |
| NCT01702428 | Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M-M-R II), in Children 12 to 15 Months of Age | COMPLETED | PHASE3 | 2012-11-09 | 2015-04-16 | 2014-11-25 |
| NCT01725685 | To Investigate the Pharmacokinetics and Safety of Fluticasone Furoate (FF)/ Umeclidinium (UMEC) Combination Compared With FF and UMEC Monotherapies in Adult Healthy Volunteers Using a Dry Powder Inhaler (DPI) | COMPLETED | PHASE1 | 2012-11-08 | 2013-01-02 | 2013-01-02 |
| NCT01702480 | Effects of Triglycerides on Age-Related Cognitive Function Decline in Older Subjects | COMPLETED | PHASE1 | 2012-11-05 | 2015-07-03 | 2015-07-03 |
| NCT01802892 | Study in Healthy Volunteers, to Evaluate the Safety, Efficacy and Dose Responses of SB-751689 (Ronacaleret) | COMPLETED | PHASE1 | 2012-11-02 | 2013-04-02 | 2013-04-02 |
| NCT01733238 | Study of PNT2258 for Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma | COMPLETED | PHASE2 | 2012-11 | 2016-08 | 2016-08 |
| NCT01711736 | Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children 6 to 35 Months of Age | COMPLETED | PHASE3 | 2012-11-01 | 2013-06-19 | 2013-02-21 |
| NCT01706198 | An Effectiveness Study Comparing Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) With Standard Treatment in Asthma | COMPLETED | PHASE3 | 2012-11-01 | 2016-12-16 | 2016-12-01 |
| NCT01691885 | RELOVAIR® Lung Deflation Study | COMPLETED | PHASE3 | 2012-11 | 2014-08 | 2014-07 |
| NCT01702493 | A Study to Assess the Relative Bioavailability of New Oral Formulations of SRT2104 in Healthy Male Volunteers | COMPLETED | PHASE1 | 2012-10-30 | 2012-12-05 | 2012-12-05 |
| NCT01711723 | A Study to Assess the Pharmacokinetics, Safety and Tolerability of Repeat Oral Doses of Darapladib (SB-480848) in Subjects With Severe Renal Impairment | COMPLETED | PHASE1 | 2012-10-29 | 2013-03-25 | 2013-03-25 |
| NCT01702467 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single, Oral Escalating Doses of GSK2647544 in Healthy Volunteers | COMPLETED | PHASE1 | 2012-10-19 | 2013-05-15 | 2013-05-15 |
| NCT01706315 | This Study Will Investigate the Safety, Tolerability and Pharmacokinetic Profile of Repeat Oral Doses of GSK2140944 in Healthy Adult Subjects | COMPLETED | PHASE1 | 2012-10-17 | 2013-12-13 | 2013-12-13 |
| NCT01627561 | Safety and Immunogenicity of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) in Healthy Female Children 4-6 Years Old | COMPLETED | PHASE3 | 2012-10-15 | 2016-10-06 | 2014-04-23 |
| NCT01706328 | A Study to Assess the Efficacy of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25 mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50 mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2012-10-15 | 2013-06-17 | 2013-06-17 |
| NCT01681992 | Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life | COMPLETED | PHASE3 | 2012-10-10 | 2015-08-18 | 2015-02-03 |
| NCT01691872 | Pharmacokinetic Study of Retigabine Extended Release (XR) Formulation in Healthy Adult Japanese and Caucasian Subjects | WITHDRAWN | PHASE1 | 2012-10-10 | 2012-10-18 | 2012-10-18 |
| NCT01691521 | Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma | COMPLETED | PHASE3 | 2012-10-08 | 2014-01-18 | 2014-01-01 |
| NCT01682876 | Immunogenicity, Safety and 1 Year Persistence of Antibodies After Either One or Two Doses of Meningococcal ACWY Conjugate Vaccine in Healthy Children 2 Through 10 Years of Age. | COMPLETED | PHASE3 | 2012-10-07 | 2014-05-30 | 2013-07-02 |
| NCT01702454 | Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345 | COMPLETED | PHASE3 | 2012-10-06 | 2013-06-05 | 2013-05-06 |
| NCT01691820 | A Study in Adolescent Females to Explore Cytomegalovirus Infection | COMPLETED | NA | 2012-10-05 | 2017-04-08 | 2017-04-08 |
| NCT01702376 | This Study Will Investigate the Effect of Single Oral Doses of Retosiban on Cardiac Repolarization, With Moxifloxacin as a Positive Control in Healthy Volunteers. | COMPLETED | PHASE1 | 2012-10-03 | 2013-01-14 | 2013-01-14 |
| NCT01691508 | Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma | COMPLETED | PHASE3 | 2012-10 | 2013-12 | 2013-12 |
| NCT01716520 | Cross-Over Study in Subjects With COPD, Evaluating Lung Function Response After Treatment With Once Daily Umeclidinium 62.5mcg, Vilanterol 25mcg, and Umeclidinium/Vilanterol 62.5/25mcg | COMPLETED | PHASE3 | 2012-10 | 2013-03 | 2013-03 |
| NCT01751178 | An Efficacy Study of Chlorhexidine Mouthwashes | COMPLETED | PHASE4 | 2012-10 | 2013-03 | 2013-03 |
| NCT01691859 | MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects | COMPLETED | PHASE3 | 2012-09-28 | 2017-05-31 | 2017-05-31 |
| NCT01343043 | A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcoma | COMPLETED | PHASE1 | 2012-09-27 | 2019-06-18 | 2019-06-18 |
| NCT01687283 | Efficacy and Safety Study of Fluticasone Proponate Inhalation Solution in Adult and Adolescent Asthma | COMPLETED | PHASE3 | 2012-09-27 | 2013-11-07 | 2013-11-07 |
| NCT01725672 | Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Extended Release Metformin and Extended Release Glimepiride in Health Volunteers | TERMINATED | PHASE1 | 2012-09-27 | 2013-08-21 | 2013-08-21 |
| NCT01696604 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2849466 in Healthy Male Subjects | COMPLETED | PHASE1 | 2012-09-26 | 2013-05-03 | 2013-05-03 |
| NCT01686633 | An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (mcg) , FF/VI 100/25 mcg, and FF 100 mcg in Adults and Adolescents With Persistent Asthma. | COMPLETED | PHASE3 | 2012-09-20 | 2013-10-15 | 2013-10-01 |
| NCT01658553 | A Study to Look at the Electrical Activity of the Heart in Subjects With Solid Tumor Cancers, Before and After Receiving the Study Treatment, GSK1120212 | COMPLETED | PHASE1 | 2012-09-19 | 2014-04-05 | 2014-04-05 |
| NCT01641042 | Comparison of GlaxoSmithKline (GSK)134612 in Subjects With Increased Risk for Meningococcal Disease Versus Healthy Subjects | COMPLETED | PHASE3 | 2012-09-10 | 2015-03-03 | 2014-10-10 |
| NCT01649765 | Pediatric Lupus Trial of Belimumab Plus Background Standard Therapy | ACTIVE_NOT_RECRUITING | PHASE2 | 2012-09-07 | 2028-04-05 | 2018-01-24 |
| NCT01641133 | Primary Vaccination With Either Synflorix™ or Prevenar 13™ or Both Vaccines and Booster Vaccination With Synflorix™ | COMPLETED | PHASE3 | 2012-09-04 | 2014-05-07 | 2013-07-15 |
| NCT01668654 | Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS | TERMINATED | PHASE3 | 2012-09-04 | 2013-06-18 | 2013-06-18 |
| NCT01340846 | A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors | COMPLETED | PHASE1 | 2012-09-03 | 2012-11-14 | 2012-11-14 |
| NCT01597635 | The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury | COMPLETED | PHASE2 | 2012-09-01 | 2014-10-06 | 2014-10-01 |
| NCT01702532 | Nicotine Mouth Film for Craving Relief. | COMPLETED | PHASE3 | 2012-09 | 2012-12 | 2012-12 |
| NCT01653483 | Aura Adolescent PK Study GSK2829332 | WITHDRAWN | PHASE2 | 2012-09 | 2013-03 | 2012-09 |
| NCT01678677 | A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Non-typeable Haemophilus Influenzae (NTHi) Investigational Vaccine (GSK2838497A) in Current and Former Smokers | COMPLETED | PHASE1 | 2012-08-31 | 2014-01-30 | 2014-01-30 |
| NCT01648101 | Assessment of the Efficacy and Safety of 2 Doses of Retigabine Immediate Release (900 mg/Day and 600 mg/Day) Used as Adjunctive Therapy in Adult Asian Subjects With Drug-resistant Partial-onset Seizures | TERMINATED | PHASE3 | 2012-08-29 | 2013-12-23 | 2013-12-01 |
| NCT01657851 | Bioequivalence - Duodart Against Avodart & Omnic | COMPLETED | PHASE1 | 2012-08-23 | 2012-12-05 | 2012-12-05 |
| NCT01659086 | Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccines GSK2654911A and GSK2654909A Administered to Adults 18 to 64 Years of Age | COMPLETED | PHASE1 | 2012-08-22 | 2014-03-19 | 2012-10-26 |
| NCT01669096 | Study in Healthy Adults to Evaluate Gene Activation After Vaccination With GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine GSK 692342 | COMPLETED | PHASE2 | 2012-08-21 | 2013-05-24 | 2012-12-06 |
| NCT01669083 | Study to Evaluate the Pharmacokinetics, Safety and Tolerability of GSK557296 in Healthy Women Volunteers After Single and Repeat Dosing | COMPLETED | PHASE1 | 2012-08-16 | 2013-03-09 | 2013-03-09 |
| NCT01669070 | A Four-way Crossover, Single and Repeat Dose Study to Determine the Dose Proportionality and Absolute Bioavailability of Fluticasone Furoate Inhalation Powder Administered by Novel Dry Powder Inhaler (NDPI) | COMPLETED | PHASE1 | 2012-08-15 | 2012-11-16 | 2012-11-16 |
| NCT01663389 | A Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C -GSK1322322 After an Intravenous and an Oral Dose | COMPLETED | PHASE1 | 2012-08-10 | 2012-10-05 | 2012-10-05 |
| NCT01657526 | Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Non-typeable Haemophilus Influenzae (NTHI) Vaccine | COMPLETED | PHASE1 | 2012-08-08 | 2013-11-25 | 2013-11-25 |
| NCT01648231 | Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Amlodipine and Losartan in Health Volunteers | COMPLETED | PHASE1 | 2012-08-06 | 2012-09-25 | 2012-09-25 |
| NCT01657552 | Eltrombopag/Boceprevir and Eltrombopag/Telaprevir Drug-Drug Interaction Study In Healthy Adult Subjects | COMPLETED | PHASE1 | 2012-08-01 | 2012-10-26 | 2012-10-26 |
| NCT01648140 | Dose Ranging of GSK2336805 in Combination Therapy | COMPLETED | PHASE2 | 2012-08-01 | 2014-07-16 | 2014-07-01 |
| NCT01648153 | Investigate the Efficacy and Safety of GSK1070806 in Obese Subjects With T2DM | COMPLETED | PHASE2 | 2012-08 | 2014-01 | 2013-09 |
| NCT01702363 | Long-term Safety Study for GSK573719 in Japanese | COMPLETED | PHASE3 | 2012-08 | 2013-12 | 2013-12 |
| NCT01602510 | Lamotrigine Phase III Study in Bipolar I Disorder | COMPLETED | PHASE3 | 2012-08 | 2015-12 | 2015-12 |
| NCT01691560 | Exploratory Study to Evaluate an Occlusion Based Dentifrice in Relief of Dentinal Hypersensitivity | COMPLETED | PHASE2 | 2012-08 | 2012-11 | 2012-11 |
| NCT01710540 | BE Study of Metformin GSK 850mg | COMPLETED | PHASE2 | 2012-08 | 2012-08 | 2012-08 |
| NCT01647659 | Relative Bioavailibilty for Pediatric Powder for Suspension (PfOS) Formulation | COMPLETED | PHASE1 | 2012-07-30 | 2012-11-12 | 2012-11-12 |
| NCT01494584 | Study in Pediatric Subjects With Epilepsy | TERMINATED | PHASE2 | 2012-07-25 | 2013-04-29 | 2013-04-29 |
| NCT01648192 | Phase I Study of GW856553 (Losmapimod) | COMPLETED | PHASE1 | 2012-07-24 | 2012-10-26 | 2012-10-26 |
| NCT01627340 | Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus | COMPLETED | PHASE4 | 2012-07-24 | 2013-12-18 | 2013-12-18 |
| NCT01691482 | A Study to Look at Day to Day Changes in Lung Function in COPD Subjects Taking Albuterol/Salbutamol and Ipratropium | COMPLETED | PHASE4 | 2012-07-23 | 2012-10-22 | 2012-10-01 |
| NCT01626820 | Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Fluviral® (2012/2013 Season) in Adults | COMPLETED | PHASE3 | 2012-07-19 | 2012-08-10 | 2012-08-10 |
| NCT01673529 | Investigation of Topical SB705498 on Healthy Volunteers | COMPLETED | PHASE1 | 2012-07-17 | 2012-10-04 | 2012-10-04 |
| NCT01610414 | Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A | COMPLETED | PHASE3 | 2012-07-13 | 2017-02-01 | 2016-11-04 |
| NCT01639339 | Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis | COMPLETED | PHASE3 | 2012-07-12 | 2020-03-12 | 2019-07-25 |
| NCT01616459 | Immunogenicity and Safety of Two Formulations of GSK Biologicals' Pneumococcal Vaccine (2830929A and 2830930A) When Administered in Healthy Infants | COMPLETED | PHASE2 | 2012-07-11 | 2014-01-22 | 2013-04-25 |
| NCT01607112 | A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix/Influsplit SSW 2012/2013 in People Aged 18 Years and Above | COMPLETED | PHASE3 | 2012-07-10 | 2012-07-31 | 2012-07-31 |
| NCT01610492 | A Study of Belimumab in Idiopathic Membranous Glomerulonephropathy | COMPLETED | PHASE2 | 2012-07-01 | 2016-09-14 | 2014-09-24 |
| NCT01636713 | A 24-week Study to Evaluate the Efficacy and Safety of GSK573719/GW642444 125/25 mcg and 62.5/25mcg Inhalation Powder Compared With Placebo in Subjects With COPD | COMPLETED | PHASE3 | 2012-07 | 2013-10 | 2013-10 |
| NCT01636778 | Japanese Phase II Study of SB-497115-GR in Hepatitis C Virus Infected Patients | COMPLETED | PHASE2 | 2012-07 | 2014-11 | 2014-05 |
| NCT01602549 | A Study to Assess the Effect of Repeat Doses of GSK962040 on the Pharmacokinetics of L-DOPA in Subjects With Parkinson's Disease Exhibiting Delayed Gastric Emptying | COMPLETED | PHASE2 | 2012-07 | 2014-05 | 2014-05 |
| NCT01536587 | Effects of Salmeterol on Autonomic Nervous System | COMPLETED | PHASE4 | 2012-07 | 2012-11 | 2012-11 |
| NCT01653509 | An Exploratory Study to Investigate the Inflammatory Response During a Cold Sore Episode | COMPLETED | PHASE1 | 2012-07 | 2012-09 | 2012-09 |
| NCT01710553 | BE STUDY OF METFORMIN GSK 1000mg | COMPLETED | PHASE2 | 2012-07 | 2012-07 | 2012-07 |
| NCT01673490 | Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia | TERMINATED | PHASE4 | 2012-06-29 | 2015-03-20 | 2015-03-20 |
| NCT01610427 | Study to Optimize the Quality of Samples for Cell-mediated Immunity (CMI) in ART-naïve HIV-1-infected Subjects | COMPLETED | NA | 2012-06-25 | 2012-10-30 | 2012-10-30 |
| NCT01621802 | Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age | COMPLETED | PHASE3 | 2012-06-21 | 2015-11-09 | 2015-07-06 |
| NCT01597687 | Pertussis Infection in Adolescents and Adults With Prolonged Cough | COMPLETED | NA | 2012-06-20 | 2013-05-02 | 2013-05-02 |
| NCT01597622 | BEL114333, a Continuation Study of BEL113750 in Subjects With Systemic Lupus Erythematosus (SLE) in Northeast Asia, and in Japan Subjects Completing the Open-label Extension of HGS1006-C1115 | COMPLETED | PHASE3 | 2012-06-11 | 2018-09-13 | 2018-09-13 |
| NCT01615796 | Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Repeat IV Doses | COMPLETED | PHASE1 | 2012-06-04 | 2014-02-21 | 2014-02-21 |
| NCT01630135 | Study FFR116364, a Placebo-controlled Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis | COMPLETED | PHASE3 | 2012-06 | 2012-08 | 2012-08 |
| NCT01622231 | Study FFR116365, an Open-label Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis | COMPLETED | PHASE3 | 2012-06 | 2012-11 | 2012-11 |
| NCT01669122 | Pharmacokinetic Study of 4 mg Nicotine Lozenge. | COMPLETED | PHASE2 | 2012-06 | 2012-08 | 2012-08 |
| NCT01604863 | A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies | SUSPENDED | PHASE1 | 2012-06 | 2014-07 | 2014-06 |
| NCT01597492 | A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE) | COMPLETED | PHASE4 | 2012-05-31 | 2015-09-24 | 2015-09-01 |
| NCT01418937 | Safety Evaluation of a Human Papillomavirus (HPV) Vaccine in Healthy Female Control Subjects From the GSK HPV 023 Study | COMPLETED | PHASE3 | 2012-05-29 | 2015-01-09 | 2015-01-09 |
| NCT01587924 | 4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease | COMPLETED | PHASE2 | 2012-05-23 | 2013-05-27 | 2013-05-27 |
| NCT01545375 | Evaluation of a Vaccine for Reducing Ear and Lung Infections in Children | COMPLETED | PHASE2 | 2012-05-21 | 2016-07-26 | 2016-07-26 |
| NCT01607385 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetic a Single Day of Dosing With GSK1614235. | COMPLETED | PHASE1 | 2012-05-18 | 2012-12-03 | 2012-12-03 |
| NCT01587898 | 4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis | COMPLETED | PHASE2 | 2012-05-17 | 2013-05-07 | 2013-05-07 |
| NCT01673555 | Effects of GSK1278863A on Pulmonary Artery Pressure in Healthy Volunteers | COMPLETED | PHASE1 | 2012-05-15 | 2012-11-19 | 2012-11-19 |
| NCT01582997 | A Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of of GSK2118436 in Japanese Subjects With BRAF Mutation Positive Solid Tumors | COMPLETED | PHASE1 | 2012-05-11 | 2015-04-16 | 2014-08-01 |
| NCT01710527 | BE Study of Metformin GSK 500mg | COMPLETED | PHASE2 | 2012-05-09 | 2012-05-18 | 2012-05-18 |
| NCT01602562 | Valaciclovir Hydrochloride Phase III for Hematopoietic Stem Cell Transplantation Patients | COMPLETED | PHASE3 | 2012-05-07 | 2013-05-24 | 2013-05-01 |
| NCT01622283 | Pharmacokinetic Study of Levocetirizine Oral Solution | COMPLETED | PHASE1 | 2012-05-02 | 2012-06-10 | 2012-06-10 |
| NCT01641692 | A 3-period Crossover Study With GSK573719 as Monotherapy in Adult Subjects With Asthma | COMPLETED | PHASE2 | 2012-05 | 2013-02 | 2013-02 |
| NCT01584843 | Efficacy and Safety of GSK1358820 (Botulinum Toxin Type A) in Patients With Strabismus | COMPLETED | PHASE3 | 2012-05 | 2014-06 | 2013-07 |
| NCT01657877 | Anti-caries Potential of a Sodium Monofluorophosphate and Calcium Sodium Phosphosilicate Dentifrice | COMPLETED | PHASE2 | 2012-05 | 2013-06 | 2013-06 |
| NCT01607398 | ADOAIR250 Anti-inflammatory Effects in Japanese Subjects With Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE4 | 2012-05 | 2013-07 | 2013-07 |
| NCT01687309 | A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GSK2586184 and the Effect of Food and Gender | COMPLETED | PHASE1 | 2012-04-30 | 2012-07-31 | 2012-07-31 |
| NCT01587716 | A Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2339345. | COMPLETED | PHASE1 | 2012-04-23 | 2012-07-30 | 2012-07-30 |
| NCT01353703 | Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine | COMPLETED | PHASE3 | 2012-04-16 | 2013-02-25 | 2013-02-25 |
| NCT01956487 | Bioequivalence of RYTHMOL SR® Manufactured at Two Different Sites | COMPLETED | PHASE1 | 2012-04-11 | 2012-06-27 | 2012-06-27 |
| NCT01462669 | Crossover Study to Evaluate the Pharmacokinetics of Ezogabine/Retigabine in Taiwanese Subjects | COMPLETED | PHASE1 | 2012-04-10 | 2012-06-27 | 2012-06-27 |
| NCT01573624 | Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma | COMPLETED | PHASE2 | 2012-04-03 | 2013-02-04 | 2013-02-04 |
| NCT01494532 | A Fixed Dose Study of Ropinirole Prolonged Release as Adjunctive Treatment in Patients With Advanced Parkinson's Disease | COMPLETED | PHASE4 | 2012-04-02 | 2014-11-18 | 2014-11-18 |
| NCT01627327 | Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once Daily Compared With Tiotropium Bromide Inhalation Powder 18mcg Once Daily in Subjects With COPD Who Have or Are At Risk for Co-morbid Cardiovascular Disease | COMPLETED | PHASE3 | 2012-04-01 | 2012-12-21 | 2012-12-01 |
| NCT01858831 | Single Oral Dose Study of Atovaquone/Proguanil Hydrochloride Combination Tablets and Atovaquone Suspension | COMPLETED | PHASE1 | 2012-04 | 2012-05 | 2012-05 |
| NCT01607372 | A Study to Investigate the Safety and Pharmacodynamics of Repeat Intranasal Administration of the TLR7 Agonist GSK2245035 in Subjects With Respiratory Allergies | COMPLETED | PHASE2 | 2012-04 | 2013-09 | 2013-09 |
| NCT01563081 | Safety Study of Levocetirizine Oral Solution for Japanese Pediatrics | COMPLETED | PHASE3 | 2012-04 | 2012-08 | 2012-08 |
| NCT01573767 | Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children | COMPLETED | PHASE2 | 2012-04 | 2014-04 | 2014-04 |
| NCT01563055 | A Phase I/II, Open-label Study of Ofatumumab Added to Chlorambucil in Previously Untreated Japanese Patients With Chronic Lymphocytic Leukemia | COMPLETED | PHASE2 | 2012-04 | 2014-11 | 2014-11 |
| NCT01592851 | Clinical Efficacy of a Toothpaste in Providing Relief From the Pain of Dentinal Hypersensitivity | COMPLETED | PHASE3 | 2012-04 | 2012-05 | 2012-05 |
| NCT01755637 | Bioequivalence Study of Albendazole 400 mg Tablets in Chinese Population | COMPLETED | PHASE1 | 2012-04 | 2012-06 | 2012-04 |
| NCT01571999 | Study to Assess the Safety and PK of GSK573719 and GSK573719/GW642444(VI) Combination in Healthy Subjects and Subjects With Severe Renal Impairment | COMPLETED | PHASE1 | 2012-03-29 | 2012-06-22 | 2012-06-22 |
| NCT01587703 | A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK525762 in Subjects With NUT Midline Carcinoma (NMC) and Other Cancers | COMPLETED | PHASE1 | 2012-03-28 | 2019-07-29 | 2018-04-13 |
| NCT01587807 | A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Inhaled GSK1995057 | COMPLETED | PHASE1 | 2012-03-28 | 2012-11-19 | 2012-11-19 |
| NCT01563029 | A Dose-ranging Study of Fluticasone Furoate (FF) | COMPLETED | PHASE2 | 2012-03-28 | 2014-09-24 | 2014-09-24 |
| NCT03285984 | Ability of Four Toothpastes to Remove Plaque | COMPLETED | NA | 2012-03-27 | 2012-05-08 | 2012-05-08 |
| NCT01551758 | A Randomised Effectiveness Study Comparing Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) With Standard Treatment in Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2012-03-13 | 2015-11-24 | 2015-11-24 |
| NCT01562444 | Study to Evaluate Long Term Immunogenicity up to 10 Years After the First Booster Immunization With Tick Borne Encephalitis Vaccine in Adults Who Received 1 of 3 Different Primary Vaccination Schedules | COMPLETED | PHASE4 | 2012-03-08 | 2016-09-30 | 2016-09-30 |
| NCT01577680 | A Study to Assess the Effects of GSK573719/VI Combination and GSK573719 Monotherapy in Subjects With Moderate Hepatic Impairment and Matched Healthy Volunteers | COMPLETED | PHASE1 | 2012-03-05 | 2012-06-29 | 2012-06-29 |
| NCT03072719 | The Efficacy of a Dentifrice in Providing Relief From Immediate and Short Term Relief From Dentinal Hypersensitivity | COMPLETED | PHASE3 | 2012-03-01 | 2012-06-12 | 2012-06-01 |
| NCT01648179 | A Study to Assess the Relative Bioavailability of Three Formulations and Food Effect on GSK1322322 in Healthy Subjects | COMPLETED | PHASE1 | 2012-03 | 2012-05 | 2012-05 |
| NCT01702519 | A Pharmacokinetic Evaluation of Two Nicotine Patches in Smokers | COMPLETED | PHASE1 | 2012-03 | 2012-03 | 2012-03 |
| NCT01520909 | Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body. | COMPLETED | PHASE3 | 2012-03 | 2014-01 | 2014-01 |
| NCT01641237 | Effect of Fluoride in a Dentifrice on Remineralization of Erosive Lesions | COMPLETED | PHASE3 | 2012-03 | 2012-05 | 2012-05 |
| NCT01592864 | The Efficacy of a Dentifrice in Providing Relief From the Pain of Dentinal Hypersensitivity | COMPLETED | PHASE3 | 2012-03 | 2012-05 | 2012-05 |
| NCT01527123 | A Study to Evaluate the Pharmacokinetics of Benzoic Acid and Hippuric Acid After Topical Administration of GSK2585823 in Japanese Subjects With Acne Vulgaris | COMPLETED | PHASE1 | 2012-02-28 | 2012-06-01 | 2012-06-01 |
| NCT01563042 | A Single Dose Pharmacokinetics (PK) Study of GSK2434735 in Healthy Male Volunteers | COMPLETED | PHASE1 | 2012-02-13 | 2012-05-23 | 2012-05-23 |
| NCT01453491 | A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis | COMPLETED | PHASE1 | 2012-02-13 | 2013-03-18 | 2013-03-18 |
| NCT01506193 | Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy Children | COMPLETED | PHASE3 | 2012-02-06 | 2014-03-31 | 2014-02-17 |
| NCT01551771 | GW824575 First Time in Human | TERMINATED | PHASE1 | 2012-02-01 | 2012-04-12 | 2012-04-12 |
| NCT01516437 | A Study to Assess Immunity to Specific Microbial Antigens in Healthy Smokers and Non-smokers and in Subjects With Stable COPD | COMPLETED | NA | 2012-02-01 | 2012-12-20 | 2012-06-28 |
| NCT01506895 | A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema | COMPLETED | PHASE2 | 2012-02 | 2013-02 | 2013-02 |
| NCT01607411 | A Clinical Study to Evaluate Experimental Children's Toothpastes in an In-Situ Caries Model | COMPLETED | PHASE3 | 2012-02 | 2012-05 | 2012-05 |
| NCT01562548 | Exploratory Efficacy Study of Guaifenesin in Upper Back Pain | COMPLETED | NA | 2012-02 | 2013-05 | 2013-05 |
| NCT01822665 | Gastrointestinal Safety Evaluation of Two Over the Counter Analgesics | COMPLETED | PHASE4 | 2012-02 | 2012-07 | 2012-07 |
| NCT01762982 | Patch Test of Benzalkonium Chloride Disinfectant Spray | COMPLETED | NA | 2012-02 | 2012-02 | 2012-02 |
| NCT01485172 | A Fixed Dose, Dose Response Study for Ropinirole Prolonged Release in Patients With Early Stage Parkinson's Disease | COMPLETED | PHASE4 | 2012-01-31 | 2014-04-30 | 2014-04-30 |
| NCT01561976 | Evaluation of Food Effect on the Pharmacokinetics of Sustained Release Metformin in Healthy Indian Volunteers | COMPLETED | NA | 2012-01-30 | 2012-02-21 | 2012-02-21 |
| NCT01340898 | Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Conjugate Vaccine When Co-administered With Routine Vaccines in Healthy Infants and Toddlers | COMPLETED | PHASE3 | 2012-01-27 | 2015-10-19 | 2014-08-04 |
| NCT01583036 | An Open-label, Single-centre Study Evaluating the Pharmacokinetics of Digoxin Alone and When Administered at Various Doses of Ezogabine/Retigabine in Healthy Adults. The Pharmacokinetics of Ezogabine/Retigabine and the N-acetyl Metabolite of Ezogabine/Retigabine (NAMR) Will Also be Assessed | COMPLETED | PHASE1 | 2012-01-16 | 2012-04-17 | 2012-04-17 |
| NCT01540708 | A Single Centre Study in Healthy Volunteers to Optimise the Rotacap Formulation and ROTAHALER Device for Delivery of Fluticasone Propionate/Salmeterol | COMPLETED | PHASE1 | 2012-01-16 | 2012-09-04 | 2012-09-04 |
| NCT01597700 | Acotral® Versus Zetia® Ezetimibe Bioequivalance Study. | COMPLETED | PHASE1 | 2012-01-13 | 2012-01-30 | 2012-01-30 |
| NCT01527110 | A Study of Intravenous Zanamivir in the Treatment of Hospitalized Patients With Influenza Infection | COMPLETED | PHASE3 | 2012-01-01 | 2013-03-29 | 2013-03-01 |
| NCT01498679 | Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry. | COMPLETED | PHASE3 | 2012-01 | 2013-07 | 2013-07 |
| NCT01498653 | Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry | COMPLETED | PHASE3 | 2012-01 | 2013-02 | 2013-02 |
| NCT01435902 | A Study of a New Asthma Medicine in Asthmatics Whose Asthma Worsens With Exercise | WITHDRAWN | PHASE3 | 2012-01 | 2012-08 | 2012-08 |
| NCT01495000 | A Study in Indian Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab | COMPLETED | PHASE3 | 2012-01 | 2013-02 | 2013-02 |
| NCT01536678 | Bioequivalence of Two Levothyroxine Tablet Formulations in Healthy Indian Volunteers | COMPLETED | PHASE4 | 2012-01 | 2012-04 | 2012-04 |
| NCT01516450 | Japanese phase1 Study of Belimumab (IV vs SC) | COMPLETED | PHASE1 | 2011-12-26 | 2012-04-11 | 2012-04-11 |
| NCT01485445 | Bioequivalence Study to Compare Fluticasone Furoate (FF) 1-strip Inhaler With FF 2-strip Inhaler and With FF/Vilanterol Combination | COMPLETED | PHASE1 | 2011-12-21 | 2012-03-12 | 2012-03-12 |
| NCT01521377 | QTc Study GSK573719+GW642444 | COMPLETED | PHASE1 | 2011-12-19 | 2012-06-05 | 2012-06-05 |
| NCT01495065 | A Study to Evaluate Single and Repeat Doses of IV GSK2251052 in Healthy Male Japanese and Caucasian Subjects and Repeat Doses of Supratherapeutic Doses of IV GSK2251052 in Healthy Volunteers | TERMINATED | PHASE1 | 2011-12-19 | 2012-02-17 | 2012-02-17 |
| NCT01485406 | Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine 2830930A Administered in Toddlers | COMPLETED | PHASE1 | 2011-12-12 | 2012-03-15 | 2012-03-15 |
| NCT01627587 | A Two Cohort Study to Look at the Metabolites of GSK221149, the Metabolism of GSK221149 Administered With a High Fat Meal and With Ketoconazole | COMPLETED | PHASE1 | 2011-12-12 | 2012-02-09 | 2012-02-09 |
| NCT01480622 | Pharmacokinetic (PK) Profiles of Tenofovir Disoproxil Fumarate (TDF) 300 mg in Healthy Chinese Subjects | COMPLETED | PHASE1 | 2011-12-05 | 2011-12-30 | 2011-12-30 |
| NCT01495013 | A Comparison of Atorvastatin and Glimepiride Fixed Dose Combination and Atorvastatin and Glimepiride Loose Combination in the Treatment of Patients With Type 2 Diabetes Mellitus | COMPLETED | PHASE3 | 2011-12 | 2013-09 | 2013-04 |
| NCT01475734 | Albiglutide Glucose Clamp Study in Subjects With Type 2 Diabetes | COMPLETED | PHASE2 | 2011-12 | 2012-07 | 2012-07 |
| NCT01328054 | A Study in Cancer Patients to Evaluate the Effect of Lapatinib on the QTc Interval | COMPLETED | PHASE4 | 2011-12 | 2015-03 | 2015-03 |
| NCT01475851 | Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B With Poor Response to Other Drugs | COMPLETED | PHASE3 | 2011-12 | 2014-10 | 2013-06 |
| NCT01480609 | Effect of Haemodialysis on the Pharmacokinetics of Ezogabine/Retigabine and Its N-acetyl Metabolite | COMPLETED | PHASE1 | 2011-11-30 | 2012-04-24 | 2012-04-24 |
| NCT01573819 | A Repeat Dose Study in Healthy Volunteers Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK356278 | COMPLETED | PHASE1 | 2011-11-24 | 2012-04-02 | 2012-04-02 |
| NCT01640990 | A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of an Intravenous Infusion of GW328267X in Healthy Volunteers | COMPLETED | PHASE1 | 2011-11-22 | 2011-12-09 | 2011-12-09 |
| NCT01602900 | Healthy Volunteer Positron Emission Tomography (PET) Brain Occupancy Study of a Phosphodiesterase 4 (PDE4) Inhibitor in Huntington's Disease | COMPLETED | PHASE1 | 2011-11-22 | 2012-04-12 | 2012-04-12 |
| NCT01462357 | Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Human Papillomavirus (HPV) Vaccine (GSK-580299) and Merck's Gardasil Vaccine When Administered According to Alternative 2-dose Schedules in 9-14 Year Old Females | COMPLETED | PHASE3 | 2011-11-21 | 2015-10-27 | 2015-10-27 |
| NCT01475721 | SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma. | COMPLETED | PHASE4 | 2011-11-18 | 2015-06-23 | 2015-06-23 |
| NCT01345240 | Study to Evaluate Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals' Candidate Malaria Vaccine (257049) | COMPLETED | PHASE3 | 2011-11-17 | 2017-02-09 | 2013-01-09 |
| NCT01462344 | 6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old | COMPLETED | PHASE4 | 2011-11-17 | 2015-11-03 | 2015-11-01 |
| NCT01484496 | A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE) | COMPLETED | PHASE3 | 2011-11-16 | 2015-10-01 | 2015-02-13 |
| NCT01424501 | Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Adults With TB Disease | TERMINATED | PHASE2 | 2011-11-14 | 2014-04-10 | 2014-04-01 |
| NCT01536418 | An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease | TERMINATED | PHASE3 | 2011-11-11 | 2013-10-17 | 2013-10-17 |
| NCT01458067 | A Phase I/IIa, First Time in Human, Study of GSK2636771 in Subjects With Advanced Solid Tumors With Phosphatase and Tensin Homolog (PTEN) Deficiency | COMPLETED | PHASE1 | 2011-11-10 | 2016-02-25 | 2015-11-12 |
| NCT01545570 | A Study to Determine the Safety, Tolerability, and Effects of GSK2374697 in Healthy Volunteers | COMPLETED | PHASE1 | 2011-11-07 | 2012-12-23 | 2012-12-23 |
| NCT01495026 | A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asia | COMPLETED | PHASE1 | 2011-11-06 | 2012-04-03 | 2012-04-03 |
| NCT01395004 | A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis | COMPLETED | PHASE2 | 2011-11 | 2013-11 | 2013-11 |
| NCT01457924 | Ofatumumab Subcutaneous Administration in Subjects With Relapsing-Remitting Multiple Sclerosis | COMPLETED | PHASE2 | 2011-11-01 | 2015-06-10 | 2013-08-23 |
| NCT01462565 | Study of a New Thermo Stable Formulation of Epoprostenol Sodium to Treat Pulmonary Arterial Hypertension (PAH) | COMPLETED | PHASE4 | 2011-11-01 | 2012-11-08 | 2012-05-16 |
| NCT01480284 | Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid Analogue | COMPLETED | PHASE3 | 2011-11 | 2014-11 | 2013-01 |
| NCT01657903 | Evaluation of Efficacy of Experimental Gel to Foam Dentifrices in Dental Erosion | COMPLETED | NA | 2011-11 | 2012-02 | 2012-02 |
| NCT01686646 | Effects of Two Doses of a Common Cold Treatment on Alertness | COMPLETED | PHASE3 | 2011-11 | 2012-11 | 2012-11 |
| NCT01457950 | A Study in Korean Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab | COMPLETED | PHASE3 | 2011-11 | 2013-06 | 2012-12 |
| NCT01597648 | A Study to Evaluate the Bioequivalence of a Combined Formulated Tablet Compared With Maraviroc and Combivir™ | COMPLETED | PHASE1 | 2011-11 | 2012-01 | 2012-01 |
| NCT01476202 | Provoked Craving Relief Study by NRT | COMPLETED | PHASE2 | 2011-11 | 2012-01 | 2012-01 |
| NCT01445587 | A Study of GSK2110183 in Subjects With Proteasome Inhibitor Refractory Multiple Myeloma | WITHDRAWN | PHASE2 | 2011-11 | 2011-11 | 2011-11 |
| NCT01466335 | An Adaptive Phase I Study to Evaluate the Safety, Efficacy and Dose Responses of Ronacaleret in Healthy Human Volunteers | COMPLETED | PHASE1 | 2011-10-27 | 2012-03-05 | 2012-03-05 |
| NCT01476137 | A Study of the Safety and Activity of the MEK Inhibitor Given Together With the AKT Inhibitor to Patients With Multiple Myeloma or Solid Tumor Cancers | COMPLETED | PHASE1 | 2011-10-26 | 2013-03-12 | 2013-03-12 |
| NCT01462292 | A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD) | COMPLETED | PHASE2 | 2011-10-26 | 2013-11-04 | 2013-05-21 |
| NCT01702350 | A Four Part Study to Investigate Relative Bioavailability, Safety and Tolerability of up to 5 Oral Formulation of GSK2251052 in Order to Identify a Formulation for Further Evaluation in a Future Later Phase Study | TERMINATED | PHASE1 | 2011-10-21 | 2011-12-08 | 2011-12-08 |
| NCT01494636 | The Safety, Tolerability, PK and PD of GSK2339345 in Healthy Subjects | COMPLETED | PHASE1 | 2011-10-17 | 2012-03-15 | 2012-03-15 |
| NCT01453998 | Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744) | COMPLETED | PHASE2 | 2011-10-14 | 2012-11-12 | 2012-11-12 |
| NCT01406314 | SAP Depleter Dose Assessment Study in Patients | COMPLETED | PHASE1 | 2011-10-13 | 2012-11-14 | 2012-11-14 |
| NCT01453478 | A Study to Look at How GSK1325756 is Taken up by the Body When Given by Mouth When Stomach Acid is Reduced | COMPLETED | PHASE1 | 2011-10-12 | 2011-12-19 | 2011-12-19 |
| NCT01521390 | Assessment of Lung Function After Single Inhalations of a Bronchodilator From 2 Configurations a Dry Powder Inhaler. | COMPLETED | PHASE1 | 2011-10-12 | 2011-12-16 | 2011-12-16 |
| NCT01485185 | Gabapentin and Donepezil Combination on Experimental Human Pain Models | COMPLETED | PHASE1 | 2011-10-11 | 2012-07-03 | 2012-07-03 |
| NCT01381562 | GSK2251052 in the Treatment of Complicated Intra-abdominal Infections | TERMINATED | PHASE2 | 2011-10-03 | 2012-03-05 | 2012-03-05 |
| NCT01439360 | An Efficacy Study of GlaxoSmithKline (GSK) Biologicals' Candidate Influenza Vaccine GSK2321138A in Children | COMPLETED | PHASE3 | 2011-10-01 | 2014-12-31 | 2014-10-31 |
| NCT01428453 | A Phase 2a Study to Evaluate the Effect of Rilapladib (SB-659032) in Alzheimer's Disease | COMPLETED | PHASE2 | 2011-10-01 | 2013-02-18 | 2013-02-04 |
| NCT01449812 | Immunogenicity and Safety Study of Booster Dose of GSK Biologicals' IPV (Poliorix™) and DTPa/Hib (Infanrix+Hib™) Vaccine | COMPLETED | PHASE3 | 2011-10-01 | 2012-01-16 | 2012-01-16 |
| NCT01453023 | Inhaled Fluticasone Furoate/Vilanterol Safety and Tolerability, PK and PD Study | COMPLETED | PHASE2 | 2011-10 | 2012-06 | 2012-06 |
| NCT01137994 | A Phase II, Randomized, Open-label Study of Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive and p95HER2-positive Metastatic Breast Cancer | WITHDRAWN | PHASE2 | 2011-10 | 2018-03 | 2016-12 |
| NCT01440387 | A Study of Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine FLU-Q-QIV in Adults Aged 18 Years and Older | COMPLETED | PHASE3 | 2011-09-30 | 2011-10-22 | 2011-10-22 |
| NCT01445301 | Study STF115287, a Clinical Confirmation Study of GSK2585823 in the Treatment of Acne Vulgaris in Japanese Subjects | COMPLETED | PHASE3 | 2011-09-27 | 2012-08-02 | 2012-08-02 |
| NCT01458054 | Effect of Omeprazole and Ritonavir on GSK2336805 Pharmacokinetics in Healthy Adults | COMPLETED | PHASE1 | 2011-09-27 | 2011-11-28 | 2011-11-28 |
| NCT02202187 | A Single Oral Escalating Dose Study of GSK2140944 in Healthy Volunteers | COMPLETED | PHASE1 | 2011-09-26 | 2012-02-15 | 2012-02-15 |
| NCT01489943 | A Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects | COMPLETED | PHASE1 | 2011-09-19 | 2011-11-10 | 2011-11-10 |
| NCT01610388 | A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Oral and Intravenous GSK1322322 in Healthy Subjects | COMPLETED | PHASE1 | 2011-09-13 | 2012-01-26 | 2012-01-26 |
| NCT01190176 | Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects | COMPLETED | PHASE3 | 2011-09-12 | 2017-09-20 | 2017-09-20 |
| NCT01290354 | Exploratory Lapatinib (Positron Emission Tomography) PET Study in Subjects With Breast Cancer | COMPLETED | PHASE1 | 2011-09-12 | 2013-03-18 | 2013-03-18 |
| NCT01435993 | Multiple Doses of Anti-NOGO A in Relapsing Forms of Multiple Sclerosis | TERMINATED | PHASE1 | 2011-09-08 | 2012-01-23 | 2012-01-23 |
| NCT01391819 | Study to Evaluate the Incidence, Clinical Characteristics and Economic Burden of Dengue in Brazilian Children | COMPLETED | NA | 2011-09-06 | 2015-01-30 | 2015-01-30 |
| NCT01506908 | Provoked Craving Assessment | COMPLETED | PHASE2 | 2011-09 | 2011-12 | 2011-12 |
| NCT01424540 | Cross-Over Study to Assess the Cardiovascular Effects of GSK2336805 | COMPLETED | PHASE1 | 2011-09-01 | 2011-10-03 | 2011-10-03 |
| NCT01480245 | Open Label Study of GSK2402968 in Subjects With Duchenne Muscular Dystrophy | TERMINATED | PHASE3 | 2011-09 | 2014-03 | 2014-03 |
| NCT01431976 | Clinical Study of Lamotrigine to Treat Newly Diagnosed Typical Absence Seizure in Children and Adolescents | COMPLETED | PHASE3 | 2011-09 | 2015-11 | 2014-02 |
| NCT01436071 | Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma | COMPLETED | PHASE3 | 2011-09 | 2012-08 | 2012-06 |
| NCT01436110 | Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma | COMPLETED | PHASE3 | 2011-09 | 2012-09 | 2012-09 |
| NCT01431950 | Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents | COMPLETED | PHASE3 | 2011-09 | 2012-10 | 2012-10 |
| NCT01431963 | Clinical Study of Lamotrigine to Treat Newly Diagnosed Epilepsy | COMPLETED | PHASE3 | 2011-09 | 2014-10 | 2013-03 |
| NCT01362296 | An Open-label Study of GSK1120212 Compared With Docetaxel in Stage IV KRAS-mutant Non-small Cell Lung Cancer | COMPLETED | PHASE2 | 2011-09 | 2013-09 | 2012-09 |
| NCT01494649 | Pilot Study to Investigate the Efficacy of a Toothpaste in Providing Relief From Dentinal Hypersensitivity | COMPLETED | NA | 2011-09 | 2011-09 | 2011-09 |
| NCT01406340 | Assessment of the Pharmacokinetics of GSK1278863 and Metabolites in Normal Subjects and Subjects With Renal Impairment | TERMINATED | PHASE1 | 2011-08-30 | 2013-08-31 | 2013-08-31 |
| NCT01416376 | Effect of Multiple Dose Levels of SRT2379 on Endotoxin-Induced Inflammation | COMPLETED | PHASE1 | 2011-08-30 | 2011-12-12 | 2011-12-12 |
| NCT01863615 | Bioequivalence Study for an Isotretinoin | COMPLETED | PHASE1 | 2011-08-26 | 2011-09-23 | 2011-09-23 |
| NCT01449188 | To Investigate the Effect of Intravenous Ondansetron on Cardiac Conduction as Compared to Placebo and Moxifloxacin in Healthy Adult Subjects | COMPLETED | PHASE1 | 2011-08-16 | 2011-12-19 | 2011-12-19 |
| NCT01416571 | Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Monovalent Pandemic H5N1 Vaccine in Adults | COMPLETED | PHASE2 | 2011-08-12 | 2012-09-28 | 2011-11-29 |
| NCT01424475 | LRRK2 Mutation and Parkinson's Disease | TERMINATED | PHASE1 | 2011-08-11 | 2015-01-12 | 2015-01-12 |
| NCT01366534 | Safety, Immunogenicity and Efficacy Against of a Combined Malaria Vaccine in Healthy Malaria-naïve Adults | COMPLETED | PHASE2 | 2011-08-10 | 2012-07-03 | 2012-02-27 |
| NCT01471327 | Japanese Phase 1 Study of Mepolizumab | COMPLETED | PHASE1 | 2011-08-09 | 2012-04-27 | 2012-04-27 |
| NCT01423058 | Safety Study Evaluating Twice-Daily Administration of Momelotinib in Primary Myelofibrosis or Post-Polycythemia Vera or Post-Essential Thrombocythemia Myelofibrosis | COMPLETED | PHASE1, PHASE2 | 2011-08 | 2014-06 | 2014-06 |
| NCT01376388 | Long-term Safety Study for GSK573719/GW642444 in Japanese | COMPLETED | PHASE3 | 2011-08 | 2012-12 | 2012-12 |
| NCT01379937 | A Study to Evaluate the Safety and Immunogenicity of a Prime-boost Schedule of GSK Biologicals' Influenza Vaccine in Children | COMPLETED | PHASE3 | 2011-07-28 | 2012-10-05 | 2012-08-02 |
| NCT01928914 | Tafenoquine Thorough QTc Study in Healthy Subjects | COMPLETED | PHASE1 | 2011-07-26 | 2012-06-04 | 2012-06-04 |
| NCT01462617 | Study to Investigate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Single & Repeat Doses of GSK2269557 | COMPLETED | PHASE1 | 2011-07-24 | 2012-03-26 | 2012-03-26 |
| NCT01439438 | Topiramate Bioequivalence Study Brazil - Fast | COMPLETED | PHASE1 | 2011-07-22 | 2011-09-11 | 2011-09-11 |
| NCT01400906 | Inhalation of Corticosteroids in Smoking and Non-smoking Asthmatics. | COMPLETED | PHASE2 | 2011-07-20 | 2012-12-12 | 2012-12-01 |
| NCT01376323 | A Study of GSK256073 in Subjects With Type 2 Diabetes Mellitus Who Are Being Treated With Metformin | COMPLETED | PHASE2 | 2011-07-13 | 2012-09-17 | 2012-09-16 |
| NCT01449799 | An Investigation of the Pharmacokinetics of GSK961081 and Fluticasone Propionate in Healthy Volunteers | COMPLETED | PHASE1 | 2011-07-13 | 2011-09-21 | 2011-09-21 |
| NCT01439373 | Safety, Antiviral Activity, and Pharmacokinetics of GSK2336805 With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects | COMPLETED | PHASE2 | 2011-07-07 | 2011-12-05 | 2011-12-05 |
| NCT01362348 | 12 Week Patient Study in Neovascular Age-related Macular Degeneration (AMD) | TERMINATED | PHASE2 | 2011-07-07 | 2012-04-16 | 2012-04-16 |
| NCT01406262 | Albiglutide Thorough ECG Study in Healthy Volunteers | COMPLETED | PHASE1 | 2011-07-06 | 2011-12-29 | 2011-12-29 |
| NCT01362322 | Immunogenicity and Safety of BoostrixTM Using a New Syringe in 10 to 15-year Old Adolescents | COMPLETED | PHASE4 | 2011-07-01 | 2012-09-03 | 2012-09-03 |
| NCT01387230 | Evaluate the Efficacy and Safety of GSK573719 Delivered Via a Novel Dry Powder Inhaler in Subjects With COPD | COMPLETED | PHASE3 | 2011-07-01 | 2012-02-13 | 2012-02-01 |
| NCT01372410 | A Randomized, Double Blind, Placebo Controlled, Incomplete Block, Crossover, Dose Ranging Study to Evaluate the Dose Response of GSK573719 Administered Once or Twice Daily Over 7 Days in Patients With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE2 | 2011-07-01 | 2011-10-27 | 2011-10-01 |
| NCT01357889 | Pharmacokinetics/Pharmacodynamics of Albiglutide | COMPLETED | PHASE2 | 2011-07 | 2012-10 | 2012-10 |
| NCT01428505 | [18F]PBR111 and Microglial Activation in Multiple Sclerosis | TERMINATED | PHASE2 | 2011-07 | 2013-03 | 2013-03 |
| NCT01476085 | Evaluating the Utility of the Apoptosis Imaging Biomarker 18F]ML10 in Patients With Non-Hodgkin's Lymphoma(NHL) | TERMINATED | PHASE1 | 2011-07 | 2011-10 | 2011-10 |
| NCT01536704 | Nicotine Lozenge Bioequivalence Study | COMPLETED | PHASE1 | 2011-07 | 2011-08 | 2011-08 |
| NCT01400932 | Study STF115288, a Clinical Confirmation Study of GI148512 in the Treatment of Acne Vulgaris in Japanese Subjects | COMPLETED | PHASE3 | 2011-07 | 2012-04 | 2012-04 |
| NCT01360398 | Infectious Pathogens in Acute Respiratory Illness in Adults and Elderly | COMPLETED | NA | 2011-06-30 | 2014-06-27 | 2014-06-27 |
| NCT01471678 | Bioavailability of Two Combination Products of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) in Asian Males. | COMPLETED | PHASE1 | 2011-06-30 | 2011-09-07 | 2011-09-07 |
| NCT01395888 | A Study to Compare the Impact of Fulticasone Furoate/Vilanterol vs. Tiotropium on Arterial Stiffness in COPD | COMPLETED | PHASE3 | 2011-06-30 | 2012-08-06 | 2012-08-01 |
| NCT01381575 | Evaluation of Immunogenicity and Safety of Two 2-dose Human Papillomavirus (HPV) Vaccine Schedules in 9-14 Year Old Girls | COMPLETED | PHASE3 | 2011-06-29 | 2014-11-13 | 2012-06-28 |
| NCT01381549 | GSK2251052 in Complicated Urinary Tract Infection | TERMINATED | PHASE2 | 2011-06-28 | 2012-03-06 | 2012-03-06 |
| NCT01357915 | Evaluation of the Long-term Persistence of GlaxoSmithKline (GSK) Biologicals' Candidate Cytomegalovirus (CMV) Vaccine | COMPLETED | NA | 2011-06-24 | 2012-09-13 | 2012-09-13 |
| NCT01342952 | Long-term Ambrisentan Extension Study for Pediatric Patients Who Participated in AMB112529 | COMPLETED | PHASE2 | 2011-06-21 | 2022-06-09 | 2022-06-09 |
| NCT01416337 | Absolute Bioavialability of GSK1120212 | COMPLETED | PHASE1 | 2011-06-20 | 2011-12-17 | 2011-12-17 |
| NCT01755611 | Bioequivalence Minocycline Bioequivalence | COMPLETED | PHASE1 | 2011-06-17 | 2011-06-25 | 2011-06-25 |
| NCT01416324 | First Time in Human Study Using GSK2330672 | COMPLETED | PHASE1 | 2011-06-15 | 2011-09-09 | 2011-09-09 |
| NCT01340833 | Determination of the Absolute Bioavailability of GSK2118436 Following a Single Oral Dose Co-Administered With an Intravenous Radiolabelled Microtracer of GSK2118436 in Subjects With BRAF Mutant Solid Tumors | COMPLETED | PHASE1 | 2011-06-08 | 2011-09-12 | 2011-09-12 |
| NCT01340911 | A Study in Healthy Male Volunteers to Investigate Different Doses of a New Drug for the Treatment of Metabolic Diseases | COMPLETED | PHASE1 | 2011-06-03 | 2011-11-24 | 2011-11-24 |
| NCT01175083 | Immunization of Children Between 8 Weeks and 2 Years of Age With GSK Pneumococcal Vaccine GSK1024850A | COMPLETED | PHASE3 | 2011-06-01 | 2013-05-23 | 2013-01-17 |
| NCT01342926 | Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration | COMPLETED | PHASE2 | 2011-06-01 | 2016-04-01 | 2016-04-01 |
| NCT01446237 | U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne | COMPLETED | NA | 2011-06-01 | 2011-12-15 | 2011-12-01 |
| NCT01471665 | GSK2190915 Neutrophilic Asthma Study | COMPLETED | PHASE2 | 2011-06 | 2012-05 | 2012-05 |
| NCT01358825 | Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™ | COMPLETED | PHASE4 | 2011-05-30 | 2011-07-15 | 2011-07-15 |
| NCT01480271 | An Investigation of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2245035 in Healthy Volunteers and Allergic Rhinitics. | COMPLETED | PHASE1 | 2011-05-30 | 2011-09-30 | 2011-09-30 |
| NCT01431989 | Amoxicillin Bioequivalence Study Brazil - Fast | COMPLETED | PHASE1 | 2011-05-27 | 2011-06-11 | 2011-06-11 |
| NCT01345253 | GSK1550188 A 52 Week Study of Belimumab Versus Placebo in the Treatment of Subjects With Systemic Lupus Erythematosus (SLE) Located in Northeast Asia | COMPLETED | PHASE3 | 2011-05-23 | 2018-09-21 | 2015-09-15 |
| NCT01416363 | Healthy Volunteer Study Using 3 Different Formulations of Firategrast | COMPLETED | PHASE1 | 2011-05-20 | 2011-09-17 | 2011-09-17 |
| NCT01353729 | A Study to Evaluate the Effect of Intravenous Zanamivir on Cardiac Conduction in Healthy Volunteers | COMPLETED | PHASE1 | 2011-05-19 | 2011-08-02 | 2011-08-02 |
| NCT01323972 | Consistency of Immunogenicity and Non Inferiority of GSK Biologicals' Candidate Malaria Vaccine Lots in Children | COMPLETED | PHASE3 | 2011-05-16 | 2012-05-04 | 2011-11-22 |
| NCT01352286 | Redirected Auto T Cells for Advanced Myeloma | COMPLETED | PHASE2 | 2011-05-13 | 2019-07-08 | 2017-08-25 |
| NCT01366573 | GSK1521498 Alcohol Interaction Study | COMPLETED | PHASE1 | 2011-05-13 | 2011-09-16 | 2011-09-16 |
| NCT01577693 | Study to Compare the Bioavailability of Dutasteride Novel Formulation Form to the Soft Gel Capsule Form in Healthy Male Subjects | COMPLETED | PHASE1 | 2011-05-12 | 2011-08-31 | 2011-08-31 |
| NCT01316939 | GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease | TERMINATED | PHASE3 | 2011-05-09 | 2013-10-23 | 2013-10-23 |
| NCT01262898 | Dose Response of 28 Days of Dosing of GSK962040 in Type I and II Diabetic Male and Female Subjects With Gastroparesis | COMPLETED | PHASE2 | 2011-05-03 | 2013-02-26 | 2013-02-26 |
| NCT01371487 | GSK1120212 Food-effect Study | COMPLETED | PHASE1 | 2011-05-02 | 2011-09-30 | 2011-09-30 |
| NCT01332578 | A Comparison of Solid and Soluble Forms of Cold and Influenza Remedies | COMPLETED | PHASE4 | 2011-05 | 2011-06 | 2011-06 |
| NCT00920140 | Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias | COMPLETED | PHASE2 | 2011-05 | 2013-04 | 2013-04 |
| NCT01362257 | A Study to Determine the Excretion Balance and Pharmacokinetics of 14C-GSK573719 | COMPLETED | PHASE1 | 2011-04-29 | 2011-06-22 | 2011-06-22 |
| NCT01245140 | Efficacy of Alitretinoin Treatment in Patients With Pustular Form of Psoriasis | COMPLETED | PHASE2 | 2011-04-26 | 2014-04-16 | 2014-03-12 |
| NCT01333813 | Hepatitis B Antibody Persistence and Immune Response to Hepatitis B Vaccine Challenge in Previously Vaccinated Children | COMPLETED | PHASE4 | 2011-04-26 | 2011-09-28 | 2011-09-28 |
| NCT01323647 | Immunogenicity and Safety of Booster Dose of PoliorixTM Vaccine in Previously Vaccinated Toddlers | COMPLETED | PHASE3 | 2011-04-25 | 2011-09-19 | 2011-09-19 |
| NCT01475695 | GSK2251052 Mass Balance in Healthy Adult Subjects | COMPLETED | PHASE1 | 2011-04-21 | 2011-05-19 | 2011-05-19 |
| NCT01323946 | Study to Evaluate the Immunogenicity and Safety of an Investigational Pandemic Influenza Vaccine in Children | COMPLETED | PHASE2 | 2011-04-18 | 2012-11-02 | 2012-06-22 |
| NCT01357902 | Lamotrigine Bioequivalence Study to Compare Dispersible Tables With Compressed Tablets in China | COMPLETED | PHASE1 | 2011-04-18 | 2011-05-23 | 2011-05-23 |
| NCT01424397 | Intranasal SB-705498 in Allergic Rhinitis (AR) Patients | COMPLETED | PHASE2 | 2011-04-14 | 2011-07-07 | 2011-07-07 |
| NCT01381445 | A Study Assessing GW870086's Potential to Cause Skin Thinning | COMPLETED | PHASE1 | 2011-04-14 | 2011-07-07 | 2011-07-07 |
| NCT01220128 | Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer | TERMINATED | PHASE2 | 2011-04-11 | 2014-11-14 | 2014-11-14 |
| NCT01190189 | Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study | COMPLETED | PHASE3 | 2011-04-01 | 2017-11-23 | 2017-11-23 |
| NCT01245049 | Immunogenicity and Safety of GSK Biologicals' Boostrix Polio Vaccine in 3 and 4-year-old Children | COMPLETED | PHASE3 | 2011-04-01 | 2012-04-02 | 2012-03-27 |
| NCT01318993 | Open-Label Extension Study of GSK1605786A | TERMINATED | PHASE3 | 2011-04-01 | 2013-10-29 | 2013-09-01 |
| NCT01323959 | Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults | COMPLETED | PHASE4 | 2011-04-01 | 2012-03-01 | 2012-03-01 |
| NCT01476098 | A Study to Investigate the Effect of SB-705498 on Chronic Cough | COMPLETED | PHASE2 | 2011-04 | 2012-01 | 2011-12 |
| NCT01376245 | A 24-week Study of Fluticasone Furoate/Vilanterol Inhalation Powder in Subjects of Asian Ancestry With COPD | COMPLETED | PHASE3 | 2011-04 | 2012-09 | 2012-09 |
| NCT02348372 | Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of GSK1278863A in Healthy Subjects | COMPLETED | PHASE1 | 2011-03-31 | 2011-06-03 | 2011-06-03 |
| NCT01320137 | Study in Allergic Adults to Support the Development of Immunological Assays | COMPLETED | NA | 2011-03-31 | 2011-05-11 | 2011-05-11 |
| NCT01300234 | Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) 300mg in Chinese Subjects With Chronic Hepatitis B (CHB) | COMPLETED | PHASE3 | 2011-03-30 | 2016-12-06 | 2012-10-17 |
| NCT01416350 | A Single and Repeat Dose PK/PD Study to Characterise Biomarker Response in Healthy Subjects Treated With Azithromycin | COMPLETED | PHASE1 | 2011-03-30 | 2011-05-12 | 2011-05-12 |
| NCT01371812 | GSK2239633 FTIH Study | COMPLETED | PHASE1 | 2011-03-29 | 2011-07-01 | 2011-07-01 |
| NCT01772238 | Bioequivalence Study of an Amoxicillin-Clavulanic | COMPLETED | PHASE1 | 2011-03-22 | 2011-03-30 | 2011-03-30 |
| NCT01323621 | Study Evaluating the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2011-03-18 | 2012-01-24 | 2012-01-01 |
| NCT01323634 | Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE3 | 2011-03-18 | 2011-12-14 | 2011-12-14 |
| NCT01323660 | An Exercise Endurance Study to Evaluate the Effects of Treatment of Chronic Obstructive Pulmonary Disease (COPD) Patients With a Dual Bronchodilator: GSK573719/GW642444.Study B | COMPLETED | PHASE3 | 2011-03-16 | 2012-07-16 | 2012-07-01 |
| NCT01190202 | Epidemiology Study of Malaria Transmission Intensity in Africa | COMPLETED | NA | 2011-03-14 | 2013-12-20 | 2013-12-20 |
| NCT01476046 | Safety Study of GSK1995057 Given as Single and Repeat Intravenous Doses in Healthy Subjects. | COMPLETED | PHASE1 | 2011-03-08 | 2012-06-17 | 2012-06-17 |
| NCT01310413 | Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age | COMPLETED | PHASE3 | 2011-03-07 | 2014-01-26 | 2011-07-21 |
| NCT01309646 | Immunogenicity and Safety of GlaxoSmithKline Biologicals' Infanrix™-IPV+Hib Vaccine | COMPLETED | PHASE3 | 2011-03-04 | 2012-02-24 | 2012-02-24 |
| NCT01336608 | A 24-week Arterial Stiffness Study With Fluticasone Furoate/Vilanterol in COPD | COMPLETED | PHASE3 | 2011-03-04 | 2014-11-04 | 2014-11-04 |
| NCT01313650 | A 24-week Evaluation of GSK573719/Vilanterol (62.5/25mcg) and Components in COPD | COMPLETED | PHASE3 | 2011-03-01 | 2012-04-05 | 2012-04-01 |
| NCT01313637 | A 24-week Evaluation of GSK573719/Vilanterol (125/25mcg) and Components in COPD | COMPLETED | PHASE3 | 2011-03-01 | 2012-04-19 | 2012-03-01 |
| NCT01316900 | 24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE3 | 2011-03-01 | 2012-04-24 | 2012-04-01 |
| NCT01328444 | An Exercise Endurance Study to Evaluate the Effects of Treatment of Chronic Obstructive Pulmonary Disease (COPD) Patients With a Dual Bronchodilator: GSK573719/GW642444. Study A | COMPLETED | PHASE3 | 2011-03-01 | 2012-06-14 | 2012-06-01 |
| NCT01316913 | 24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE3 | 2011-03 | 2012-04 | 2012-04 |
| NCT01295320 | Study of Long Term Immune Responses and Safety of the GSK Herpes Zoster Vaccine in Healthy Subjects | COMPLETED | PHASE2 | 2011-02-28 | 2013-06-20 | 2013-06-20 |
| NCT01319006 | Relative Bioavailability Study for GSK1278863A | COMPLETED | PHASE1 | 2011-02-25 | 2011-04-18 | 2011-04-18 |
| NCT01772212 | Bioequivalence Study for Terbinafine 250 mg | COMPLETED | PHASE1 | 2011-02-24 | 2011-03-15 | 2011-03-15 |
| NCT01336621 | Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS) | COMPLETED | PHASE3 | 2011-02-21 | 2017-09-13 | 2016-12-14 |
| NCT01353742 | Lamivudine and Adefovir Dipivoxil Fixed Dose Combination | COMPLETED | PHASE1 | 2011-02-21 | 2011-04-12 | 2011-04-12 |
| NCT01153841 | Primary Vaccination Study With GSK Biologicals' Pneumococcal Vaccine in Healthy Infants in Vietnam | COMPLETED | PHASE3 | 2011-02-17 | 2011-07-26 | 2011-07-26 |
| NCT01262911 | Effect of SRT2379 on Endotoxin-Induced Inflammation | COMPLETED | PHASE1 | 2011-02-17 | 2011-04-26 | 2011-04-26 |
| NCT01277042 | Study to Assess Immune Responses and Safety of the GSK-580299 Vaccine in Healthy Women (26 to 45 Years) | COMPLETED | PHASE3 | 2011-02-17 | 2012-02-28 | 2011-09-26 |
| NCT01387204 | Study to Investigate the Absorption, Distribution, Metabolism and Elimination of [14C]GSK1120212 | COMPLETED | PHASE1 | 2011-02-15 | 2011-07-18 | 2011-07-18 |
| NCT01332513 | An Open Label, Randomised, Repeat Dose Study to Assess the Pharmacokinetic Performance of Five Ezogabine/Retigabine Modified Release (MR) Formulations at Steady State Compared to the Immediate Release (IR) Formulation. | COMPLETED | PHASE1 | 2011-02-10 | 2011-05-23 | 2011-05-23 |
| NCT01262872 | Impact of GSK Biologicals' 2189242A Vaccine on Nasopharyngeal Carriage, Safety & Immunogenicity in Children & Infants | COMPLETED | PHASE2 | 2011-02-09 | 2013-03-18 | 2013-03-18 |
| NCT01258608 | Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma | COMPLETED | PHASE1, PHASE2 | 2011-02-08 | 2017-11-29 | 2013-05-31 |
| NCT01342913 | A Study to Evaluate the 24 Hour Spirometric Effect (FEV1) of Fluticasone Furoate/Vilanterol Inhalation Powder (100mcg Fluticasone Furoate (FF)/25mcg Vilanterol (VI)) Compared With Salmeterol/Fluticasone Propionate Inhalation Powder (50mcg Salmeterol/500mcg Fluticasone Propionate (FP)) | COMPLETED | PHASE3 | 2011-02-01 | 2011-10-19 | 2011-10-01 |
| NCT01366521 | Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils | COMPLETED | PHASE2 | 2011-02 | 2012-03 | 2012-03 |
| NCT01266967 | A Study of GSK2118436 in BRAF Mutant Metastatic Melanoma to the Brain | COMPLETED | PHASE2 | 2011-02 | 2012-11 | 2011-11 |
| NCT01313663 | A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population | TERMINATED | PHASE2 | 2011-02 | 2012-07 | 2012-07 |
| NCT01466348 | Effects of a Common Cold Treatment on Cognitive Function | COMPLETED | PHASE4 | 2011-02 | 2011-04 | 2011-04 |
| NCT01213472 | Evaluation of a New Anti-cancer Immunotherapy in Patients With Non-operable and Progressing Metastatic Cutaneous Melanoma | COMPLETED | PHASE1 | 2011-01-31 | 2018-04-17 | 2018-04-17 |
| NCT01767532 | Bioequivalence Study of Cephalexin Suspension 125 | COMPLETED | PHASE1 | 2011-01-30 | 2011-02-08 | 2011-02-08 |
| NCT01767571 | Bioequivalence Study of Cephalexin Suspension 250 | COMPLETED | PHASE1 | 2011-01-30 | 2011-02-08 | 2011-02-08 |
| NCT01262963 | An Absorption, Distribution, Metabolism and Excretion (ADME) Study of Single Oral Dose [14C] GSK2118436 in Subjects With BRAF Mutant Solid Tumors | COMPLETED | PHASE1 | 2011-01-26 | 2011-04-08 | 2011-04-08 |
| NCT01313676 | Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE3 | 2011-01-25 | 2015-07-15 | 2015-07-15 |
| NCT01249365 | The Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study | COMPLETED | PHASE3 | 2011-01-24 | 2017-01-10 | 2017-01-10 |
| NCT01324258 | Trial of GSK1120212 and GSK1120212 in Combination With GEM in Japanese Subjects With Solid Tumors | COMPLETED | PHASE1 | 2011-01-24 | 2013-07-08 | 2013-07-08 |
| NCT01262976 | Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Human Immunodeficiency Virus (HIV)-Positive Adults | COMPLETED | PHASE2 | 2011-01-17 | 2015-06-04 | 2012-07-17 |
| NCT01231620 | A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza | COMPLETED | PHASE3 | 2011-01-15 | 2015-03-18 | 2015-03-18 |
| NCT01332552 | A First Time in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Single and Repeat Doses of GSK2485852 in Chronically Infected Hepatitis C Subjects | TERMINATED | PHASE1 | 2011-01-14 | 2011-04-06 | 2011-04-06 |
| NCT01738893 | Bioequivalence Study of 300 mg Gabapentin | COMPLETED | PHASE1 | 2011-01-14 | 2011-01-22 | 2011-01-22 |
| NCT01231503 | Safety and Immunogenicity of GSK Biologicals' Malaria Vaccine 257049 When Administered on 7 Schedules to African Infants | COMPLETED | PHASE2 | 2011-01-13 | 2014-12-23 | 2014-04-30 |
| NCT01267968 | An Open-label, Randomized, Single Period, Parallel-Cohort Study To Evaluate Serum and Pulmonary Pharmacokinetics Following Single and Multiple Dose Administration of Intravenous GSK2251052 in Healthy Adult Subjects | COMPLETED | PHASE1 | 2011-01-11 | 2011-03-16 | 2011-03-16 |
| NCT01428479 | Phase1 Study of GR121167, Single and Multiple Dose Study in Healthy Japanese Males | COMPLETED | PHASE1 | 2011-01-07 | 2011-04-04 | 2011-04-04 |
| NCT01411111 | A Repeat Dose Study to Investigate the Interaction of GSK2190915 on the Pharmacokinetics of Rosuvastatin | COMPLETED | PHASE1 | 2011-01-06 | 2011-02-23 | 2011-02-23 |
| NCT01323985 | SAP Depleter Dose Escalation Study in Healthy Volunteers | COMPLETED | PHASE1 | 2011-01-06 | 2011-06-30 | 2011-06-30 |
| NCT01332331 | Efficacy and Safety of Ambrisentan in Children 8-18yrs | TERMINATED | PHASE2 | 2011-01-04 | 2013-11-12 | 2013-11-12 |
| NCT01266993 | Persistence and Booster Study of GSK Biologicals' Meningococcal Vaccine (GSK134612) in Healthy Children | COMPLETED | PHASE3 | 2011-01-03 | 2014-05-17 | 2014-03-31 |
| NCT01316887 | A 52-Week, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Tolerability of GSK573719/GW642444 and GSK573719 in Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2011-01-01 | 2012-07-21 | 2012-07-01 |
| NCT01039909 | A Clinical Study to Assess the Effects of SRT2104 Upon Immobilization-Induced Skeletal Muscle Atrophy in Healthy Human Volunteers | WITHDRAWN | PHASE1 | 2011-01 | 2011-02 | 2011-02 |
| NCT01045564 | Safety and Immunogenicity of Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure | WITHDRAWN | PHASE2 | 2011-01 | 2013-02 | 2013-02 |
| NCT01277679 | Evaluation of MRI Measures of Lung Water With Posture Changes in Healthy Volunteers and in Patients With Cardiac Failure | COMPLETED | PHASE1 | 2011-01 | 2011-08 | 2011-08 |
| NCT01227889 | A Study Comparing GSK2118436 to Dacarbazine (DTIC) in Previously Untreated Subjects With BRAF Mutation Positive Advanced (Stage III) or Metastatic (Stage IV) Melanoma | COMPLETED | PHASE3 | 2010-12-23 | 2016-09-16 | 2011-12-19 |
| NCT01294592 | Comparative Efficacy of Dutasteride Plus Tamulosin With Lifestyle Advice Versus Watchful Waiting Plus Lifestyle Advice in the Management of Treatment naïve Men With Moderately Symptomatic Benign Prostatic Hyperplasia and Prostate Enlargement | COMPLETED | PHASE4 | 2010-12-22 | 2013-10-17 | 2013-10-17 |
| NCT01466322 | A Study to Assess the Relative Bioavailability of Different Formulations of GSK2018682, a Sphingosine-1-phosphate Receptor Subtype 1 Agonist, in Healthy Volunteers. | COMPLETED | PHASE1 | 2010-12-22 | 2011-02-15 | 2011-02-15 |
| NCT01277666 | A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease | COMPLETED | PHASE3 | 2010-12-20 | 2013-07-11 | 2013-07-11 |
| NCT01258530 | A Study to Evaluate the Bioequivalence of Over-encapsulated Oseltamivir Capsules to Marketed Oseltamivir Capsules in Healthy Volunteers | COMPLETED | PHASE1 | 2010-12-20 | 2011-02-03 | 2011-02-03 |
| NCT01251744 | Study of the Transmission of Cytomegalovirus (CMV) Infection From Mother to Foetus | COMPLETED | NA | 2010-12-09 | 2015-06-17 | 2013-11-06 |
| NCT01218308 | A Study to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine in Children | COMPLETED | PHASE3 | 2010-12-09 | 2012-01-09 | 2012-01-09 |
| NCT01248884 | Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744) | COMPLETED | PHASE2 | 2010-12-09 | 2012-01-05 | 2012-01-05 |
| NCT01745562 | Bioequivalence Trial of Alprazolam 0.5 mg Tablets | COMPLETED | PHASE1 | 2010-12-07 | 2010-12-17 | 2010-12-17 |
| NCT01094171 | Study to Evaluate the Safety of Co-administration of GSK Biologicals' Poliorix and Infanrix in Healthy Children in Russia | COMPLETED | PHASE4 | 2010-12-03 | 2012-10-27 | 2012-10-27 |
| NCT01248858 | Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK2126458 and GSK1120212 Combination Therapy in Subjects With Advanced Solid Tumors. | TERMINATED | PHASE1 | 2010-12-03 | 2015-04-23 | 2014-01-30 |
| NCT01254019 | A Clinical Study to Assess the Efficacy and Safety of GSK2402968 in Subjects With Duchenne Muscular Dystrophy | COMPLETED | PHASE3 | 2010-12-02 | 2013-06-28 | 2013-06-28 |
| NCT01853956 | Bioequivalence Trial of Alprazolam 0.25 mg Tablets | COMPLETED | PHASE1 | 2010-12-02 | 2010-12-10 | 2010-12-10 |
| NCT01205217 | Lapatinib or Trastuzumab Given Prior to Surgery With Chemotherapy in Patients With Early Breast Cancer | WITHDRAWN | PHASE2 | 2010-12 | 2010-12 | 2010-12 |
| NCT01299610 | A Study to Test the Effect of 2 Different Doses of Topical GW870086X on Atopic Dermatitis Also Including a Postive Control and a Placebo | COMPLETED | PHASE2 | 2010-12-01 | 2011-04-14 | 2011-03-01 |
| NCT01424514 | SB705498 Proof of Concept Chamber Challenge in Subjects With Non Allergic Rhinitis | COMPLETED | PHASE2 | 2010-12-01 | 2011-04-18 | 2011-04-01 |
| NCT01248975 | Safety and Efficacy Study Adding GSK2190915 to Mid-dose Inhaled Corticosteroid/Long Acting Beta Agonist Combination Treatment for Asthma | COMPLETED | PHASE2 | 2010-12 | 2011-10 | 2011-10 |
| NCT01245426 | A Study in Asthmatics to Determine the Efficacy and Dose Response of Repeat Doses of GW870086X on Forced Expiratory Volume in 1 Second (FEV1) | COMPLETED | PHASE2 | 2010-12 | 2011-08 | 2011-07 |
| NCT01319019 | A 4-week Dose-Ranging, Dose-Interval, Efficacy, Safety and Tolerability Study of GSK961081 in Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE2 | 2010-12 | 2011-09 | 2011-09 |
| NCT01235975 | Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine Given as One Dose to Healthy Subjects Above 56 Years | COMPLETED | PHASE3 | 2010-11-30 | 2011-08-03 | 2011-07-29 |
| NCT01294566 | FTIH to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses of GSK1322888 in Healthy Caucasian and Japanese Volunteers | COMPLETED | PHASE1 | 2010-11-29 | 2011-03-23 | 2011-03-23 |
| NCT01236040 | Immunogenicity and Safety of Pandemic Influenza Vaccines in Adults Aged 18 - 49 Years Old | COMPLETED | PHASE1 | 2010-11-29 | 2012-08-20 | 2011-09-06 |
| NCT01592799 | Study on the Burden of Influenza-related Hospitalizations and Emergency Room (ER) Visits in Children in Spain | COMPLETED | NA | 2010-11-23 | 2011-05-23 | 2011-05-23 |
| NCT01222078 | Investigating Re-Dosing With Otelixizumab in Adults With Newly-Diagnosed Type 1 Diabetes Mellitus | TERMINATED | PHASE2 | 2010-11-22 | 2011-05-19 | 2011-05-19 |
| NCT01245062 | GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma | COMPLETED | PHASE3 | 2010-11-22 | 2016-12-16 | 2011-10-26 |
| NCT01266980 | A Study to Assess the Effects of Repeat Doses of Fluticasone Furoate and GW642444M Combination in Healthy Subjects and in Subjects With Severe Impairment. | COMPLETED | PHASE1 | 2010-11-18 | 2011-03-22 | 2011-03-22 |
| NCT01428466 | Japanese Phase 1 Study of GSK2585823 | COMPLETED | PHASE1 | 2010-11-18 | 2011-02-15 | 2011-02-15 |
| NCT01323673 | Ethanol-Free Clobetasol Propionate Foam 0.05% (Olux-E Foam) vs Vehicle Foam in the Treatment of Chronic Hand Dermatitis. | COMPLETED | PHASE4 | 2010-11-15 | 2011-03-29 | 2011-03-01 |
| NCT01235949 | Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A and Prophylactic Antipyretic Treatment | COMPLETED | PHASE4 | 2010-11-12 | 2012-12-08 | 2012-03-28 |
| NCT01198769 | Immunogenicity and Safety Study of Rotarix TM in Taiwanese Infants Who Received Hepatitis B Immunoglobulin After Birth. | COMPLETED | PHASE4 | 2010-11-11 | 2011-04-18 | 2011-04-18 |
| NCT01218113 | Efficacy and Safety of GSK Biologicals HIV Vaccine in Antiretroviral Therapy (ART)-naïve HIV-1 Infected Persons | COMPLETED | PHASE2 | 2010-11-08 | 2012-11-05 | 2012-11-05 |
| NCT01376232 | Study to Assess the Pharmacokinetics of GSK1278863A Coadministered With a High Fat Meal or an Inhibitor of CYP2C8 (Gemfibrozil) | COMPLETED | PHASE1 | 2010-11-08 | 2010-12-20 | 2010-12-20 |
| NCT01267006 | Blood Levels and Effects of GSK1325756 in Healthy Adult Volunteers Aged 40 to 80 Years Old | COMPLETED | PHASE1 | 2010-11-05 | 2011-01-27 | 2011-01-27 |
| NCT03549130 | A Pivotal Study to Assess the Effectiveness of Nasal Dilator (Breathe Right Nasal Strips) | COMPLETED | PHASE2 | 2010-11-04 | 2011-02-17 | 2011-02-17 |
| NCT01218126 | Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-centre, Dose Ranging Study to Evaluate the Efficacy and Safety of Losmapimod Tablets Administered Twice Daily Compared With Placebo for 24 Weeks in Adult Subjects With Chronic Obstructive Pulmonary Disease (COPD). | COMPLETED | PHASE2 | 2010-11-04 | 2011-12-21 | 2011-12-21 |
| NCT01277692 | A First Time in Human Study to Assess GSK2336805 in Healthy Volunteers and Single Doses in Chronically Infected Hepatitis C Patients. | COMPLETED | PHASE1 | 2010-11-03 | 2011-05-09 | 2011-05-09 |
| NCT01236638 | Extension Study Evaluating the Long Term Safety and Efficacy Study of CYT387 in Primary Myelofibrosis (PMF) or Post-polycythemia Vera (PV) or Post-essential Thrombocythemia (ET) | COMPLETED | PHASE2 | 2010-11 | 2014-06 | 2014-06 |
| NCT01328106 | Efficacy and Safety Study of GSK1120212, a MEK Inhibitor, in Subjects With Uveal Melanoma | WITHDRAWN | PHASE2 | 2010-11 | 2012-05 | 2011-08 |
| NCT01286844 | GSK2190915 Pediatric Study | WITHDRAWN | PHASE2 | 2010-11 | 2011-05 | 2011-05 |
| NCT01231607 | Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia | COMPLETED | PHASE3 | 2010-10-28 | 2012-02-28 | 2012-02-01 |
| NCT01031069 | Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females | COMPLETED | PHASE4 | 2010-10-26 | 2017-04-19 | 2016-01-13 |
| NCT01494610 | Pharmacokinetic and Pharmacodynamic (PK and PD) Study of Fluticasone Propionate and Salmeterol Combination Product Delivered in a Capsule-based Inhaler and in a Multi-dose Dry Powder Inhaler in Moderate Asthma Patients and Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients. | COMPLETED | PHASE1, PHASE2 | 2010-10-25 | 2011-06-08 | 2011-06-08 |
| NCT03549117 | A Pivotal Subjective Sleep Study of a Nasal Dilator (Breathe Right Tan) | COMPLETED | PHASE2 | 2010-10-25 | 2011-01-14 | 2011-01-14 |
| NCT01449838 | Phase I Study of Colistin Methanesulfonate Sodium | COMPLETED | PHASE1 | 2010-10-23 | 2010-12-09 | 2010-12-09 |
| NCT01231568 | An Open Label Study to Examine the Effects of a High-Fat Meal and Particle Size on the Pharmacokinetics of Orally Administered GSK2118436 in Subjects With BRAF Mutation Positive Tumor | COMPLETED | PHASE1 | 2010-10-21 | 2011-05-13 | 2011-05-13 |
| NCT01266941 | A Study to Assess the Effects of Fluticasone Furoate and GW642444M Combination in Healthy Subjects and in Subjects With Mild, Moderate or Severe Hepatic Impairment. | COMPLETED | PHASE1 | 2010-10-18 | 2011-07-15 | 2011-07-15 |
| NCT02135848 | 3 Month PHI PAD PoM Study | COMPLETED | PHASE2 | 2010-10-15 | 2011-11-01 | 2011-11-01 |
| NCT01160198 | A Study to Demonstrate the Efficacy and Tolerability of Ferrous Bisglycinate Chelate in Iron Deficiency Anaemia and to Compare These With Those of Ferrous Ascorbate. | COMPLETED | PHASE3 | 2010-10-13 | 2011-02-18 | 2011-02-18 |
| NCT01431937 | Assessment of Repeat Ascending Doses of GSK2018682 in Healthy Volunteers | COMPLETED | PHASE1 | 2010-10-10 | 2011-03-29 | 2011-03-29 |
| NCT01262885 | A Randomized, Single Blind, Placebo Controlled Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses and Repeat Escalating Oral Doses of GSK2251052 in Healthy Adult Subjects | COMPLETED | PHASE1 | 2010-10-07 | 2011-08-25 | 2011-08-25 |
| NCT01190215 | Immunogenicity and Safety Study of FluarixTM Vaccine in Children Who Have Previously Been Vaccinated With PandemrixTM | COMPLETED | PHASE4 | 2010-10-04 | 2011-07-07 | 2011-07-07 |
| NCT01213849 | Dose Proportionality Study: Blood Levels of Fluticasone Furoate (FF) and Vilanterol (VI) Following Different Doses of FF/VI Via an Inhaler | COMPLETED | PHASE1 | 2010-10-04 | 2010-11-25 | 2010-11-25 |
| NCT01196988 | Immunogenicity and Safety Study of GSK Biologicals' Influenza Vaccine When Administered in Children | COMPLETED | PHASE3 | 2010-10-04 | 2011-06-15 | 2011-06-15 |
| NCT01204671 | Safety and Immunogenicity Study of GSK Biologicals' Seasonal Influenza Candidate Vaccine (GSK2321138A) | COMPLETED | PHASE3 | 2010-10-04 | 2011-06-06 | 2011-06-06 |
| NCT01153893 | Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Nigeria | COMPLETED | PHASE3 | 2010-10-04 | 2011-02-16 | 2011-02-16 |
| NCT01198756 | A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Children | COMPLETED | PHASE3 | 2010-10-01 | 2011-07-01 | 2011-07-01 |
| NCT01178073 | A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH) | COMPLETED | PHASE3 | 2010-10-01 | 2014-07-31 | 2014-07-31 |
| NCT01357876 | Effect of Metformin on Gut Peptides , Bile Acids and Lipid Profiles in Type 2 Diabetics | COMPLETED | PHASE1 | 2010-10-01 | 2011-07-07 | 2011-07-07 |
| NCT01287065 | A Study in Asthmatic Patients to Determine if There is Any Difference in Dosing With Fluticasone Furoate/Vilanterol Inhalation Powder in the Morning or Evening on Lung Function | COMPLETED | PHASE2 | 2010-10 | 2011-09 | 2011-09 |
| NCT01196975 | A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults | COMPLETED | PHASE3 | 2010-10-01 | 2011-06-24 | 2011-01-25 |
| NCT01277081 | Effect of Paracetamol on the Common Cold | COMPLETED | PHASE2 | 2010-10 | 2010-12 | 2010-12 |
| NCT01195779 | Trial to Evaluate Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2584786A in Healthy Children | TERMINATED | PHASE2 | 2010-09-30 | 2011-03-22 | 2011-03-22 |
| NCT01165203 | Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects | COMPLETED | PHASE2 | 2010-09-30 | 2013-05-14 | 2012-07-06 |
| NCT01318980 | A Single Dose Study to Assess the Regional Absorption and Bioavailability of 100mg GSK2190915A | COMPLETED | PHASE1 | 2010-09-30 | 2011-03-11 | 2011-03-11 |
| NCT01204658 | Safety & Immunogenicity of Pneumococcal Vaccine 2189242A Co-administered With DTPa-HBV-IPV/Hib in Healthy Infants | COMPLETED | PHASE2 | 2010-09-27 | 2012-10-01 | 2011-11-03 |
| NCT01357850 | A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure | COMPLETED | PHASE2 | 2010-09-15 | 2012-09-18 | 2012-09-18 |
| NCT01196026 | Immunogenicity and Safety Study of Fluarix™ Vaccine in Children Who Have Previously Been Vaccinated With Pandemrix™ | COMPLETED | PHASE4 | 2010-09-15 | 2011-05-26 | 2011-05-26 |
| NCT01218204 | A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With Atorvastatin | COMPLETED | PHASE2 | 2010-09-14 | 2011-06-29 | 2011-06-29 |
| NCT01192165 | Safety and Tolerability Study of GSK1120212, a MEK Inhibitor, in Combination With Docetaxel, Erlotinib, Pemetrexed, Pemetrexed + Carboplatin, Pemetrexed + Cisplatin, or Nab-Paclitaxel | COMPLETED | PHASE1 | 2010-09-14 | 2013-10-07 | 2013-10-07 |
| NCT01254071 | A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry. | COMPLETED | PHASE1 | 2010-09-10 | 2010-12-21 | 2010-12-21 |
| NCT01160224 | Oral GW766944 (Oral CCR3 Antagonist) | COMPLETED | PHASE2 | 2010-09-08 | 2011-08-29 | 2011-08-29 |
| NCT01536574 | Open-Label Extension Study With REQUIP PR for Subjects From Study ROP111528 | COMPLETED | PHASE3 | 2010-09-02 | 2012-03-28 | 2012-03-01 |
| NCT01466361 | Evaluation of the Nicotine Lozenge in Relief of Provoked Acute Craving | COMPLETED | PHASE2 | 2010-09 | 2010-12 | 2010-12 |
| NCT01181895 | Study B2C112060: A Study of the Efficacy and Safety of Vilanterol Inhalation Powder in Adults and Adolescents With Persistent Asthma | COMPLETED | PHASE3 | 2010-09-01 | 2011-08-26 | 2011-08-01 |
| NCT01105936 | Assess the Blood-Oxygen-Level-Dependent (BOLD) Signal Changes in the Brain by Paracetamol as Measured by Functional Magnetic Resonance Imaging (fMRI) in Subjects With Osteoarthritis (OA) | COMPLETED | PHASE4 | 2010-09-01 | 2011-08-01 | 2011-08-01 |
| NCT01156792 | Safety and Efficacy Study of Adding GSK2190915 to Low Dose Inhaled Corticosteroid Treatment for Asthma Subjects > or = 12 Years of Age | COMPLETED | PHASE2 | 2010-09 | 2011-10 | 2011-10 |
| NCT01205451 | A Multicenter, Open-label, Single Dose Study of the Safety and Efficacy of GSK1358820 (Botulinum Toxin Type A) in Chinese Subjects With Post-stroke Focal Upper Limb Spasticity | COMPLETED | PHASE3 | 2010-09 | 2012-03 | 2011-12 |
| NCT01195792 | A 35 Day Study to Investigate the Effects of GSK1521498 on Bodyweight in Obese Subjects With Over-Eating Behaviours. | COMPLETED | PHASE2 | 2010-09 | 2011-05 | 2011-05 |
| NCT01227928 | Efficacy and Safety of Pazopanib Monotherapy After First-line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Asian Women | COMPLETED | PHASE2 | 2010-09 | 2014-01 | 2012-10 |
| NCT01721135 | A Study to Evaluate the Effect of Two Different Repeat Doses of GSK2190915 on the QTc Interval. | WITHDRAWN | PHASE1 | 2010-09 | 2014-12 | 2014-12 |
| NCT01153932 | Phase II Doubleblind Exploratory Study of GSK2402968 in Ambulant Subjects With Duchenne Muscular Dystrophy | COMPLETED | PHASE2 | 2010-09 | 2012-09 | 2012-03 |
| NCT01205230 | VEG113971: An Open-Label Study of the Effects of Ketoconazole or Esomeprazole on Pazopanib PK | COMPLETED | PHASE4 | 2010-09 | 2011-08 | 2011-08 |
| NCT01366560 | Effect of GSK962040 on Oesophageal Function | COMPLETED | PHASE1 | 2010-08-31 | 2010-10-22 | 2010-10-22 |
| NCT01171963 | Study to Assess the Efficacy, Immunogenicity and Safety of Liquid Human Rotavirus Vaccine, in Healthy Chinese Infants | COMPLETED | PHASE3 | 2010-08-29 | 2012-05-12 | 2012-05-12 |
| NCT01154088 | Immunogenicity and Safety of Meningococcal Vaccine GSK 134612 Versus Mencevax™ ACWY in Healthy 18-25 Year Olds | COMPLETED | PHASE3 | 2010-08-27 | 2010-12-30 | 2010-12-30 |
| NCT01165138 | Study HZA106827: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics | COMPLETED | PHASE3 | 2010-08-20 | 2011-10-19 | 2011-10-01 |
| NCT01165242 | Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine GSK 134612 Versus Menactra® in Healthy Adolescents/Adults | COMPLETED | PHASE2 | 2010-08-19 | 2011-07-29 | 2011-02-25 |
| NCT01171989 | Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose | COMPLETED | PHASE2 | 2010-08-18 | 2010-12-03 | 2010-12-03 |
| NCT01209078 | GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection | COMPLETED | PHASE2 | 2010-08-17 | 2011-01-18 | 2011-01-18 |
| NCT01762787 | Phase I Methodology Study to Validate the Cantharidin Blister Model in Healthy Volunteers | COMPLETED | PHASE1 | 2010-08-17 | 2011-01-14 | 2011-01-14 |
| NCT01154062 | A Study to Evaluate Pazopanib Tablets in Patients Who Have Neovascular Age-related Macular Degeneration | COMPLETED | PHASE1 | 2010-08-16 | 2011-04-29 | 2011-04-29 |
| NCT01153763 | A Study of GSK2118436 in BRAF Mutant Metastatic Melanoma | COMPLETED | PHASE2 | 2010-08-09 | 2016-06-01 | 2011-07-01 |
| NCT02207452 | Helium-3 MRI Imaging Study in COPD | COMPLETED | PHASE1 | 2010-08-05 | 2011-07-04 | 2011-07-04 |
| NCT01165177 | Study to Evaluate Efficacy, Safety and Immunogenicity of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 50 Years and Older | COMPLETED | PHASE3 | 2010-08-02 | 2015-07-27 | 2014-05-09 |
| NCT01165229 | Study to Evaluate Efficacy, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 70 Years and Older | COMPLETED | PHASE3 | 2010-08-02 | 2015-07-24 | 2015-07-24 |
| NCT01191775 | A Study of PNT2258 in Patients With Advanced Solid Tumors | COMPLETED | PHASE1 | 2010-08 | 2012-04 | 2012-04 |
| NCT01192191 | A Long-term Safety Study of Fluticasone Furoate (FF)/GW642444 in Japanese Subjects With COPD | COMPLETED | PHASE3 | 2010-08 | 2012-01 | 2012-01 |
| NCT01192178 | Fall Epidemic Viral Pediatric Study | COMPLETED | PHASE4 | 2010-08 | 2010-12 | 2010-12 |
| NCT01453296 | Pharmacokinetics and Pharacodynamics of GW642444 in Paedetric Subjects | COMPLETED | PHASE2 | 2010-08 | 2011-04 | 2011-04 |
| NCT01160237 | Study to Evaluate the Immune Response and the Safety of Fluarix TM/ Influsplit SSW® 2010/2011 or Pandemrix TM | TERMINATED | PHASE3 | 2010-08 | 2011-02 | 2011-02 |
| NCT01231581 | Study of GSK1120212 Plus Gemcitabine vs Placebo Plus Gemcitabine in Metastatic Pancreatic Cancer | COMPLETED | PHASE2 | 2010-08 | 2013-02 | 2012-04 |
| NCT01148459 | Safety and Immunogenicity of GSK Biologicals' Investigational Malaria Vaccine in HIV Infected Infants and Children | COMPLETED | PHASE3 | 2010-07-30 | 2013-05-24 | 2013-05-24 |
| NCT01160003 | A Blinded, Dose Ascending Study to Assess the Pharmacokinetics, Safety and Tollerability of Repeat Inhaled Doses of Nebulised GW870086X in Healthy Adult Male Volunteers. | COMPLETED | PHASE1 | 2010-07-29 | 2010-11-05 | 2010-11-05 |
| NCT01138033 | Study of a Focal Adhesion Kinase Inhibitor in Subjects With Solid Tumors | COMPLETED | PHASE1 | 2010-07-27 | 2015-12-21 | 2015-12-21 |
| NCT01611805 | Japanese Phase I of GSK1605786 | COMPLETED | PHASE1 | 2010-07-22 | 2010-10-06 | 2010-10-06 |
| NCT01159964 | Evaluation of a New Anti-cancer Vaccine for Patients With Non-small Cell Lung Cancer, After Tumor Removal by Surgery | TERMINATED | PHASE1 | 2010-07-20 | 2014-09-10 | 2011-10-19 |
| NCT01381536 | Phase I Study of GSK1550188 in Japanese Subjects With Systemic Lupus Erythematosus (SLE) | COMPLETED | PHASE1 | 2010-07-20 | 2010-11-27 | 2010-11-27 |
| NCT01124422 | Fluticasone Propionate/Salmeterol Combination 250/50 DISKUS in the Exercise Endurance Time in Patients With Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE4 | 2010-07-19 | 2011-05-02 | 2011-05-01 |
| NCT01160172 | A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Staphylococcal Investigational Vaccine in Healthy Adults | COMPLETED | PHASE1 | 2010-07-19 | 2012-08-23 | 2012-08-23 |
| NCT01745614 | Bioequivalence Study of Nimesulide 100 mg Tablets | COMPLETED | PHASE1 | 2010-07-18 | 2010-07-26 | 2010-07-26 |
| NCT01128855 | A Double-blind, Escalating Dose, Randomized, Placebo-controlled Study Assessing PK, Safety, Tolerability in Non-ambulant DMD Subjects | COMPLETED | PHASE1 | 2010-07-12 | 2011-10-25 | 2011-10-25 |
| NCT01119625 | Immunological Persistence After Priming With GSK1024850A Vaccine and Safety& Immunogenicity After Booster Dose | COMPLETED | PHASE3 | 2010-07-12 | 2011-02-17 | 2011-02-17 |
| NCT01153685 | Immunogenicity & Safety Study of Fluviral® (2010 - 2011 Season) in Adults Aged 18 to 60 Years and Over 60 Years | COMPLETED | PHASE3 | 2010-07-09 | 2010-07-31 | 2010-07-31 |
| NCT01114503 | A Safety and Tolerability Study of Otelixizumab in Thyroid Eye Disease | TERMINATED | PHASE2 | 2010-07-07 | 2012-08-29 | 2012-08-29 |
| NCT01098474 | Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Healthy Infants | COMPLETED | PHASE2 | 2010-07-07 | 2012-03-16 | 2011-04-30 |
| NCT01149343 | Evaluation of a New Vaccine Treatment for Patients With Metastatic Skin Cancer | COMPLETED | PHASE1 | 2010-07-02 | 2016-12-19 | 2014-02-11 |
| NCT01144663 | Immunogenicity and Safety of Meningococcal Vaccine GSK 134612 Co-administered With Pneumococcal and DTPa-HBV-IPV/Hib Vaccines | COMPLETED | PHASE3 | 2010-07-01 | 2013-09-10 | 2012-06-22 |
| NCT01154114 | Study to Evaluate Darapladib in Moderately Hepatically Impaired Subjects | COMPLETED | PHASE1 | 2010-07-01 | 2010-10-15 | 2010-10-15 |
| NCT01147861 | A Phase 1 Study to Evaluate the Effect of GSK256073, an HM74A Receptor Agonist, on Glucose and NEFA Levels in Type 2 Diabetics | COMPLETED | PHASE1 | 2010-07-01 | 2010-09-07 | 2010-09-07 |
| NCT01165125 | A Drug Interaction Study With Fluticasone Furoate/GW642444 Inhalation Powder and Ketoconazole | COMPLETED | PHASE1 | 2010-07-01 | 2010-08-28 | 2010-08-28 |
| NCT01161160 | Safety and Immune Response of Candidate H1N1 Influenza Vaccines GSK2340274A and GSK234072A in Children 3 to Less Than 10 Years Old | COMPLETED | PHASE2 | 2010-07-01 | 2011-01-31 | 2010-08-23 |
| NCT01244984 | A Long-term Safety Study of Fluticasone Furoate (FF)/GW642444 and FF in Japanese Subjects With Asthma | COMPLETED | PHASE3 | 2010-07 | 2012-01 | 2012-01 |
| NCT01227902 | Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures | COMPLETED | PHASE3 | 2010-07 | 2012-12 | 2012-12 |
| NCT01159912 | Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents | COMPLETED | PHASE3 | 2010-06-30 | 2012-01-16 | 2012-01-01 |
| NCT01435915 | Ropinirole PR Pharmacokinetics Study Among Chinese Healthy Subjects | COMPLETED | PHASE1 | 2010-06-28 | 2010-08-05 | 2010-08-05 |
| NCT01147744 | Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once Daily | COMPLETED | PHASE2 | 2010-06-28 | 2011-10-06 | 2011-10-06 |
| NCT01209026 | Corrected QT (QTc) Study With Flucticasone Furoate and GW642444 | COMPLETED | PHASE1 | 2010-06-23 | 2011-01-04 | 2011-01-04 |
| NCT01000974 | Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants | COMPLETED | PHASE3 | 2010-06-18 | 2013-07-17 | 2011-11-18 |
| NCT01138007 | A Fixed Dose Study of 323U66 SR in the Treatment of Major Depressive Disorder (MDD) | COMPLETED | PHASE3 | 2010-06-17 | 2012-08-07 | 2012-08-01 |
| NCT01144299 | A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults | COMPLETED | PHASE3 | 2010-06-17 | 2010-07-10 | 2010-07-10 |
| NCT01147900 | Evaluation of Boostrix™10 Years After Previous Booster Vaccination | COMPLETED | PHASE4 | 2010-06-15 | 2012-05-08 | 2012-05-08 |
| NCT01267071 | A Study to Evaluate the Pharmacokinetics and Absolute Bioavailability of GSK962040 Given as an Oral Dose Simultaneously With an Intravenous Microtracer Dose of [14C]-GSK962040 in Healthy Volunteers | COMPLETED | PHASE1 | 2010-06-14 | 2010-09-01 | 2010-09-01 |
| NCT01119651 | A Study to Evaluate the Potential of Tazarotene Foam to Cause an Allergic Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers. | COMPLETED | PHASE1 | 2010-06-14 | 2010-06-26 | 2010-06-26 |
| NCT01147718 | A Drug Interaction Study of Albiglutide and Digoxin | COMPLETED | PHASE1 | 2010-06-11 | 2010-11-29 | 2010-11-29 |
| NCT01154101 | Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type Psoriasis | COMPLETED | PHASE2 | 2010-06-07 | 2011-11-09 | 2011-11-09 |
| NCT01138098 | Evaluation of Antibody Persistence and Immune Memory Against the Hepatitis B Antigen in Previously Vaccinated Children | COMPLETED | PHASE4 | 2010-06-07 | 2010-11-26 | 2010-11-26 |
| NCT01147731 | A Drug Interaction Study With Albiglutide and Warfarin | COMPLETED | PHASE1 | 2010-06-04 | 2010-09-09 | 2010-09-09 |
| NCT01134055 | Dose Ranging Study of Pazopanib to Treat Neovascular Age-Related Macular Degeneration | COMPLETED | PHASE2 | 2010-06-01 | 2012-10-01 | 2012-10-01 |
| NCT01266954 | An Open Label Study To Investigate the Pharmacokinetics and Pharmacodynamics of Repeat Escalating Doses of the Oral AKT Inhibitor GSK2141795 by 18F FDG PET Analysis in Subjects With Ovarian Cancer | COMPLETED | PHASE1 | 2010-06-01 | 2011-09-01 | 2011-09-01 |
| NCT01134042 | Study HZA106829: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics | COMPLETED | PHASE3 | 2010-06 | 2011-10 | 2011-10 |
| NCT01147848 | HZA113091 Efficacy and Safety of Fluticasone Furoate/Vilanterol (GW642444) in Adults and Adolescents | COMPLETED | PHASE3 | 2010-06 | 2011-07 | 2011-07 |
| NCT01147809 | Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag | COMPLETED | PHASE2 | 2010-06 | 2015-03 | 2015-01 |
| NCT01138072 | A Drug Interaction Study Between Simvastatin, Atorvastatin, Rosuvastatin, and GSK2248761 in Healthy Subjects. | COMPLETED | PHASE1 | 2010-06 | 2010-08 | 2010-08 |
| NCT01031108 | A Clinical Trial to Assess the Safety of Oral SRT2104 and Its Effects on Vascular Dysfunction in Otherwise Healthy Cigarette Smokers and Subjects With Type 2 Diabetes Mellitus | COMPLETED | PHASE1 | 2010-05-28 | 2011-10-12 | 2011-10-12 |
| NCT01387217 | GSK2018682 FTIH in Healthy Volunteers | COMPLETED | PHASE1 | 2010-05-21 | 2010-12-20 | 2010-12-20 |
| NCT01147692 | A Drug Interaction Study of Simvastatin and Albiglutide | COMPLETED | PHASE1 | 2010-05-19 | 2010-08-27 | 2010-08-27 |
| NCT01424436 | Modulation of Abeta Levels by GSK933776 in Alzheimer's Disease Patient | COMPLETED | PHASE1 | 2010-05-19 | 2011-12-08 | 2011-12-08 |
| NCT01286831 | A Single Dose Study to Determine the Excretion, Balance and Metabolic Disposition of Radiolabelled GW642444. | COMPLETED | PHASE1 | 2010-05-18 | 2010-07-09 | 2010-07-09 |
| NCT01114620 | Study of GSK Biologicals' Influenza Vaccine Arepanrix™ in Japanese Adults 65 Years of Age or Older | COMPLETED | PHASE4 | 2010-05-17 | 2010-12-09 | 2010-11-05 |
| NCT01123083 | Trial of Otelixizumab for Adolescents and Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-2 | COMPLETED | PHASE3 | 2010-05-17 | 2012-03-09 | 2012-03-09 |
| NCT01299558 | Study to Look at and Compare How Inhaled and Intravenous Fluticasone Furoate and GW642444 Are Processed by the Body in Healthy Subjects | COMPLETED | PHASE1 | 2010-05-17 | 2010-07-15 | 2010-07-15 |
| NCT01090453 | Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants | COMPLETED | PHASE2 | 2010-05-17 | 2011-10-11 | 2011-10-11 |
| NCT01943942 | Bioequivalence Study of Montelukast 10 mg Tablets | COMPLETED | PHASE1 | 2010-05-16 | 2010-05-26 | 2010-05-26 |
| NCT01863654 | Bioequivalence Study of Montelukast 5 mg Chewable | COMPLETED | PHASE1 | 2010-05-16 | 2010-05-26 | 2010-05-26 |
| NCT01106092 | Study to Evaluate the Immunogenicity and Reactogenicity of a Booster Dose of GSK2036874A Vaccine in Healthy Toddlers | COMPLETED | PHASE2 | 2010-05-13 | 2010-09-02 | 2010-09-02 |
| NCT01110031 | Ofatumumab Cardiac Repolarization (QTc) Study in Fludarabine-Refractory Chronic Lymphocytic Leukemia Subjects | COMPLETED | PHASE1 | 2010-05-13 | 2012-06-26 | 2012-04-12 |
| NCT01101555 | Repeat Dose Subcutaneous Rhumatoid Arthritis Efficacy Study | COMPLETED | PHASE1 | 2010-05-12 | 2012-11-29 | 2011-09-16 |
| NCT01132443 | W0261-101: A Phase 1, Single Center, Randomized, Open-Label Study to Evaluate the Bioavailability of Clindamycin From Clindamycin 1%-Benzoyl Peroxide 3% Gel, Topical Gel (Clindamycin 1%- Benzoyl Peroxide 5%), and Once Daily Gel (Clindamycin 1%-Benzoyl Peroxide 5%) in Subjects With Acne | COMPLETED | PHASE1 | 2010-05-06 | 2010-06-12 | 2010-06-12 |
| NCT01114607 | A Study to Assess the Relative Bioavailability of Four New Formulations of GSK1605786 in Healthy Subjects | COMPLETED | PHASE1 | 2010-05-05 | 2010-06-29 | 2010-06-29 |
| NCT01138085 | Safety, Pharmacokinetics (PK) of AKT and MEK Combination | COMPLETED | PHASE1 | 2010-05-04 | 2014-11-19 | 2014-11-19 |
| NCT01745601 | Bioequivalence Study of Escitalopram Tablets 10 mg | COMPLETED | PHASE1 | 2010-05-04 | 2010-05-19 | 2010-05-19 |
| NCT01332292 | Pharmacokinetics and PharmacoDynamics of GW685698 in Paedeatric Asthmatic Patients | COMPLETED | PHASE2 | 2010-05 | 2011-01 | 2011-01 |
| NCT01098539 | A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. | COMPLETED | PHASE3 | 2010-05 | 2012-11 | 2012-11 |
| NCT01128894 | A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide. | COMPLETED | PHASE3 | 2010-05 | 2011-09 | 2011-09 |
| NCT01139580 | The Purpose of This Study is to Demonstrate the Safety and Effectiveness of Calcipotriene Foam in Subjects With Scalp and Body Psoriasis | COMPLETED | PHASE3 | 2010-05 | 2010-12 | 2010-12 |
| NCT01128595 | Randomised Study Comparing the Effects of Inhaled FF/GW642444M Combination, FF and GW642444M on an Allergen Induced Asthmatic Response | COMPLETED | PHASE2 | 2010-05 | 2011-05 | 2011-05 |
| NCT00866580 | A Study for Evaluation of GSK Biologicals' Pandemic Influenza Vaccine | WITHDRAWN | PHASE3 | 2010-05 | 2011-07 | 2011-07 |
| NCT01098487 | A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) | COMPLETED | PHASE4 | 2010-05 | 2014-05 | 2014-05 |
| NCT01551797 | A Pharmacokinetic Study to Compare Sustained Release and Standard Paracetamol Formulations. | COMPLETED | PHASE1 | 2010-05 | 2010-10 | 2010-10 |
| NCT01110200 | Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization Study | COMPLETED | PHASE4 | 2010-04-30 | 2012-05-08 | 2012-04-01 |
| NCT01098006 | A Study in Adult Subjects With Chronic Hepatitis B Infection to Support the Development of Immunological Assays | COMPLETED | NA | 2010-04-29 | 2012-02-20 | 2012-02-20 |
| NCT01077531 | Safety, Pharmacodynamics and Pharmacokinetics of GSK2136525 Repeat Dose in Rheumatoid Arthritis | TERMINATED | PHASE1 | 2010-04-28 | 2013-03-19 | 2013-03-19 |
| NCT01110018 | GSK573719 IV Enabling Study | COMPLETED | PHASE1 | 2010-04-28 | 2010-06-09 | 2010-06-09 |
| NCT01424462 | Healthy Volunteer Pilot Study Using 3 Types of Modified Release Formulations of Firategrast to Investigate How Quickly Absorption From the Digestive System Takes Place. | COMPLETED | PHASE1 | 2010-04-19 | 2010-07-06 | 2010-07-06 |
| NCT01209104 | Pharmacokinetics and Safety of GSK1325756 in Elderly Subjects and Adult Subjects of in the Fed and Fasted States and in the Presence of a Proton Pump Inhibitors | COMPLETED | PHASE1 | 2010-04-14 | 2010-05-24 | 2010-05-24 |
| NCT01101568 | A Study to Investigate the Interaction of GSK1292263 With Rosuvastatin and Simvastatin in Healthy Subjects | COMPLETED | PHASE1 | 2010-04-14 | 2010-06-24 | 2010-06-24 |
| NCT01107587 | Study to Assess the Safety of GSK Biologicals' Liquid Human Rotavirus Vaccine in Healthy Infants | COMPLETED | PHASE1 | 2010-04-13 | 2010-06-28 | 2010-06-28 |
| NCT01096056 | Trial to Evaluate the Safety and the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Healthy Children | COMPLETED | PHASE1 | 2010-04-05 | 2010-12-13 | 2010-12-13 |
| NCT01030822 | Booster and Catch-up Vaccination With Vaccine GSK1024850A | COMPLETED | PHASE3 | 2010-04-02 | 2011-08-19 | 2011-08-19 |
| NCT01115322 | A Study to Evaluate the Potential of Tazarotene Foam to Cause a Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers | COMPLETED | PHASE1 | 2010-04-01 | 2010-04-10 | 2010-04-10 |
| NCT01099488 | A Study in Healthy Adults Having Received a Single Vaccine Administration to Support the Development of Immunological Assays | COMPLETED | NA | 2010-04-01 | 2010-12-07 | 2010-12-07 |
| NCT01153815 | A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GSK1358820 (Botulinum Toxin Type A) in Chinese Subjects With Post-stroke Upper Limb Spasticity | COMPLETED | PHASE3 | 2010-04 | 2011-06 | 2011-06 |
| NCT01098461 | Dose Ranging Study of Albiglutide in Japanese Subjects | COMPLETED | PHASE2 | 2010-04 | 2011-05 | 2011-05 |
| NCT01381640 | A Study to Compare Two Paracetamol Tablets | WITHDRAWN | PHASE1 | 2010-04 | 2010-05 | 2010-05 |
| NCT01128738 | GSK1358820 (Botulinum Toxin A) PhIII DB & OL Study in Patients With Axillary Hyperhidrosis | COMPLETED | PHASE3 | 2010-04 | 2011-08 | 2011-08 |
| NCT01008956 | Safety and Immune Response of One-Dose of Candidate H1N1 Influenza Vaccine GSK2340274A in Adults | WITHDRAWN | PHASE2 | 2010-04 | 2010-10 | 2010-10 |
| NCT01110044 | Study of a Birth Dose of GlaxoSmithKline Biologicals' 251154 Vaccine | WITHDRAWN | PHASE2 | 2010-04 | 2012-08 | 2012-08 |
| NCT01138046 | Phase I/II Study of Lapatinib in Combination With Paclitaxel as 1L Chemotherapy for ErbB2-positive MBC | COMPLETED | PHASE2 | 2010-04 | 2014-01 | 2014-01 |
| NCT01122862 | Effect of a Commercial Cosmetic Mouth Rinse on Plaque Re-growth | COMPLETED | PHASE2 | 2010-04 | 2010-05 | 2010-05 |
| NCT01476072 | 31P MRS Ischaemic Exercise Optimisation and COPD | COMPLETED | PHASE1 | 2010-04 | 2011-08 | 2011-08 |
| NCT01767428 | Pharmacokinetic Study to Compare Two Formulations of Paracetamol | COMPLETED | PHASE1 | 2010-04 | 2010-04 | 2010-04 |
| NCT01453049 | An Efficacy and Safety Study of Fixed-dose Rosiglitazone/Glimepiride to Treat Chinese Type 2 Diabetes Patients | TERMINATED | PHASE3 | 2010-04 | 2010-10 | 2010-10 |
| NCT01114841 | A Study To Evaluate The Contact Sensitization Potential Of Tazarotene Foam On Skin In Healthy Volunteers | COMPLETED | PHASE1 | 2010-03-31 | 2010-06-26 | 2010-06-26 |
| NCT01745575 | Bioequivalence Trial of Alprazolam 2 mg Tablets | COMPLETED | PHASE1 | 2010-03-28 | 2010-04-05 | 2010-04-05 |
| NCT01112787 | A Study to Evaluate the Irritation Potential of Tazarotene Foam on Skin in Healthy Volunteers | COMPLETED | PHASE1 | 2010-03-26 | 2010-04-26 | 2010-04-26 |
| NCT01092611 | Long-term Follow-up of Participants From Studies Evaluating GSK HIV Vaccine | COMPLETED | PHASE1 | 2010-03-22 | 2014-05-19 | 2014-03-17 |
| NCT01077505 | An Evaluation of the Pharmacokinetics of an Oral Contraceptive (Brevicon) When Co-administered With Albiglutide . | COMPLETED | PHASE1 | 2010-03-15 | 2010-11-24 | 2010-11-24 |
| NCT01086436 | Study to Evaluate the Safety of Rotarix™ in Chinese Children | COMPLETED | PHASE1 | 2010-03-13 | 2010-04-16 | 2010-04-16 |
| NCT01072214 | A Safety Study to Evaluate Pazopanib Eye Drops in Healthy Volunteers | COMPLETED | PHASE1 | 2010-03-09 | 2010-06-28 | 2010-06-28 |
| NCT01086449 | Safety and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine 1437173A in Healthy Ethnic Japanese Adults | COMPLETED | PHASE1 | 2010-03-04 | 2010-11-25 | 2010-06-25 |
| NCT01128634 | Pharmacokinetic and Safety of GSK573719 and GW642444 Administered Individually and Concurrently, With Verapamilin in Healthy Subjects | COMPLETED | PHASE1 | 2010-03-04 | 2010-04-26 | 2010-04-26 |
| NCT01018017 | A Clinical Study to Assess the Safety, Tolerability, and Activity of Oral SRT2104 Capsules Administered for 28 Days to Subjects With Type 2 Diabetes Mellitus | COMPLETED | PHASE2 | 2010-03-03 | 2010-12-25 | 2010-12-25 |
| NCT01162590 | Study to Evaluate the Reactogenicity and Safety of Rotarix™ in Chinese Adults | COMPLETED | PHASE1 | 2010-03-01 | 2010-03-31 | 2010-03-31 |
| NCT01086423 | Immunogenicity and Safety Study of GSK Biologicals' Infanrix-IPV+Hib™ Vaccine | COMPLETED | PHASE3 | 2010-03-01 | 2010-11-19 | 2010-11-19 |
| NCT01086410 | Safety Study of the Effects of Inhaled Fluticasone Furoate/GW642444 on the Hypothalamic-Pituitary-Adrenal (HPA) Axis | COMPLETED | PHASE3 | 2010-03 | 2010-09 | 2010-09 |
| NCT01014208 | Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B Cell Lymphoma | COMPLETED | PHASE3 | 2010-03 | 2014-11 | 2014-02 |
| NCT01047397 | Repeat Dose Safety and Efficacy Study for Compound to Treat Anemia | COMPLETED | PHASE2 | 2010-03 | 2011-02 | 2011-02 |
| NCT01086384 | Asthma Exacerbation Study | COMPLETED | PHASE3 | 2010-02-22 | 2011-09-15 | 2011-09-01 |
| NCT01154166 | A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group Study of Six Months Treatment With Ropinirole PR as Adjunctive Therapy in Patients With Parkinson's Disease Who Are Not Optimally Controlled on L-Dopa | COMPLETED | PHASE3 | 2010-02-15 | 2011-09-29 | 2011-09-01 |
| NCT01051661 | Safety and Efficacy of H1N1 Vaccines in Children Aged 6 Months to Less Than 10 Years of Age | COMPLETED | PHASE3 | 2010-02-12 | 2011-09-09 | 2011-08-31 |
| NCT01424423 | NOGO-A in Multiple Sclerosis FTIH | TERMINATED | PHASE1 | 2010-02-11 | 2010-08-26 | 2010-08-26 |
| NCT01059617 | Safety and Immune Response of Candidate H1N1 Influenza Vaccine GSK2340274A Following Seasonal Influenza Vaccination in Adults | COMPLETED | PHASE1 | 2010-02-09 | 2011-10-21 | 2011-01-14 |
| NCT01039961 | PK Study of IV Formulation of GW856553 | COMPLETED | PHASE1 | 2010-02-02 | 2010-04-15 | 2010-04-15 |
| NCT00979771 | A Study to Investigate the Ability of GSK706769 to Maintain Clinical Remission After Withdrawal of Enbrel in Rheumatoid Arthritis Patients | WITHDRAWN | PHASE2 | 2010-02-01 | 2011-04-28 | 2011-04-28 |
| NCT01345266 | Characterisation of Healthy Volunteers, Asthma and Chronic Obstructive Pulmonary Disease Patients for Inhalation Profile, Pharyngometry, Spirometric Indices and Lung Morphometry | COMPLETED | PHASE1 | 2010-02-01 | 2010-06-28 | 2010-06-28 |
| NCT01035749 | Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children Aged 10 to Less Than 18 Years | COMPLETED | PHASE2 | 2010-02-01 | 2011-05-10 | 2010-09-27 |
| NCT01037114 | Long-term Persistence Study in Healthy Adults Previously Vaccinated With Twinrix Adult | COMPLETED | PHASE4 | 2010-01-27 | 2014-02-28 | 2014-02-28 |
| NCT01086462 | Intravenous Microdose Pharmacokinetic (PK) Study With [14C]-GSK2239633 | COMPLETED | PHASE1 | 2010-01-21 | 2010-02-22 | 2010-02-22 |
| NCT01299597 | A Single-centre Open Label Study to Investigate the Effect of Repeat Doses of SB-649868 on the Pharmacokinetics of Simvastatin and Atorvastatin in Healthy Male Volunteers. | COMPLETED | PHASE1 | 2010-01-18 | 2010-02-26 | 2010-02-26 |
| NCT01051700 | A Safety Study in Healthy Volunteers to Evaluate Safety, How Fast the Drug is Absorbed, and the Side Effects of the Drug in Humans | COMPLETED | PHASE1 | 2010-01-12 | 2010-05-27 | 2010-05-27 |
| NCT01072162 | Relative Bioavailibilty for Pediatric Powder for Suspension (PfOS) Formulation and Food Effect | COMPLETED | PHASE1 | 2010-01-12 | 2010-04-07 | 2010-04-07 |
| NCT01110057 | Efficacy Study in Lumbosacral Radiculopathy | COMPLETED | PHASE2 | 2010-01-07 | 2010-08-23 | 2010-08-23 |
| NCT01018030 | Dose Finding Study of Fluticasone Furoate Nasal Spray for Uncomplicated Acute Rhinosinusitis | COMPLETED | PHASE2 | 2010-01-06 | 2010-07-16 | 2010-07-01 |
| NCT01035645 | First Time in Human Study of Intravenous Interleukin-18 Antibody | COMPLETED | PHASE1 | 2010-01-05 | 2012-07-11 | 2012-07-11 |
| NCT01262989 | SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fast Admin | COMPLETED | PHASE1 | 2010-01-04 | 2010-01-26 | 2010-01-26 |
| NCT01039675 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Combination of GSK573719 and GW642444 in Subjects With COPD | COMPLETED | PHASE2 | 2010-01-01 | 2010-04-20 | 2010-04-01 |
| NCT01072149 | A Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic (PD) Profiles of 3 Doses of Fluticasone Furoate (FF)/GW642444 Inhalation Powder at the End of a 28-day Treatment Period in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Compared to Placebo | COMPLETED | PHASE3 | 2010-01-01 | 2010-07-01 | 2010-07-01 |
| NCT01128569 | Randomised Study Comparing the Effects of Inhaled Fluticasone Furoate (FF)/Vilanterol (VI; GW642444M) Combination and FF on an Allergen Induced Asthmatic Response | COMPLETED | PHASE2 | 2010-01 | 2010-10 | 2010-10 |
| NCT01051622 | PBMC (Peripheral Blood Mononuclear Cells) /Lymphocyte SPECT (Single Photon Emission Computerized Tomography) Imaging in Crohn's Disease | COMPLETED | PHASE1 | 2010-01 | 2011-02 | 2011-02 |
| NCT01424449 | A PET Study in Healthy Volunteers | COMPLETED | PHASE1 | 2010-01 | 2010-07 | 2010-07 |
| NCT01021553 | A Study To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Study in Men With Premature Ejaculation | COMPLETED | PHASE2 | 2009-12-23 | 2011-05-05 | 2011-05-05 |
| NCT01371799 | A Study to Examine the Pharmacodynamic Effects of GSK1034702 on Neurophysiological Biomarkers of Cognition in Nicotine Abstained Otherwise Healthy Smokers | COMPLETED | PHASE1 | 2009-12-17 | 2010-06-18 | 2010-06-18 |
| NCT01030965 | 28-day Repeat Dose Study of GSK573719 | COMPLETED | PHASE2 | 2009-12-15 | 2010-07-04 | 2010-07-04 |
| NCT01079910 | To Investigate the Clinical Efficacy of an Experimental Toothpaste | WITHDRAWN | PHASE1 | 2009-12-09 | 2009-12-10 | 2009-12-10 |
| NCT01051063 | Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy | COMPLETED | PHASE1 | 2009-12-09 | 2016-04-26 | 2016-04-26 |
| NCT01014117 | Effect of SRT2104 on Endotoxin-induced Inflammation | COMPLETED | PHASE1 | 2009-12-09 | 2010-05-10 | 2010-05-10 |
| NCT01027845 | Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A in Healthy Japanese Children | COMPLETED | PHASE3 | 2009-12-08 | 2011-09-17 | 2010-08-13 |
| NCT01330303 | SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fed Admin | COMPLETED | PHASE1 | 2009-12-08 | 2009-12-22 | 2009-12-22 |
| NCT00950612 | Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Healthy HIV Negative Adolescents | COMPLETED | PHASE2 | 2009-12-08 | 2010-09-30 | 2010-09-30 |
| NCT01018628 | A Clinical Study to Assess the Safety and Pharmacokinetics of SRT2379 in Normal Healthy Male Volunteers | COMPLETED | PHASE1 | 2009-12-07 | 2010-08-06 | 2010-08-06 |
| NCT01014091 | Study to Evaluate the Safety and Immunogenicity of GSK Biological Pandemic Candidate Influenza Vaccine (H1N1) in Children | TERMINATED | PHASE3 | 2009-12-01 | 2011-01-14 | 2011-01-14 |
| NCT01009060 | Study to Evaluate the Efficacy and Safety of GSK239512 in Schizophrenia | COMPLETED | PHASE2 | 2009-12-01 | 2011-08-10 | 2011-08-10 |
| NCT01000727 | The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial | COMPLETED | PHASE3 | 2009-12-01 | 2014-04-24 | 2014-04-01 |
| NCT00964028 | Safety Study of GSK Biologicals' DTPa-IPV/Hib (Infanrix™-IPV/Hib) | COMPLETED | PHASE3 | 2009-12-01 | 2010-04-12 | 2010-04-12 |
| NCT00972725 | Evaluation of the Immune Response of a HIV Candidate Vaccine After Administration of One Chloroquine Dose | COMPLETED | PHASE2 | 2009-12-01 | 2010-10-04 | 2010-10-04 |
| NCT01428440 | PET Study to Study Tumour Apoptosis | TERMINATED | PHASE2 | 2009-12 | 2011-07 | 2011-07 |
| NCT01039805 | Evaluation of Single Doses of GSK962040 in Critically Ill Patients With Enteral Feed Intolerance | COMPLETED | PHASE2 | 2009-12 | 2011-07 | 2011-07 |
| NCT01439308 | Intranasal SB-705498 in Non-allergic Rhinitis Patients | COMPLETED | PHASE2 | 2009-12 | 2010-05 | 2010-04 |
| NCT01592227 | A Study to Compare Two Paracetamol Formulations. | COMPLETED | PHASE1 | 2009-12 | 2009-12 | 2009-12 |
| NCT01540721 | Pharmacokinetic Study Investigating the Extent of Paracetamol Absorption From a New Formulation of Paracetamol Compared With Panadol® Extend | COMPLETED | PHASE1 | 2009-12 | 2009-12 | 2009-12 |
| NCT01540734 | Pharmacokinetic Study Investigating the Extent of Paracetamol Absorption From a New Formulation of Paracetamol Compared With Panadol® | COMPLETED | PHASE1 | 2009-12 | 2009-12 | 2009-12 |
| NCT00996944 | Clinical Evaluation of Ropinirole IR (Immediate Release) Tablets in Patients Who Are Diagnosed With Symptomatic Restless Legs Syndrome (RLS) Associated With Chronic Kidney Disease (CKD) Managed With Haemodialysis (Including Haemofiltration and Haemodiafiltration) | TERMINATED | PHASE2 | 2009-11-30 | 2010-06-29 | 2010-06-01 |
| NCT01021293 | Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Poliorix™ Vaccine | COMPLETED | PHASE3 | 2009-11-28 | 2010-07-05 | 2010-07-05 |
| NCT00985751 | Safety & Immunogenicity of Pneumococcal Vaccine 2189242A in Children Aged 12-23 Months at the Time of First Vaccination | COMPLETED | PHASE2 | 2009-11-24 | 2011-03-02 | 2010-10-12 |
| NCT01332071 | Avandamet Bioequivalence Study Brazil - Fed Administration | COMPLETED | PHASE1 | 2009-11-24 | 2009-12-06 | 2009-12-06 |
| NCT01128621 | A Study in Type 2 Diabetic Subjects on Stable Metformin Therapy to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Co-administering Single and Multiple Oral Doses of GSK1292263 | COMPLETED | PHASE2 | 2009-11-23 | 2010-04-12 | 2010-04-12 |
| NCT01031186 | First Time in Human Study | COMPLETED | PHASE1 | 2009-11-23 | 2010-04-07 | 2010-04-07 |
| NCT01039883 | A Study to Compare the Blood Levels of Albaconazole in Healthy Subjects Who Have Received a Single Dose of 400 mg Albaconazole as a Tablet Versus Albaconazole as a Capsule | COMPLETED | PHASE1 | 2009-11-23 | 2010-01-20 | 2010-01-20 |
| NCT00992121 | An Open-Label Pharmacodynamic Study of Bevacivumab and Pazopanib in Renal Cell Carcinoma | COMPLETED | PHASE1 | 2009-11-18 | 2013-11-01 | 2013-11-01 |
| NCT01003418 | Study to Evaluate Safety and Immunogenicity of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children | TERMINATED | PHASE2 | 2009-11-17 | 2010-11-25 | 2010-11-25 |
| NCT00985465 | Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Mali | COMPLETED | PHASE3 | 2009-11-12 | 2010-07-26 | 2010-06-26 |
| NCT00996762 | A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib | COMPLETED | PHASE1 | 2009-11-12 | 2012-09-18 | 2012-09-18 |
| NCT01181908 | Alcohol Interaction Study | COMPLETED | PHASE1 | 2009-11-11 | 2009-12-30 | 2009-12-30 |
| NCT00979602 | Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older | COMPLETED | PHASE3 | 2009-11-09 | 2011-02-01 | 2011-01-10 |
| NCT00969436 | Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM | COMPLETED | PHASE3 | 2009-11-09 | 2011-02-21 | 2011-02-21 |
| NCT01000324 | Antibody Persistence & Immune Memory in Healthy Adults Previously Vaccinated With Twinrix Adult | COMPLETED | PHASE4 | 2009-11-06 | 2014-07-25 | 2014-07-25 |
| NCT00996671 | Phase I Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of GSK2256098 in Healthy Volunteers | COMPLETED | PHASE1 | 2009-11-06 | 2010-03-17 | 2010-03-17 |
| NCT01000857 | Repeat Dose Study of Controlled-Release Paroxetine Tablets and Immediate-Release Paroxetine Tablets in Healthy Japanese Male Subjects | COMPLETED | PHASE1 | 2009-11-05 | 2010-02-25 | 2010-02-25 |
| NCT01000493 | Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder | COMPLETED | PHASE2 | 2009-11-02 | 2010-06-28 | 2010-06-28 |
| NCT01009255 | Study to Evaluate the Efficacy and Safety of GSK239512 in Alzheimer's Disease | COMPLETED | PHASE2 | 2009-11-02 | 2010-11-10 | 2010-11-10 |
| NCT00935987 | Safety and Efficacy Study of CYT387 in Primary Myelofibrosis (PMF) or Post-polycythemia Vera (PV) or Post-essential Thrombocythemia (ET) | COMPLETED | PHASE1, PHASE2 | 2009-11 | 2012-04 | 2012-04 |
| NCT01000506 | Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma | COMPLETED | PHASE2 | 2009-11-01 | 2012-03-23 | 2012-03-23 |
| NCT01014988 | Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital | COMPLETED | PHASE2 | 2009-11 | 2015-02 | 2015-02 |
| NCT01075243 | Post-operative Dental Pain Study Comparing Two Different Dosage of Analgesic Efficacy | COMPLETED | PHASE4 | 2009-11 | 2010-03 | 2010-03 |
| NCT01039610 | A Single Center Four Part Study in Healthy Adult Subjects to Evaluate: the Safety, Tolerability and Pharmacokinetics of a Single Oral Dose and Repeat Escalating Oral Doses of GSK945237; the Effect of Linezolid on Hematology Safety Parameters; and the Effects of GSK945237 and Moxifloxacin on QTc. | WITHDRAWN | PHASE1 | 2009-11 | 2010-08 | 2010-08 |
| NCT01128946 | Enamel Remineralization Potential of Dentifrices in Situ | COMPLETED | PHASE4 | 2009-11 | 2010-03 | 2010-03 |
| NCT01495494 | A Multiple Use Tolerability Study of a Breathe Right Nasal Strip Prototype | COMPLETED | PHASE1 | 2009-11 | 2009-11 | 2009-11 |
| NCT01476189 | A Study to Compare to the Pharmacokinetic Profile of Two Paracetamol Formulations | COMPLETED | PHASE1 | 2009-11 | 2009-12 | 2009-12 |
| NCT01476215 | A Pharmacokinetic Study Investigating the Rate and Extent of Paracetamol Absorption of Three Experimental Sustained Release Pediatric Suspensions | COMPLETED | PHASE1 | 2009-11 | 2009-11 | 2009-11 |
| NCT01037127 | Study to Determine the Effectiveness of GSK1120212 in BRAF Mutation-positive Melanoma Previously Treated With or Without a BRAF Inhibitor | COMPLETED | PHASE2 | 2009-11 | 2013-01 | 2011-07 |
| NCT00984659 | Validation of a New Shortness of Breath With Daily Activities Questionnaire in Patients With Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE4 | 2009-10-29 | 2010-07-01 | 2010-07-01 |
| NCT00996125 | Immunogenicity and Safety Study of GSK Biologicals' Human Papillomavirus 580299 Vaccine in Healthy Female Subjects | COMPLETED | PHASE3 | 2009-10-24 | 2010-12-08 | 2010-12-08 |
| NCT01339247 | Paxil CR Bioequivalence Study Brazil - Fed Administration | COMPLETED | PHASE1 | 2009-10-20 | 2009-11-16 | 2009-11-16 |
| NCT00976820 | Safety and Immunogenicity of H1N1 Vaccines in Children Aged 6 Months to Less Than 9 Years of Age | COMPLETED | PHASE2 | 2009-10-20 | 2011-03-21 | 2011-03-21 |
| NCT01018186 | Fluticasone Furoate/GW642444 Inhalation Powder Long-Term Safety Study | COMPLETED | PHASE3 | 2009-10-19 | 2011-05-12 | 2011-05-01 |
| NCT01054885 | Efficacy and Safety Study of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and the Individual Components in Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2009-10-19 | 2011-02-08 | 2011-02-01 |
| NCT00976261 | A 2-Part Trial in Subjects With Type 2 Diabetes and in Healthy Subjects to Evaluate GSK1614235, a New Glucose Lowering Drug to Treat Type 2 Diabetes | COMPLETED | PHASE1 | 2009-10-17 | 2010-09-05 | 2010-09-05 |
| NCT00996840 | SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS | COMPLETED | PHASE2 | 2009-10-16 | 2013-02-09 | 2013-02-09 |
| NCT00992784 | Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine in Elderly People | COMPLETED | PHASE3 | 2009-10-15 | 2010-05-27 | 2010-05-27 |
| NCT00996268 | An Open-label Single Dose Randomized, Parallel Group Study Followed by Single-blind Repeat Dosing, to Compare the Relative Bioavailability of GSK2212836. | COMPLETED | PHASE1 | 2009-10-15 | 2010-01-04 | 2010-01-04 |
| NCT01209052 | First Time in Human Study With GSK1325756 | COMPLETED | PHASE1 | 2009-10-15 | 2010-03-02 | 2010-03-02 |
| NCT00992511 | Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults, Using Two Different Manufacturing Processes | COMPLETED | PHASE3 | 2009-10-14 | 2010-11-09 | 2010-11-09 |
| NCT00980005 | Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children | COMPLETED | PHASE3 | 2009-10-13 | 2010-06-17 | 2010-03-02 |
| NCT00989404 | Crossover Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Repeat Dose Zanamivir/Placebo Via Devices Administered Twice Daily for 5 Days | COMPLETED | PHASE1 | 2009-10-12 | 2009-12-07 | 2009-12-07 |
| NCT01019603 | A Study to Evaluate the Bioavailability of Tazarotene Foam, 0.1%, and Tazorac Gel, 0.1%, in Subjects With Acne Vulgaris | COMPLETED | PHASE1 | 2009-10-12 | 2009-12-20 | 2009-12-20 |
| NCT00979407 | Study to Evaluate Immunological Equivalence Between Two Investigational Influenza Vaccines in Adults (H1N1) | COMPLETED | PHASE3 | 2009-10-12 | 2010-11-04 | 2009-11-09 |
| NCT00984139 | Persistence of Immunity Against Hepatitis B in 12-13 Year Old Adolescents After Infant Hepatitis B Vaccination | COMPLETED | PHASE4 | 2009-10-12 | 2010-04-07 | 2010-04-07 |
| NCT00985088 | Safety and Immunogenicity of H1N1 Vaccines in Adults Aged 18 Years and Older | COMPLETED | PHASE2 | 2009-10-11 | 2010-12-16 | 2009-11-09 |
| NCT00910962 | A Study to Evaluate the Safety of 12 Weeks of Dosing With GW856553 and Its Effects on Inflammatory Markers, Infarct Size, and Cardiac Function in Subjects With Myocardial Infarction Without ST-segment Elevation | COMPLETED | PHASE2 | 2009-10-08 | 2012-03-06 | 2012-03-06 |
| NCT00985790 | Immunogenicity and Safety Study of a GlaxoSmithKline Biologicals' Candidate Influenza Vaccine in Healthy Children | COMPLETED | PHASE2 | 2009-10-08 | 2010-05-21 | 2010-05-21 |
| NCT00989287 | Immunogenicity and Safety Study of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults | COMPLETED | PHASE3 | 2009-10-07 | 2010-10-26 | 2009-10-09 |
| NCT01053988 | A 6-month Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2009-10-05 | 2011-04-14 | 2011-02-01 |
| NCT01013974 | A Study of GSK573719 in Healthy Japanese Male Subjects | COMPLETED | PHASE1 | 2009-10-05 | 2009-12-18 | 2009-12-18 |
| NCT01001169 | Safety and Immunogenocity Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Japanese Children | COMPLETED | PHASE2 | 2009-10-01 | 2010-05-17 | 2010-05-17 |
| NCT01122849 | Exploratory Subjective Sleep Study of a Prototype Nasal Dilator | COMPLETED | PHASE2 | 2009-10-01 | 2010-02-01 | 2010-02-01 |
| NCT00964340 | A Clinical Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral SRT2104 Capsules Administered to Healthy Elderly Subjects for 28 Days | COMPLETED | PHASE1 | 2009-10-01 | 2010-04-27 | 2010-04-27 |
| NCT00989612 | Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) | COMPLETED | PHASE2 | 2009-10-01 | 2010-04-19 | 2010-04-19 |
| NCT01017120 | A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne | COMPLETED | PHASE3 | 2009-10-01 | 2010-11-09 | 2010-11-01 |
| NCT01016977 | A Phase 4, Single-Blind, Randomized, Study to Compare the Tolerability and Efficacy of 0.1% Tazorac Cream When Used in Combination With Either Duac Gel or Acanya Gel for the Treatment of Facial Acne Vulgaris | COMPLETED | PHASE4 | 2009-10 | 2010-04 | 2010-04 |
| NCT01017146 | A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - W0260-301 | COMPLETED | PHASE3 | 2009-10 | 2010-11 | 2010-11 |
| NCT00985673 | Safety and Immunogenicity of H1N1 Vaccine With Trivalent Inactivated Seasonal Influenza Vaccine in Adults | COMPLETED | PHASE2 | 2009-10-01 | 2010-12-29 | 2009-12-28 |
| NCT01082081 | Post-operative Dental Pain Study Comparing Analgesic Efficacy | COMPLETED | PHASE4 | 2009-10 | 2010-03 | 2010-03 |
| NCT01366508 | A Study to Characterize Event Related Potential Markers of Attentional Bias Towards Words and Images of Food | TERMINATED | PHASE1 | 2009-10 | 2010-10 | 2009-12 |
| NCT00832364 | Trial of an Injectable Biologic and U0279 as Combination Therapy for Severe Plaque-Type Psoriasis | WITHDRAWN | PHASE4 | 2009-10 | 2010-04 | 2010-03 |
| NCT00908037 | Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP) | COMPLETED | PHASE2 | 2009-09-30 | 2014-02-01 | 2014-02-01 |
| NCT00972517 | Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Children | COMPLETED | PHASE3 | 2009-09-29 | 2010-11-22 | 2010-11-22 |
| NCT00963937 | Study to Evaluate the Efficacy and Safety of Oral Sumatriptan for the Acute Treatment of Migraine in Children and Adolescents | COMPLETED | PHASE3 | 2009-09-28 | 2010-12-03 | 2010-12-01 |
| NCT00903201 | 28 Day Repeat Dose in Cystic Fibrosis Patients | COMPLETED | PHASE2 | 2009-09-28 | 2010-12-29 | 2010-12-29 |
| NCT01036061 | GSK618334 Repeat Dose Study | COMPLETED | PHASE1 | 2009-09-28 | 2010-02-17 | 2010-02-17 |
| NCT03105297 | To Characterize the Performance of the Nasal Dilator Strip in Lowering Nasal Resistance During Sleep, Promoting Nasal Route Breathing and Reducing the Signs and Symptoms of Sleep Disordered Breathing in a Group of Chronic Nocturnal Nasal Congestion Sufferers Who Report Trouble With Their Sleep. | COMPLETED | PHASE2 | 2009-09-25 | 2010-08-10 | 2010-08-10 |
| NCT01017952 | A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2009-09-25 | 2011-10-17 | 2011-10-01 |
| NCT00976560 | Clinical Study to Test a New Drug to Treat Major Depression | COMPLETED | PHASE2 | 2009-09-25 | 2010-07-07 | 2010-07-07 |
| NCT01009463 | A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2009-09-25 | 2011-10-31 | 2011-10-01 |
| NCT00947115 | Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects | COMPLETED | PHASE3 | 2009-09-22 | 2015-02-03 | 2015-02-03 |
| NCT00976105 | Effects of Repeat Dosing of GSK1521498 | COMPLETED | PHASE1 | 2009-09-22 | 2010-03-09 | 2010-03-09 |
| NCT00975936 | Phase 0 Microdose Study | COMPLETED | PHASE1 | 2009-09-21 | 2009-11-12 | 2009-11-12 |
| NCT01371682 | A Study Conducted in Healthy Subjects to Demonstrate Bioequivalence Between Ropinirole Prolonged Release Tablets Manufactured at Crawley and Aranda | COMPLETED | PHASE1 | 2009-09-18 | 2009-12-02 | 2009-12-02 |
| NCT01039974 | GSK962040 Drug-drug Interaction Study With Ketoconazole | COMPLETED | PHASE1 | 2009-09-18 | 2009-11-30 | 2009-11-30 |
| NCT01000597 | Study to Look at and Compare How Inhaled and Intravenous Fluticasone Furoate is Processed by the Body in Healthy Caucasian, Japanese, Korean and Chinese Subjects | COMPLETED | PHASE1 | 2009-09-17 | 2009-12-23 | 2009-12-23 |
| NCT01036022 | Effect of GSK1399686 in Patients With Mild to Moderately Active Ulcerative Colitis | COMPLETED | PHASE2 | 2009-09-15 | 2013-01-10 | 2013-01-10 |
| NCT00975884 | Study to Evaluate Immunogenicity & Safety of an Investigational Influenza Vaccine in Adults | COMPLETED | PHASE3 | 2009-09-14 | 2010-04-30 | 2010-04-30 |
| NCT00968890 | Immunogenicity and Safety of Vaccine GSK2340272A (H1N1) and GSK Biologicals Fluarix™ Vaccine When Co-administered in Elderly | COMPLETED | PHASE2 | 2009-09-12 | 2010-09-23 | 2010-09-23 |
| NCT00971321 | Safety, Immunogenicity Study of GSK Biologicals' Pandemic Influenza Candidate Vaccine (H1N1) (GSK2340272A) | COMPLETED | PHASE2 | 2009-09-10 | 2010-11-24 | 2010-11-24 |
| NCT00964158 | Safety and Immunogenicity Study of GSK Biologicals' Pandemic Influenza Candidate Vaccine (H1N1) (GSK2340272A) | COMPLETED | PHASE3 | 2009-09-10 | 2010-11-27 | 2010-11-27 |
| NCT01316926 | Paxil CR Bioequivalence Study Brazil | COMPLETED | PHASE1 | 2009-09-09 | 2009-10-05 | 2009-10-05 |
| NCT00968539 | Study to Evaluate the Immunogenicity & Safety of an Investigational Influenza Vaccine (H1N1) in Adults | COMPLETED | PHASE3 | 2009-09-08 | 2010-09-28 | 2010-09-28 |
| NCT00968526 | Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults | COMPLETED | PHASE3 | 2009-09-08 | 2010-09-23 | 2010-09-23 |
| NCT00971425 | Evaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1) | COMPLETED | PHASE3 | 2009-09-08 | 2010-10-08 | 2009-11-16 |
| NCT00950807 | GSK573719 Dose Ranging Study in Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE2 | 2009-09-01 | 2010-03-15 | 2010-03-01 |
| NCT01090440 | Pharmacokinetics, Effect of Food, Safety and Tolerability of a New Tablet Formulation of GSK1144814 in Healthy Subjects | COMPLETED | PHASE1 | 2009-09-01 | 2009-10-09 | 2009-10-09 |
| NCT01231464 | A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fluticasone Furoate Nasal Spray for 2 Weeks in Chinese Adult and Adolescent Subjects With Allergic Rhinitis | COMPLETED | PHASE3 | 2009-09 | 2010-07 | 2010-05 |
| NCT01706250 | U0289-401: Eight Week, Split-face, Study to Determine and Compare the Efficacy and Tolerability of MAXCLARITY™ II to PROACTIV™ | COMPLETED | PHASE4 | 2009-09-01 | 2010-01-25 | 2010-01-01 |
| NCT02524665 | 8 Week Study to Evaluate and Compare the Efficacy and Tolerability of MAXCLARITY II and MURAD To Treat Acne | COMPLETED | PHASE4 | 2009-09 | 2009-12 | 2009-12 |
| NCT00974363 | Study to Evaluate Persistence of Antibodies After Vaccination With Meningococcal Vaccine GSK 134612 | COMPLETED | PHASE3 | 2009-09 | 2013-05 | 2013-05 |
| NCT00980200 | Efficacy and Safety Study in Subjects With Asthma | COMPLETED | PHASE2 | 2009-09 | 2010-01 | 2010-01 |
| NCT00976391 | A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine | COMPLETED | PHASE3 | 2009-09 | 2012-05 | 2011-10 |
| NCT00891761 | A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic Chemotherapy | WITHDRAWN | PHASE3 | 2009-09 | 2010-07 | 2010-07 |
| NCT01115452 | Efficacy of Potassium Nitrate Solution in Reducing Dentinal Hypersensitivity | COMPLETED | PHASE2 | 2009-09 | 2009-10 | 2009-10 |
| NCT01077622 | A Phase I/II, a Single Arm, Open-label Study of Ofatumumab (GSK1841157) in Patients With Previously Treated Chronic Lymphocytic Leukemia | COMPLETED | PHASE2 | 2009-09-01 | 2011-04-01 | 2011-04-01 |
| NCT00996216 | Clinical Trial for Non-responders Who Previously Participated in Eltrombopag Studies TPL 103922 or TPL 108390 | COMPLETED | PHASE3 | 2009-09 | 2013-02 | 2013-02 |
| NCT01105949 | An Evaluation of Two Novel Nasal Strip Prototypes on Nasal Patency | COMPLETED | PHASE1 | 2009-09 | 2009-10 | 2009-10 |
| NCT00996021 | Study to Assess Cardiac Conduction of GSK1349572 | COMPLETED | PHASE1 | 2009-09 | 2009-12 | 2009-11 |
| NCT00972686 | Dose-Escalation Study of GSK2126458 | COMPLETED | PHASE1 | 2009-08-31 | 2015-03-31 | 2012-12-12 |
| NCT01030939 | Study to Investigate Safety, Tolerability, Pharmacokinetics and Cardiac Function After Repeat Doses of SB-649868 in Healthy-volunteers | COMPLETED | PHASE1 | 2009-08-27 | 2010-01-06 | 2010-01-06 |
| NCT00964106 | Validation Study of Multiple Probe Compounds for Drug Interaction Evaluation | COMPLETED | PHASE1 | 2009-08-26 | 2011-08-29 | 2011-08-29 |
| NCT00955682 | Study to Evaluate Persistence of Antibodies After Vaccination With Meningococcal Vaccine GSK134612 | COMPLETED | PHASE3 | 2009-08-25 | 2012-09-10 | 2009-12-16 |
| NCT00969228 | Study to Evaluate Immunogenicity, Reactogenicity and Safety of Rotarix™ Vaccine in Korean Infants | COMPLETED | PHASE4 | 2009-08-25 | 2010-07-23 | 2010-07-23 |
| NCT00950586 | Safety, Blood Levels, Drug Interaction and Effects of Repeated Doses of GSK1034702 | COMPLETED | PHASE1 | 2009-08-24 | 2009-12-24 | 2009-12-24 |
| NCT01014962 | A Study of the Effects of Increasing Doses of a Drug for the Treatment of Nail Fungus | COMPLETED | PHASE1 | 2009-08-24 | 2009-12-04 | 2009-12-04 |
| NCT00937326 | Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Type 2 Diabetic Human Subjects | COMPLETED | PHASE2 | 2009-08-19 | 2010-09-18 | 2010-09-18 |
| NCT00955773 | A Study of the GSK MEK Inhibitor GSK1120212 and Everolimus in Cancer Subjects | COMPLETED | PHASE1 | 2009-08-17 | 2011-11-08 | 2011-11-08 |
| NCT00942162 | A Study to Test the Benefit of a New Anti-cancer Treatment in Patients With Unresectable Advanced Melanoma | COMPLETED | PHASE2 | 2009-08-14 | 2015-04-01 | 2012-06-27 |
| NCT00955383 | GSK2190915 Safety and Pharmacokinetic Study in Healthy Japanese Subjects | COMPLETED | PHASE1 | 2009-08-14 | 2009-10-12 | 2009-10-12 |
| NCT00970307 | Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age | COMPLETED | PHASE2 | 2009-08-13 | 2010-01-27 | 2010-01-27 |
| NCT01013766 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK1362885 in Type 2 Diabetics | COMPLETED | PHASE1 | 2009-08-13 | 2009-11-20 | 2009-11-20 |
| NCT01428427 | Combination Study of GSK1120212 With Gemcitabine in Subjects With Solid Tumors | COMPLETED | PHASE1 | 2009-08-12 | 2011-07-18 | 2011-07-18 |
| NCT00920192 | Safety Study of Foretinib (GSK1363089) in Adults With Liver Cancer | COMPLETED | PHASE1 | 2009-08-12 | 2015-03-24 | 2012-03-07 |
| NCT00935831 | Single Dose Safety Study for Compound to Treat Anemia in Patients With Renal Impairment | COMPLETED | PHASE1 | 2009-08-12 | 2010-04-27 | 2010-04-27 |
| NCT00951041 | Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults | COMPLETED | PHASE2 | 2009-08-11 | 2010-08-30 | 2010-08-30 |
| NCT00950833 | Long-term Follow-up Study of Children Previously Primed With GSK Pneumococcal Vaccine (GSK1024850A) and of Unprimed Children | COMPLETED | PHASE3 | 2009-08-10 | 2010-10-27 | 2010-09-16 |
| NCT00937950 | Gynaecological Follow-up of a Subset of 580299/008 (NCT00122681) Study Subjects | COMPLETED | PHASE3 | 2009-08-05 | 2014-01-20 | 2014-01-20 |
| NCT00938158 | A Study of the Pharmacokinetics of Albiglutide in Normal and Renally Impaired Subjects. | COMPLETED | PHASE1 | 2009-08-05 | 2011-04-12 | 2011-04-12 |
| NCT00937404 | Safety and Reactogenicity of GSK Biologicals' Inactivated Poliomyelitis Vaccine (IPV) (Poliorix) in Infants | COMPLETED | PHASE1 | 2009-08-04 | 2009-11-13 | 2009-11-13 |
| NCT01706263 | U0289-402: An Open Label, 8 Week Study to Evaluate the Efficacy and Tolerability of MAXCLARITY II in Subjects With Acne | COMPLETED | PHASE4 | 2009-08-01 | 2009-11-20 | 2009-11-20 |
| NCT01015638 | Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications | COMPLETED | PHASE4 | 2009-08 | 2009-09 | 2009-09 |
| NCT00969059 | Study in Neuropathic Pain Patients With Peripheral Nerve Injury | COMPLETED | PHASE2 | 2009-08 | 2010-07 | 2010-07 |
| NCT01128972 | Evaluation of a Test Mouthwash and Dentifrice Regimen in an In-situ Model of Dental Erosion | COMPLETED | PHASE2 | 2009-08 | 2009-10 | 2009-10 |
| NCT01270958 | A Phase-IV, Open-label Study to Evaluate Safety/Tolerability of Once-daily AVAMYS (TM) Aqueous Nasal Spray 110mcg Among Vietnamese Adult Patients With Established Perennial Allergic Rhinitis | COMPLETED | PHASE4 | 2009-08 | 2010-02 | 2010-02 |
| NCT00911300 | Evaluation of Fondaparinux in Patients With a Heart Rhythm Disturbance Who Undergo Restoration of Normal Heart Rhythm | COMPLETED | PHASE2 | 2009-08 | 2011-09 | 2011-09 |
| NCT00938392 | Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine for the Elderly | COMPLETED | PHASE3 | 2009-07-30 | 2009-10-05 | 2009-10-05 |
| NCT00976144 | Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of GSK573719 (LAMA) and GW642444 (LABA)Administered Individually and Concurrently in Healthy Japanese Subjects | COMPLETED | PHASE1 | 2009-07-29 | 2009-09-22 | 2009-09-22 |
| NCT00937846 | Brain Uptake of GSK1034702: a Positron Emission Tomography (PET) Scan Study | COMPLETED | PHASE1 | 2009-07-15 | 2009-08-28 | 2009-08-28 |
| NCT00938184 | Single Dose Study of Controlled-Release Paroxetine Tablets in Healthy Japanese Male Subjects | COMPLETED | PHASE1 | 2009-07-14 | 2009-09-02 | 2009-09-02 |
| NCT00920218 | Safety & Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A | COMPLETED | PHASE2 | 2009-07-14 | 2012-03-21 | 2011-04-26 |
| NCT00929331 | Immunogenicity & Safety Study of Fluviral® (2009 - 2010 Season) in Adults Aged 18 to 60 Years and Over 60 Years | COMPLETED | PHASE3 | 2009-07-11 | 2009-08-01 | 2009-08-01 |
| NCT00866528 | Study of Pazopanib and Paclitaxel in Advanced Non-small Cell Lung Cancer | COMPLETED | PHASE1 | 2009-07-09 | 2012-10-25 | 2012-10-25 |
| NCT00833989 | Safety Escalating Repeat IV, in Stroke Patients | COMPLETED | PHASE2 | 2009-07-08 | 2011-01-31 | 2011-01-31 |
| NCT00946257 | Subcutaneous Administration of Otelixizumab to T1DM Patients | COMPLETED | PHASE1 | 2009-07-08 | 2013-06-25 | 2011-08-01 |
| NCT01205178 | G6PD (Glucose-6-phosphate Dehydrogenase) Study to Evaluate Hemolysis Potential of TFQ (Tafenoquine) | COMPLETED | PHASE1 | 2009-07-02 | 2013-04-01 | 2013-04-01 |
| NCT01209039 | A Repeat Dose Positron Emission Tomography Study With GSK1144814 | COMPLETED | PHASE1 | 2009-07-01 | 2009-10-25 | 2009-10-25 |
| NCT00964366 | Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne Medications | COMPLETED | PHASE4 | 2009-07 | 2009-08 | 2009-08 |
| NCT00964223 | A Study to Evaluate Tolerability of Two Topical Drug Products in the Treatment of Facial Acne | COMPLETED | PHASE4 | 2009-07 | 2009-11 | 2009-11 |
| NCT00945932 | A Study to Evaluate the Effect of Repeat Doses of GW870086X in Mild to Moderate Asthmatics | COMPLETED | PHASE2 | 2009-07 | 2009-12 | 2009-12 |
| NCT01755702 | Paracetamol With Caffeine to Treat Episodic Tension Type Headache | TERMINATED | PHASE2, PHASE3 | 2009-07 | 2010-03 | 2010-03 |
| NCT01476176 | A Pharmacokinetic Study of an Experimental Paracetamol Formulation | COMPLETED | PHASE1 | 2009-07 | 2009-08 | 2009-08 |
| NCT00849472 | Treatment With Pazopanib for Neoadjuvant Breast Cancer | COMPLETED | PHASE2 | 2009-07 | 2013-04 | 2011-12 |
| NCT00871403 | Study of Pazopanib and Pemetrexed in Advanced Non-small Cell Lung Cancer | COMPLETED | PHASE2 | 2009-07 | 2011-03 | 2011-03 |
| NCT00920296 | DDI Study of Etravirine and GSK1265744 | COMPLETED | PHASE1 | 2009-07 | 2009-09 | 2009-09 |
| NCT00942136 | GSK1349572 Proton Pump Inhibitor Drug Interaction and Supratherapeutic Dose Study | COMPLETED | PHASE1 | 2009-07 | 2009-09 | 2009-09 |
| NCT00850642 | GSK2190915 Moderate to Severe Asthma Study | TERMINATED | PHASE2 | 2009-06-26 | 2010-06-02 | 2010-06-02 |
| NCT00871338 | Study to Evaluate GSK Biologicals' GSK2197870A Vaccine Given as Primary Course in Infants | COMPLETED | PHASE2 | 2009-06-24 | 2010-12-09 | 2010-03-31 |
| NCT00907777 | Vaccination With GSK 1024850A in Children Primed With GSK 1024850A & Boosted With Pneumovax 23™ | COMPLETED | PHASE3 | 2009-06-23 | 2009-10-05 | 2009-10-05 |
| NCT00920257 | A Phase I, Open-Label, First-Time-In-Human Study of the Oral AKT Inhibitor GSK2141795 | COMPLETED | PHASE1 | 2009-06-16 | 2013-04-17 | 2013-04-17 |
| NCT00920374 | A Study for Evaluation of Immunogenicity and Reactogenicity of FluarixTM / Influsplit SSW® 2009/2010 in Adults | COMPLETED | PHASE3 | 2009-06-16 | 2009-07-08 | 2009-07-08 |
| NCT00903617 | Study to Test GSK256073 in Patients With Dyslipidemia | COMPLETED | PHASE2 | 2009-06-15 | 2010-02-16 | 2010-02-16 |
| NCT00976066 | [11C]Carfentanil PET Study of GSK1521498 | COMPLETED | PHASE1 | 2009-06-15 | 2009-12-07 | 2009-12-07 |
| NCT00911144 | Booster Vaccination Study With a Pneumococcal Vaccine in Children Primed With the Same Vaccine | COMPLETED | PHASE3 | 2009-06-11 | 2010-01-11 | 2010-01-11 |
| NCT01119846 | A Study in Type 2 Diabetics of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics | COMPLETED | PHASE2 | 2009-06-05 | 2010-03-19 | 2010-03-19 |
| NCT00880321 | A Phase I Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of GSK2118436 in Subjects With Solid Tumors | COMPLETED | PHASE1 | 2009-06-04 | 2012-03-20 | 2011-03-25 |
| NCT01026064 | Cantharidin-induced Skin Blister for Testing Anti-inflammatory Effects of Macrolides | COMPLETED | PHASE1 | 2009-06-04 | 2009-11-27 | 2009-11-27 |
| NCT00861744 | Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age | COMPLETED | PHASE2 | 2009-06-03 | 2012-06-18 | 2010-07-21 |
| NCT00892775 | Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working Seeds | COMPLETED | PHASE2 | 2009-06-03 | 2010-12-13 | 2010-09-17 |
| NCT00920439 | Safety and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' IPV Vaccine (PoliorixTM) in Toddlers | COMPLETED | PHASE3 | 2009-06-01 | 2009-08-03 | 2009-08-03 |
| NCT00972504 | 723/726 Proof of Concept Study in Allergen Challenge Chamber in Hannover | COMPLETED | PHASE2 | 2009-06-01 | 2009-08-14 | 2009-08-01 |
| NCT00861809 | The Effect of Single Doses of the Motilin Receptor Agonist GSK962040 in Type I Diabetic Patients With Gastroparesis | COMPLETED | PHASE2 | 2009-06 | 2010-11 | 2010-11 |
| NCT00929526 | Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study | COMPLETED | PHASE3 | 2009-06 | 2011-02 | 2011-02 |
| NCT00884533 | QTc Study of Rosi XR in Healthy Volunteers | WITHDRAWN | PHASE1 | 2009-06 | 2009-08 | 2009-08 |
| NCT01551836 | At What Time Therapeutic Plasma Concentrations of Paracetamol Are Achieved in Two Marketed Formulations | COMPLETED | PHASE1 | 2009-06 | 2009-06 | 2009-06 |
| NCT00920088 | Drug Interaction Study of Darunavir/Ritonavir and Lopinavir/Ritonavir on GSK2248761 PK and CYP450 Probe Drugs | COMPLETED | PHASE1 | 2009-06 | 2009-11 | 2009-11 |
| NCT00849875 | A Study of Safety and Clinical Activity of Immunotherapy Plus Chemotherapy in Metastatic Melanoma Patients | TERMINATED | PHASE2 | 2009-05-26 | 2014-11-17 | 2014-11-17 |
| NCT00896480 | Study of GSK2132231A Antigen-Specific Cancer Immunotherapeutic in Patients With Inoperable Metastatic Cutaneous Melanoma | COMPLETED | PHASE2 | 2009-05-19 | 2014-11-03 | 2014-11-03 |
| NCT00896064 | Evaluation of a Booster Dose of Pneumococcal Vaccine Formulations in Young Adults | COMPLETED | PHASE2 | 2009-05-18 | 2009-08-05 | 2009-08-05 |
| NCT00907985 | A Study to Evaluate the Effect of Single Doses of Drug A (Lamotrigine) and Drug B (Vofopitant) Alone and in Combination on Resting Motor Threshold in Healthy Subjects | TERMINATED | PHASE1 | 2009-05-15 | 2010-06-10 | 2010-06-10 |
| NCT00903422 | Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS) | COMPLETED | PHASE1 | 2009-05-14 | 2013-12-05 | 2012-06-26 |
| NCT00891176 | Persistence of Antibodies at 3, 4 and 6 Years of Age After Vaccination With Meningococcal, Pneumococcal and Hib Vaccines | COMPLETED | PHASE3 | 2009-05-14 | 2012-11-21 | 2012-11-21 |
| NCT00875446 | First Time in Human Study of GSK1223249 in Amyotrophic Lateral Sclerosis | COMPLETED | PHASE1 | 2009-05-13 | 2011-09-09 | 2011-09-09 |
| NCT01362244 | Mepolizumab in Nasal Polyposis | COMPLETED | PHASE2 | 2009-05-12 | 2014-12-05 | 2014-12-05 |
| NCT00896558 | A Repeat Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Subjects | COMPLETED | PHASE1 | 2009-05-11 | 2009-09-25 | 2009-09-25 |
| NCT00877877 | Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects. | COMPLETED | PHASE3 | 2009-05-07 | 2015-01-06 | 2015-01-06 |
| NCT00861380 | Evaluation of Effectiveness of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A Against Invasive Disease | COMPLETED | PHASE3 | 2009-05-04 | 2013-10-05 | 2012-01-31 |
| NCT00875485 | Evaluation of Antibody Persistence & Immune Memory in Subjects Vaccinated During Adolescence With Twinrix™ | COMPLETED | PHASE4 | 2009-05-01 | 2014-07-01 | 2014-07-01 |
| NCT00879970 | Thiazolidinedione Intervention With Vitamin D Evaluation | TERMINATED | PHASE4 | 2009-05 | 2010-11 | 2010-11 |
| NCT00992160 | Vestipitant 28-day Tolerance Study | COMPLETED | PHASE2 | 2009-05 | 2009-09 | 2009-09 |
| NCT00811798 | Safety Study of GSK Biologicals' HPV Vaccine (GSK-580299) in Healthy Female Subjects. | COMPLETED | PHASE3 | 2009-05 | 2010-09 | 2010-09 |
| NCT00926367 | Two-week Study to Compare the Tolerance and Irritation Potential of Two Combination Topical Gel Acne Medications | COMPLETED | PHASE4 | 2009-05 | 2009-07 | 2009-06 |
| NCT00908206 | Effects of GSK598809 on Brain Activation in Abstinent Alcoholics | WITHDRAWN | PHASE1 | 2009-05 | 2009-07 | 2009-07 |
| NCT00985985 | Efficacy and Safety Study of Nicotine Mint Lozenge (2mg and 4mg) in Smoking Cessation | COMPLETED | PHASE3 | 2009-05 | 2011-03 | 2011-03 |
| NCT00823719 | Phase II Study of Ofatumumab Plus Ifosfamide, Carboplatin, Etoposide (ICE) or Dexamethasone, Cytarabine, Cisplatin (DHAP) Chemotherapy Regimen in Relapsed/ Refractory Diffuse Large B Cell Lymphoma (DLBCL) | COMPLETED | PHASE2 | 2009-05 | 2011-09 | 2011-07 |
| NCT00924911 | Relative Bioavailability Study in Healthy Subjects | COMPLETED | PHASE1 | 2009-04-27 | 2009-07-09 | 2009-07-09 |
| NCT00896363 | Safety and Efficacy Study in Patients With Major Depressive Disorder | COMPLETED | PHASE2 | 2009-04-23 | 2010-02-09 | 2010-02-09 |
| NCT02224521 | GSK2190915A - Bioavailability Study | COMPLETED | PHASE1 | 2009-04-20 | 2010-06-08 | 2010-06-08 |
| NCT01767584 | Bioequivalence Study of Cephalexin Tablets 1g | COMPLETED | PHASE1 | 2009-04-06 | 2009-04-14 | 2009-04-14 |
| NCT00920660 | Clinical Study to Assess the Effects of SRT2104 and Prednisolone on Biomarkers in Blood in Healthy Volunteers | COMPLETED | PHASE1 | 2009-04-06 | 2009-06-12 | 2009-06-12 |
| NCT01153802 | An Open Label Positron Emission Tomography Study in Healthy Male Subjects to Investigate Brain DAT and SERT Occupancy,Pharmacokinetics and Safety of Single Oral Doses of GSK1360707, Using 11C- PE2I and 11C-DASB as PET Ligands | COMPLETED | PHASE1 | 2009-04-03 | 2009-10-12 | 2009-10-12 |
| NCT00891982 | A Clinical Study to Evaluate the Tolerability of a Topical Antibiotic and Retinoid Used in a Combined Regimen With a BPO Wash | COMPLETED | PHASE3 | 2009-04-01 | 2009-06-05 | 2009-06-01 |
| NCT00871741 | Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age. | TERMINATED | PHASE2 | 2009-04-01 | 2009-06-25 | 2009-06-25 |
| NCT00871000 | Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-year-old Children. | COMPLETED | PHASE3 | 2009-04-01 | 2009-11-18 | 2009-11-18 |
| NCT00852540 | Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA | COMPLETED | PHASE3 | 2009-04 | 2010-09 | 2010-07 |
| NCT00866294 | Controlled-release Paroxetine in Major Depressive Disorder (Double-blind, Placebo-controlled Study) | COMPLETED | PHASE3 | 2009-04 | 2010-02 | 2010-02 |
| NCT00849381 | Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Brazil, Taiwan or Thailand | COMPLETED | PHASE3 | 2009-04 | 2012-12 | 2012-12 |
| NCT01128543 | Lapatinib in Combination With Vinorelbine | COMPLETED | PHASE2 | 2009-04 | 2012-03 | 2012-03 |
| NCT00883935 | GSK1349572 Drug Interaction Study With Atazanavir/Ritonavir and Atazanavir | COMPLETED | PHASE1 | 2009-04 | 2009-06 | 2009-06 |
| NCT00871117 | Immunogenicity and Safety of Kinrix + (Measles Mumps Rubella) MMR Vaccine With and Without Varicella Vaccine in Healthy Children 4-6 Years | COMPLETED | PHASE3 | 2009-03-31 | 2010-06-15 | 2010-01-15 |
| NCT00920556 | A Clinical Study to Assess the Safety and Activity of SRT501 Alone or in Combination With Bortezomib in Patients With Multiple Myeloma | TERMINATED | PHASE2 | 2009-03-30 | 2010-11-04 | 2010-11-04 |
| NCT00866619 | Efficacy of GSK Biologicals' Candidate Malaria Vaccine 257049 Against Malaria Disease in Infants and Children in Africa | COMPLETED | PHASE3 | 2009-03-27 | 2014-01-31 | 2011-03-01 |
| NCT00871156 | Tafenoquine/Chloroquine DDI Study | COMPLETED | PHASE1 | 2009-03-24 | 2009-08-26 | 2009-08-26 |
| NCT00933062 | Clinical Study to Assess the Pharmacokinetics, Safety and Tolerability of SRT2104 Administered to Normal Healthy Male Volunteers | COMPLETED | PHASE1 | 2009-03-23 | 2009-05-12 | 2009-05-12 |
| NCT00861029 | VEG111485: A QTc Study of Pazopanib | COMPLETED | PHASE1 | 2009-03-19 | 2010-02-15 | 2010-02-15 |
| NCT00840320 | Repeat Dose Safety Study for Compound to Treat Anemia | COMPLETED | PHASE1 | 2009-03-13 | 2009-09-02 | 2009-09-02 |
| NCT00849069 | Study to Assess the Safety of a New GSK Biologicals' GSK2231395A Candidate Vaccine | TERMINATED | PHASE1 | 2009-03-12 | 2009-04-07 | 2009-04-07 |
| NCT00880048 | A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder | TERMINATED | PHASE2 | 2009-03-11 | 2010-06-21 | 2010-06-21 |
| NCT00849329 | A Study to Examine the Effects of Esomeprazole on the Pharmacokinetics of Orally Administered Lapatinib in Subjects With Metastatic ErbB2 Positive Breast Cancer | COMPLETED | PHASE1 | 2009-03-10 | 2009-11-24 | 2009-11-24 |
| NCT00814710 | Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 10 Weeks of Age | COMPLETED | PHASE3 | 2009-03-07 | 2009-11-13 | 2009-11-13 |
| NCT00821054 | A Study to Examine the Effects of Low and High-fat Meals on Orally Administered Lapatinib in Metastatic ErbB2 Positive Breast Cancer Patients | COMPLETED | PHASE1 | 2009-03-06 | 2011-03-22 | 2011-03-22 |
| NCT00880399 | A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder | TERMINATED | PHASE2 | 2009-03-01 | 2010-06-16 | 2010-06-01 |
| NCT00857766 | A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE4 | 2009-03 | 2010-03 | 2010-03 |
| NCT00823836 | Clinical Evaluation of Ropinirole Prolonged Release/Extended Release (PR/XR) Tablet for Adjunctive Therapy to L-dopa in Subjects With Advanced Parkinson's Disease | COMPLETED | PHASE3 | 2009-03 | 2010-12 | 2010-12 |
| NCT00812812 | Paxil Japanese Post Marketing Paediatric Study in Depression (Double-blind, Placebo Controlled Study) | TERMINATED | PHASE4 | 2009-03 | 2011-02 | 2011-02 |
| NCT00811733 | A Phase II Trial of Ofatumumab in Subjects With Waldenstrom's Macroglobulinemia | COMPLETED | PHASE2 | 2009-03-01 | 2014-02-01 | 2011-06-01 |
| NCT00852761 | A Study to Evaluate the Efficacy and Tolerability of Topical Therapies for the Condition of Plaque-Type Psoriasis | COMPLETED | PHASE4 | 2009-03 | 2009-08 | 2009-06 |
| NCT00839254 | Impact on Carriage, Acute Otitis Media, Immuno & Safety of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A | COMPLETED | PHASE3 | 2009-02-18 | 2012-01-31 | 2012-01-31 |
| NCT00835237 | Evaluation of GlaxoSmithKline Biologicals' Boostrix® Vaccine in Comparison With Decavac™ Vaccine. | COMPLETED | PHASE3 | 2009-02-17 | 2009-10-15 | 2009-07-23 |
| NCT00829010 | Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age. | COMPLETED | PHASE3 | 2009-02-17 | 2012-06-27 | 2011-06-13 |
| NCT00857857 | A Study to Evaluate the Effect of GW870086X on Allergen Challenge in Mild Asthmatics | COMPLETED | PHASE2 | 2009-02-16 | 2009-11-03 | 2009-11-03 |
| NCT00814762 | Safety of the HIV Vaccine 732462 in HIV Infected Subjects Aged 18 to 55 Years Old | COMPLETED | PHASE1 | 2009-02-03 | 2010-08-18 | 2010-08-18 |
| NCT00790907 | Fondaparinux Trial With Unfractionated Heparin (UFH) During Revascularization in Acute Coronary Syndromes (ACS) | COMPLETED | PHASE4 | 2009-02 | 2010-05 | 2010-05 |
| NCT00838916 | A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 Diabetes | COMPLETED | PHASE3 | 2009-02 | 2013-05 | 2012-01 |
| NCT00838903 | Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes | COMPLETED | PHASE3 | 2009-02 | 2013-04 | 2012-01 |
| NCT00839527 | A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes | COMPLETED | PHASE3 | 2009-02 | 2013-04 | 2012-01 |
| NCT00887484 | A Comparative Study of the Tolerability of Two Combination Therapies for the Treatment of Acne | COMPLETED | PHASE4 | 2009-02 | 2009-06 | 2009-06 |
| NCT00858286 | A Follow-up Survey to Compare Stable Dosing (SERETIDE) With SYMBICORT, SMART, Maintenance and Reliever Therapy in One Inhaler in Moderate and Severe Asthmatics. | COMPLETED | PHASE4 | 2009-02 | 2010-04 | 2010-04 |
| NCT01587950 | The Effects of Potassium Nitrate in Reducing Dentinal Hypersensitivity | COMPLETED | PHASE1 | 2009-02 | 2009-04 | 2009-04 |
| NCT01550926 | A Study to Assess the Pharmacologic Equivalence of Two Orlistat Dosage Forms | COMPLETED | PHASE1 | 2009-02 | 2009-03 | 2009-03 |
| NCT00828763 | GSK1349572 Mass Balance Study | COMPLETED | PHASE1 | 2009-02 | 2009-03 | 2009-03 |
| NCT00748410 | Study to Evaluate the Pharmacodynamics of SB-656933 in Patients With Ulcerative Colitis | TERMINATED | PHASE2 | 2009-01-22 | 2009-12-12 | 2009-12-12 |
| NCT00938275 | A Clinical Study to Assess the Effect of Food and Gender on the Pharmacokinetics of SRT2104 Administered as an Oral Suspension or Capsule Formulation to Normal Healthy Volunteers | COMPLETED | PHASE1 | 2009-01-20 | 2009-03-27 | 2009-03-27 |
| NCT00833378 | Drug Interaction Study Between Eltrombopag and Lopinavir/Ritonavir in Healthy Adult Subjects. | COMPLETED | PHASE1 | 2009-01-19 | 2009-03-11 | 2009-03-11 |
| NCT00823940 | A Phase 1 Study to Evaluate the Safety and Tolerability of GSK1362885 in Healthy Normal Subjects | COMPLETED | PHASE1 | 2009-01-13 | 2009-04-27 | 2009-04-27 |
| NCT00802464 | Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years | COMPLETED | PHASE2 | 2009-01-12 | 2010-07-02 | 2010-07-02 |
| NCT00817063 | Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema | COMPLETED | PHASE3 | 2009-01-08 | 2012-04-26 | 2012-04-26 |
| NCT00814489 | Evaluation of Non-typable Haemophilus Influenzae and Pneumococcal Protein Vaccine Formulations in Young Adults | COMPLETED | PHASE1 | 2009-01-08 | 2010-06-10 | 2009-05-04 |
| NCT00808444 | Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6-12wks of Age | COMPLETED | PHASE3 | 2009-01-05 | 2009-11-02 | 2009-11-02 |
| NCT00799825 | Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US | COMPLETED | PHASE3 | 2009-01-01 | 2012-08-02 | 2012-08-02 |
| NCT01563172 | Effect of Dentifrice Usage Regime on Delivery and Efficacy of Fluoride | COMPLETED | PHASE4 | 2009-01-01 | 2009-06-01 | 2009-06-01 |
| NCT00849017 | Safety and Efficacy Study of Albiglutide in Type 2 Diabetes | COMPLETED | PHASE3 | 2009-01 | 2013-02 | 2011-11 |
| NCT00849056 | Safety and Efficacy of Albiglutide in Type 2 Diabetes | COMPLETED | PHASE3 | 2009-01 | 2013-01 | 2011-11 |
| NCT00802737 | Efficacy and Safety of Ofatumumab Retreatment and Maintenance Treatment in Patients With B-cell Chronic Lymphocytic Leukemia (CLL) | COMPLETED | PHASE4 | 2009-01 | 2013-05 | 2011-09 |
| NCT00861601 | Phase 2, Pharmacokinetics Study of Eltrombopag in Japanese Thrombocytopenic Subjects With Chronic Liver Disease | COMPLETED | PHASE2 | 2009-01 | 2009-08 | 2009-08 |
| NCT00858455 | A Study to Evaluate the Effect of Antacid and Multivitamin and Mineral Tablet on the Study Drug GSK1349572 | COMPLETED | PHASE1 | 2009-01 | 2009-03 | 2009-03 |
| NCT00866515 | Drug Interaction Study to Investigate Co-administration of GW642444M With Ketoconazole | COMPLETED | PHASE1 | 2008-12-22 | 2009-03-27 | 2009-03-27 |
| NCT01039454 | Effects of the D3 Antagonist GSK598809 on Food Reward and Reinforcement | COMPLETED | PHASE1 | 2008-12-18 | 2010-04-26 | 2010-04-26 |
| NCT00805389 | Study to Compare the Efficacy of GSK Biologicals' Adjuvants in Combination With the Antigen of the Hepatitis B Vaccine | COMPLETED | PHASE2 | 2008-12-15 | 2011-07-14 | 2010-09-29 |
| NCT00811356 | A First Time in Human Study in Healthy Volunteers to Investigate a New Medicine to Treat Malaria | TERMINATED | PHASE1 | 2008-12-11 | 2009-03-30 | 2009-03-30 |
| NCT00843193 | Efficacy and Safety Study of GSK679586 in Patients With Severe Asthma | COMPLETED | PHASE2 | 2008-12-09 | 2010-07-25 | 2010-07-25 |
| NCT00814957 | An Open Label Positron Emission Tomography (PET) Study of GSK618334 in Healthy Male Subjects Using 11C-PHNO as PET Ligand | COMPLETED | PHASE1 | 2008-12-08 | 2009-06-11 | 2009-06-11 |
| NCT01929278 | W0265-103: A Single-Center, Evaluator-Blinded, Randomized, Placebo Controlled, Phase 1 Clinical Trial Evaluating The Phototoxic Potential Of Topically Applied Clindamycin 1.0% - Tretinoin 0.025% Gel (Ct Gel) In Healthy Volunteers | COMPLETED | PHASE1 | 2008-12-08 | 2008-12-19 | 2008-12-19 |
| NCT00792909 | Vaccination Course in Primed Children and Age-matched Unprimed Children With Pneumococcal Vaccine GSK1024850A | COMPLETED | PHASE3 | 2008-12-02 | 2009-07-02 | 2009-07-02 |
| NCT00796445 | A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor | TERMINATED | PHASE3 | 2008-12-01 | 2016-01-27 | 2016-01-27 |
| NCT00812929 | A Clinical Trial to Test a Study Drug in Volunteers Who Develop Asthma Following Exercise | COMPLETED | PHASE2 | 2008-12-01 | 2009-07-15 | 2009-06-01 |
| NCT00799903 | The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial | COMPLETED | PHASE3 | 2008-12-01 | 2013-10-17 | 2013-10-01 |
| NCT00843024 | Migraine Study in Adolescent Patients | COMPLETED | PHASE3 | 2008-12 | 2010-06 | 2010-05 |
| NCT00784550 | A 24-Week Study to Evaluate the Safety and Efficacy of ADVAIR DISKUS® Inhaler 250/50mcg Plus SPIRIVA HANDIHALER® Inhaler Versus SPIRIVA HANDIHALER® Inhaler Plus Placebo DISKUS® Inhaler in Subjects With Chronic Obstructive Pulmonary Disease (COPD). | COMPLETED | PHASE4 | 2008-12 | 2009-12 | 2009-12 |
| NCT00812773 | Study to Evaluate GSK2190915 in Subjects With Mild Asthma | COMPLETED | PHASE2 | 2008-12 | 2009-07 | 2009-07 |
| NCT00748306 | Study in Mild Asthmatic Patients | COMPLETED | PHASE2 | 2008-12 | 2009-09 | 2009-09 |
| NCT00793468 | Relapse Prevention Study in Newly Abstinent Smokers | WITHDRAWN | PHASE2 | 2008-12 | 2008-12 | 2008-12 |
| NCT01568749 | A Study Investigating the Pharmacokinetic Profiles of Four Extended Release Paracetamol Formulations | COMPLETED | PHASE1 | 2008-12 | 2009-08 | 2009-08 |
| NCT00843492 | A Study to Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patients With a Plaster Cast or Other Type of Immobilization for a Below-knee Injury Not Needing Surgery | COMPLETED | PHASE3 | 2008-12 | 2010-06 | 2010-01 |
| NCT01075256 | Dose Response of a Tubule Occlusion Agent | COMPLETED | PHASE4 | 2008-12 | 2009-03 | 2009-03 |
| NCT00861484 | Proof of Mechanism in ELT | COMPLETED | PHASE1 | 2008-11-26 | 2009-12-11 | 2009-12-11 |
| NCT00937872 | A Clinical Study to Evaluate the Pharmacokinetics and the Absolute Bioavailability of SRT2104 Given as a 250mg Oral Suspension and Intravenous Microdose of 100 µg Carbon-14 Radio-labeled SRT2104 in Healthy Male Subjects | COMPLETED | PHASE1 | 2008-11-22 | 2008-12-22 | 2008-12-22 |
| NCT01915758 | W0265-104: A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Photoallergic Potential of Topically Applied Clindamycin Phosphate 1.0% and Tretinoin 0.025% (CT Gel) in Healthy Volunteers | COMPLETED | PHASE1 | 2008-11-21 | 2009-02-20 | 2009-02-20 |
| NCT00849134 | First Time in Human Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and the Effect of Food of Single Assending Doses of GSK1482160. | COMPLETED | PHASE1 | 2008-11-17 | 2009-04-06 | 2009-04-06 |
| NCT00857883 | A First-Time-In-Human Study in Healthy Subjects | COMPLETED | PHASE1 | 2008-11-17 | 2009-08-01 | 2009-08-01 |
| NCT00812981 | A Study for Evaluation of GSK Biologicals' Pandemic Influenza Vaccine. | COMPLETED | PHASE3 | 2008-11-15 | 2009-06-07 | 2009-06-07 |
| NCT00828867 | Single Dose Escalation First Time in Human PK Study | COMPLETED | PHASE1 | 2008-11-14 | 2009-12-07 | 2009-12-07 |
| NCT00749411 | Safety and Tolerability of Repeat Dosing of GSK233705/GW642444 in COPD | COMPLETED | PHASE2 | 2008-11-13 | 2009-02-12 | 2009-02-12 |
| NCT00907933 | Intranasal SB-705498 in Healthy Volunteers | COMPLETED | PHASE1 | 2008-11-10 | 2009-02-11 | 2009-02-11 |
| NCT00783003 | A Study to Assess the Safety and Pharmacokinetics of Inhaled Doses of GSK233705 and GW642444 in Healthy Subjects | COMPLETED | PHASE1 | 2008-11-10 | 2009-02-06 | 2009-02-06 |
| NCT00778895 | Clinical Study in Children, 6 Months to 3 Years of Age, to Assess Two Dose Levels of an Experimental Flu Vaccine, Using a Licensed Influenza Virus Vaccine, Vaxigrip® as the Control | COMPLETED | PHASE2 | 2008-11-10 | 2009-08-19 | 2009-08-19 |
| NCT00989625 | A Pharmacokinetic Study to Evaluate TREXIMET in Adolescents With Migraine and Healthy Subjects Administered at Three Doses. | COMPLETED | PHASE1 | 2008-11-04 | 2009-09-10 | 2009-09-10 |
| NCT00695305 | An Imaging Study in Patients With Atherosclerosis Taking Rilapladib or Placebo for 12 Weeks | COMPLETED | PHASE2 | 2008-11 | 2010-05 | 2010-05 |
| NCT00792636 | A Study to Determine the Effect of Sumatriptan and Naproxen Sodium Combination Tablet, Sumatriptan Tablet, and Naproxen Sodium Tablet on Blood Pressure When Treating Migraine Headaches That Occur During a 6-month Period | COMPLETED | PHASE4 | 2008-11 | 2009-11 | 2009-11 |
| NCT00774995 | Immune Response of Healthy Subjects Who Received Neonatal Vaccination Course With Engerix™-B Vaccine. | COMPLETED | PHASE4 | 2008-11 | 2010-06 | 2010-06 |
| NCT01005966 | In Situ Caries Model of Fluoride Toothpastes | COMPLETED | PHASE3 | 2008-11 | 2009-03 | 2009-03 |
| NCT00758264 | Co-administration of Meningococcal Vaccine GSK134612 and Pneumococcal Vaccine GSK1024850A vs Individual Administration | COMPLETED | PHASE3 | 2008-10-30 | 2009-11-02 | 2009-06-02 |
| NCT00779766 | Efficacy, Immunogenicity and Safety of GSK Biologicals' HPV GSK 580299 Vaccine in Healthy Chinese Female Subjects | COMPLETED | PHASE3 | 2008-10-22 | 2016-02-28 | 2011-09-06 |
| NCT00711126 | A Study To Investigate Safety, Blood Levels And Effects Of Giving GW642444, By Mouth, By Inhalation & By Injection | COMPLETED | PHASE1 | 2008-10-21 | 2008-12-17 | 2008-12-17 |
| NCT00718666 | The Long-term Antibody Persistence of GSK Biologicals' Meningococcal Vaccine GSK134612 in Healthy Toddlers | COMPLETED | PHASE2 | 2008-10-20 | 2014-03-28 | 2013-11-13 |
| NCT01381419 | First Time in Human Study (FTIH) With Positron Emission Tomography (PET) | COMPLETED | PHASE1 | 2008-10-20 | 2009-04-01 | 2009-04-01 |
| NCT00771615 | Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years | COMPLETED | PHASE2 | 2008-10-16 | 2009-12-04 | 2009-05-26 |
| NCT00765076 | Clinical Study of the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in People Aged 65 Years or Older | COMPLETED | PHASE3 | 2008-10-16 | 2009-12-04 | 2009-12-04 |
| NCT00772889 | Evaluation of the Safety and Immunogenicity of the Influenza Vaccine GSK2186877A in the Elderly | COMPLETED | PHASE3 | 2008-10-09 | 2009-12-15 | 2009-12-15 |
| NCT00760617 | Evaluation of Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Years and Older | COMPLETED | PHASE3 | 2008-10-06 | 2009-05-15 | 2009-05-15 |
| NCT00733980 | A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder | COMPLETED | PHASE2 | 2008-10-02 | 2010-06-18 | 2010-06-18 |
| NCT00725283 | Evaluation of a New Anti-cancer Immunotherapy After Chemotherapy in Adult Patients With Acute Myeloid Leukemia (AML) | COMPLETED | PHASE1 | 2008-10-01 | 2016-06-22 | 2016-06-22 |
| NCT00751348 | Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136 | COMPLETED | PHASE3 | 2008-10-01 | 2010-05-27 | 2010-05-27 |
| NCT00766090 | Safety and Efficacy of GW685698X an Inhaled Corticosteroid Once Daily and Twice Daily for the Treatment of Asthma | COMPLETED | PHASE2 | 2008-10 | 2009-03 | 2009-03 |
| NCT00776919 | Trial of Clindamycin / Benzoyl Peroxide Gel in Subjects With Acne | COMPLETED | PHASE3 | 2008-10 | 2009-09 | 2009-09 |
| NCT00764790 | Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine Versus a Licensed Comparator in Children | COMPLETED | PHASE3 | 2008-10-01 | 2009-06-01 | 2009-03-05 |
| NCT00732472 | A Study to Assess the Safety and Tolerability of Once Daily Inhaled Doses of GSK573719 Made With Magnesium Stearate in Subjects With Chronic Obstructive Pulmonary Disease(COPD)for 7 Days | COMPLETED | PHASE2 | 2008-10 | 2009-08 | 2009-08 |
| NCT00753688 | Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy | COMPLETED | PHASE3 | 2008-10 | 2012-12 | 2010-11 |
| NCT00828464 | Study to Evaluate Safety, Efficacy and Tolerability of Clobetasol Propionate for Chronic Hand Dermatitis | COMPLETED | PHASE4 | 2008-10 | 2009-01 | 2009-01 |
| NCT00774735 | GSK1349572 Drug Interaction Study With Protease Inhibitors | COMPLETED | PHASE1 | 2008-10 | 2008-12 | 2008-12 |
| NCT00774111 | GSK1349572 Drug Interaction Study With Etravirine | COMPLETED | PHASE1 | 2008-10 | 2008-12 | 2008-12 |
| NCT00706238 | MAGE-A3 Antigen-Specific Cancer Immunotherapeutic in Patients With Progressive Metastatic Cutaneous Melanoma | TERMINATED | PHASE2 | 2008-09-29 | 2011-01-19 | 2011-01-19 |
| NCT00887367 | EtOH Interaction Study | COMPLETED | PHASE1 | 2008-09-29 | 2008-12-03 | 2008-12-03 |
| NCT00721812 | A First Time In Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK1399686 | COMPLETED | PHASE1 | 2008-09-25 | 2009-05-27 | 2009-05-27 |
| NCT00732420 | Open-label Study of Topotecan and Pazopanib in Advanced Solid Tumors | COMPLETED | PHASE1 | 2008-09-24 | 2013-06-12 | 2013-06-12 |
| NCT00972673 | A Study of GW685698X in Healthy Japanese Male Subjects | COMPLETED | PHASE1 | 2008-09-24 | 2008-12-19 | 2008-12-19 |
| NCT00753649 | Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants | COMPLETED | PHASE4 | 2008-09-23 | 2013-03-12 | 2013-03-12 |
| NCT00733551 | Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK962040 Administered to Healthy Adult Subjects. | COMPLETED | PHASE1 | 2008-09-23 | 2009-07-20 | 2009-07-20 |
| NCT00964249 | Phase I Study of GW642444M in Healthy Japanese Male Subjects | COMPLETED | PHASE1 | 2008-09-20 | 2008-12-01 | 2008-12-01 |
| NCT00964405 | Phase I Study of GSK233705 in Healthy Japanese Male Subjects | COMPLETED | PHASE1 | 2008-09-20 | 2008-12-20 | 2008-12-20 |
| NCT00742144 | Ofatumumab in Japanese Patients With CD20 Positive Follicular Lymphoma or Chronic Lymphocytic Leukemia | COMPLETED | PHASE1 | 2008-09-19 | 2009-11-18 | 2009-11-18 |
| NCT01424384 | Emotional Processing in Healthy Volunteers in the Presence of an Investigational Anxiolytic | COMPLETED | PHASE1 | 2008-09-19 | 2009-04-30 | 2009-04-30 |
| NCT00756067 | Evaluation of Pneumococcal Vaccine Formulations in Elderly | COMPLETED | PHASE1 | 2008-09-19 | 2009-05-28 | 2009-05-28 |
| NCT00730847 | A Study to Assess the Safety and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (Cervarix) in Healthy Female Filipino Subjects Vaccinated According to the Prescribing Information From the Age of 10 Years Onwards. | TERMINATED | PHASE4 | 2008-09-17 | 2012-01-16 | 2012-01-16 |
| NCT00753272 | Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older | COMPLETED | PHASE3 | 2008-09-15 | 2011-01-05 | 2010-06-18 |
| NCT00757523 | Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne Vulgaris | COMPLETED | PHASE4 | 2008-09-10 | 2009-06-24 | 2009-04-24 |
| NCT00783549 | A Study in Healthy Volunteers of Single Doses of Orally Administered Investigational Product to Investigate Safety, Tolerability, and Pharmacokinecs. | COMPLETED | PHASE1 | 2008-09-04 | 2009-03-31 | 2009-03-31 |
| NCT00743860 | A Healthy Volunteer Pharmacokinetic Study of Single and Repeat Doses of SB-480848 | COMPLETED | PHASE1 | 2008-09 | 2008-12 | 2008-12 |
| NCT00851344 | Allergen Challenge Chamber Study With Single Dose Oral GSK835726 Compared With Placebo | COMPLETED | PHASE2 | 2008-09 | 2008-11 | 2008-11 |
| NCT00742885 | Immunogenicity and Safety of GSK Biologicals' (Pre-) Pandemic Influenza Candidate Vaccine | COMPLETED | PHASE2 | 2008-09-01 | 2009-03-07 | 2009-03-07 |
| NCT00682279 | A Phase I Study Of Oral Topotecan And Lapatinib In Subjects With Advanced Solid Tumors | WITHDRAWN | PHASE1 | 2008-09 | 2011-03 | 2011-03 |
| NCT00752726 | Effect of Orlistat in Body Composition | COMPLETED | PHASE4 | 2008-09 | 2009-07 | 2009-07 |
| NCT01231490 | Acute Osteoarthritis Experimental Model Study. | COMPLETED | PHASE2 | 2008-09 | 2009-03 | 2009-01 |
| NCT00843011 | Food and Relative Bioavailability Study | COMPLETED | PHASE1 | 2008-08-28 | 2008-10-23 | 2008-10-23 |
| NCT00742508 | A Phase I/II Clinical Study of SK&F-105517-D in Japanese Patients With Chronic Heart Failure | COMPLETED | PHASE1 | 2008-08-28 | 2009-08-21 | 2009-08-21 |
| NCT00734032 | A Phase II Clinical Study of SB-480848 in Dyslipidemic Patients | COMPLETED | PHASE2 | 2008-08-26 | 2009-01-16 | 2009-01-16 |
| NCT00920803 | A Clinical Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SRT501 in Subjects With Colorectal Cancer and Hepatic Metastases | COMPLETED | PHASE1 | 2008-08-19 | 2009-11-11 | 2009-11-11 |
| NCT00733785 | PK, Dose Proportionality, Food Effect And Repeat Dose Study Of Rosiglitazone XR In Healthy Volunteers | COMPLETED | PHASE1 | 2008-08-13 | 2008-11-28 | 2008-11-28 |
| NCT00733577 | A Study to Test How SB756050 Affects Subjects With Type 2 Diabetes Mellitus After 6 Days of Dosing. | COMPLETED | PHASE1 | 2008-08-11 | 2009-03-03 | 2009-03-03 |
| NCT00742261 | A Bioavailability Study of GSK1363089 in Subjects With Solid Tumors | COMPLETED | PHASE1 | 2008-08-11 | 2009-06-24 | 2009-06-24 |
| NCT00727428 | Immunogenicity and Safety of GSK Biologicals' FluLaval® TF | COMPLETED | PHASE1 | 2008-08-05 | 2009-02-17 | 2008-08-29 |
| NCT00731822 | A Study To Assess Single Dosage Strength Of GW685698/GW642444 Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE2 | 2008-08 | 2009-02 | 2009-02 |
| NCT00724867 | A Continuation Trial for Subjects With Lupus Who Completed Protocol HGS1006-C1056 in the United States | COMPLETED | PHASE3 | 2008-08 | 2015-03 | 2015-03 |
| NCT00726336 | GSK1349572 Drug Interaction With Tenofovir | COMPLETED | PHASE1 | 2008-08 | | 2008-10 |
| NCT00678886 | Trial of Otelixizumab for Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-1 | COMPLETED | PHASE3 | 2008-07-29 | 2012-01-31 | 2012-01-31 |
| NCT00687622 | Open-label Study to Investigate the Safety, PK, and Pharmacodynamics of GSK1120212 in Subjects With Solid Tumors or Lymphoma | COMPLETED | PHASE1 | 2008-07-28 | 2011-11-08 | 2011-06-07 |
| NCT00728208 | GSK372475 PK Study in Healthy Volunteers | COMPLETED | PHASE1 | 2008-07-28 | 2008-12-29 | 2008-12-29 |
| NCT00723775 | GSK706769/KALETRA Drug-drug Interaction Study | COMPLETED | PHASE1 | 2008-07-24 | 2008-11-08 | 2008-11-08 |
| NCT00731250 | A Study To Assess The Effect Of SB-705498 In A Capsaicin Challenge Model | COMPLETED | PHASE1 | 2008-07-22 | 2009-03-31 | 2009-03-01 |
| NCT00718120 | Immunogenicity and Safety Study of GSK Biologicals' Fluviral® (2008 - 2009 Season) in Adults Over 18 Years | COMPLETED | PHASE3 | 2008-07-18 | 2008-08-09 | 2008-08-09 |
| NCT00730405 | Efficacy and Safety Study of 4 Dose Regimens of Oral Albaconazole in Subjects With Distal Subungual Onychomycosis | COMPLETED | PHASE2 | 2008-07-16 | 2010-02-19 | 2010-02-19 |
| NCT00714285 | Immunogenicity and Safety Study of a GSK Influenza Vaccine Candidate in Adults. | COMPLETED | PHASE1 | 2008-07-14 | 2009-01-28 | 2009-01-28 |
| NCT00719043 | Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged ≥18 Years | COMPLETED | PHASE2 | 2008-07-11 | 2011-02-18 | 2010-04-22 |
| NCT01607086 | Compare the Properties and Characteristics of an Investigational Formulation of Lamotrigine With Placebo | COMPLETED | PHASE1 | 2008-07-11 | 2008-07-18 | 2008-07-18 |
| NCT00722293 | A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors | COMPLETED | PHASE1 | 2008-07-08 | 2014-02-25 | 2012-06-11 |
| NCT00706563 | A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix™ / Influsplit SSW® 2008/2009 in Adults | COMPLETED | PHASE3 | 2008-07-07 | 2008-07-30 | 2008-07-30 |
| NCT00876018 | Nutrition, Physical Performance & Fitness in Indian School Children | COMPLETED | PHASE4 | 2008-07-07 | 2008-12-19 | 2008-12-19 |
| NCT00749359 | PAXIL CR Bioequivalence Study | COMPLETED | PHASE1 | 2008-07-07 | 2008-09-16 | 2008-09-16 |
| NCT00750256 | A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK1278863A in Healthy Subjects | COMPLETED | PHASE1 | 2008-07-07 | 2008-12-12 | 2008-12-12 |
| NCT00708552 | Study of SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-moderate Alzheimer's Disease | COMPLETED | PHASE2 | 2008-07-04 | 2010-03-09 | 2010-03-01 |
| NCT00728897 | A Healthy Volunteer Study to Investigate the Relative Bioavailability of Two Forms of GSK598809 Capsules. | COMPLETED | PHASE1 | 2008-07-02 | 2008-07-29 | 2008-07-29 |
| NCT00710684 | A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's Disease | COMPLETED | PHASE2 | 2008-07-01 | 2010-11-16 | 2010-05-21 |
| NCT00723450 | Lamictal as Add-on Treatment for Bipolar I Disorder in Pediatric Patients | COMPLETED | PHASE3 | 2008-07 | 2013-08 | 2013-08 |
| NCT00715910 | The Long-term Antibody Persistence of GSK Biologicals' Meningococcal Vaccine GSK134612 in Healthy Adolescents/Adults | COMPLETED | PHASE2 | 2008-07 | 2013-10 | 2013-04 |
| NCT00698516 | Study of Oral Topotecan With Bevacizumab for Recurrent Small Cell Lung Cancer | COMPLETED | PHASE2 | 2008-07 | 2010-05 | 2010-05 |
| NCT00699608 | An Evaluation of Potential Next-day Residual Effects of Eszopiclone in Healthy Volunteers. | COMPLETED | PHASE3 | 2008-07 | 2008-10 | 2008-10 |
| NCT00929370 | A Repeat Dose Study With GSK1018921 to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics in Healthy Volunteers and Patients With Schizophrenia and to Evaluate Its Effect on PK of Midazolam. | TERMINATED | PHASE1 | 2008-07 | 2009-03 | 2008-10 |
| NCT00707798 | Evaluation of Pneumococcal Vaccine Formulations in Young Adults | COMPLETED | PHASE1 | 2008-06-30 | 2009-01-15 | 2009-01-15 |
| NCT00707967 | Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in HIV-positive Adults. | COMPLETED | PHASE2 | 2008-06-30 | 2009-05-27 | 2009-05-27 |
| NCT00733304 | An Extension to Study MD7108240 | COMPLETED | PHASE2 | 2008-06-25 | 2009-09-09 | 2009-09-09 |
| NCT00695448 | Phase I Open-Label, Dose-Escalation Study of GSK1059615 in Patients With Solid Tumors or Lymphoma | TERMINATED | PHASE1 | 2008-06-24 | 2009-03-31 | 2009-03-31 |
| NCT00678301 | Primary Vaccination Course in Children Receiving the Pneumococcal Vaccine GSK 1024850A, Zilbrix™ Hib and Polio Sabin™ | COMPLETED | PHASE3 | 2008-06-18 | 2009-12-10 | 2009-11-09 |
| NCT00659178 | Combination Study Of SB-485232 (Interleukin 18) And Doxil For Advanced Stage Epithelial Ovarian Cancer | COMPLETED | PHASE1 | 2008-06-18 | 2011-02-18 | 2011-02-18 |
| NCT00686868 | Study to Evaluate SC Route of Administration of Ofatumumab in RA Patients | COMPLETED | PHASE1 | 2008-06-13 | 2011-05-02 | 2011-03-11 |
| NCT00680914 | Primary Vaccination Course in Children Receiving Pneumococcal Conjugate Vaccine GSK 1024850A or Prevenar™ and Hiberix™ | COMPLETED | PHASE3 | 2008-06-10 | 2009-05-08 | 2009-05-08 |
| NCT00728052 | A Human Volunteer Study Investigating Single Oral Doses of GSK598809 in Otherwise Healthy Smokers | COMPLETED | PHASE1 | 2008-06-09 | 2008-08-19 | 2008-08-19 |
| NCT00696423 | Immunogenicity and Safety of GSK Biologicals' Infanrix/Hib in Children | COMPLETED | PHASE3 | 2008-06-07 | 2008-07-26 | 2008-07-26 |
| NCT00695669 | A Trial to Test the Response to Different Vaccination Regimens With an H5N1 Vaccine With AS03 in Adults Aged 18-64 | COMPLETED | PHASE2 | 2008-06-05 | 2009-01-08 | 2008-08-13 |
| NCT00633022 | A Study to Evaluate the Effects of 3 Months Dosing With GW856553, as Assessed FDG-PET/CT Imaging | COMPLETED | PHASE2 | 2008-06-02 | 2009-12-03 | 2009-12-03 |
| NCT00688272 | Study In Healthy Subjects To Evaluate The Photo-Irritant Potential Of Eltrombopag | COMPLETED | PHASE1 | 2008-06-02 | 2008-09-25 | 2008-09-25 |
| NCT00693706 | Safety and Immune Response Study of GSK Biologicals' Influenza Virus Vaccine 1388442A Compared With Fluarix | COMPLETED | PHASE1 | 2008-06-02 | 2009-03-26 | 2009-03-01 |
| NCT00713609 | Safety and Efficacy Study of Clindamycin/Benzoyl Peroxide/Tazarotene Cream in Subjects With Acne | COMPLETED | PHASE2 | 2008-06 | 2009-03 | 2009-03 |
| NCT00703846 | STUDY TO ASSESS THE LONG-TERM SAFETY OF EXTINA (KETOCONAZOLE) FOAM, 2% | COMPLETED | PHASE4 | 2008-06 | 2010-04 | 2010-04 |
| NCT00682643 | A Clinical Study With Fluticasone Furoate Nasal Spray And Vehicle Placebo For The Treatment Of Perennial (Year-round) Allergic Rhinitis | COMPLETED | PHASE4 | 2008-06 | 2011-02 | 2011-02 |
| NCT00911157 | The Treatment of Acute Deep Vein Thrombosis (DVT) of GSK576428 (Fondaparinux Sodium) in Japanese Patients | COMPLETED | PHASE3 | 2008-06 | 2009-11 | 2009-11 |
| NCT00708305 | Evaluation of Plaque Fluid Fluoride Retention From Fluoride Toothpastes | COMPLETED | PHASE3 | 2008-06 | 2008-10 | 2008-10 |
| NCT00709618 | Lapatinib + Vinorelbine in ErbB2 Overexpressing, First or Second Line Metastatic Breast Cancer Subjects | TERMINATED | PHASE2 | 2008-06 | 2012-05 | 2012-05 |
| NCT00678587 | Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures | TERMINATED | PHASE3 | 2008-06 | 2009-10 | 2009-10 |
| NCT00712855 | A Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma | COMPLETED | PHASE1 | 2008-06 | 2012-08 | 2011-08 |
| NCT00820924 | Study of Lapatinib in Breast Cancer Patients With HER-2 Non-amplified Primary Tumors and HER-2 Positive or EGFR Positive Circulating Tumor Cells | TERMINATED | PHASE2 | 2008-06 | 2011-07 | 2011-07 |
| NCT00695071 | Study to Assess Blood Levels of Itraconazole During a Two-Week Period | COMPLETED | PHASE1 | 2008-06 | 2008-07 | 2008-07 |
| NCT00824356 | Allergen Challenge Chamber Study With Single Dose Intranasal GSK1004723 Compared With Placebo | COMPLETED | PHASE2 | 2008-06 | 2008-08 | 2008-08 |
| NCT00712933 | A Continuation Trial for Subjects With Lupus That Completed Protocol HGS1006-C1056 or HGS1006-C1057 | COMPLETED | PHASE3 | 2008-05-30 | 2016-12-09 | 2016-12-09 |
| NCT00694902 | Single Dose Escalation Study FTIM in Order to Assess Safety and Tolerability of GSK610677 | COMPLETED | PHASE1 | 2008-05-26 | 2008-09-23 | 2008-09-23 |
| NCT00684671 | Evaluation of Immune Memory to Twinrix or Comparator by Challenge Dose Administration 4 Years After Primary Vaccination | COMPLETED | PHASE4 | 2008-05-26 | 2008-11-03 | 2008-11-03 |
| NCT01597609 | A Study to Characterise the Physiology of Weight Loss and Regain Under Dietary, Behavioural and Pharmacological Interventions in Healthy Obese Subjects | COMPLETED | PHASE1 | 2008-05-22 | 2010-03-04 | 2010-03-04 |
| NCT00671216 | A Study to Assess the Safety and Pharmacokinetics of Inhaled Doses of GSK233705 and GW642444 in Healthy Subjects. | COMPLETED | PHASE1 | 2008-05-20 | 2008-07-07 | 2008-07-07 |
| NCT00661557 | Comparison of GSK134612 in Subjects Previously Vaccinated Against Meningococcal Disease Versus Non-vaccinated Subjects | COMPLETED | PHASE2 | 2008-05-19 | 2008-12-19 | 2008-12-19 |
| NCT00945503 | Positron Emission Tomography (PET) Study to Describe the Relationship Between Plasma Concentrations and Brain Gly-T1 Occupancy of GSK1018921 Over Time. | COMPLETED | PHASE1 | 2008-05-19 | 2008-12-22 | 2008-12-22 |
| NCT00676052 | Dose-Ranging Study Of GSK233705B In Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE2 | 2008-05-16 | 2008-12-22 | 2008-12-22 |
| NCT00711386 | GSK706769 Repeat Dose Study | COMPLETED | PHASE1 | 2008-05-16 | 2008-09-12 | 2008-09-12 |
| NCT00808093 | Repeat Dose Food Effect Study of GSK256073F in Healthy Adult Subjects | COMPLETED | PHASE1 | 2008-05-12 | 2008-08-27 | 2008-08-27 |
| NCT00674583 | Comparison of GSK Biologicals' Meningococcal Vaccine (GSK134612) and Licensed MenC-CRM197 Vaccine in Healthy Children | COMPLETED | PHASE3 | 2008-05-09 | 2009-01-08 | 2008-09-02 |
| NCT00875784 | An Open-label, Randomized, 3-period Crossover Study to Evaluate Sumatriptan Pharmacokinetics for a TREXIMA™ (Sumatriptan Succinate / Naproxen Sodium) Tablet Followed by IMITREX® (Sumatriptan Succinate) | COMPLETED | PHASE1 | 2008-05-06 | 2008-06-14 | 2008-06-14 |
| NCT00803673 | A Healthy Volunteer Study With Inhaled GSK573719 and Placebo | COMPLETED | PHASE1 | 2008-05-05 | 2008-10-16 | 2008-10-16 |
| NCT00675064 | Single-Blind, Placebo-Controlled, Randomized Study Testing Single Ascending Doses Of GSK369796 In Healthy Subjects | COMPLETED | PHASE1 | 2008-05-02 | 2008-10-12 | 2008-10-12 |
| NCT00743405 | Safety, Tolerability and Pharmacokinetics of GSK1034702 in Healthy Subjects | COMPLETED | PHASE1 | 2008-05-02 | 2008-12-15 | 2008-12-15 |
| NCT00933530 | A Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Normal Healthy Male Volunteers | COMPLETED | PHASE1 | 2008-05 | 2008-11 | 2008-11 |
| NCT00566020 | A Clinical Evaluation Of BW430C (Lamotrigine) In Bipolar I Disorder- Long-term Extension Of Study SCA104779 (NCT00550407) - | COMPLETED | PHASE3 | 2008-05 | 2010-10 | 2010-10 |
| NCT00640328 | Ofatumumab Dose-finding in Relapsing Remitting Multiple Sclerosis (RRMS) Patients | COMPLETED | PHASE2 | 2008-05 | 2011-10 | 2010-05 |
| NCT00704431 | A Study With Darapladib to Collect Tolerability Information | COMPLETED | PHASE1 | 2008-05 | 2008-10 | 2008-10 |
| NCT00684177 | Retapamulin Versus Placebo in Secondarily-Infected Traumatic Lesions (SITL) | COMPLETED | PHASE3 | 2008-05 | 2009-10 | 2009-10 |
| NCT00828750 | Clinical Evaluation of Eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura (ITP) | COMPLETED | PHASE3 | 2008-05 | 2011-02 | 2011-02 |
| NCT00685750 | Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma | TERMINATED | NA | 2008-04-28 | 2013-12-17 | 2013-12-17 |
| NCT00702910 | A Study to Investigate the Effect of Inhaling Single Doses of Different Formulations of GW642444M in Asthmatic Patients | COMPLETED | PHASE1 | 2008-04-27 | 2008-10-04 | 2008-10-04 |
| NCT00650910 | Study To Examine The Effects Of Lapatinib On The Pharmacokinetics Of Digoxin In Subjects w/ ErbB2 Positive Breast Cancer | COMPLETED | PHASE1 | 2008-04-23 | 2009-07-10 | 2009-07-10 |
| NCT00679939 | Study In Postmenopausal Women With Type 2 Diabetes Looking At Approved Diabetes Drugs And How They Affect Bone Health | COMPLETED | PHASE4 | 2008-04-21 | 2010-09-16 | 2010-09-16 |
| NCT00664365 | FTIH Study With GSK958108 | COMPLETED | PHASE1 | 2008-04-12 | 2008-08-22 | 2008-08-22 |
| NCT00711776 | Bioequivalence Study of Aciclovir 5% Cream in Japanese Healthy Volunteers | COMPLETED | PHASE1 | 2008-04-10 | 2008-08-17 | 2008-08-17 |
| NCT00652938 | Evaluation of Immunogenicity and Safety of Human Papillomavirus (HPV) Vaccine Co-administered With Another Vaccine in Healthy Female Subjects | COMPLETED | PHASE3 | 2008-04-09 | 2010-01-08 | 2009-08-28 |
| NCT00659555 | Study Of The Repeat Dosing Of Ketoconazole On The Pharmacokinetics Of A Single Dose Of Pazopanib (GW786034) Eye Drops | COMPLETED | PHASE1 | 2008-04-04 | 2008-05-10 | 2008-05-10 |
| NCT00621322 | Safety and Immunogenicity Study of GSK Biologicals Tuberculosis Vaccines (692342) to Healthy Adults | COMPLETED | PHASE2 | 2008-04-03 | 2009-04-03 | 2009-04-03 |
| NCT00678977 | A Phase I, Open-label, Study of Pazopanib in Combination With Gemcitabine and Gemcitabine Plus Cisplatin for Advanced Solid Tumors | COMPLETED | PHASE1 | 2008-04-03 | 2011-06-30 | 2010-03-30 |
| NCT00652951 | Co-administration of Pneumococcal Conjugate Vaccine With DTPa-IPV-Hib Versus Co-administration With DTPa-HBV-IPV/Hib | COMPLETED | PHASE3 | 2008-04-01 | 2010-12-01 | 2009-05-12 |
| NCT00615524 | Phase II Study Evaluating Exemestane Alone Or In Combination With Pazopanib In Postmenopausal Women With Hormone Receptor Positive Breast Cancer | WITHDRAWN | PHASE2 | 2008-04 | 2012-11 | 2012-11 |
| NCT00689117 | A Clinical Study to Evaluate the Safety and Effectiveness of an Investigational Product Called CT Gel | COMPLETED | PHASE3 | 2008-04 | 2009-05 | 2009-04 |
| NCT00674635 | Phase II Study Evaluating the Safety and Efficacy of GSK315234A in Patients With Rheumatoid Arthritis | COMPLETED | PHASE2 | 2008-04 | 2010-12 | 2010-12 |
| NCT00688207 | Mild Alzheimer''s Disease to Assess the of Extended Release Formulation of Rosiglitazone (RSG XR) | COMPLETED | PHASE1 | 2008-04 | 2008-09 | 2008-09 |
| NCT00657657 | Safety and Immunogenicity of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine | COMPLETED | PHASE4 | 2008-04 | 2008-08 | 2008-08 |
| NCT02602002 | Experimental Medicine Study to Validate Pharmacodynamic Pain Assessments in Healthy Volunteers With an Opioid Analgesic (Remifentanil) | COMPLETED | PHASE1 | 2008-04 | 2008-06 | 2008-06 |
| NCT00666081 | Study to Investigate AKT Inhibitor GSK690693 in Subjects With Relapsed or Refractory Hematologic Malignancies | WITHDRAWN | PHASE1 | 2008-04 | 2009-12 | 2009-12 |
| NCT00513253 | A Phase I Study to Test Alternate Oral Formulations vs the Current Tablet Formulation of Lapatinib | WITHDRAWN | PHASE1 | 2008-04 | 2008-05 | 2008-05 |
| NCT00708097 | In Situ Caries Efficacy of Fluoride Toothpastes | COMPLETED | PHASE3 | 2008-04 | 2008-07 | 2008-07 |
| NCT00675116 | GW823296 Repeat Dose Study In Healthy Male And Female Subjects | COMPLETED | PHASE1 | 2008-04 | 2008-07 | 2008-07 |
| NCT00675857 | A Phase IIa Proof-of-concept Study of NC-503 in Patients With Type II Diabetes | COMPLETED | PHASE2 | 2008-04 | 2010-05 | 2010-01 |
| NCT00575159 | A Study to Assess the Safety of Single Doses of GSK189075 in Subjects With Type 1 Diabetes Mellitus | COMPLETED | PHASE2 | 2008-03-31 | 2008-12-18 | 2008-12-18 |
| NCT00615576 | Repeat Dose Study in Male Healthy Volunteer Smokers | COMPLETED | PHASE1 | 2008-03-26 | 2008-07-24 | 2008-07-24 |
| NCT00652743 | Immunogenicity of GSK Biologicals' Pandemic Influenza Vaccine (GSK1562902A) at Different Boosting Vaccination Schedules | COMPLETED | PHASE3 | 2008-03-23 | 2011-06-08 | 2011-06-08 |
| NCT02447393 | Phase 1 Study of Levocetirizine | COMPLETED | PHASE1 | 2008-03-18 | 2008-04-30 | 2008-04-30 |
| NCT00621894 | Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation | COMPLETED | PHASE2 | 2008-03-15 | 2009-05-15 | 2009-05-01 |
| NCT00637195 | Immunogenicity and Safety of a Commercially Available Vaccine Co-administered With GSK HPV Vaccine (580299) | COMPLETED | PHASE3 | 2008-03-11 | 2009-06-18 | 2008-06-20 |
| NCT00601172 | A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting. | COMPLETED | PHASE3 | 2008-03-10 | 2009-04-13 | 2009-04-13 |
| NCT00612456 | To Evaluate the Pharmacodynamics, Safety, and Pharmacokinetics of Pazopanib Drops in Adult Subjects With Neovascular AMD | COMPLETED | PHASE2 | 2008-03-05 | 2009-06-17 | 2009-01-01 |
| NCT00624819 | Assessment of Antibody Persistence in Children Previously Vaccinated With Pneumococcal Conjugate Vaccine | COMPLETED | PHASE3 | 2008-03-03 | 2008-06-02 | 2008-06-02 |
| NCT00633074 | Non-inferiority Study of GSK Biologicals' Influenza Vaccine GSK576389A Using Different Formulations | COMPLETED | PHASE2 | 2008-03-03 | 2008-04-11 | 2008-04-11 |
| NCT00730756 | A Pilot Study In Adults And Adolescents With Irritant (Non-Allergic) Rhinitis | COMPLETED | PHASE2 | 2008-03 | 2009-02 | 2009-02 |
| NCT00688519 | Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 Studies | COMPLETED | PHASE3 | 2008-03 | 2008-12 | 2008-12 |
| NCT00624065 | Research Study To Test Carvedilol CR + Lisinopril Versus Lisinopril + Placebo In Patients With High Blood Pressure | COMPLETED | PHASE3 | 2008-03 | 2008-08 | 2008-08 |
| NCT00633217 | Advair HFA For Chronic Obstructive Pulmonary Disease(COPD) | COMPLETED | PHASE4 | 2008-03 | 2009-02 | 2009-02 |
| NCT00689481 | Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis Two of Two Phase 3 Studies | COMPLETED | PHASE3 | 2008-03 | 2008-10 | 2008-10 |
| NCT00526669 | Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib | COMPLETED | PHASE2 | 2008-03 | 2015-01 | 2011-04 |
| NCT00671424 | A Study To Compare Effects Of GSK189075 In Combination With Either Furosemide Or Hydrochlorothiazide | COMPLETED | PHASE1 | 2008-03 | 2008-05 | 2008-05 |
| NCT01567995 | Randomised, Double-blind, Placebo-controlled Study of Topical Clobetasone Butyrate 0.05% Cream in Subjects With Eczema for Two Weeks to Evaluate the Efficacy and Safety | COMPLETED | PHASE3 | 2008-02-28 | 2009-02-10 | 2009-01-01 |
| NCT00625196 | Comparing Two Respiratory Drugs in Combination and Separately From a Novel Inhaler Device in Healthy Japanese Subjects | COMPLETED | PHASE1 | 2008-02-27 | 2008-05-06 | 2008-05-06 |
| NCT00609596 | A Study To Compare 3 Different Formulations Of Tamsulosin At Steady State. | COMPLETED | PHASE1 | 2008-02-26 | 2008-04-23 | 2008-04-23 |
| NCT00605241 | A Study To Assess The Effects Of A Single Dose Of GSK598809 In Modulating Nicotine Reward | COMPLETED | PHASE1 | 2008-02-25 | 2009-03-20 | 2009-03-20 |
| NCT00675090 | Bridging Study With GSK239512 In Patients With Mild To Moderate Alzheimer's Disease | COMPLETED | PHASE1 | 2008-02-21 | 2009-06-16 | 2009-06-16 |
| NCT00642148 | A 12 Week Study To Assess Efficacy And Safety Of GW856553 In Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE2 | 2008-02-14 | 2009-07-27 | 2009-07-27 |
| NCT00611559 | Study of a New Formulation of DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old Children | COMPLETED | PHASE4 | 2008-02-14 | 2008-06-25 | 2008-06-25 |
| NCT00614614 | Immuno,Safety of GSK Vaccine 134612 Given at Age of 12-15 Months 15-18 Months Post-priming With GSK Vaccine 792014 | COMPLETED | PHASE3 | 2008-02-13 | 2009-09-17 | 2009-07-31 |
| NCT00600782 | Immunogenicity and Safety of a Candidate Tuberculosis (TB) Vaccine Given to Healthy Adults in a TB-endemic Region | COMPLETED | PHASE2 | 2008-02-05 | 2008-12-19 | 2008-12-19 |
| NCT00627575 | AED/Statin Interaction Study | COMPLETED | PHASE1 | 2008-02-04 | 2008-09-12 | 2008-09-12 |
| NCT00627458 | Immunogenicity and Reactogenicity of a Booster Dose of GSK Bio's DTPa-HBV-IPV/Hib Vaccine | COMPLETED | PHASE2 | 2008-02-01 | 2008-08-18 | 2008-08-18 |
| NCT00635128 | Safety and Immunogenicity of a Booster Dose of GSK Biological's Boostrix-Polio Vaccine | COMPLETED | PHASE4 | 2008-02-01 | 2008-07-08 | 2008-07-08 |
| NCT00606684 | A Study To Assess Efficacy And Safety Of Different Doses Of GW642444 In Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE2 | 2008-02 | 2008-10 | 2008-10 |
| NCT00651534 | To Estimate Relative Bioavailability of 5 Formulations of Ronacaleret Given to Healthy Postmenopausal Females | COMPLETED | PHASE1 | 2008-02 | | |
| NCT00549263 | Bioequivalence Study of SB797620 in Healthy Japanese Volunteers | WITHDRAWN | PHASE1 | 2008-02 | | |
| NCT00549328 | Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung Cancer | TERMINATED | PHASE2 | 2008-02 | 2009-04 | 2009-04 |
| NCT00651352 | A Single Dose Bioequivalence Study OfTwo Formulations Of Nicotine Lozenges | COMPLETED | PHASE1 | 2008-02 | 2008-03 | 2008-03 |
| NCT00554619 | A Study to Evaluate GSK1325760A - a Long-Term Extension Study | COMPLETED | PHASE3 | 2008-02 | 2011-01 | 2011-01 |
| NCT00605761 | SD Cystic Fibrosis Study | COMPLETED | PHASE1 | 2008-02 | 2008-12 | 2008-12 |
| NCT00612118 | A Phase II Study Evaluating Intranasal GSK256066 and Azelastine Hydrochloride in Subjects With Seasonal Allergic Rhinitis | COMPLETED | PHASE2 | 2008-02 | 2008-05 | 2008-05 |
| NCT00573170 | TREXIMET® Versus Butalbital-containing Combination Medications for the Acute Treatment of Migraine in Adults | COMPLETED | PHASE3 | 2008-02 | 2009-08 | 2009-08 |
| NCT00659191 | A Healthy Volunteer And Patient Study To Assess The Safety, Tolerability And Pharmacokinetics Of GSK1265744 | COMPLETED | PHASE1 | 2008-02 | 2008-11 | 2008-11 |
| NCT00651079 | GSK1247303 First Time in Human Study | TERMINATED | PHASE1 | 2008-02 | 2008-05 | 2008-05 |
| NCT00703547 | A First Time in Human Study of GSK586529 in Healthy Volunteers | COMPLETED | PHASE1 | 2008-01-28 | 2008-04-11 | 2008-04-11 |
| NCT00557622 | Clinical Evaluation of BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder (PTSD) | TERMINATED | PHASE2 | 2008-01-25 | 2008-12-11 | 2008-12-11 |
| NCT00616928 | Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years | COMPLETED | PHASE3 | 2008-01-23 | 2009-03-19 | 2008-10-15 |
| NCT00586339 | Safety and Immunogenicity of GlaxoSmithKline Biologicals' HPV Vaccine 580299 (Cervarix) in HIV Infected Females | COMPLETED | PHASE2 | 2008-01-17 | 2011-07-18 | 2011-07-18 |
| NCT00599612 | To Assess the Excretion Balance and Pharmacokinetics of a Single Oral Dose of [14C]GW856553 in Healthy Adult Males | COMPLETED | PHASE1 | 2008-01-17 | 2008-02-18 | 2008-02-18 |
| NCT00625859 | A Study to Assess the Safety of Repeated Doses of GSK189075 and WELLBUTRIN SR in Healthy Male Subjects | COMPLETED | PHASE1 | 2008-01-16 | 2008-04-10 | 2008-04-10 |
| NCT00605371 | Bioequivalence and Food Effect of 250mg of Lamotrigine XR | COMPLETED | PHASE1 | 2008-01-15 | 2008-03-06 | 2008-03-06 |
| NCT00546078 | Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America | COMPLETED | PHASE2 | 2008-01-14 | 2009-12-01 | 2008-12-22 |
| NCT00609492 | Evaluate Safety and Immunogenicity of a Booster Dose of Pneumococcal Conjugate Vaccine in Preterm Born Infants. | COMPLETED | PHASE3 | 2008-01-03 | 2009-03-30 | 2008-11-10 |
| NCT00615212 | Effect of GSK376501 on CYP450 Activity in Healthy Adult Subjects | COMPLETED | PHASE1 | 2008-01-02 | 2008-02-15 | 2008-02-15 |
| NCT00611455 | Investigating Clinical Efficacy of Ofatumumab in Adult Rheumatoid Arthritis (RA) Patients Who Had an Inadequate Response to MTX Therapy | TERMINATED | PHASE3 | 2008-01-01 | 2013-07-15 | 2009-06-08 |
| NCT00655824 | Long-term Efficacy and Safety of Repeated Ofatumumab Treatment Courses in RA Patients Who Previously Received Ofatumumab or Placebo in Trial Hx-CD20-403 | TERMINATED | PHASE2 | 2008-01-01 | 2013-03-19 | 2011-05-25 |
| NCT00603252 | Study to Show That the Combined Hepatitis A and B Vaccine is Non-inferior to Monovalent Vaccines in Adults | COMPLETED | PHASE4 | 2008-01 | 2008-06 | 2008-06 |
| NCT00610168 | Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination. | COMPLETED | PHASE4 | 2008-01-01 | 2008-04-30 | 2008-04-30 |
| NCT00622830 | Phase I Study of SB-480848(Darapladib) -Repeat Dose Study in Healthy Japanese Male Subjects- | COMPLETED | PHASE1 | 2008-01 | 2008-03 | 2008-03 |
| NCT00579982 | An Open-Label Trial Measuring Satisfaction And Convenience Of Two Formulations Of Lamotrigine In Subjects With A Mood Disorder | COMPLETED | PHASE3 | 2008-01 | 2008-02 | 2008-02 |
| NCT00612820 | A Phase II Study Evaluating Intranasal GSK256066 and Fluticasone Propionate in Subjects With Seasonal Allergic Rhinitis (SAR) | COMPLETED | PHASE2 | 2008-01 | 2008-05 | 2008-05 |
| NCT00609674 | A Clinical Study To Test A Nasal Spray (Fluticasone Furoate Nasal Spray) For The Treatment Of Perennial (Year-round) Allergic Rhinitis | COMPLETED | PHASE4 | 2008-01 | 2008-06 | 2008-06 |
| NCT00603525 | Investigating Clinical Efficacy of Ofatumumab in Adult Rheumatoid Arthritis (RA) Patients Who Had an Inadequate Response to TNF-α Antagonist Therapy | TERMINATED | PHASE3 | 2008-01 | 2013-07 | 2011-03 |
| NCT00605449 | A Drug Interaction Study Between Simvastatin and GSK376501 | COMPLETED | PHASE1 | 2008-01 | 2008-03 | 2008-03 |
| NCT00606697 | A Study With GW597599 And GR205171: Potential New Drugs For The Treatment Of Primary Insomnia | COMPLETED | PHASE2 | 2007-12-19 | 2008-05-07 | 2008-05-07 |
| NCT00694993 | Single and Repeat Dose First Time in Human Study for an Intranasal H1/H3 Dual Antagonist in Healthy Male Subjects | COMPLETED | PHASE1 | 2007-12-17 | 2008-05-26 | 2008-05-26 |
| NCT00578227 | Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus Vaccine With Another Vaccine in Healthy Female Subjects | COMPLETED | PHASE3 | 2007-12-15 | 2009-04-28 | 2008-12-01 |
| NCT00586469 | A Randomized Study to Compare the Safety and Immunogenicity of Fluviral® Made With New Versus Aged Bulk | COMPLETED | PHASE4 | 2007-12-14 | 2008-01-14 | 2008-01-14 |
| NCT00555022 | Effect of GSK1160724 In Healthy Volunteers | COMPLETED | PHASE1 | 2007-12-12 | 2008-04-07 | 2008-04-07 |
| NCT00537719 | Scintigraphy Study to Assess Gastric Emptying in Healthy Subjects Given GSK716155 or Placebo. | COMPLETED | PHASE1 | 2007-12-07 | 2008-04-04 | 2008-04-04 |
| NCT00549900 | A Single Centre Study to Evaluate the Safety and Immunogenicity of the Human Papillomavirus Vaccine (GSK-580299) in Chinese Females | COMPLETED | PHASE1 | 2007-12-02 | 2008-07-12 | 2008-07-12 |
| NCT00603382 | A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Non-steroidal Therapy. | COMPLETED | PHASE2 | 2007-12-01 | 2008-10-02 | 2008-10-01 |
| NCT00603746 | A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Moderate-Dose ICS Therapy. | COMPLETED | PHASE2 | 2007-12-01 | 2008-09-20 | 2008-09-01 |
| NCT00600171 | Efficacy And Safety Of GW642444M Comparing Placebo In Adolescent And Adult Subjects With Persistent Asthma. | COMPLETED | PHASE2 | 2007-12 | 2008-09 | 2008-09 |
| NCT00603278 | A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Low-Dose ICS Therapy. | COMPLETED | PHASE2 | 2007-12 | 2008-11 | 2008-11 |
| NCT00586612 | Primary & Booster Study to Evaluate the Immunogenicity and Safety of Menitorix Vaccine in Preterm Infants | COMPLETED | PHASE3 | 2007-12-01 | 2008-12-30 | 2008-12-30 |
| NCT00456313 | No Resistance After Long Term Treatment SERETIDE | WITHDRAWN | PHASE4 | 2007-12 | 2007-12 | 2007-12 |
| NCT00622388 | Ofatumumab in Patients With Relapsed/Progressive Diffused Large B-Cell Lymphoma (DLBCL) Ineligible for or Relapse/Progression After Transplant | COMPLETED | PHASE2 | 2007-12 | 2014-08 | 2010-05 |
| NCT00558103 | Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer | COMPLETED | PHASE2 | 2007-12 | 2011-12 | 2011-05 |
| NCT00608699 | A Study To See If GSK256073A Can Block Niacin-Induced Flushing In Healthy Volunteers | COMPLETED | PHASE1 | 2007-12 | 2008-04 | 2008-04 |
| NCT00524576 | Challenge Dose of Hepatitis B Vaccine in Subjects Who Previously Received Engerix™-B Vaccine | COMPLETED | PHASE4 | 2007-11-28 | 2008-05-14 | 2008-05-14 |
| NCT00570492 | Phase 4 Fluticasone Furoate Nasal Spray (VERAMYST) Long Term Pediatric Growth Study. | COMPLETED | PHASE4 | 2007-11-26 | 2011-03-17 | 2011-03-01 |
| NCT00578175 | Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age | COMPLETED | PHASE2 | 2007-11-20 | 2009-03-17 | 2009-02-24 |
| NCT00607906 | First-Time-in-Humans Study to Assess Safety, Pharmacokinetics & Pharmacodynamics of SB756050 | COMPLETED | PHASE1 | 2007-11-16 | 2008-03-10 | 2008-03-10 |
| NCT00549744 | Clinical Endpoint Trial Investigating Once Daily and Bronchodilator Dosing | COMPLETED | PHASE2 | 2007-11-16 | 2008-08-27 | 2008-08-27 |
| NCT00619424 | A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid Tumors | COMPLETED | PHASE1 | 2007-11-15 | 2009-09-04 | 2009-09-04 |
| NCT00552279 | Immunogenicity and Safety of GlaxoSmithKline Biologicals' Huma Papillomavirus (HPV) Vaccine 580299 in Healthy Females 15 - 25 Years of Age | COMPLETED | PHASE3 | 2007-11-12 | 2009-07-20 | 2009-02-26 |
| NCT00548171 | Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination in Study NCT01267058 | COMPLETED | PHASE4 | 2007-11-05 | 2008-04-30 | 2008-04-30 |
| NCT00842153 | Evaluation of the Efficacy and Tolerability of Clobetasol Propionate Foam Compared to Vehicle Foam | COMPLETED | PHASE4 | 2007-11 | 2008-01 | 2007-12 |
| NCT00436345 | Pharmacoeconomic Consequences Of Analgesia in the Intensive Care Unit (ICU) | TERMINATED | PHASE3 | 2007-11 | 2008-09 | 2008-08 |
| NCT00568334 | Study of Two Formulations of GSK Biologicals' Varicella Vaccine | COMPLETED | PHASE2 | 2007-11-01 | 2008-04-29 | 2008-03-18 |
| NCT00518336 | Follow-up Study to Evaluate the Long-term Efficacy of the HPV Vaccine (580299) in Healthy Young Adult Women in Brazil | COMPLETED | PHASE2 | 2007-11 | 2010-09 | 2008-07 |
| NCT00550407 | An Evaluation Of BW430C (Lamotrigine) Versus Placebo In The Prevention Of Mood Episodes In Bipolar I Disorder Patients | COMPLETED | PHASE3 | 2007-11 | 2009-10 | 2009-10 |
| NCT00554762 | Dose Response and Efficacy of GW842166 in Pain | WITHDRAWN | PHASE1 | 2007-11 | 2008-03 | 2008-03 |
| NCT00708123 | In Situ Caries of Fluoride Toothpastes | COMPLETED | PHASE3 | 2007-11 | 2008-04 | 2008-04 |
| NCT00527826 | Influence Of Salmeterol Xinafoate/Fluticasone Propionate (50/500 µg BID) On The Course Of The Disease And Exacerbation Frequency In COPD Patients Gold Stage III And IV | COMPLETED | PHASE4 | 2007-11 | 2009-07 | 2009-07 |
| NCT00558363 | ARTS - AVODART After Radical Therapy For Prostate Cancer Study | COMPLETED | PHASE2 | 2007-11 | 2011-03 | 2010-12 |
| NCT00479856 | Lapatinib In Combination With Chemotherapy In Subjects With Relapsed Breast Cancer | TERMINATED | PHASE2 | 2007-11 | 2010-03 | 2009-09 |
| NCT00559884 | A Study to Compare the Safety and Drug Levels in Blood When Using Various Forms of GSK189075 Given to Healthy Subjects | COMPLETED | PHASE1 | 2007-11 | | |
| NCT00559299 | Patient Tolerability Study of GSK163090 | COMPLETED | PHASE1 | 2007-11 | 2008-06 | 2008-06 |
| NCT00555035 | GSK1349572 First Time in Human Study | COMPLETED | PHASE1 | 2007-11 | 2008-02 | 2008-02 |
| NCT00557128 | Study to Examine the Effect of Food on the Pharmacokinetics of the Fixed Dose Combination of COREG CR and Lisinopril. | COMPLETED | PHASE1 | 2007-11 | 2007-12 | 2007-12 |
| NCT00605852 | Investigation Of a New Oral Anti-Histamine in Healthy Male Subjects | COMPLETED | PHASE1 | 2007-10-29 | 2008-05-03 | 2008-05-03 |
| NCT00538473 | Evaluate Safety and Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults | COMPLETED | PHASE2 | 2007-10-23 | 2007-12-12 | 2007-12-01 |
| NCT00547248 | Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines | COMPLETED | PHASE3 | 2007-10-22 | 2008-10-07 | 2008-05-10 |
| NCT00537654 | A Study To Compare Giving AVODART And FLOMAX Together Or In A Combination Capsule In The Fed And Fasted State | COMPLETED | PHASE1 | 2007-10-18 | 2008-02-22 | 2008-02-22 |
| NCT00541970 | Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio's HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs | COMPLETED | PHASE1 | 2007-10-17 | 2013-03-18 | 2013-03-18 |
| NCT00545025 | Revaccination With Influenza Vaccine GSK1247446A | COMPLETED | PHASE2 | 2007-10-15 | 2007-12-12 | 2007-12-12 |
| NCT00529516 | Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults | COMPLETED | PHASE3 | 2007-10-15 | 2008-06-04 | 2007-12-21 |
| NCT00538213 | Evaluation of Safety and Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults | COMPLETED | PHASE2 | 2007-10-15 | 2007-11-28 | 2007-11-01 |
| NCT00404768 | The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term Labor | COMPLETED | PHASE2 | 2007-10-12 | 2011-07-07 | 2011-07-07 |
| NCT00551811 | Evaluate the Effects of the Drug (SB-656933-AAA) on the Body After a Single Dose in Subjects Who Have Inhaled Ozone | COMPLETED | PHASE1 | 2007-10-08 | 2008-07-22 | 2008-07-22 |
| NCT00540592 | Immunogenicity and Safety Study to Evaluate Different Formulations of GSK Biologicals' Influenza Vaccine GSK576389A | COMPLETED | PHASE2 | 2007-10-08 | 2008-06-10 | 2008-06-10 |
| NCT00540228 | Study to Evaluate an Influenza Vaccine Candidate | COMPLETED | PHASE2 | 2007-10-05 | 2008-05-08 | 2008-05-08 |
| NCT00480025 | GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer | TERMINATED | PHASE3 | 2007-10-04 | 2014-09-23 | 2013-12-06 |
| NCT00534638 | Effectiveness, Safety and Immunogenicity of GSK Biologicals' HPV Vaccine GSK580299 (Cervarix) Administered in Healthy Adolescents | COMPLETED | PHASE4 | 2007-10-04 | 2014-12-17 | 2014-12-17 |
| NCT00549679 | Study To Evaluate Safety And Tolerability Of GSK256066 In Chronic Obstructive Pulmonary Disease (COPD) Patients | COMPLETED | PHASE2 | 2007-10-04 | 2008-12-15 | 2008-12-15 |
| NCT00538057 | Comparing Two Respiratory Drugs When Used In Combination And Separately From A Novel Inhaler Device In Healthy Subjects | COMPLETED | PHASE1 | 2007-10-02 | 2007-12-01 | 2007-12-01 |
| NCT00481767 | Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (GSK580299) in Healthy Female Subjects 10-25 Years of Age. | COMPLETED | PHASE3 | 2007-10-01 | 2010-07-26 | 2010-02-25 |
| NCT00550420 | Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers | TERMINATED | PHASE3 | 2007-10-01 | 2009-02-12 | 2009-02-12 |
| NCT00503009 | Study Of RV-39 In Patients Who Also Have Asthma | TERMINATED | PHASE4 | 2007-10 | 2008-07 | 2008-07 |
| NCT00534872 | A Clinical Study to Evaluate the Pharmacokinetic Profile of SB-649868 in Elderly and Female Population | WITHDRAWN | PHASE1 | 2007-10 | 2007-10 | 2007-10 |
| NCT00596245 | Open-Label, Placebo-Controlled, Parallel Group Study in Healthy Volunteers to Evaluate the Effects of Two Single MT 400 or Naproxen Sodium Tablets | COMPLETED | PHASE1 | 2007-10 | 2007-12 | 2007-12 |
| NCT00529568 | Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Benefit Subjects With Hepatitis C Liver Disease | COMPLETED | PHASE3 | 2007-10 | 2011-08 | 2011-08 |
| NCT00516321 | Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver Disease | COMPLETED | PHASE3 | 2007-10 | 2011-05 | 2011-04 |
| NCT00549653 | A Study Investigating Blood Concentrations Of Rosuvastatin When Co-administered With GW856553 In Healthy Men | COMPLETED | PHASE1 | 2007-10 | 2007-12 | 2007-12 |
| NCT00527605 | Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH) | COMPLETED | PHASE3 | 2007-10 | 2009-03 | 2009-03 |
| NCT00848965 | A Randomised, Double Blind, Placebo Controlled, 4 Period, Incomplete Block, Crossover Study Assessing the Dose-response Curve of Fluticasone Propionate in an Antigen Challenge Chamber | COMPLETED | PHASE4 | 2007-10 | 2008-01 | 2008-01 |
| NCT00551694 | A Second Study to Determine the Effect of GSK256073A on HVTs | COMPLETED | PHASE1 | 2007-10 | 2007-12 | 2007-12 |
| NCT00549211 | A First Time in Human Study in Healthy Male Volunteers for Compound GSK557296. | COMPLETED | PHASE1 | 2007-10 | | |
| NCT00556920 | Study to Demonstrate the Bioequivalence of the Fixed Dose Combination of COREG CR™ and Lisinopril to Its Components | COMPLETED | PHASE1 | 2007-10 | 2007-12 | 2007-12 |
| NCT00549510 | Study to Investigate Dose Proportionality of the Fixed Dose Combination of COREG CR and Lisinopril. | COMPLETED | PHASE1 | 2007-10 | 2007-12 | 2007-12 |
| NCT00539136 | A Study to Examine the Absorption of GSK561679 in Healthy Male Volunteers | COMPLETED | PHASE1 | 2007-10 | 2008-03 | 2008-03 |
| NCT00537043 | A Study to Compare COREG CR to COREG CR Fixed-dose Combination in Patients With High Blood Pressure | COMPLETED | PHASE1 | 2007-10 | 2008-01 | 2008-01 |
| NCT00540501 | A Study to Evaluate Orally-Administered Oseltamivir and Intravenous Zanamivir in Healthy Subjects | WITHDRAWN | PHASE1 | 2007-10 | 2007-10 | 2007-10 |
| NCT00515268 | Endotoxin Challenge Study For Healthy Men and Women | COMPLETED | PHASE1 | 2007-09-27 | 2008-04-23 | 2008-04-23 |
| NCT00536809 | Phase I/II Study of Lapatinib in Combination With Oxaliplatin and Capecitabine in Subjects With Advanced Colorectal Cancer | COMPLETED | PHASE1 | 2007-09-26 | 2008-10-31 | 2008-10-31 |
| NCT00508365 | Evaluation of Potential for Orthostatic Hypotension in Elderly Hypertensives | COMPLETED | PHASE1 | 2007-09-25 | 2008-06-03 | 2008-06-03 |
| NCT00528281 | A Phase II Trial of Lapatinib (TYKERB) + Pemetrexed (ALIMTA) in Advanced Non Small Cell Lung Cancer With an Initial Dose Finding Phase | COMPLETED | PHASE1 | 2007-09-20 | 2009-05-27 | 2009-05-27 |
| NCT00536679 | Relative Bioavailability and Food Effect Study for GSK163090 in Healthy Male and Female Volunteers | COMPLETED | PHASE1 | 2007-09-20 | 2007-11-05 | 2007-11-05 |
| NCT00564746 | To Assess the Excretion Balance and Pharmacokinetics of a Single Oral Dose of [14C]SB-681323 in Healthy Adult Males | COMPLETED | PHASE1 | 2007-09-20 | 2007-10-26 | 2007-10-26 |
| NCT00548496 | A Phase IIa Study Of Men And Post-Menopausal Women With A Fractured Distal Radius | TERMINATED | PHASE2 | 2007-09-20 | 2008-11-26 | 2008-11-26 |
| NCT00532298 | Non-Inferiority of Various GSK Bio's Influenza Vaccine Presentations in Adults Aged 65 Years and Over | COMPLETED | PHASE2 | 2007-09-20 | 2007-11-02 | 2007-11-01 |
| NCT00514904 | Non-Inferiority of Meningococcal Vaccine GSK134612 Versus Mencevax™ in 2-10 Year Old Subjects | COMPLETED | PHASE3 | 2007-09-18 | 2009-01-06 | 2008-09-03 |
| NCT00533507 | Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 8 Weeks of Age | COMPLETED | PHASE3 | 2007-09-18 | 2008-06-06 | 2008-06-01 |
| NCT00513565 | A Study To Investigate Effects Of GSK561679 On Brain Activation During Emotional Processing In Healthy Volunteers | COMPLETED | PHASE1 | 2007-09-13 | 2009-05-14 | 2009-05-14 |
| NCT00569062 | A Study of GW856553X For the Treatment of Depression | TERMINATED | PHASE2 | 2007-09-12 | 2008-06-25 | 2008-06-25 |
| NCT00519480 | A Study To Assess The Safety And Tolerability Of GSK189075 When Given With A Total Daily Dose Of >/ 2000mg of Metformin | COMPLETED | PHASE1 | 2007-09-11 | 2008-04-01 | 2008-04-01 |
| NCT00516672 | Phase I Study of Pazopanib Alone and In Combination With Lapatinib in Japanese Patients With Solid Tumors | COMPLETED | PHASE1 | 2007-09-10 | 2015-10-14 | 2010-08-30 |
| NCT00562848 | A Study to Evaluate Safety, Side Effects, Muscle Activity and Speed of Gastric Emptying of GSK962040 | COMPLETED | PHASE1 | 2007-09-10 | 2008-06-27 | 2008-06-27 |
| NCT00539760 | A Phase I Rheumatoid Arthritis Study in Healthy Volunteers | COMPLETED | PHASE1 | 2007-09-05 | 2008-04-05 | 2008-04-05 |
| NCT00555061 | Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections. | COMPLETED | PHASE4 | 2007-09 | 2008-08 | 2008-08 |
| NCT00539994 | Retapamulin Ointment in Healthy Adults Nasally Colonized With Staphylococcus Aureus | COMPLETED | PHASE2 | 2007-09 | 2008-01 | 2008-01 |
| NCT00539825 | Effect of GSK704838 In Healthy Volunteers | COMPLETED | PHASE1 | 2007-09 | 2008-02 | 2008-02 |
| NCT00752089 | Experimental Dentifrice Remineralization/Fluoride Uptake in an in Situ Model | COMPLETED | PHASE2 | 2007-09 | 2008-01 | 2008-01 |
| NCT00536497 | Relative Bioavailability Study on a Single Dose of GW842166X in Healthy Male and Female Subjects. | WITHDRAWN | PHASE1 | 2007-09 | | |
| NCT00657020 | Functional Magnetic Resonance Imaging (fMRI) Investigation of Nicotine Withdrawal Symptoms | COMPLETED | PHASE4 | 2007-09 | 2008-02 | 2008-02 |
| NCT00682461 | Oral Tolerability Of Two Nicotine Dosage Forms | COMPLETED | PHASE1 | 2007-09 | 2009-01 | 2009-01 |
| NCT00561795 | Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological Tumors | COMPLETED | PHASE2 | 2007-09 | 2008-04 | 2008-04 |
| NCT00540423 | Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP) | COMPLETED | PHASE3 | 2007-09 | 2008-12 | 2008-12 |
| NCT00532610 | A Study to Compare the Effect on Heart Rhythm of 3 Days of GSK189075, Placebo, or Moxifloxacin in Healthy Adults | COMPLETED | PHASE1 | 2007-09 | 2008-02 | 2008-02 |
| NCT00549497 | A Randomized Study Evaluating Steroid Hormone Levels, Safety And Tolerability Of GW870086X In Healthy Volunteers | COMPLETED | PHASE1 | 2007-09 | 2008-01 | 2008-01 |
| NCT00539201 | GSK706769 A First Time in Human Study For Males and Females | TERMINATED | PHASE1 | 2007-09 | 2008-02 | 2008-02 |
| NCT00552708 | A Study Investigating the Bioequivalence of the Fixed Dose Combination of COREG CR to COREG CR and ZESTRIL. | COMPLETED | PHASE1 | 2007-09 | 2007-12 | 2007-12 |
| NCT00519649 | Long-term Persistence of Immunity Against Hepatitis B in 7-8 Years Old Children After Hepatitis B Vaccination. | COMPLETED | PHASE4 | 2007-08-31 | 2007-12-31 | 2007-12-31 |
| NCT00725764 | Phase 2 Study of GSK1363089 (Formerly XL880) in Adults With Squamous Cell Cancer of the Head and Neck | COMPLETED | PHASE2 | 2007-08-27 | 2009-05-02 | 2009-05-02 |
| NCT00530790 | Clinical Evaluation of Ropinirole CR-RLS ( SK&F101468)Tablets in Restless Legs Syndrome | COMPLETED | PHASE2 | 2007-08-23 | 2008-02-01 | 2008-02-01 |
| NCT00513409 | Assess Reacto- and Immunogenicity of Pneumococcal Conjugate Vaccine When Given as Booster or a 2 Dose Catch up Schedule | COMPLETED | PHASE2 | 2007-08-22 | 2008-08-28 | 2008-02-20 |
| NCT00495469 | Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive | COMPLETED | PHASE2 | 2007-08-17 | 2008-06-05 | 2008-06-05 |
| NCT00536835 | Study to Assess the Pharmacokinetics and Pharmacodynamics of GSK461364 in Subjects With Non-Hodgkins Lymphoma | COMPLETED | PHASE1 | 2007-08-16 | 2009-09-29 | 2009-09-29 |
| NCT00549120 | Optimising the Propranolol Block Model | COMPLETED | PHASE1 | 2007-08-15 | 2007-10-26 | 2007-10-26 |
| NCT00527020 | First Time in Human Study With GSK1018921 | COMPLETED | PHASE1 | 2007-08-10 | 2008-07-12 | 2008-07-12 |
| NCT00490568 | Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers | TERMINATED | PHASE3 | 2007-08-08 | 2009-06-01 | 2009-06-01 |
| NCT00501865 | Study to Assess the Effect of Food on the Concentration of GW273225 in the Body of Healthy Male and Female Volunteers | COMPLETED | PHASE1 | 2007-08-06 | 2007-10-11 | 2007-10-11 |
| NCT00506350 | Evaluate Reactogenicity & Immunogenicity of an Influenza Pandemic Candidate Vaccine (GSK1562902A) in Primed Adults | COMPLETED | PHASE2 | 2007-08-01 | 2009-10-12 | 2009-10-12 |
| NCT00530309 | Clinical Assessment of GSK716155 for Type 2 Diabetes Mellitus | COMPLETED | PHASE1 | 2007-08-01 | 2008-04-17 | 2008-04-17 |
| NCT00622609 | Anti-MAG First Administration to Human | COMPLETED | PHASE1 | 2007-08-01 | 2009-04-09 | 2009-04-09 |
| NCT00841776 | Comparative Antimicrobial Efficacy of Two Topical Acne Therapies for the Treatment of Facial Acne | COMPLETED | PHASE4 | 2007-08 | 2009-01 | 2008-11 |
| NCT00508261 | Co-Administration of Meningococcal Vaccine GSK134612 With Infanrix Hexa™ Versus Individual Administration of Each Vaccine | COMPLETED | PHASE3 | 2007-08-01 | 2008-10-27 | 2008-05-26 |
| NCT00837213 | Comparative Efficacy and Safety of Benzoyl Peroxide Used in Combination With Clindamycin vs. Benzoyl Peroxide Used in Combination With Clindamycin and Doxycycline in the Treatment of Moderate Acne | COMPLETED | PHASE4 | 2007-08 | 2008-08 | 2008-08 |
| NCT00519376 | A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In COPD Patients. | COMPLETED | PHASE2 | 2007-08 | 2007-11 | 2007-11 |
| NCT00516139 | Lamotrigine Extended-Release In Elderly Patients With Epilepsy | COMPLETED | PHASE3 | 2007-08 | 2010-07 | 2010-07 |
| NCT00517634 | Study Of Fluticasone Propionate/Salmeterol In Asthmatic Subjects | COMPLETED | PHASE4 | 2007-08 | 2008-07 | 2008-07 |
| NCT00502775 | Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine | COMPLETED | PHASE4 | 2007-08 | 2007-11 | 2007-11 |
| NCT00519636 | Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS | COMPLETED | PHASE4 | 2007-08 | 2007-11 | 2007-11 |
| NCT00539006 | Comparator Study Evaluating Patient Preference Of FFNS vs. FPNS | COMPLETED | PHASE4 | 2007-08 | 2007-11 | 2007-11 |
| NCT00524303 | Lapatinib +/- Trastuzumab In Addition To Standard Neoadjuvant Breast Cancer Therapy. | COMPLETED | PHASE2 | 2007-08 | 2015-08 | 2010-10 |
| NCT00511563 | A Study In Patients With Irritable Bowel Syndrome To Measure Hormone Response After Dosing With GW876008 And Gsk561679 | WITHDRAWN | PHASE2 | 2007-08 | | 2012-11 |
| NCT00540436 | Evaluate the Efficacy, Safety and Pharmacokinetics of GSK1325760A in the Treatment of Pulmonary Arterial Hypertension | COMPLETED | PHASE2 | 2007-08 | 2009-01 | 2009-01 |
| NCT00540553 | Study to Test Safety, Tolerability and Blood Levels of GSK971086 After 1 Dose & 7 Days of Dosing in Healthy Adult Males | COMPLETED | PHASE1 | 2007-08 | 2008-04 | 2008-04 |
| NCT00517543 | A Study to Examine the Effect of Particle Size on Bioequivalence and Bioavailability | COMPLETED | PHASE1 | 2007-08 | 2007-10 | 2007-10 |
| NCT00553657 | The Study To Test The Effect of Standardization Of Fluid Intake In Female Patients With Overactive Bladder | COMPLETED | PHASE1 | 2007-08 | 2008-01 | 2008-01 |
| NCT00532077 | A Study to Evaluate the Effects of SB-751689 or rhPTH(1-34) on Excretion of Calcium and Phosphate in Women | COMPLETED | PHASE1 | 2007-08 | 2008-01 | 2008-01 |
| NCT00551772 | A Study To Assess The Pharmacokinetics Of SB-742457 Formulated As A Capsule And A Tablet In Healthy Elderly Volunteers. | COMPLETED | PHASE1 | 2007-08 | | |
| NCT00551564 | Study to Determine the Utility of Novel Technologies and Biomarkers to Measure Human Response to Rosiglitazone Maleate | COMPLETED | PHASE1 | 2007-07-31 | 2008-09-08 | 2008-09-08 |
| NCT00500058 | A Phase I, Dose-Escalation Study to Assess the Safety and Biological Activity of Recombinant Human Interleukin-18 | COMPLETED | PHASE1 | 2007-07-31 | 2010-03-04 | 2010-03-04 |
| NCT00510874 | Study to Evaluate the Safety and Immune Response of Two-Doses of Candidate Influenza Vaccine GSK 1557484A in Adults | COMPLETED | PHASE1 | 2007-07-28 | 2008-10-24 | 2008-06-17 |
| NCT00490204 | Cetirizine Placebo Controlled Study For Perennial Allergic Rhinitis | COMPLETED | PHASE3 | 2007-07-27 | 2007-10-03 | 2007-10-03 |
| NCT00511823 | The Pharmacokinetic Interaction Between Oral Casopitant and Oral Dolasetron, Granisetron or Rosiglitazone in Subjects | COMPLETED | PHASE1 | 2007-07-23 | 2007-09-21 | 2007-09-21 |
| NCT00502593 | Evaluate Safety & Immunogenicity of a Pandemic Influenza Vaccine (GSK1562902A) in Children | COMPLETED | PHASE2 | 2007-07-23 | 2009-12-04 | 2009-12-04 |
| NCT00478725 | Part A: Radiolabel Study With GW786034 Part B: Single Dose of GW786034 | COMPLETED | PHASE1 | 2007-07-18 | 2008-07-01 | 2008-07-01 |
| NCT00604825 | Treatment Of Hot Flashes/Flushes In Postmenopausal Women (WARM Study) | COMPLETED | PHASE2 | 2007-07-17 | 2008-07-23 | 2008-07-23 |
| NCT00540943 | Study of Pazopanib, Irinotecan and Cetuximab in Combination to Treat 2nd Line Metastatic Colorectal Cancer | COMPLETED | PHASE1 | 2007-07-13 | 2010-05-03 | 2010-05-03 |
| NCT00488514 | Long-Term Safety of Treximet (Sumatriptan/Naproxen Sodium) for Migraine in Adolescents | COMPLETED | PHASE3 | 2007-07-13 | 2009-08-20 | 2009-08-01 |
| NCT00479427 | A Study Of The Effects Of CB2 Compound Of GW842166 In Patients With Osteoarthritis | COMPLETED | PHASE2 | 2007-07-06 | 2007-10-09 | 2007-10-09 |
| NCT00471081 | Immunogenicity and Safety of Meningococcal Vaccine GSK134612 Given as 1 or 2 Doses to Healthy 9-12 Months Old Toddlers. | COMPLETED | PHASE2 | 2007-07-05 | 2008-11-26 | 2008-10-23 |
| NCT00489554 | Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 12wks of Age | COMPLETED | PHASE3 | 2007-07-03 | 2008-03-31 | 2008-03-31 |
| NCT00492544 | Immunogenicity and Safety of GSK Biologicals' HPV Vaccine 580299 in Healthy Japanese Females 10-15 Years of Age | COMPLETED | PHASE3 | 2007-07-02 | 2008-03-28 | 2008-03-28 |
| NCT00495274 | Bioequivalence and Food Effect Study in Healthy Volunteers | COMPLETED | PHASE1 | 2007-07-02 | 2007-09-26 | 2007-09-26 |
| NCT00496015 | Prophylactic Antipyretic Treatment in Children Receiving Booster Dose of Pneumococcal Conjugate Vaccine GSK1024850A | COMPLETED | PHASE3 | 2007-07-02 | 2009-02-17 | 2008-03-25 |
| NCT00509275 | A Study to Evaluate Efficacy and Safety of Three W0027 Regimens in the Treatment of Moccasin Type Tinea Pedis (MTTP) | COMPLETED | PHASE1 | 2007-07 | 2008-08 | 2008-08 |
| NCT00469378 | Study Of White Blood Cells In The Cerebrospinal Fluid And Blood Of Patients With Relapsing Forms Of Multiple Sclerosis | COMPLETED | PHASE2 | 2007-07 | 2010-02 | 2009-05 |
| NCT00551317 | A Study Investigating the Concentrations of Darapladib in Blood and the Safety of This Compound in Healthy Japanese Men | COMPLETED | PHASE1 | 2007-07 | 2007-09 | 2007-09 |
| NCT00981409 | The Treatment of Acute Pulmonary Thromboembolism (PE) of GSK576428 (Fondaparinux Sodium) in Japanese Patients | COMPLETED | PHASE3 | 2007-07 | 2008-12 | 2008-12 |
| NCT00505453 | A Phase III, Open-Label, Single-Dose Study to Evaluate the Safety and Immunogenicity of Fluviral® Vaccine | COMPLETED | PHASE3 | 2007-07 | 2007-08 | |
| NCT00345683 | Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 12 to 15 Months of Age. | COMPLETED | PHASE3 | 2007-07 | 2008-11 | 2008-09 |
| NCT00486954 | Lapatinib in Combination With Weekly Paclitaxel in Patients With ErbB2 Amplified Advanced Gastric Cancer | COMPLETED | PHASE3 | 2007-07 | 2012-10 | 2012-01 |
| NCT00517673 | To Evaluate Safety, Tolerability, Pharmacokinetics, And Food Effect Of Single Doses Of GSK945237 In Healthy Subjects | COMPLETED | PHASE1 | 2007-07 | 2008-09 | 2008-09 |
| NCT00501462 | A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney Function | COMPLETED | PHASE1 | 2007-07 | 2008-03 | 2008-03 |
| NCT00474864 | Study To Evaluate The Effects Of GW856553 On Endothelial Function/Vascular Compliance In Subjects With Dyslipidaemia. | COMPLETED | PHASE2 | 2007-07 | 2008-04 | 2008-04 |
| NCT00488098 | GSK372475 Bioequivalence Study | COMPLETED | PHASE1 | 2007-07 | | |
| NCT00508534 | A Study To Evaluate The Effects Of Repeat Dosing Of Esomeprazole On The Pharmacokinetics Of SB-751689 In Healthy People | COMPLETED | PHASE1 | 2007-07 | 2007-08 | 2007-08 |
| NCT00466947 | COMPAS (Clinical Otitis Media & Pneumonia Study): Pneumonia & Acute Otitis Media (AOM ) Efficacy Study of the Pneumococcal Conjugate Vaccine | COMPLETED | PHASE3 | 2007-06-28 | 2011-07-28 | 2010-08-31 |
| NCT00513279 | To Investigate If Single Doses Of GSK618334 Are Safe And To Investigate Blood Levels Of GSK618334 | COMPLETED | PHASE1 | 2007-06-28 | 2007-10-04 | 2007-10-04 |
| NCT00511524 | An Imaging Study to Investigate the Distribution of GW842166X in the Brain. | COMPLETED | PHASE1 | 2007-06-26 | 2007-07-04 | 2007-07-04 |
| NCT00492648 | Month 30 & 42 Extension Studies of CRD-004 Primary Study | COMPLETED | PHASE2 | 2007-06-25 | 2008-06-23 | 2008-06-23 |
| NCT00504790 | Phase I Study to Assess the Safety, Pharmacokinetics, & Pharmacodynamics of GSK923295 in Subjects w/ Refractory Cancer | COMPLETED | PHASE1 | 2007-06-25 | 2012-05-08 | 2012-05-07 |
| NCT00515502 | Safety Study Using GSK573719 And Tiotropium In Patients With Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE2 | 2007-06-21 | 2007-11-06 | 2007-11-06 |
| NCT00483860 | A Phase I Topotecan Study in Subjects With Cancer and Impaired Renal Function | COMPLETED | PHASE1 | 2007-06-20 | 2012-02-06 | 2012-02-06 |
| NCT00480324 | Efficacy, Safety, Reactogenicity & Immunogenicity of the Rotarix Vaccine in Japanese Infants | COMPLETED | PHASE3 | 2007-06-19 | 2009-11-21 | 2009-03-31 |
| NCT00511654 | 28-day Repeat Dose and Drug Interaction Study With Orvepitant (GW823296) | COMPLETED | PHASE1 | 2007-06-12 | 2008-01-11 | 2008-01-11 |
| NCT00485732 | A Study to Evaluate the Immune Response and Safety of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine/Cervarix TM Vaccine in Healthy Females Aged 15-25 Years | COMPLETED | PHASE3 | 2007-06-11 | 2008-03-30 | 2008-03-30 |
| NCT00508911 | A Study To Evaluate The Effect Of GW876008 On The Pharmacokinetics Of Oral Contraceptive Pills | TERMINATED | PHASE1 | 2007-06-08 | 2007-10-22 | 2007-10-22 |
| NCT00520663 | Radiolabel Study In Healthy Volunteers For Insomnia-Targeting Drug | COMPLETED | PHASE1 | 2007-06-08 | 2007-08-10 | 2007-08-10 |
| NCT00474266 | Safety & Immunogenicity Study of Meningococcal Vaccine GSK134612 Given With Priorix-Tetra™ to 12-23 Month-Old Children | COMPLETED | PHASE3 | 2007-06-05 | 2008-03-26 | 2008-02-26 |
| NCT00504439 | A Study To Evaluate The Safety And Tolerability Of SB-656933-AAA Following Repeated Doses In Healthy Adult Subjects | COMPLETED | PHASE1 | 2007-06-04 | 2007-09-06 | 2007-09-06 |
| NCT00500461 | Study To Examine Safety, Tolerability And Pharmacokinetics Of Intravenous Doses And Oral Dose Of GSK233705 | COMPLETED | PHASE1 | 2007-06-04 | 2007-07-25 | 2007-07-01 |
| NCT00489970 | Persistence Study of GSK Biologicals' Tdap Vaccine 1, 3, 5 and 9 Years Following Administration as an Initial Single Dose in Healthy Young Adults and to Evaluate the Immunogenicity and Safety of Boostrix as a Second Dose of Tdap, When Administered at Year 9 | COMPLETED | PHASE3 | 2007-06-01 | 2016-03-01 | 2011-09-01 |
| NCT00473668 | Non-inferiority of GSK Biologicals' DTPw-HBV/Hib Compared to Two Formulations of GSK Biologicals' DTPw-HBV/Hib | COMPLETED | PHASE3 | 2007-06-01 | 2008-01-30 | 2008-01-30 |
| NCT00680485 | Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK580416 | TERMINATED | PHASE1 | 2007-06 | 2007-10 | 2007-10 |
| NCT00478738 | A 2 Part Study Examining Doses Of GSK961081 In Healthy Volunteers And Then In COPD Patients | COMPLETED | PHASE2 | 2007-06 | 2008-05 | 2008-05 |
| NCT00476307 | Immunogenicity and Reactogenicity of Fluarix™ (Influsplit SSW®) 2007/2008 in People 18 Years Old or Above | COMPLETED | PHASE3 | 2007-06 | 2007-07 | |
| NCT00501267 | A Study To Test The Interaction of Two Medications for Treatment of Overactive Bladder | COMPLETED | PHASE1 | 2007-06 | 2007-08 | 2007-08 |
| NCT00494780 | Ofatumumab (Humax-CD20) With CHOP (Cyclophosphamide,Doxorubicin, Vincristine, Predisolone) in Follicular Lymphoma (FL) Patients | COMPLETED | PHASE2 | 2007-06 | 2010-09 | 2009-04 |
| NCT00477464 | Lapatinib in Combination With Capecitabine in Japanese Patients With Metastatic Breast Cancer | COMPLETED | PHASE2 | 2007-06 | 2010-12 | 2010-12 |
| NCT00549198 | KIVEXA Vs TRUVADA, Both Administered With Efavirenz, In ART-Naive Subjects | COMPLETED | PHASE4 | 2007-06 | 2009-12 | 2009-12 |
| NCT00488449 | Study Of Pharmacokinetics and Pharmacodynamics Effects Of GSK256073A On Healthy Volunteers | COMPLETED | PHASE1 | 2007-06 | 2007-11 | 2007-11 |
| NCT00485069 | REQUIP (Ropinirole Hydrochloride) IR Long-Term Phase 4 Study | COMPLETED | PHASE4 | 2007-06 | 2009-12 | 2009-12 |
| NCT00495014 | Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight Subjects | COMPLETED | PHASE1 | 2007-06 | 2007-12 | 2007-12 |
| NCT00478621 | Human Papillomavirus Vaccine Safety & Immunogenicity Trial in Healthy Young Adult Women With HPV Vaccine (GSK1674330A) | COMPLETED | PHASE1 | 2007-05-25 | 2008-10-13 | 2008-06-30 |
| NCT00500201 | A Healthy Volunteer Study to Assess the Relative Bioavailability of 2 Forms of SB773812 Tablets. | COMPLETED | PHASE1 | 2007-05-24 | 2007-07-25 | 2007-07-25 |
| NCT00454987 | Study of Long-term Antibody Persistence After a Booster Dose of Menitorix Vaccine | COMPLETED | PHASE4 | 2007-05-16 | 2007-10-12 | 2007-10-12 |
| NCT00471237 | A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis. | TERMINATED | PHASE2 | 2007-05-14 | 2008-12-26 | 2008-12-26 |
| NCT00475436 | A Single Centre Randomized Study Evaluating The Safety And Tolerability Of GSK573719 In Healthy Volunteers | COMPLETED | PHASE1 | 2007-05-14 | 2007-09-18 | 2007-09-18 |
| NCT00455572 | Cancer Immunotherapy GSK1572932A as Adjuvant Therapy for Patients With Tumor-antigen-positive Non-Small Cell Lung Cancer | TERMINATED | PHASE1 | 2007-05-11 | 2013-08-08 | 2013-08-04 |
| NCT00449774 | Bioequivalence And Effect Of Food And Water On Lamotrigine in Healthy Volunteers | COMPLETED | PHASE1 | 2007-05-07 | 2007-06-19 | 2007-06-19 |
| NCT00440128 | The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With Cancer | COMPLETED | PHASE1 | 2007-05-04 | 2008-07-17 | 2008-07-17 |
| NCT00464815 | Non-Inferiority of Meningococcal Vaccine GSK134612 Versus Mencevax™ in 11-17 Year-Old Subjects | COMPLETED | PHASE3 | 2007-05-02 | 2008-09-10 | 2008-04-16 |
| NCT00460564 | Study Of GSK1358820 In Patients With Post-Stroke Upper Limb Spasticity | COMPLETED | PHASE3 | 2007-05 | 2008-12 | 2008-12 |
| NCT00470834 | Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy | COMPLETED | PHASE4 | 2007-05 | 2013-02 | 2013-02 |
| NCT00452699 | A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg BID To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg BID In Symptomatic Subjects With Asthma | COMPLETED | PHASE4 | 2007-05 | 2009-05 | 2009-05 |
| NCT00452348 | A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg Twice Daily To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg Twice Daily In Symptomatic Patients With Asthma | COMPLETED | PHASE4 | 2007-05 | 2009-04 | 2009-04 |
| NCT00394836 | HuMax-CD20 i(Ofatumumab) n Follicular Lymphoma (FL) Patients Refractory to Rituximab | COMPLETED | PHASE2 | 2007-05 | 2013-09 | 2009-04 |
| NCT00437073 | Brain Metastases In ErbB2-Positive Breast Cancer | TERMINATED | PHASE2 | 2007-05 | 2010-02 | 2009-01 |
| NCT00447226 | Randomized Discontinuation Study of Lapatinib Versus Placebo in Subjects With Documented Tumor Progression After Chemotherapy, or Where no Approved Therapy Exists | TERMINATED | PHASE2 | 2007-05 | 2009-09 | 2009-05 |
| NCT00702507 | Prospective Two-Year Study to Assess Miconazole Nitrate Resistance in Neonates and Infants | COMPLETED | PHASE4 | 2007-05 | 2010-12 | 2010-12 |
| NCT00487968 | Eltrombopag Taste Testing in Healthy Adult Volunteers | COMPLETED | PHASE1 | 2007-05 | | |
| NCT00551473 | Open-label Comparison of 24hr Gastric pH on Days 1, 2, 7 With Once-daily Administration of Lavoltidine 40 mg. | COMPLETED | PHASE1 | 2007-05 | | |
| NCT00460655 | Study of GSK1358820 In Patients With Post-Stroke Lower Limb Spasticity | COMPLETED | PHASE3 | 2007-05 | 2008-12 | 2008-12 |
| NCT00436007 | Safety and Immunogenicity Study of GSK Biologicals' Malaria Vaccine 257049, When Incorporated Into an EPI Regimen | COMPLETED | PHASE2 | 2007-04-30 | 2009-10-07 | 2008-09-15 |
| NCT00463437 | Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines | COMPLETED | PHASE3 | 2007-04-25 | 2008-06-14 | 2008-01-21 |
| NCT00454909 | Immunogenicity and Safety of Meningococcal Vaccine GSK134612 vs. Menactra® in Healthy Adolescent/Adults Aged 10-25 Years. | COMPLETED | PHASE2 | 2007-04-23 | 2008-04-11 | 2007-10-31 |
| NCT00548769 | Firategrast (SB683699) Surface Area Study in Multiple Sclerosis Patients | COMPLETED | PHASE1 | 2007-04-21 | 2007-11-26 | 2007-11-26 |
| NCT00495729 | 15-Day Repeated-Dose Study With SB-649868 And Its Interaction With CYP3A4 Isoenzyme In Healthy Male Subjects. | COMPLETED | PHASE1 | 2007-04-18 | 2007-08-04 | 2007-08-04 |
| NCT00460707 | A Study to Assess the Safety and Interaction Between Casopitant and Ketoconazole When Taken By Healthy Adults | COMPLETED | PHASE1 | 2007-04-16 | 2007-08-27 | 2007-08-27 |
| NCT00465816 | Primary Study to Demonstrate Non-inferiority and Immunogenicity of GSK Biologicals' Meningococcal Vaccine 134612 | COMPLETED | PHASE3 | 2007-04-11 | 2008-04-28 | 2008-04-28 |
| NCT00434304 | Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's Disease (PD) | COMPLETED | PHASE2 | 2007-04-09 | 2009-03-10 | 2009-03-01 |
| NCT00453986 | Lot Consistency, Immuno, Safety of Meningococcal Vaccine GSK134612 Given With Fluarix™ to 18-55 Year-Old Adults | COMPLETED | PHASE3 | 2007-04-09 | 2008-05-21 | 2007-11-30 |
| NCT00463697 | A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In Asthmatic Patients | COMPLETED | PHASE1 | 2007-04-02 | 2007-08-04 | 2007-08-04 |
| NCT00493818 | Open-label Study to Investigate the Safety, Tolerability, PK, and Pharmacodynamics of the AKT Inhibitor GSK690693 | TERMINATED | PHASE1 | 2007-04 | 2008-06 | 2008-06 |
| NCT00456625 | Immune Response to Hepatitis B Vaccine Challenge Dose in Subjects Who Received a Primary Neonatal Hepatitis B Vaccine. | COMPLETED | PHASE4 | 2007-04 | 2008-01 | 2008-01 |
| NCT00456807 | Complementary Testing to Evaluate Immunogenicity of Human Papillomavirus (HPV) Vaccine (580299) in Healthy Female Subjects Aged >/= 26 Years | COMPLETED | PHASE3 | 2007-04 | 2008-01 | 2008-01 |
| NCT00518115 | Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only | COMPLETED | PHASE2 | 2007-04 | 2008-05 | 2008-05 |
| NCT00460148 | Parkinson's Disease Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole | COMPLETED | PHASE2 | 2007-04 | 2007-08 | |
| NCT00422903 | Letrozole In Combination With Lapatinib In Neoadjuvant Treatment Of Early Breast Cancer | COMPLETED | PHASE2 | 2007-04 | 2011-04 | 2011-04 |
| NCT00448058 | A Study Of New Medicine (GSK 372475) For The Treatment Of Depression | COMPLETED | PHASE2 | 2007-04 | 2008-12 | 2008-12 |
| NCT00470145 | Comparison Of Two Tablet Formulations Of SB-568859 | COMPLETED | PHASE1 | 2007-04 | 2007-07 | |
| NCT00504816 | A Study of the Effects of GSK189075 on PK Profiles of an Oral Contraceptive Pill When Given to Healthy Female Volunteers | COMPLETED | PHASE1 | 2007-04 | 2008-04 | 2008-01 |
| NCT00501930 | A Study to Evaluate and Study Drug Levels in Blood Plasma When Giving High Doses of GSK189075 to Healthy Volunteers | COMPLETED | PHASE1 | 2007-04 | | |
| NCT00468806 | Study of Safety, Blood Levels and Brain Receptor Occupancy of GSK598809 Using PET Imaging in Health Males. | COMPLETED | PHASE1 | 2007-04 | 2008-05 | 2008-05 |
| NCT00448435 | Clinical Assessment Of GW815SF HFA MDI In Pediatric Patients With Bronchial Asthma | COMPLETED | PHASE3 | 2007-04 | 2008-01 | 2008-01 |
| NCT00540878 | A Study to Estimate the Effect of Formulation on the Relative Absorption of SB-751689 Administered to Healthy Women | COMPLETED | PHASE1 | 2007-04 | | |
| NCT00447486 | A Study of GW842166 in Adults With Osteoarthritis Pain | COMPLETED | PHASE2 | 2007-04 | | |
| NCT00499928 | A Study To Investigate The Metabolism And Excretion Of 14C SB-751689 Given To Healthy Males And Postmenopausal Women | COMPLETED | PHASE1 | 2007-04 | 2007-07 | 2007-07 |
| NCT00468689 | Evaluation Of SB-751689 Administered At Supratherapeutic Dose Levels In Healthy Adult Subjects. | COMPLETED | PHASE1 | 2007-04 | 2007-08 | 2007-08 |
| NCT00725712 | Study of GSK1363089 in Metastatic Gastric Cancer | COMPLETED | PHASE2 | 2007-03-31 | 2009-11-30 | 2009-11-01 |
| NCT00464568 | A 5-way Treatment Period Trial of Single Doses of Intranasal GSK256066 in Patients With Rhinitis | COMPLETED | PHASE2 | 2007-03-28 | 2007-05-16 | 2007-05-16 |
| NCT00453479 | A Dose Ascending, Study To Examine The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of GSK233705B. | COMPLETED | PHASE2 | 2007-03-28 | 2007-10-11 | 2007-10-11 |
| NCT00555139 | A Study To Compare The Putative Anxiolytic Effect Of 2 New Drugs In Subjects With Social Anxiety Disorder | COMPLETED | PHASE1 | 2007-03-27 | 2008-01-10 | 2008-01-10 |
| NCT00443131 | Characterisation of the Immune Responses of 2 Experimental Malaria Vaccines | COMPLETED | PHASE2 | 2007-03-26 | 2007-07-13 | 2007-07-01 |
| NCT00449670 | Assess Consistency of Immunogenicity of GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1562902A) in Adults | COMPLETED | PHASE3 | 2007-03-24 | 2008-06-10 | 2007-07-12 |
| NCT00405392 | Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal Osteoporosis | COMPLETED | PHASE4 | 2007-03-22 | 2008-05-27 | 2008-05-27 |
| NCT00468897 | A Study To Demonstrate The Bioequivalence Of Rosiglitazone XR (BRL-049653) 8mgs XR Manufactured At Two Different Sites. | COMPLETED | PHASE1 | 2007-03-21 | 2007-05-02 | 2007-05-02 |
| NCT00437840 | A Study To Investigate The Safety, Tolerability And Blood Levels Of GSK598809 | COMPLETED | PHASE1 | 2007-03-20 | 2007-06-20 | 2007-06-20 |
| NCT00459550 | A Clinical Study to Assess Single and Repeat Doses of a New Medication (GSK933776) in Patients With Alzheimer's Disease | COMPLETED | PHASE1 | 2007-03-12 | 2011-05-30 | 2011-05-30 |
| NCT00432380 | A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals' HRV Liquid Vaccine in Healthy Infants. | COMPLETED | PHASE2 | 2007-03-09 | 2007-09-04 | 2007-09-04 |
| NCT00453687 | A Single Centre Randomized Study Evaluating The Safety And Tolerability Of GSK233705 In Healthy Volunteers. | COMPLETED | PHASE1 | 2007-03-09 | 2007-05-16 | 2007-05-16 |
| NCT00483535 | Oral Contraceptive Interaction Study for GW273225 | TERMINATED | PHASE1 | 2007-03-07 | 2007-11-16 | 2007-11-16 |
| NCT00437632 | Study To Investigate If Repeat Doses Of GSK598809 Are Safe And Well Tolerated And To Evaluate Blood Levels Of GSK598809 | COMPLETED | PHASE1 | 2007-03-01 | 2008-08-22 | 2008-08-22 |
| NCT00443053 | Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis) | COMPLETED | PHASE3 | 2007-03 | 2009-07 | 2009-07 |
| NCT00461500 | SERETIDE 100/50 bd (Twice Daily) Versus FLIXOTIDE 100 bd As Initial Maintenance Therapy In Moderate Asthma In Adults | COMPLETED | PHASE4 | 2007-03 | 2007-12 | 2007-12 |
| NCT00452686 | Study to Assess Safety & Immunogenicity of GSK Biologicals' Boostrix (dTpa) Vaccine vs. Chinese DT Vaccine | COMPLETED | PHASE3 | 2007-03 | 2007-05 | |
| NCT00449046 | Clinical Assessment Of GW815SF Salmeterol/Fluticasone Propionate(HFA MDI) In Pediatric Patients With Bronchial Asthma -A Long Term (24-week) Study- | COMPLETED | PHASE3 | 2007-03 | 2007-11 | 2007-11 |
| NCT00424177 | Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT) | COMPLETED | PHASE2 | 2007-03 | 2008-11 | 2008-08 |
| NCT00474513 | An Imaging Study to Investigate the Distribution of GSK239512 in the Brain. | COMPLETED | PHASE1 | 2007-03 | 2008-03 | 2008-03 |
| NCT00463320 | A Study To Evaluate The Safety, Tolerability And Pk Of Pazopanib Eye Drops In Healthy Adult And Elderly Subjects. | COMPLETED | PHASE1 | 2007-03 | 2007-08 | |
| NCT00449709 | A Study To Assess The Pharmacokinetics Of Different Modified Release Formulations Of GSK221149 In Healthy Adult Subjects | TERMINATED | PHASE1 | 2007-03 | | |
| NCT00424697 | A Study to Investigate the Effects of GW876008 on Brain Activation During Emotional Processing in Healthy Subjects. | COMPLETED | PHASE1 | 2007-03 | 2007-12 | 2007-12 |
| NCT00421421 | Effects Of Dutasteride On Risk Reduction Of Acute Urinary Retention Relapse Following Trial Without Catheter | TERMINATED | PHASE4 | 2007-03 | | |
| NCT00469040 | Safety, Blood Levels and Effects of GW642444 | COMPLETED | PHASE1 | 2007-02-28 | 2007-04-16 | 2007-04-16 |
| NCT00428090 | Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease | COMPLETED | PHASE3 | 2007-02-27 | 2008-09-05 | 2008-09-01 |
| NCT00435396 | Study to Evaluate Safety and Immunogenicity of the GSK Bio CMV Vaccine in CMV-seronegative Healthy Male Adult Subjects | COMPLETED | PHASE1 | 2007-02-22 | 2008-08-27 | 2008-08-27 |
| NCT00434512 | Dose-ranging Study to Evaluate the Safety & Immunogenicity of a HIV Vaccine 732461 in Healthy HIV Seronegative Volunteers | COMPLETED | PHASE2 | 2007-02-20 | 2008-06-13 | 2008-06-13 |
| NCT00437229 | A Study to Assess the Safety & Interaction Between GW679769, Dexamethasone, & Ondansetron When Taken by Healthy Adults | COMPLETED | PHASE1 | 2007-02-19 | 2007-05-15 | 2007-05-15 |
| NCT00444509 | Single Dose GW685698X Magnesium Stearate Study In Asthmatic Patients. | COMPLETED | PHASE1 | 2007-02-17 | 2007-04-09 | 2007-04-09 |
| NCT00439868 | A Study To Evaluate The Effect Of WELLBUTRIN XL On Intraocular Pressure | COMPLETED | PHASE1 | 2007-02-16 | 2007-06-08 | 2007-06-08 |
| NCT00522678 | Repeat Dose GW685698X With Magnesium Stearate, Excipient Bridging Study, In Healthy Volunteers | COMPLETED | PHASE1 | 2007-02-15 | 2007-04-25 | 2007-04-25 |
| NCT00434577 | Safety and Immunogenicity of the Zoster Vaccine GSK1437173A in Elderly Subjects | COMPLETED | PHASE2 | 2007-02-14 | 2010-07-14 | 2007-10-04 |
| NCT00426361 | Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus (HPV) Vaccine With Other Vaccines in Healthy Female Subjects | COMPLETED | PHASE3 | 2007-02-13 | 2008-07-25 | 2008-03-17 |
| NCT00420316 | Long-term Efficacy and Safety of Subjects Approximately 3 Years After Priming With 2 Doses of GSK Bio's HRV Vaccine. | COMPLETED | PHASE3 | 2007-02-12 | 2007-08-08 | 2007-08-08 |
| NCT00427908 | Study in Children to Evaluate Non-Inferiority and Persistence up to 5 Years of GSK Bio Meningococcal Vaccine 134612 | COMPLETED | PHASE2 | 2007-02-07 | 2007-12-03 | 2007-12-03 |
| NCT00412191 | Bioequivalence And Lack Of Food Effects Of 300mg Lamotrigine XR | COMPLETED | PHASE1 | 2007-02-06 | 2007-04-27 | 2007-04-27 |
| NCT00430521 | Safety & Immunogenicity of an Alternative Immunization Schedule of GSK Bio's Pandemic Influenza Vaccine (GSK1119711A) | COMPLETED | PHASE2 | 2007-02-05 | 2008-10-20 | 2008-10-20 |
| NCT00435045 | Evaluation of Efficacy and Safety of Omacor, Co-Administered With Atorvastatin, in Subjects With Hypertriglyceridemia | COMPLETED | PHASE3 | 2007-02 | 2007-10 | 2007-10 |
| NCT00441441 | A 12-Week Study To Assess The Safety Of Fluticasone Propionate/Salmeterol 100/50 Hydrofluoroalkane (HFA) Versus Fluticasone Propionate 100 HFA In Children With Asthma | COMPLETED | PHASE3 | 2007-02 | 2008-01 | 2008-01 |
| NCT00390143 | Study in Adolescents/Adults to Evaluate the Persistence up to 3.5 Yrs of GSK Biologicals Meningococcal Vaccine 134612 | COMPLETED | PHASE2 | 2007-02 | 2009-05 | 2009-05 |
| NCT00541320 | Phase IIa Venous Thromboembolism (VTE) Prevention Study In Total Knee Replacement (TKR) | WITHDRAWN | PHASE2 | 2007-02 | | |
| NCT00501397 | A Study of the Effects of Ketoconazole Taken Orally Has on the PK Profiles of a Dose of GSK189075 in Healthy Volunteers | COMPLETED | PHASE1 | 2007-02 | | |
| NCT00461682 | Sb-705498 Rectal Pain Study | TERMINATED | PHASE2 | 2007-01-26 | 2007-09-01 | 2007-09-01 |
| NCT00420745 | To Assess Safety, Reactogenicity & Immunogenicity of 2 Doses of GSK's Oral Human Rotavirus Vaccine in Pre-Term Infants | COMPLETED | PHASE3 | 2007-01-25 | 2008-03-25 | 2008-03-01 |
| NCT00423046 | Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age | COMPLETED | PHASE3 | 2007-01-24 | 2012-05-14 | 2008-03-07 |
| NCT00396630 | A Study to Explore the Existence of Horizontal Transmission of the RIX4414 Vaccine Strain Between Twins Within a Family. | COMPLETED | PHASE3 | 2007-01-23 | 2008-02-13 | 2008-01-23 |
| NCT00500331 | Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM) | COMPLETED | PHASE2 | 2007-01-23 | 2008-02-14 | 2008-02-14 |
| NCT00470483 | A Study To Compare Emotional Changes In Subjects With Social Anxiety Disorder | COMPLETED | PHASE1 | 2007-01-22 | 2009-01-07 | 2009-01-07 |
| NCT00440323 | Disturbed Sleep Model Study. | COMPLETED | PHASE1 | 2007-01-05 | 2007-07-03 | 2007-07-03 |
| NCT00380393 | Efficacy of RTS,S/AS01 Vaccine Against Episodes of Malaria Due to P. Falciparum Infection in Children. | COMPLETED | PHASE2 | 2007-01-03 | 2008-11-11 | 2008-08-15 |
| NCT00412854 | Study to Assess Safety & Immunogenicity of GSK Biologicals' DTPa/Hib Vaccine vs Separate Administration of DTPa and Hib. | COMPLETED | PHASE3 | 2007-01-03 | 2007-06-25 | 2007-06-01 |
| NCT00421720 | A Study Comparing Two Analgesia/Sedation Regimens, Remifentanil/Propofol Versus Sufentanil/Propofol In Mechanically Ventilated Intensive Care Patients Requiring Analgesia And Sedation. | TERMINATED | PHASE4 | 2007-01 | | |
| NCT00424034 | A Study of GSK1325760A in Healthy Japanese Subjects | COMPLETED | PHASE1 | 2007-01 | 2007-02 | 2007-02 |
| NCT00329745 | Year 3 Extension for Efficacy Follow-up in Subjects Vaccinated in Studies Rota-028, 029 or 030 (NCT00197210) | COMPLETED | PHASE3 | 2007-01 | 2008-07 | 2008-07 |
| NCT00406562 | Study to Assess the Safety & Reactogenicity of GSK Biologicals' dTpa Vaccine (Boostrix) When Given at 6-8 Years of Age. | COMPLETED | PHASE3 | 2007-01 | 2007-02 | |
| NCT00410163 | Ofatumumab With Fludarabine and Cyclophosphamide in B-CLL Patients | COMPLETED | PHASE2 | 2007-01 | 2013-05 | 2009-03 |
| NCT00404261 | Evaluation Of Patient Satisfaction Of Metered Dose Inhaler (MDI) With Counter In Asthmatics And Chronic Obstructive Pulmonary Disease Patients (COPD). | COMPLETED | PHASE4 | 2007-01 | 2007-08 | 2007-08 |
| NCT00430157 | Trial With Allergic Rhinitis Patients Taking GSK256066 Versus Placebo In A Pollen Challenge Chamber | COMPLETED | PHASE2 | 2007-01 | | |
| NCT00427596 | A Two-Part Study to Determine: Best Medication Formulation and Food Effect | COMPLETED | PHASE1 | 2007-01 | 2007-08 | 2007-08 |
| NCT00410371 | Study to Compare Two Formulations of Lamotrigine in Healthy Subjects | COMPLETED | PHASE1 | 2006-12-28 | 2007-01-25 | 2007-01-25 |
| NCT00356369 | Study in Adolescents/Adults to Evaluate Non-inferiority&Persistence up to 5 Years of GSK Bio MenACWY Conjugate Vaccine | COMPLETED | PHASE2 | 2006-12-23 | 2008-02-28 | 2007-09-07 |
| NCT00435461 | Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine | COMPLETED | PHASE4 | 2006-12-20 | 2007-02-28 | 2007-02-01 |
| NCT00420641 | MDD POC Study GSK372475 Subjects Depressive Disease | COMPLETED | PHASE2 | 2006-12-19 | 2008-10-15 | 2008-06-01 |
| NCT00441116 | A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Male Subjects With Androgenetic Alopecia | COMPLETED | PHASE3 | 2006-12-15 | 2008-01-21 | 2008-01-21 |
| NCT00385099 | Effects Of GW876008 On The Bowel In Patients With Irritable Bowel Syndrome | COMPLETED | PHASE2 | 2006-12-08 | 2007-10-15 | 2007-10-15 |
| NCT00370513 | A Phase I Study of Pazopanib in Adult Patients With Liver Cancer | COMPLETED | PHASE1 | 2006-12-06 | 2009-04-08 | 2009-04-08 |
| NCT00398476 | Fluticasone Nasal Spray Patient Preference Study | COMPLETED | PHASE3 | 2006-12-01 | 2006-12-04 | 2006-12-04 |
| NCT00382993 | A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2) | COMPLETED | PHASE3 | 2006-12 | 2007-11 | 2007-11 |
| NCT00411697 | Persistence of Hepatitis B Antibody Levels & Immune Response to a Hepatitis B Vaccine Challenge | COMPLETED | PHASE4 | 2006-12 | 2007-05 | 2007-05 |
| NCT00411073 | Study Of The Effects Of SB 480848 (Darapladib) On The Electrical Conduction Of The Heart | COMPLETED | PHASE1 | 2006-12 | | |
| NCT00394056 | Vestipitant Or Vestipitant/Paroxetine Combination In Subjects With Tinnitus And Hearing Loss. | COMPLETED | PHASE2 | 2006-12 | 2009-08 | 2009-08 |
| NCT00346749 | ADVAIR DISKUS® (Fluticasone Propionate/Salmeterol) Inhaler Versus SEREVENT DISKUS® (Salmeterol) Inhlaer On Inflammatory Cells And Markers In Chronic Obstructive Pulmonary Disease. ADVAIR DISKUS® and SEREVENT DISKUS® Inhalers Are Trademarks of the GSK Group of Companies. | TERMINATED | PHASE4 | 2006-12 | 2007-07 | 2007-07 |
| NCT00370032 | Study to Assess the Effect Of Alosetron On Mucosal Blood Flow | COMPLETED | PHASE4 | 2006-12 | 2007-12 | 2007-12 |
| NCT00424255 | Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery | COMPLETED | PHASE3 | 2006-12 | 2013-11 | 2013-03 |
| NCT00390806 | Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer | COMPLETED | PHASE3 | 2006-12 | 2013-09 | 2012-07 |
| NCT00426816 | To Evaluate The Effects Of SB-649868 (10, 30 Mg And 60 Mg) On Subjects With Primary Insomnia | COMPLETED | PHASE2 | 2006-12 | 2007-05 | 2007-05 |
| NCT00350727 | Pazopanib In Combination With Lapatinib In Adult Patients With Relapsed Malignant Glioma | COMPLETED | PHASE2 | 2006-12 | 2009-12 | 2009-12 |
| NCT00395317 | Study Of SB-683699 Compared To Placebo In Subjects With Relapsing-Remitting Multiple Sclerosis (MS) | COMPLETED | PHASE2 | 2006-12 | 2010-08 | 2009-08 |
| NCT00368303 | A Local Register Study For Major Depression Of Paroxetine Controlled Release | COMPLETED | PHASE3 | 2006-12 | | |
| NCT00537459 | A Study On Concentrations Of 16448 In Blood And The Safety Of This Compound In Healthy Males With Premature Ejaculation | COMPLETED | PHASE2 | 2006-12 | | |
| NCT00441974 | Adefovir Dipivoxil For The Treatment Of Chinese Compensated Chronic Hepatitis B(CHB)Patients | COMPLETED | PHASE4 | 2006-12 | 2008-09 | 2008-09 |
| NCT00423761 | An Investigation To Determine The Potential Interaction Effect Between GW876008 And Midazolam. | COMPLETED | PHASE1 | 2006-12 | | |
| NCT00397215 | Evaluate Safety & Immunogenicity of a Pandemic Influenza Vaccine (GSK1562902A) in Adults Over 60 Years of Age | COMPLETED | PHASE2 | 2006-11-17 | 2009-09-14 | 2009-09-14 |
| NCT00397943 | Safety and Immunogenicity of 2 Formulations of Tuberculosis Vaccine GSK692342 Given at 0,1 Months to Healthy Adults | COMPLETED | PHASE2 | 2006-11-15 | 2009-12-01 | 2009-12-01 |
| NCT00398645 | A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Persistent Asthma. | COMPLETED | PHASE2 | 2006-11-15 | 2007-08-30 | 2007-08-01 |
| NCT00405080 | A Study in Healthy Subjects to Assess How Dosing of Rifampin Affects What the Body Does to a Dose of GW679769 (Casopitant). | COMPLETED | PHASE1 | 2006-11-11 | 2007-01-05 | 2007-01-05 |
| NCT00397722 | Treatment Of Patients With Social Anxiety Disorder | COMPLETED | PHASE2 | 2006-11-09 | 2007-09-05 | 2007-09-05 |
| NCT00431236 | A Study of the Drug Casopitant for the Prevention of Nausea Caused By Cisplatin-Based Highly Emetogenic Chemotherapy | COMPLETED | PHASE3 | 2006-11-06 | 2007-10-09 | 2007-10-09 |
| NCT00372112 | A Study To Assess The Safety And Tolerability Of GW642444 In Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE2 | 2006-11-03 | 2007-05-10 | 2007-05-01 |
| NCT00383123 | Study Comparing the Immune Response and Safety of Fluarix and Fluzone Influenza Vaccines in Children | COMPLETED | PHASE3 | 2006-11-02 | 2007-10-19 | 2007-10-01 |
| NCT00404274 | A Study Testing the Effect and Safety of Casopitant (GW679769) While Taking Warfarin in Healthy Human Volunteers | COMPLETED | PHASE1 | 2006-11-01 | 2007-03-18 | 2007-03-18 |
| NCT00376896 | Study On The Effect Of GW876008 On Cerebral Blood Flow In Irritable Bowel Syndrome (IBS) Patients And Healthy Volunteers | COMPLETED | PHASE1 | 2006-11 | 2008-10 | 2008-10 |
| NCT00366080 | Effectiveness Of The Drug GSK189254 In Treating Patients With Narcolepsy | TERMINATED | PHASE2 | 2006-11 | 2008-01 | 2008-01 |
| NCT00370331 | RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag | COMPLETED | PHASE3 | 2006-11 | 2008-07 | 2008-07 |
| NCT00383162 | A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 1 of 2) | COMPLETED | PHASE3 | 2006-11 | 2007-10 | 2007-10 |
| NCT00402363 | Evaluation of Efficacy and Safety of Lovaza (Omega-3-Acid Ethyl Esters) in Recurrent, Symptomatic Atrial Fibrillation | COMPLETED | PHASE3 | 2006-11 | 2010-01 | 2010-01 |
| NCT00382772 | A Study in Infants to Test Two Preparations (Freeze-dried or Liquid) of the Rotavirus Vaccine (HRV Vaccine). | COMPLETED | PHASE3 | 2006-11 | 2007-08 | 2007-04 |
| NCT00430781 | Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer | COMPLETED | PHASE2 | 2006-11 | 2011-07 | 2008-07 |
| NCT00411372 | Shortness Of Breath Questionnaire Validation Study | WITHDRAWN | PHASE3 | 2006-11 | | |
| NCT00387127 | Lapatinib Versus Placebo Given Concurrently With Cisplatin And Radiotherapy In Patients With Unresected Head And Neck Cancer | COMPLETED | PHASE2 | 2006-11 | 2014-01 | 2009-06 |
| NCT00398125 | Monotherapy Versus Placebo Over 10 Days in Integrase Naive HIV-1 Infected Adults | COMPLETED | PHASE2 | 2006-11 | 2007-04 | |
| NCT00367679 | Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer | COMPLETED | PHASE2 | 2006-11 | 2008-04 | 2008-04 |
| NCT00807014 | Evaluation of Quality of Life, Efficacy, and Tolerance of Duac® Gel Compared to Differin® Gel in the Treatment of Acne | COMPLETED | PHASE4 | 2006-11 | 2008-08 | 2008-08 |
| NCT00411814 | A Study Of GSK679586A When Infused Into Healthy And Mild Asthmatic Volunteers | COMPLETED | PHASE1 | 2006-11 | 2008-02 | 2008-02 |
| NCT00408785 | A Study Of BOTOX For The Treatment Of Glabellar Lines | COMPLETED | PHASE3 | 2006-11-01 | 2007-05-09 | 2007-05-09 |
| NCT00435695 | Study Of Safety, Blood Levels, And Brain Receptor Occupancy Of GSK163090 Using PET Imaging In Healthy Males | COMPLETED | PHASE1 | 2006-11 | 2007-12 | 2007-12 |
| NCT00443170 | A Placebo-controlled Study to Investigate the Safety, and Pharmacokinetics of Oral GSK626616AC in Healthy Subjects | COMPLETED | PHASE1 | 2006-11 | | |
| NCT00501683 | A Single Dose Of GSK189075 Taken By Mouth Containing Small Amounts Of Radioactivity Studied In Healthy Male Volunteers | COMPLETED | PHASE1 | 2006-11 | | |
| NCT00448890 | Evaluation of Single and Repeat Doses of GSK729327 in Healthy Volunteers | COMPLETED | PHASE1 | 2006-11 | 2009-01 | 2008-12 |
| NCT00429728 | A Study To Investigate The Metabolism Of GW876008 In Smokers Compared To Non-Smokers. | COMPLETED | PHASE1 | 2006-11 | | |
| NCT00719121 | Study on Anti-inflammatory Effects of Topical R115866 Gel | COMPLETED | PHASE1 | 2006-11 | 2007-03 | 2006-12 |
| NCT00385255 | Immunogenicity, Safety of GSKs Tdap Vaccine Boostrix When Coadministered With GSKs Influenza Vaccine Fluarix in Adults | COMPLETED | PHASE3 | 2006-10-23 | 2007-02-28 | 2007-02-28 |
| NCT00554255 | A Study of SB751689 in Japanese Postmenopausal Women | COMPLETED | PHASE1 | 2006-10-23 | 2006-12-12 | |
| NCT00387387 | Study On Pazopanib When Given With FOLFOX6 (Fluorouracil, Oxaliplatin, Leucovorin) Or CapeOx (Capecitabine, Oxaliplatin) | COMPLETED | PHASE1 | 2006-10-20 | 2009-08-14 | 2009-08-14 |
| NCT00404378 | Study Of Healthy Subjects To Assess The Effect Of Ketoconazole And The Way The Body Will React To Casopitant [GW679769] | COMPLETED | PHASE1 | 2006-10-20 | 2007-01-05 | 2007-01-05 |
| NCT00385840 | Study to Evaluate the Immunogenicity and Safety of a Second Vaccination With the Adjuvanted Influenza Vaccine Candidate | COMPLETED | PHASE2 | 2006-10-20 | 2007-02-05 | 2007-02-01 |
| NCT00411190 | Study To Determine The Effects Of Doses Of Relacatib On The Metabolism Of Acetaminophen, Ibuprofen And Atorvastatin | COMPLETED | PHASE1 | 2006-10-19 | 2006-12-15 | 2006-12-15 |
| NCT00386113 | Study to Evaluate Reactogenicity and Immunogenicity of Revaccination With Adjuvanted Influenza Vaccine in Elderly | COMPLETED | PHASE2 | 2006-10-16 | 2006-11-14 | 2006-11-14 |
| NCT00394030 | Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy Volunteers | COMPLETED | PHASE1 | 2006-10-16 | 2007-03-20 | 2007-03-20 |
| NCT00421707 | Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome | COMPLETED | PHASE2 | 2006-10-14 | 2008-06-25 | 2008-06-25 |
| NCT00411866 | Effects Of The Drug Ketoconazole On How The Body Handles The Drug SB773812 | COMPLETED | PHASE1 | 2006-10-13 | 2007-10-10 | 2007-10-10 |
| NCT00426608 | To Investigate Effects GSK561679 on Part of the Body's System That Controls the Balance of Many of the Hormones. | COMPLETED | PHASE1 | 2006-10-06 | 2007-01-08 | 2007-01-08 |
| NCT00377611 | Study on the Incidence of Influenza and Its Complications, in Subjects Aged 50 Years and Over Vaccinated With Fluarix™ | COMPLETED | PHASE4 | 2006-10-05 | 2007-06-20 | 2007-06-20 |
| NCT00374842 | Study to Evaluate the Immunogenicity and Safety of 2 Formulations of GlaxoSmithKline (GSK) Biologicals' GSK1247446A Low Dose Influenza Vaccine Candidate | COMPLETED | PHASE2 | 2006-10-03 | 2006-11-30 | 2006-11-01 |
| NCT00387413 | A Study Of GSK189254 And Duloxetine In The Electrical Hyperalgesia Model Of Healthy Volunteers | COMPLETED | PHASE1 | 2006-10-02 | 2007-05-31 | 2007-05-31 |
| NCT00363077 | Study to Evaluate the Immunogenicity and the Safety of an Adjuvanted Influenza Vaccine Candidate | COMPLETED | PHASE2 | 2006-10-02 | 2006-11-17 | 2006-11-01 |
| NCT00390910 | Study to Evaluate the Safety and Immunogenicity of a 10-valent Pneumococcal Conjugate Vaccine in Preterm Infants | COMPLETED | PHASE3 | 2006-10-01 | 2008-05-02 | 2007-07-02 |
| NCT00398580 | 28-Day Study of Testosterone Co-administered With Dutasteride in Hypogonadal Men | COMPLETED | PHASE2 | 2006-10 | 2007-10 | 2007-10 |
| NCT00404963 | A Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight Subjects | COMPLETED | PHASE1 | 2006-10 | 2007-05 | 2007-05 |
| NCT00376779 | Immunogenicity and Safety of a DTPa-HBV-IPV/Hib Vaccine Given at 2, 3 and 4 Months of Age | COMPLETED | PHASE2 | 2006-10 | 2007-05 | 2007-05 |
| NCT00386698 | Study to Evaluate Reactogenicity and Immunogenicity of Revaccination With Adjuvanted Influenza Vaccine in Elderly Adults | COMPLETED | PHASE2 | 2006-10 | 2006-12 | |
| NCT00386100 | A Type 2 Diabetes Study of the Longer-Term Glycemic Effect of AVANDAMET vs. Metformin | COMPLETED | PHASE4 | 2006-10 | 2009-09 | 2009-09 |
| NCT00370227 | Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine | COMPLETED | PHASE3 | 2006-10 | 2007-03 | |
| NCT00400608 | A Study In Pediatric Subjects With Asthma Using ADVAIR HFA, ADVAIR HFA With Spacer, And ADVAIR DISKUS | COMPLETED | PHASE4 | 2006-10 | 2007-02 | |
| NCT00422604 | Safety And Efficacy Of GSK233705 Plus Salmeterol Compared With 2 Active Comparators And Placebo In Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE2 | 2006-10 | 2007-05 | 2007-05 |
| NCT00373542 | 12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome | COMPLETED | PHASE4 | 2006-10 | 2007-06 | 2007-06 |
| NCT00393146 | A Study To Investigate The Effect Of 28 Days Of Dosing With GW856553 On Patients With Rheumatoid Arthritis | COMPLETED | PHASE2 | 2006-10 | 2008-01 | 2008-01 |
| NCT00387257 | Effect Of Rilapladib (SB-659032) On Platelet Aggregation | COMPLETED | PHASE1 | 2006-10 | 2007-04 | 2007-04 |
| NCT00426751 | Efficacy Of Eptifibatide Compared To Abciximab In Primary Percutaneous Coronary Intervention (PCI) For Acute ST Elevation Myocardial Infarction (STEMI) | COMPLETED | PHASE3 | 2006-10 | 2007-12 | 2007-12 |
| NCT00437242 | Odiparcil QT Definitive Study | TERMINATED | PHASE1 | 2006-10 | | |
| NCT00439959 | Monotherapy Versus Placebo Over 14 or 17 Days in Healthy and Hepatitis C Infected Adults | TERMINATED | PHASE1 | 2006-10 | 2007-03 | 2007-03 |
| NCT00457925 | Absorption, Distribution, Metabolism And Excretion Study For GSK221149A | COMPLETED | PHASE1 | 2006-10 | | |
| NCT00386347 | A Study To Evaluate Formulations And Food Effect On GSK364735 In Healthy Subjects. | COMPLETED | PHASE1 | 2006-10 | | |
| NCT00439881 | A Study To Look At The Safety Of SB-681323 In Healthy Adult Subjects After Intravenous Administration Of A Single Dose | COMPLETED | PHASE1 | 2006-10 | | |
| NCT00427141 | A Three-Part Study Of GSK580416 In Healthy Subjects | COMPLETED | PHASE1 | 2006-10 | | |
| NCT00400335 | Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride | COMPLETED | PHASE1 | 2006-10 | | |
| NCT00444769 | Dental Pain 3rd Molar Tooth Extraction GW842166 | COMPLETED | PHASE2 | 2006-10 | | |
| NCT00388596 | A Study Of SB-751689, Atorvastatin, Ketoconazole, And Rosuvastatin In Health Postmenopausal Women. | COMPLETED | PHASE1 | 2006-10 | | |
| NCT00401479 | A Study To Investigate The Effect Of Solabegron (GW427353) On Gastrointestinal Transit In Healthy Volunteers | COMPLETED | PHASE1 | 2006-10 | | |
| NCT00494767 | Investigation Of Weight Loss And Body Composition Changes After Dosing With Either Placebo Or One Of Two Active Drugs | COMPLETED | PHASE1 | 2006-09-29 | 2007-06-07 | 2007-06-07 |
| NCT00442871 | Study Of SB-497115 in Healthy Subjects and Subjects With Mild, Moderate or Severe Renal Impairment | COMPLETED | PHASE1 | 2006-09-28 | 2008-01-03 | 2008-01-03 |
| NCT00289185 | Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants | COMPLETED | PHASE2 | 2006-09-27 | 2009-01-15 | 2008-02-11 |
| NCT00369824 | Evaluation of Safety and Immunogenicity of Co-administering HPV Vaccine With Other Vaccines in Healthy Female Subjects | COMPLETED | PHASE3 | 2006-09-26 | 2008-02-13 | 2007-11-22 |
| NCT00370396 | Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine. | COMPLETED | PHASE3 | 2006-09-25 | 2007-11-06 | 2007-06-04 |
| NCT00345878 | Study to Evaluate the Immune Response and Safety of GSK Biologicals' HPV Vaccine in Healthy Women Aged 18-35 Years | COMPLETED | PHASE3 | 2006-09-25 | 2007-12-21 | 2007-12-21 |
| NCT00377585 | Demonstrate the Superiority of the Immune Response of Adjuvanted Influenza Vaccine Induced in an Adult Population | COMPLETED | PHASE2 | 2006-09-22 | 2007-01-30 | |
| NCT00363194 | A Two-way Crossover Study Of The Effect Of Food On The Pharmacokinetics Of Pazopanib In Cancer Patients | COMPLETED | PHASE1 | 2006-09-21 | 2009-06-19 | 2009-06-19 |
| NCT00345358 | Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine | COMPLETED | PHASE3 | 2006-09-18 | 2007-11-15 | 2007-11-15 |
| NCT00385008 | TREXIMA and RELPAX Gastric Scintigraphy Inside and Outside a Migraine | COMPLETED | PHASE3 | 2006-09-13 | 2006-11-24 | 2006-11-24 |
| NCT00359619 | Human Papillomavirus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Biologicals Novel HPV Vaccine | COMPLETED | PHASE2 | 2006-09-12 | 2007-01-30 | 2007-01-30 |
| NCT00361803 | Topotecan Pharmacokinetic Characterization Study | COMPLETED | PHASE1 | 2006-09-12 | 2007-08-09 | 2007-08-09 |
| NCT00358449 | Intravenous Mepolizumab In Children With Eosinophilic Esophagitis | COMPLETED | PHASE2 | 2006-09-11 | 2008-11-25 | 2008-11-25 |
| NCT00404586 | Effects Of Single Doses Of GW784568X On Allergic Rhinitis Symptoms In Male Subjects Whilst In An Environmental Chamber | COMPLETED | PHASE1 | 2006-09-11 | 2007-01-16 | 2007-01-16 |
| NCT00358813 | Observational Pharmacokinetic Study Of GW679769 In Subjects With Renal Impairment | COMPLETED | PHASE1 | 2006-09-08 | 2008-08-22 | 2008-08-22 |
| NCT00363545 | To Assess Immunogenicity, Reactogenicity & Safety of 2 Formulations of GSK's HRV Vaccine as 2-dose Vaccination (Infants) | COMPLETED | PHASE3 | 2006-09-01 | 2007-04-12 | 2007-04-12 |
| NCT00363870 | A Study to Demonstrate the Efficacy of GSK Biologicals' Influenza Vaccine in Adults | COMPLETED | PHASE4 | 2006-09 | 2007-06 | 2007-06 |
| NCT00370318 | Prophylactic Antipyretic Treatment in Children Receiving Pneumococcal Conjugate and Standard Infant Vaccines | COMPLETED | PHASE3 | 2006-09 | 2007-04 | |
| NCT00345579 | Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 2, 4, 6 and 12 to 15 Months of Age | COMPLETED | PHASE3 | 2006-09 | 2008-03 | 2007-10 |
| NCT00387881 | TREXIMET (Formerly Known as TREXIMA) for the Acute Treatment of Probable Migraine (ICHD-II 1.6.1) | COMPLETED | PHASE3 | 2006-09 | 2008-02 | 2008-02 |
| NCT00359983 | Long-Term Antibody Persistence at 1, 3 and 5 Years After a Fourth Dose of GSK Biologicals' Hib-MenCY-TT Vaccine Compared to ActHIB | COMPLETED | PHASE3 | 2006-09 | 2011-05 | 2007-11 |
| NCT00380211 | Safety and Immunogenicity of FluLaval™ TR and Fluarix® (Influenza Vaccines) in Young and Older Adults | COMPLETED | PHASE3 | 2006-09 | 2006-11 | |
| NCT00379977 | Study to Assess the Safety & Reactogenicity of GSK Biologicals' DTPa/Hib Vaccine When Given at 3, 4 and 5 Months of Age | COMPLETED | PHASE3 | 2006-09 | 2006-12 | |
| NCT00345956 | To Evaluate Immunogenicity, Reactogenicity & Safety of 2 Doses of GSK Bio HRV Liquid Vaccine Given to Infants (Vietnam) | COMPLETED | PHASE3 | 2006-09 | 2007-03 | |
| NCT02075632 | Study to Evaluate Product Duration of Use Experience With Alclometasone Dipropionate Cream | COMPLETED | PHASE2 | 2006-09 | 2006-11 | 2006-11 |
| NCT00387764 | Extension Study to VEG105192 to Assess Pazopanib in Patients With Advanced/Metastatic Renal Cell Cancer | COMPLETED | PHASE3 | 2006-09 | 2012-10 | 2009-12 |
| NCT00437164 | A Study To Assess GW677954 Used In Combination With Insulin In Subjects Who Have Type 2 Diabetes Mellitus | TERMINATED | PHASE2 | 2006-09 | 2006-11 | 2006-11 |
| NCT00380354 | Study To Evaluate GSK256066 In Subjects With Mild Bronchial Asthma | COMPLETED | PHASE2 | 2006-09 | 2007-06 | |
| NCT00406757 | Clinical Evaluation of Nelarabine (506U78)in Japanese Patients With Leukemia or Lymphoma | COMPLETED | PHASE1 | 2006-08-30 | 2009-07-15 | 2009-07-15 |
| NCT00370097 | FLOVENT Hydrofluoroalkane (HFA) In 6-12 Month Old Subjects | COMPLETED | PHASE1 | 2006-08-30 | 2007-04-12 | 2007-04-12 |
| NCT00390845 | P38 Mitogen-activated Protein (Map) Kinase Inhibitor (SB-681323)Study In Patients With Neuropathic Pain | COMPLETED | PHASE2 | 2006-08-30 | 2008-08-11 | 2008-08-11 |
| NCT00360230 | Partially-blind (Observer-blind) Study of Safety and Immunogenicity of Two Malaria Vaccines in Ghanaian Children | COMPLETED | PHASE2 | 2006-08-30 | 2008-05-30 | 2007-08-25 |
| NCT00419692 | Restless Legs Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole And The Effect Of Food | COMPLETED | PHASE1 | 2006-08-24 | 2006-12-12 | 2006-12-12 |
| NCT00376714 | Safety And Tolerability Study In Patients With Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE2 | 2006-08-16 | 2007-04-03 | |
| NCT00743067 | A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally Daily to Subjects With Solid Tumors | COMPLETED | PHASE1 | 2006-08-09 | 2009-11-09 | 2009-05-02 |
| NCT00395694 | Clinical Evaluation of BW430C in Epilepsy | COMPLETED | PHASE3 | 2006-08-07 | 2009-03-26 | 2009-03-01 |
| NCT00344318 | Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine | COMPLETED | PHASE3 | 2006-08-07 | 2007-10-17 | 2007-04-27 |
| NCT00381394 | A Study Evaluating Sitamaquine Compared With Amphotericin B In The Treatment Of Visceral Leishmaniasis. | COMPLETED | PHASE2 | 2006-08-04 | 2007-09-14 | 2007-09-14 |
| NCT00368576 | A Study To Determine The Effect Of SB-480848 On Asthma | COMPLETED | PHASE1 | 2006-08 | 2007-10 | 2007-10 |
| NCT00333450 | Immune Memory Evaluation in Children Following a Primary Vaccination With Pneumococcal Conjugate Vaccines. | COMPLETED | PHASE3 | 2006-08 | 2006-12 | |
| NCT00381667 | Study to Assess GW642444 in Asthma Patients | COMPLETED | PHASE2 | 2006-08 | 2007-01 | 2007-01 |
| NCT00429299 | Neoadjuvant Study With Chemotherapy, Lapatinib And Trastuzumab In Breast Cancer | COMPLETED | PHASE2 | 2006-08 | 2012-06 | 2012-06 |
| NCT00471588 | Characterize The Modulatory Effects Of Dopamine D2/D3 Receptor Agonist And Antagonist Drugs On Compulsive Behaviors | COMPLETED | PHASE1 | 2006-08 | 2007-12 | 2007-12 |
| NCT00374322 | Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer | COMPLETED | PHASE3 | 2006-08 | 2013-07 | 2011-09 |
| NCT00392587 | A Study To Investigate The Effects Of GW856553 On Patients With COPD (Chronic Obstructive Pulmonary Disease) | COMPLETED | PHASE2 | 2006-08 | | |
| NCT00376038 | Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To Subjects With Type 2 Diabetes | COMPLETED | PHASE1 | 2006-08 | 2006-10 | 2006-10 |
| NCT00394186 | A Study To Investigate GW427353 In Subjects With Irritable Bowel Syndrome (IBS) | COMPLETED | PHASE2 | 2006-08 | | |
| NCT00451321 | TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM) | TERMINATED | PHASE2 | 2006-07-31 | 2011-12-01 | 2011-12-01 |
| NCT00401583 | A Study To Test The Effect Of GW786034 (Pazopanib) On P450 Enzymes | COMPLETED | PHASE1 | 2006-07-28 | 2008-02-20 | 2008-02-20 |
| NCT00344032 | Evaluation of the Immune and Safety Response of GlaxoSmithKline (GSK) Biologicals' HPV Vaccine in Healthy Indian Women | COMPLETED | PHASE3 | 2006-07-28 | 2007-12-04 | 2007-12-01 |
| NCT00346073 | Safety and Immunogenicity of GSK's Tdap Vaccine (Boostrix) in Adults Aged 19 to 64 Years | COMPLETED | PHASE3 | 2006-07-13 | 2007-03-07 | 2007-03-01 |
| NCT00348140 | Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease | COMPLETED | PHASE3 | 2006-07-12 | 2009-03-20 | 2009-03-20 |
| NCT00348309 | Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease | COMPLETED | NA | 2006-07-06 | 2009-01-28 | 2009-01-01 |
| NCT00310388 | Open-Label Extension Study of the Phase 3 VRX-RET-E22-302 Double-Blind Trial. 115097 | TERMINATED | PHASE3 | 2006-07-05 | 2018-05-24 | 2017-04-18 |
| NCT00356915 | Itraconazole Tablets Vs. Itraconazole Capsules vs. Placebo in Onychomycosis of the Toenail. | COMPLETED | PHASE3 | 2006-07 | 2008-10 | 2008-10 |
| NCT00363311 | Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men | COMPLETED | PHASE4 | 2006-07 | 2010-07 | 2010-03 |
| NCT00347360 | The COREG And Lisinopril Combination Therapy In Hypertensive Subjects (COSMOS) Trial | COMPLETED | PHASE3 | 2006-07 | 2008-04 | 2008-04 |
| NCT00356564 | Persistence of the Immune Response to Hepatitis B in 7-9 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib | COMPLETED | PHASE4 | 2006-07 | 2006-12 | |
| NCT00345904 | Study to Evaluate the Safety and Immunogenicity of Fluarix™ 2006/2007 in Adults Aged 18 Years or Above | COMPLETED | PHASE3 | 2006-07 | 2006-08 | |
| NCT00347919 | Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Advanced Or Metastatic Breast Cancer | COMPLETED | PHASE2 | 2006-07 | 2015-03 | 2008-08 |
| NCT00567424 | GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial Seizures | WITHDRAWN | PHASE2 | 2006-07 | 2008-03 | 2008-03 |
| NCT00366834 | Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting | COMPLETED | PHASE3 | 2006-07 | 2009-10 | 2007-10 |
| NCT00403585 | Study of Adefovir Dipivoxil for Korean Patients With Chronic Hepatitis B(CHB) Who Have Completed ADF 103814 | COMPLETED | PHASE4 | 2006-07 | 2008-04 | 2008-04 |
| NCT00337922 | Pharmacokinetic Study Of EPZICOM Tablet | COMPLETED | PHASE4 | 2006-07 | | |
| NCT00726323 | A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC) | COMPLETED | PHASE2 | 2006-06-30 | 2010-08-18 | 2010-08-18 |
| NCT00356603 | Study Of Sumatriptan Succinate Injection Kit In Patients With Migraine or Cluster Headache In Japan | COMPLETED | PHASE3 | 2006-06-20 | 2006-08-07 | 2006-08-07 |
| NCT00331149 | A Comparison of Ropinirole Immediate Release With Ropinirole Prolonged Release in Patients With Advanced Parkinson's | COMPLETED | PHASE3 | 2006-06-20 | 2007-08-29 | 2007-08-29 |
| NCT00381238 | Open-Label Extension Assessing Long-Term Safety Of Rosiglitazone In Subjects With Mild To Moderate Alzheimer's Disease | COMPLETED | PHASE2 | 2006-06-20 | 2009-02-03 | 2009-02-01 |
| NCT00358540 | Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide | COMPLETED | PHASE1 | 2006-06-01 | 2010-10-22 | 2010-10-22 |
| NCT00716144 | Dose Ranging Study of the Safety and Efficacy of R115966 in Plaque Psoriasis | COMPLETED | PHASE2 | 2006-06-01 | 2007-05-01 | 2007-05-01 |
| NCT00337818 | Human Papillomavirus (HPV) Vaccine Consistency and Non-inferiority Trial in Young Adult Women | COMPLETED | PHASE3 | 2006-06 | 2009-01 | 2006-06 |
| NCT00344006 | Chlorproguanil-Dapsone-Artesunate Versus COARTEM For Uncomplicated Malaria | COMPLETED | PHASE3 | 2006-06 | 2007-08 | 2007-08 |
| NCT00334607 | Study of 2 Doses of HRV Vaccine Given Concomitantly or Separately With Routine Vaccinations in Healthy Infants in USA | COMPLETED | PHASE3 | 2006-06 | 2007-06 | 2007-02 |
| NCT00334334 | Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine. | COMPLETED | PHASE3 | 2006-06 | 2007-08 | 2007-07 |
| NCT00335881 | Persistence of the Immune Response to Hepatitis B in 4-6 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib | COMPLETED | PHASE4 | 2006-06 | 2006-11 | |
| NCT00326118 | Study in Toddlers to Demonstrate Non-inferiority of GSK Biologicals' Hib-MenC & to Evaluate Persistence up to 5 Years. | COMPLETED | PHASE3 | 2006-06-01 | 2007-11-06 | 2007-11-01 |
| NCT00332566 | Assess Immunogenicity, Reactogenicity, Safety of a Booster of GSK Biologicals DTPw-HBV/Hib Kft Compared to DTPw-HBV/Hib | COMPLETED | PHASE3 | 2006-06 | 2006-10 | 2006-10 |
| NCT00349349 | HuMax-CD20 in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients Failing Fludarabine and Alemtuzumab | COMPLETED | PHASE2 | 2006-06 | 2012-06 | 2008-05 |
| NCT00357097 | The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate To Severe Restless Legs Syndrome | COMPLETED | PHASE3 | 2006-06 | 2007-12 | 2007-12 |
| NCT00445510 | This Study Will Examine the Effects of GSK256066 to Protect Mild Steroid-naive Asthmatics Against an Antigen Challenge | COMPLETED | PHASE2 | 2006-06 | | |
| NCT00327522 | Safety and Immune Response Study of an Investigational Pneumococcal Vaccine. | COMPLETED | PHASE2 | 2006-06 | | |
| NCT01059591 | First Study in Humans With GSK424887 | COMPLETED | PHASE1 | 2006-05-25 | 2007-01-25 | 2007-01-25 |
| NCT00432679 | A Study Of BRL49653C For The Treatment Of Type 2 Diabetes (Combination Therapy With Sulfonyl Urea) -With Placebo Study | COMPLETED | PHASE3 | 2006-05-24 | 2007-03-28 | 2007-03-28 |
| NCT00347139 | Repeat Doses Of A New Medication (GW642444) In Asthmatic Patients | COMPLETED | PHASE2 | 2006-05-23 | 2007-01-10 | 2007-01-10 |
| NCT01059578 | First Study in Humans With GSK206136 | COMPLETED | PHASE1 | 2006-05-23 | 2006-12-18 | 2006-12-18 |
| NCT00379756 | A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia | COMPLETED | PHASE4 | 2006-05-22 | 2007-05-17 | 2007-05-17 |
| NCT00363480 | Results Of Patient Rated Asthma Control Test In Comparison To Diary Card Data | COMPLETED | PHASE4 | 2006-05-17 | 2007-09-14 | 2007-09-01 |
| NCT00321373 | Study to Evaluate an Influenza Vaccine Candidate | COMPLETED | PHASE2 | 2006-05-11 | 2006-07-18 | 2006-07-01 |
| NCT00406432 | A Repeat Dose Pharmacokinetic Study Of Paroxetine CR Tablet In Healthy Chinese Subjects | COMPLETED | PHASE1 | 2006-05-09 | 2006-06-02 | 2006-06-02 |
| NCT00310375 | Open-label Extension Study of the Phase 3 VRX-RET-E22-301 Double-Blind Trial | COMPLETED | PHASE3 | 2006-05-01 | 2017-03-15 | 2016-11-30 |
| NCT00346775 | Validation Of Preference Module Of Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q) | COMPLETED | PHASE3 | 2006-05-01 | 2006-06-29 | 2006-06-29 |
| NCT00327665 | Study to Evaluate the Safety and Immunogenicity of an Investigational Pneumococcal Vaccine in the Elderly Population | COMPLETED | PHASE1 | 2006-05-01 | 2007-01-08 | 2007-01-01 |
| NCT00319098 | Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged 18 Years and Above | COMPLETED | PHASE3 | 2006-05-01 | 2007-07-31 | 2007-01-01 |
| NCT00312013 | Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer | COMPLETED | PHASE3 | 2006-05 | 2009-07 | 2009-07 |
| NCT00329355 | Menstrual Migraine Treatment With TREXIMET (Formerly Known as TREXIMA) | COMPLETED | PHASE3 | 2006-05 | 2006-11 | 2006-11 |
| NCT00405119 | A Study To Investigate The Effectiveness Of AH234844 (Lavoltidine) Compared With NEXIUM And Ranitidine. | COMPLETED | PHASE2 | 2006-05 | 2007-03 | 2007-03 |
| NCT00355082 | Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy | COMPLETED | PHASE3 | 2006-05 | 2008-11 | 2008-11 |
| NCT00329459 | Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as TREXIMA, for Menstrual Migraine in Women With Dysmenorrhea | COMPLETED | PHASE3 | 2006-05 | 2006-11 | 2006-11 |
| NCT00322335 | Long-term Persistence Study to Assess a Booster Dose of GSK Biologicals' Hib-MenC | COMPLETED | PHASE3 | 2006-05 | 2010-09 | 2006-07 |
| NCT00329576 | Evaluate Immune Response Approximately 5 to 6 Years After Receiving Different Formulations of GSK Bio Hep B Vaccine | COMPLETED | PHASE4 | 2006-05 | 2006-08 | |
| NCT00387972 | Study Of Denagliptin In Subjects With Type 2 Diabetes Mellitus (T2DM) | WITHDRAWN | PHASE2, PHASE3 | 2006-05 | 2007-10 | 2007-10 |
| NCT00354809 | Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia | COMPLETED | PHASE2 | 2006-05 | 2007-07 | 2007-07 |
| NCT00356811 | Lapatinib Combined With Paclitaxel For Patients With First-Line ErbB2-Amplified Metastatic Breast Cancer | COMPLETED | PHASE2 | 2006-05 | 2013-12 | 2008-03 |
| NCT00363142 | A Study of an Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected Subjects | COMPLETED | PHASE3 | 2006-05 | 2008-06 | 2008-06 |
| NCT00333021 | Abdominal Surgery Study Of GSK576428 (Fondaparinux Sodium)In Japanese Patients | COMPLETED | PHASE3 | 2006-05 | 2007-02 | |
| NCT00330616 | Study Of Bupropion SR (323U66) In Patients With Major Depressive Disorder In Japan | COMPLETED | PHASE2 | 2006-05 | 2007-11 | 2007-11 |
| NCT00343486 | Dose Ranging Study Of Solabegron Versus Placebo In Female Patients With Overactive Bladder Symptoms | COMPLETED | PHASE2 | 2006-05 | | |
| NCT00348192 | SB-742457 And Donepezil In Alzheimer's Disease | COMPLETED | PHASE2 | 2006-05 | | |
| NCT00314912 | Open-Label Extension of the Phase III Study With Tramiprosate (3APS) in Patients With Mild to Moderate Alzheimer's Disease | UNKNOWN | PHASE3 | 2006-05 | | |
| NCT00388076 | Pazopanib (VOTRIENT) Plus Paclitaxel (TAXOL), Pazopanib Plus Paclitaxel (TAXOL) Plus Carboplatin (PARAPLATIN), and Pazopanib Plus Paclitaxel (TAXOL) Plus Lapatinib (TYKERB) | COMPLETED | PHASE1 | 2006-04-28 | 2009-07-21 | 2009-07-21 |
| NCT00321763 | Study to Demonstrate the Lot-to-lot Consistency and to Evaluate the Safety of an Adjuvanted Influenza Vaccine Candidate | COMPLETED | PHASE2 | 2006-04-27 | 2006-07-07 | 2006-07-01 |
| NCT00316693 | Human Papillomavirus (HPV) Vaccine (Cervarix TM) Efficacy, Immunogenicity & Safety Trial in Adult Japanese Women With GSK Biologicals HPV-16/18 Vaccine | COMPLETED | PHASE2 | 2006-04-26 | 2009-02-10 | 2009-02-10 |
| NCT00317109 | Study to Asses DTPw-HBV/Hib at 15-18 Months (m) and Mencevax™ ACW at 24 to 30 m in Primed Subjects | COMPLETED | PHASE3 | 2006-04-19 | 2007-05-17 | 2007-05-01 |
| NCT00359463 | Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment | COMPLETED | PHASE1 | 2006-04-18 | 2007-03-07 | 2007-03-07 |
| NCT00307021 | Double-blind Study of Safety and Immunogenicity of Two Candidate Malaria Vaccines in Gabonese Children | COMPLETED | PHASE2 | 2006-04-07 | 2007-08-22 | 2006-09-15 |
| NCT00371488 | GW572016 Combined With Trastuzumab For The Treatment Of Previously Trastuzumab-Treated Breast Cancer | COMPLETED | PHASE1 | 2006-04-06 | 2007-12-10 | 2007-12-10 |
| NCT00239577 | A Trial of a Walter Reed Army Institute of Research (WRAIR) Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy US Adults | COMPLETED | PHASE2 | 2006-04-05 | 2007-06-19 | 2007-06-19 |
| NCT00309166 | Evaluation of the Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV Vaccine in Young Males. | COMPLETED | PHASE2 | 2006-04-05 | 2007-06-19 | 2007-06-01 |
| NCT00370942 | GW823093C For The Treatment Of Type 2 Diabetes Mellitus | TERMINATED | PHASE2 | 2006-04-01 | 2006-11-25 | 2006-11-01 |
| NCT00371735 | Chlorproguanil-Dapsone-Artesunate (CDA) Versus Chlorproguanil-Dapsone (LAPDAP) For Uncomplicated Malaria | COMPLETED | PHASE3 | 2006-04 | 2007-05 | 2007-05 |
| NCT00320463 | Compare Immunogenicity & Safety of 2 Formulations of GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine Given in Healthy Infants | COMPLETED | PHASE3 | 2006-04 | 2007-01 | |
| NCT00352898 | Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™ | COMPLETED | PHASE2 | 2006-04 | 2006-11 | |
| NCT00327184 | Primary & Booster Study in Infants to Demonstrate Non-inferiority, Persistence & Immunogenicity of Hib-MenC Vaccine | COMPLETED | PHASE3 | 2006-04 | 2006-11 | 2006-11 |
| NCT00422994 | A Study To Investigate The Effects Of End Stage Renal Disease And Hemodialysis On The Pharmacokinetics Of Ropinirole | COMPLETED | PHASE1 | 2006-04 | 2006-12 | 2006-12 |
| NCT00358488 | Study Investigating Repeat Doses Of A New Medication (GSK159797) In Asthmatic Patients | COMPLETED | PHASE2 | 2006-04 | 2007-01 | 2007-01 |
| NCT00338351 | Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine. | COMPLETED | PHASE2 | 2006-04 | 2006-10 | |
| NCT00334282 | Safety and Efficacy of GW786034 (Pazopanib) In Metastatic Renal Cell Carcinoma | COMPLETED | PHASE3 | 2006-04 | 2014-12 | 2008-05 |
| NCT00340080 | Clinical Utility Of Genetic Screening For HLA-B*5701, On Susceptibility To Abacavir Hypersensitivity | COMPLETED | PHASE4 | 2006-04 | | |
| NCT00309647 | Study to Evaluate the Safety and Immunogenicity of Pandemic Monovalent (H5N1) Influenza Vaccines (Whole Virus Formulation) in Adults 18 and 60 Years of Age | COMPLETED | PHASE1 | 2006-03-29 | 2006-11-16 | 2006-11-01 |
| NCT00309634 | Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged Between 18 and 60 Years | COMPLETED | PHASE1 | 2006-03-27 | 2006-10-28 | 2006-10-28 |
| NCT00406003 | Single Dose Pharmacokinetic (PK) Study Of Paroxetine CR(12.5-37.5mg) In Healthy Chinese Subjects | COMPLETED | PHASE1 | 2006-03-24 | 2006-04-26 | 2006-04-26 |
| NCT00372957 | Study Of GW823093 In Japanese Subjects With Type 2 Diabetes Mellitus | COMPLETED | PHASE2 | 2006-03-22 | 2006-06-28 | 2006-06-28 |
| NCT00379730 | Prednisolone Novel Endpoint Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE1 | 2006-03-21 | 2007-05-03 | |
| NCT00329602 | Long-term Study Of Ropinirole In Restless Legs Syndrome | COMPLETED | PHASE4 | 2006-03 | 2008-09 | 2008-09 |
| NCT00334152 | Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women | COMPLETED | PHASE3 | 2006-03 | 2006-07 | 2006-07 |
| NCT00358358 | Chronic Obstructive Pulmonary Disease Endpoints Study | COMPLETED | PHASE4 | 2006-03 | 2007-02 | 2007-02 |
| NCT00306241 | A Study to Evaluate the Immunogenicity and Safety of GSK Biologicals' HPV Vaccine in Healthy Women Aged 18-35 Years | COMPLETED | PHASE3 | 2006-03 | 2007-06 | 2007-06 |
| NCT00316680 | Immuno & Safety Study With 2 Formulations of DTPw-HBV/HIB When Given at Birth With Hepatitis B at 2, 4 and 6 Mths.Age. | TERMINATED | PHASE3 | 2006-03 | 2006-11 | |
| NCT00353288 | Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™ | COMPLETED | PHASE2 | 2006-03 | 2006-11 | 2006-11 |
| NCT00326248 | Casopitant (Oral) And ZOFRAN To Prevent Postoperative Nausea And Vomiting In Women | COMPLETED | PHASE3 | 2006-03 | 2006-07 | 2006-07 |
| NCT00377728 | Trial With Rhinitic Patients Taking GSK256066 Versus Placebo In A Pollen Challenge Chamber | COMPLETED | PHASE2 | 2006-03 | 2006-05 | 2006-05 |
| NCT00291902 | A Pharmacokinetic Study Of SB-681323 In Subjects With Coronary Heart Disease Undergoing Percutaneous Intervention | COMPLETED | PHASE2 | 2006-03 | | |
| NCT00354510 | Topical GW842470X In Adults Patients With Moderate Atopic Dermatitis | COMPLETED | PHASE2 | 2006-03 | | |
| NCT00281632 | A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer | COMPLETED | PHASE2 | 2006-03 | 2010-10 | 2008-04 |
| NCT00891293 | A Second Open-Label Extension of a Double-Blind, Parallel, Phase IV Study to Assess the Efficacy and Safety of Adjunctive Lovaza® (Formerly Known as Omacor®) Therapy in Hypertriglyceridemic Subjects Treated With Antara™ | COMPLETED | PHASE4 | 2006-03 | 2008-05 | 2008-05 |
| NCT00371566 | A Study Of Lapatinib Versus Placebo Followed By Chemoradiation In Patients With Locally Advanced Head And Neck Cancer | COMPLETED | PHASE2 | 2006-03 | 2007-12 | 2007-12 |
| NCT00351923 | Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration Routes | COMPLETED | PHASE3 | 2006-03 | 2006-12 | |
| NCT00289783 | Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine | COMPLETED | PHASE3 | 2006-02-22 | 2008-02-26 | 2007-08-27 |
| NCT00306293 | VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2 | COMPLETED | PHASE4 | 2006-02-20 | 2006-11-27 | 2006-11-27 |
| NCT00331058 | Comparison Of Molecular Targets In Mild To Severe Asthmatics And Healthy Subjects | TERMINATED | PHASE1 | 2006-02-18 | 2011-07-07 | 2011-07-07 |
| NCT00368979 | Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects | COMPLETED | PHASE3 | 2006-02-17 | 2007-12-06 | 2007-12-01 |
| NCT00294047 | Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older | COMPLETED | PHASE3 | 2006-02-16 | 2014-01-29 | 2014-01-29 |
| NCT00320424 | Hip Fracture Study of GSK576428 (Fondaparinux Sodium) | COMPLETED | PHASE3 | 2006-02-16 | 2006-10-26 | 2006-10-26 |
| NCT00289172 | Assess the Immunogenicity & Safety of 2 Doses of Oral Live Attenuated Human Rota(HRV)Vaccine in Healthy Infants in India | COMPLETED | PHASE3 | 2006-02-10 | 2006-09-08 | |
| NCT00453791 | The Safety and Tolerability of GW805858 in Healthy Volunteers and Mild Asthmatics | TERMINATED | PHASE1 | 2006-02-07 | 2006-04-10 | 2006-04-10 |
| NCT00289198 | Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR) | COMPLETED | PHASE3 | 2006-02-07 | 2006-07-04 | 2006-07-01 |
| NCT00291343 | Immune Response & Safety of GSK Biologicals' Mencevax™ ACWY in Subjects Primed in the DTPW-HBV=HIB-MENAC-TT-011 Study | COMPLETED | PHASE3 | 2006-02-01 | 2007-03-15 | 2007-03-15 |
| NCT00314860 | RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole | COMPLETED | PHASE3 | 2006-02 | 2006-12 | 2006-12 |
| NCT00197275 | Lot-to-lot Consistency of Tritanrix™-HepB/Hib-MenAC & Its Non-inferiority vs Tritanrix™-HepB/Hiberix™ in Infants | COMPLETED | PHASE3 | 2006-02 | 2006-11 | |
| NCT00354536 | In-patient Study With GSK716155 In Patients With Type 2 Diabetes Mellitus | COMPLETED | PHASE2 | 2006-02 | 2006-09 | 2006-09 |
| NCT00320398 | Total Hip Replacement Study Of GSK576428 (Fondaparinux Sodium) | COMPLETED | PHASE3 | 2006-01-30 | 2006-07-18 | 2006-07-18 |
| NCT00282295 | US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal Disease | COMPLETED | PHASE4 | 2006-01-25 | 2006-08-08 | 2006-08-08 |
| NCT00136604 | Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m | COMPLETED | PHASE3 | 2006-01-22 | 2006-04-23 | 2006-04-23 |
| NCT00296517 | Study In Patients With Depression Not Responding to Selective Serotonin Re-uptake Inhibitors | COMPLETED | PHASE3 | 2006-01-19 | 2008-03-28 | 2008-03-28 |
| NCT00354965 | Pharmacokinetic Profiles Of Amoxicillin 2000 mg And Clavulanate 125 mg In Adolescent Patients | COMPLETED | PHASE1 | 2006-01-19 | 2007-04-02 | 2007-04-02 |
| NCT00290329 | Safety of Purified Meningococcal Vaccine With Serogroups ACWY, in 3,000 Filipino Subjects Aged > 2 Years | COMPLETED | PHASE4 | 2006-01-14 | 2006-10-17 | 2006-10-01 |
| NCT00297063 | BRL49653C In Type 2 Diabetes -Comparison Study With Pioglitazone And Placebo By Monotherapy- | COMPLETED | PHASE3 | 2006-01-11 | 2007-05-31 | 2007-05-31 |
| NCT00273052 | COREG MR Versus TOPROL-XL On The Lipid Profile Of Normolipidemic Or Mildly Dyslipidemic Patients With Hypertension | COMPLETED | PHASE3 | 2006-01-05 | 2007-12-28 | 2007-12-01 |
| NCT00290342 | Evaluation of the Immunogenicity, Safety and Reactogenicity of the Combined DTPa-IPV Vaccine in Healthy Infants | COMPLETED | PHASE3 | 2006-01-01 | 2007-01-23 | 2007-01-01 |
| NCT00307034 | Safety & Immunogenicity Study of 10-Valent Pneumococcal Conjugate Vaccine When Administered as a 2-Dose Schedule | COMPLETED | PHASE3 | 2006-01-01 | 2007-01-25 | 2007-01-01 |
| NCT00358410 | An Exploratory Study Examining The Effects Of Taking GW679769 Once-Daily For 4 Days In Patients With Functional Dyspepsia | COMPLETED | PHASE2 | 2006-01 | 2006-08 | 2006-08 |
| NCT00297180 | Weight Loss In Obese Subjects Taking Either GW869682 Or Placebo 3 Times Per Day For 12 Weeks | COMPLETED | PHASE2 | 2006-01 | 2006-09 | 2006-09 |
| NCT00280436 | Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia | COMPLETED | PHASE2 | 2006-01 | 2007-03 | 2007-03 |
| NCT00291356 | GSK189075, GW869682 Or Placebo In Type 2 Diabetic Patients | COMPLETED | PHASE2 | 2006-01 | 2006-05 | 2006-05 |
| NCT00280423 | Effects Of GW679769 On Sleep Onset And Maintenance And Next Day Functioning In Subjects With Primary Insomnia | COMPLETED | PHASE2 | 2006-01 | 2007-02 | 2007-02 |
| NCT00379990 | A Study To Investigate GW274150 Or Prednisolone In Rheumatoid Arthritis Taken Repeatedly For 28 Days. | COMPLETED | PHASE2 | 2006-01 | 2007-12 | 2007-12 |
| NCT00282724 | Efficacy and Safety of Two Doses of Liarozole vs. Placebo for the Treatment of Lamellar Ichthyosis | COMPLETED | PHASE2, PHASE3 | 2006-01 | 2007-04 | 2007-04 |
| NCT00332319 | Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury Patients | TERMINATED | PHASE2 | 2006-01 | 2007-02 | 2007-02 |
| NCT00324961 | Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B | COMPLETED | PHASE4 | 2006-01 | 2009-01 | 2009-01 |
| NCT00316719 | Adefovir Dipivoxil In Compensated Chronic Hepatitis B Patients | COMPLETED | PHASE3 | 2006-01 | 2008-01 | 2008-01 |
| NCT00269022 | Use Of SB-705498 In The Acute Treatment Of Migraine | COMPLETED | PHASE2 | 2006-01 | | |
| NCT00269061 | Study In Patients With Type 2 Diabetes Who Are Taking Metformin And Sulfonylurea, Metformin And Insulin, Or Insulin | COMPLETED | PHASE1 | 2006-01 | | |
| NCT00332046 | fMRI Study Comparing BOLD Activation Patterns Using GW679769 In Subjects With Social Anxiety Disorder | COMPLETED | PHASE1 | 2006-01 | | |
| NCT00279019 | Safety Study Using GSK233705 And Tiotropium In Patients With Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE1 | 2005-12-12 | 2006-06-13 | 2006-06-13 |
| NCT00281684 | SB-705498 Dental Pain Study After Tooth Extraction | COMPLETED | PHASE2 | 2005-12-07 | 2007-10-03 | 2007-10-03 |
| NCT00359177 | Observational Study Evaluating The Processing Or Breakdown Of GW679769 In Subjects With Hepatic Impairment | COMPLETED | PHASE1 | 2005-12-01 | 2006-10-12 | 2006-10-12 |
| NCT00235755 | Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy | COMPLETED | PHASE3 | 2005-12 | 2008-04 | 2008-04 |
| NCT00321477 | A Study Of GW679769 Compared To Placebo In Women With Overactive Bladder | COMPLETED | PHASE2 | 2005-12 | 2007-02 | 2007-02 |
| NCT00274703 | An Evaluation Of Mepolizumab In Therapy Of Eosinophilic Oesophagitis In Adult Patients | COMPLETED | PHASE2 | 2005-12 | 2007-03 | 2007-03 |
| NCT00325169 | SERETIDE Plus Tiotropium Versus Individual Components | COMPLETED | PHASE2 | 2005-12 | 2006-08 | 2006-08 |
| NCT00264667 | Study In Patients With Dyslipidaemia | COMPLETED | PHASE2 | 2005-12 | 2007-06 | |
| NCT00316147 | Immunogenicity & Safety of GSK's Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination Schedules | COMPLETED | PHASE3 | 2005-12 | 2006-08 | |
| NCT00318669 | Social Anxiety Disorder Study Of Paroxetine | COMPLETED | PHASE3 | 2005-12 | 2006-11 | 2006-11 |
| NCT00319137 | An Adaptive Design Trial Of GW274150 In The Treatment Of Acute Migraine | COMPLETED | PHASE2 | 2005-12 | | |
| NCT00320411 | GW572016 In Patients With ErbB2 Over - Expressing Advanced Or Metastatic Breast Cancer | COMPLETED | PHASE2 | 2005-11-28 | 2009-04-01 | 2009-04-01 |
| NCT00400660 | A First Time In Human Study To Assess The Compound GSK615915 | COMPLETED | PHASE1 | 2005-11-23 | 2006-07-03 | 2006-07-03 |
| NCT00258050 | To Examine The Effects Of Lapatinib On Orally And Intravenously Administered Midazolam In Cancer Patients | COMPLETED | PHASE1 | 2005-11-21 | 2007-02-08 | 2007-02-08 |
| NCT00353873 | Seretide Versus Flixotide In Asthmatic Children Not Controlled By Inhaled Corticosteroids | COMPLETED | PHASE4 | 2005-11-18 | 2006-10-26 | 2006-10-26 |
| NCT00372255 | Study on the Immunogenicity and Tolerability of Influsplit SSW® 2005/2006 in Children Aged 6 - 13 Years | COMPLETED | PHASE4 | 2005-11-17 | 2006-03-28 | 2006-03-28 |
| NCT00903409 | Open-Label Extension of a Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Lovaza® and Simvastatin Therapy in Hypertriglyceridemic Subjects | COMPLETED | PHASE3 | 2005-11-15 | 2008-06-27 | 2008-06-27 |
| NCT00256854 | Converting From Ropinirole Immediate Release (IR) To Ropinirole Controlled-Release for RLS (Restless Legs Syndrome) | COMPLETED | PHASE3 | 2005-11-14 | 2006-09-21 | 2006-09-21 |
| NCT00268996 | Integrated Biomarker And Imaging Study - 2 | COMPLETED | PHASE2 | 2005-11-10 | 2007-08-28 | 2007-08-28 |
| NCT00338338 | The Efficacy And Safety Of Lacidipine And Amlodipine Once-Daily Treatment In Hypertensive Adult Patients | COMPLETED | PHASE4 | 2005-11-07 | 2007-09-14 | 2007-09-14 |
| NCT00244751 | Antifibrotic Activity Of GI262570 In Chronic Hepatitis C Subjects | COMPLETED | PHASE2 | 2005-11-02 | 2008-03-13 | 2008-03-13 |
| NCT00291382 | Airway Hyper-responsiveness Study In Asthma Using Salmeterol/Fluticasone Propionate Combination Product | COMPLETED | PHASE4 | 2005-11 | 2007-07 | 2007-07 |
| NCT00246701 | Evaluation of Efficacy and Safety of Combined Omacor (Omega-3-acid Ethyl Esters) and Simvastatin Therapy in Hypertriglyceridemic Subjects | COMPLETED | PHASE3 | 2005-11-01 | 2006-06-01 | 2006-06-01 |
| NCT00240643 | Use Of SB424323 With Aspirin In Non-Valvular Atrial Fibrillation In Patients At A Low Or Intermediate Risk For Stroke | COMPLETED | PHASE2 | 2005-11 | 2006-12 | 2006-12 |
| NCT00523913 | A Study Of BRL49653C For The Treatment Of Type 2 Diabetes | COMPLETED | PHASE3 | 2005-11 | 2007-04 | |
| NCT00127010 | Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases | COMPLETED | PHASE3 | 2005-11 | 2006-06 | |
| NCT00307567 | Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488 | COMPLETED | PHASE2 | 2005-11 | 2006-03 | |
| NCT00290277 | Evaluate the Immunogenicity & Safety of GSK Biologicals' HPV Vaccine in Female Subjects Aged 10-14 Years | COMPLETED | PHASE3 | 2005-11 | 2006-08 | |
| NCT00307554 | A Lot-to-lot Consistency (3 Lots of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine) & Non-inferiority Study | COMPLETED | PHASE3 | 2005-11 | 2006-06 | |
| NCT00269048 | SB-480848 In Subjects With Coronary Heart Disease | COMPLETED | PHASE2 | 2005-11 | 2006-09 | 2006-09 |
| NCT00297258 | Pazopanib In Patients With Relapsed Or Refractory Soft Tissue Sarcoma | COMPLETED | PHASE2 | 2005-11 | 2014-02 | 2014-02 |
| NCT00320385 | Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer | COMPLETED | PHASE3 | 2005-11 | 2010-10 | 2007-06 |
| NCT00256919 | Single Dose Study Of GW856553 On A Protein That Is An Indicator For Rheumatoid Arthritis (RA) | COMPLETED | PHASE2 | 2005-11 | 2006-11 | 2006-11 |
| NCT00320450 | SB-681323 In Subjects With Rheumatoid Arthritis | COMPLETED | PHASE2 | 2005-11 | 2006-10 | 2006-10 |
| NCT00259987 | Effects Of Lapatinib (GW572016) In Patients With Relapsed Adenocarcinoma Of The Esophagus | COMPLETED | PHASE2 | 2005-11 | 2007-05 | |
| NCT00318656 | 24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 Diabetes | COMPLETED | PHASE4 | 2005-11 | 2007-10 | 2007-10 |
| NCT00250276 | Evaluation of the Immune Responses of GSK Biologicals' HPV Vaccine Following Manufacturing Process Adaptation. | COMPLETED | PHASE3 | 2005-10-28 | 2007-03-01 | 2007-03-01 |
| NCT00307541 | Assess the Immunogenicity of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine | COMPLETED | PHASE3 | 2005-10-27 | 2006-04-07 | 2006-04-07 |
| NCT00373243 | A Study Of GW406381 In Volunteers With Moderate Hepatic Impairment | COMPLETED | PHASE1 | 2005-10-19 | 2006-09-26 | 2006-09-26 |
| NCT00318149 | Safety Study of Four Candidate Influenza Vaccines to Prevent Influenza Disease in the Elderly Population | COMPLETED | PHASE2 | 2005-10-10 | 2006-05-14 | 2006-05-14 |
| NCT00483899 | Examine the Effect of Repeat Inhaled Doses of GW870086X on Lung Function in Mild Asthmatic Male Subjects | COMPLETED | PHASE1 | 2005-10-07 | 2006-12-15 | 2006-12-15 |
| NCT00318058 | Safety Study of an Adjuvanted Candidate Influenza Vaccine to Prevent Influenza Disease in the Elderly Population | COMPLETED | PHASE1 | 2005-10-03 | 2005-11-04 | 2005-11-01 |
| NCT00360126 | An Open-Label Extension Study Of Lamotrigine In Subjects With Bipolar Disorder | COMPLETED | PHASE4 | 2005-10 | 2007-02 | 2007-02 |
| NCT00197288 | Study Comparing the Immune Response of Fluarix and Fluzone Influenza Vaccines | COMPLETED | PHASE3 | 2005-10 | 2006-06 | 2006-05 |
| NCT00328718 | Pediatric ADVAIR DISKUS Versus Oral Montelukast Chewable Tablets | COMPLETED | PHASE3 | 2005-10 | 2007-04 | 2007-04 |
| NCT00241644 | Vaccine Efficacy Against Rotavirus Diarrhea; Vaccine Given With Routine Childhood Vaccinations in Healthy African Infants | COMPLETED | PHASE3 | 2005-10 | 2008-06 | 2008-06 |
| NCT00355641 | Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome | COMPLETED | PHASE3 | 2005-10 | 2007-10 | 2007-10 |
| NCT00240617 | Study Of Treximet, Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks | COMPLETED | PHASE3 | 2005-10 | 2006-06 | 2006-06 |
| NCT00264615 | Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa | COMPLETED | PHASE3 | 2005-10 | 2006-06 | 2006-06 |
| NCT00242866 | Use Of GW274150 In The Prophylactic Treatment Of Migraine | COMPLETED | PHASE2 | 2005-10 | 2007-09 | 2007-09 |
| NCT00244764 | GW786034 In Subjects With Locally Recurrent Or Metastatic Clear Cell Renal Cell Carcinoma | COMPLETED | PHASE2 | 2005-10 | 2013-09 | 2008-03 |
| NCT00240630 | Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks | COMPLETED | PHASE3 | 2005-10 | 2006-06 | 2006-06 |
| NCT00316706 | Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine | COMPLETED | PHASE3 | 2005-10 | 2009-01 | 2009-01 |
| NCT00267488 | Intravenous Weekly Topotecan In Subjects With Recurrent Or Persistent Endometrial Cancer | COMPLETED | PHASE2 | 2005-10 | 2007-12 | 2007-12 |
| NCT00264654 | Long-term Study Of Paroxetine in Women and Men | COMPLETED | PHASE3 | 2005-10 | 2005-11 | 2005-11 |
| NCT00349427 | A Study Of Rosiglitazone Plus Insulin To Treat Type 2 Diabetes Mellitus Patients | COMPLETED | PHASE3 | 2005-10 | | |
| NCT00259896 | In-patient Study in Patients With Type 2 Diabetes Mellitus | COMPLETED | PHASE1 | 2005-10 | | |
| NCT00246636 | Evaluation of Efficacy and Safety of Omacor (Omega-3-acid Ethyl Esters) as Add-on Therapy in Hypertriglyceridemic Subjects Treated With Antara (Fenofibrate) Followed by an 8-week Extension | COMPLETED | PHASE4 | 2005-10 | 2007-03 | 2007-02 |
| NCT00358384 | Chronic Plaque Psoriasis Study With Topical Formulation Of GW786034 | COMPLETED | PHASE1 | 2005-09-26 | 2006-02-24 | 2006-02-24 |
| NCT00158756 | Immune Response Post Pry Vaccination of 2 Formulations of DTPw-HBV Vaccine Given With Rotavirus Vaccine to Infants | COMPLETED | PHASE3 | 2005-09-12 | 2006-11-23 | 2006-11-01 |
| NCT02153320 | Study to Evaluate the Persistence of the Cellular and Humoral Immune Response Following Vaccinations With GlaxoSmithKline (GSK) Biologicals' Candidate Vaccines Containing HBsAg and Different Adjuvants in Healthy Adult Volunteers | COMPLETED | PHASE1 | 2005-09-05 | 2005-10-28 | 2005-10-28 |
| NCT00226499 | Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and Chickenpox | COMPLETED | PHASE3 | 2005-09-01 | 2006-10-12 | 2006-10-12 |
| NCT00196989 | Study In People With Type 2 Diabetes | COMPLETED | PHASE2 | 2005-09 | 2007-04 | 2007-04 |
| NCT00259870 | SB-773812 Administered In Adults With Schizophrenia | COMPLETED | PHASE2 | 2005-09 | 2007-08 | |
| NCT00197223 | Post-marketing Study to Evaluate the Efficacy of Influenza Vaccine | COMPLETED | PHASE3 | 2005-09 | 2006-05 | 2005-10 |
| NCT00244725 | Odiparcil For The Prevention Of Venous Thromboembolism | COMPLETED | PHASE2 | 2005-09 | 2006-09 | 2006-09 |
| NCT00296491 | Study Of Allergic Rhinitis In Patients Who Also Have Asthma | COMPLETED | PHASE4 | 2005-09 | 2007-10 | 2007-10 |
| NCT00296530 | Study Of Patients With Allergic Rhinitis And Asthma | COMPLETED | PHASE4 | 2005-09 | 2007-07 | 2007-07 |
| NCT00232596 | Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy | COMPLETED | PHASE3 | 2005-09 | 2008-01 | 2008-01 |
| NCT00224523 | Long Term Safety Of GW685698X Via Nasal Biopsy | COMPLETED | PHASE3 | 2005-09 | 2007-02 | 2007-02 |
| NCT00319332 | A Comparative Study Of Iodine I 131 Tositumomab Therapeutic Regimen Versus Ibritumomab Tiuxetan Therapeutic Regimen | WITHDRAWN | PHASE3 | 2005-09 | 2021-02 | 2021-02 |
| NCT00224497 | A Dose Ranging Study To Investigate The Efficacy And Safety Of SB-742457 In Alzheimer's Disease | COMPLETED | PHASE2 | 2005-09 | | |
| NCT00320307 | Comparison of Abacavir Following Once-Daily And Twice-Daily Administration In HIV Infected Subjects | COMPLETED | PHASE1 | 2005-09 | | |
| NCT00217763 | European Study of 3APS in Mild to Moderate Alzheimer's Disease Patients | UNKNOWN | PHASE3 | 2005-09 | 2007-12 | |
| NCT00364273 | GSK159802 In Healthy Male Subjects And Asthmatics | COMPLETED | PHASE1 | 2005-08-24 | 2006-07-06 | 2006-07-06 |
| NCT00197028 | Examine Safety and Immune Responses of GSK 257049 Vaccine When Administered to Infants Living in a Malaria-endemic Region | COMPLETED | PHASE2 | 2005-08-23 | 2007-12-27 | 2007-12-27 |
| NCT00256867 | A Study In Patients With Type 2 Diabetes Mellitus | COMPLETED | PHASE3 | 2005-08-18 | 2006-10-31 | 2006-10-31 |
| NCT00334646 | Cyclophosphamide Drug Interaction Study In Cancer Patients | TERMINATED | PHASE1 | 2005-08-10 | 2009-10-14 | 2009-10-14 |
| NCT00327197 | Assessment Of Disease Pathology And Key Therapeutic Targets In Severe Asthma | TERMINATED | PHASE1 | 2005-08-02 | 2011-06-06 | 2011-06-06 |
| NCT00370435 | Study Of 90mg Of GW274150 In Subjects Over 50 Years, Who Have Rheumatoid Arthritis (RA) | COMPLETED | PHASE2 | 2005-08 | 2005-09 | 2005-09 |
| NCT00197262 | Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR) | COMPLETED | PHASE3 | 2005-08 | 2005-10 | 2005-10 |
| NCT00273039 | A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder | COMPLETED | PHASE2 | 2005-08 | 2006-09 | 2006-09 |
| NCT02948881 | A Study To Assess The Quality Of Bone In Patients Taking Oral Ibandronate Versus Placebo | COMPLETED | PHASE4 | 2005-08 | 2007-07 | 2007-07 |
| NCT00137930 | Study of Immunogenicity & Safety of 2 Different Formulations of Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis | COMPLETED | PHASE2 | 2005-08 | 2005-11 | |
| NCT00126945 | Evaluate 4 Different Formulations of Meningococcal Serogroups A,C,W-135,Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 15-19 Yrs | COMPLETED | PHASE2 | 2005-08 | 2005-10 | |
| NCT00257582 | Study Of Cutaneous Disease Accompanied With Pruritus In Pediatrics | COMPLETED | PHASE3 | 2005-08 | | |
| NCT00257569 | Study Of Atopic Dermatitis In Pediatrics | COMPLETED | PHASE3 | 2005-08 | | |
| NCT00257595 | Perennial Allergic Rhinitis In Pediatric Subjects | COMPLETED | PHASE3 | 2005-08 | | |
| NCT00372801 | Effectiveness Of Single Doses Of Ibuprofen In Patients With Osteoarthritis Of The Knee | COMPLETED | PHASE1 | 2005-08 | | |
| NCT00351143 | A Comparative Study To Determine If Motivating Asthma Education (Compliance Enhancement) Has An Effect On Asthma Control | COMPLETED | PHASE4 | 2005-07-26 | 2007-06-13 | 2007-06-13 |
| NCT00318630 | The Effect Of AVANDIA On The Late Asthmatic Response | COMPLETED | PHASE1 | 2005-07-22 | 2006-06-30 | 2006-06-30 |
| NCT00117325 | Study Of Adults And Adolescents With Vasomotor Rhinitis | COMPLETED | PHASE3 | 2005-07-11 | 2006-02-09 | 2006-02-09 |
| NCT00146744 | Safety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02A in Healthy PPD-positive Adults | COMPLETED | PHASE2 | 2005-07 | 2006-05 | 2006-05 |
| NCT00118703 | Once-Daily Investigational Nasal Spray In Adults And Adolescents With Vasomotor Rhinitis | COMPLETED | PHASE3 | 2005-07-01 | 2006-02-09 | 2006-02-01 |
| NCT00123903 | COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria | TERMINATED | PHASE3 | 2005-07 | 2006-05 | 2006-05 |
| NCT00126984 | Study in Children to Evaluate the Immunogenicity and Safety of 4 Formulations of GSK Bio MenACWY-TT Conjugate Vaccine | COMPLETED | PHASE2 | 2005-07 | 2008-02 | 2008-02 |
| NCT00134732 | Study of 2 Doses of Oral Live Attenuated Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis | COMPLETED | PHASE3 | 2005-07 | 2006-05 | |
| NCT00306943 | Annual Study for Fluarix Registration | COMPLETED | PHASE3 | 2005-07 | 2005-08 | 2005-08 |
| NCT00364429 | SPECT Investigation Of The NMDA Receptor System In Healthy Volunteers And Patients With Schizophrenia | TERMINATED | PHASE1 | 2005-07 | 2005-07 | 2005-07 |
| NCT00343278 | Pharmacokinetic Study Of Valaciclovir Hydrochloride Tablets | COMPLETED | PHASE4 | 2005-07 | 2005-08 | 2005-08 |
| NCT00253058 | Study Of Perennial Allergic Rhinitis In Pediatrics | COMPLETED | PHASE3 | 2005-07 | | |
| NCT01745458 | SB-659032 Platelet Aggregation Study | COMPLETED | PHASE1 | 2005-07 | 2005-12 | 2005-12 |
| NCT00197197 | Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5/X4-Tropic Treatment-Experienced HIV-Infected Subjects | TERMINATED | PHASE3 | 2005-07 | 2005-10 | 2005-10 |
| NCT00144859 | Safety And Anti-Inflammatory Effect Of SB681323 In Patients With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE2 | 2005-07 | | |
| NCT00244712 | Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV | COMPLETED | PHASE4 | 2005-07 | 2008-04 | 2008-04 |
| NCT00297076 | Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects | TERMINATED | PHASE3 | 2005-07 | 2007-10 | 2007-10 |
| NCT00358475 | Study Of Perennial Allergic Rhinitis | COMPLETED | PHASE3 | 2005-06-21 | 2005-10-12 | 2005-10-01 |
| NCT00269035 | SPECT Study With SB-773812 In Schizophrenic Patients | COMPLETED | PHASE1 | 2005-06-21 | 2007-05-26 | 2007-05-26 |
| NCT00134693 | A Single Dose Of Compound SB-681323 Compared To Prednisolone On A Protein That Is an Indicator For Rheumatoid Arthritis | COMPLETED | PHASE2 | 2005-06-21 | 2006-08-03 | 2006-08-03 |
| NCT00228917 | Safety Study of Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY Vaccines in Children | COMPLETED | PHASE3 | 2005-06-16 | 2006-01-20 | 2006-01-20 |
| NCT00140712 | Ropinirole Tablets In Young Patients With Restless Legs Syndrome | COMPLETED | PHASE1 | 2005-06-10 | 2008-02-28 | 2008-02-28 |
| NCT00356642 | Study Of Single And Ten Day Repeat Atopical Applications Of GW842470X Cream On The Skin Of Patients With Atopic Dermatitis | COMPLETED | PHASE1 | 2005-06-10 | 2005-12-21 | 2005-12-21 |
| NCT00127608 | Detection and Characterisation of Varicella Zoster Virus From Dermal Lesions of Chickenpox-infected Patients | COMPLETED | PHASE3 | 2005-06-07 | 2006-07-13 | 2006-07-13 |
| NCT00113308 | COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis | COMPLETED | PHASE3 | 2005-06 | 2006-09 | 2006-09 |
| NCT00259883 | Combination Of PAXIL Tablet And Benzodiazepines | COMPLETED | PHASE4 | 2005-06 | 2006-02 | 2006-02 |
| NCT00413023 | Study Of The Effects Of A New Antidepressant Therapy In Patients With Major Depressive Disorder (MDD) | COMPLETED | PHASE2 | 2005-06 | 2006-09 | 2006-09 |
| NCT00139334 | A Study to Test 2 Doses of the HRV Vaccine Given With or Without OPV in Healthy Infants in Bangladesh | COMPLETED | PHASE2 | 2005-06 | 2006-01 | |
| NCT00227422 | Assess the Non-inferiority of GSK Biologicals' Mencevax™ ACWY (Manufactured by a New Process) vs Mencevax™ ACWY (the Already Existing Vaccine in the Market) When Given as a Single Dose to Subjects Aged 2-30 Yrs | COMPLETED | PHASE4 | 2005-06 | 2005-11 | |
| NCT00197080 | Ropinirole XR (Extended Release) In Patients With Restless Legs Syndrome | COMPLETED | PHASE3 | 2005-06 | 2006-01 | |
| NCT00316186 | First-line Treatment Of Subjects With Extensive Disease Small Cell Lung Cancer With Weekly Hycamtin And Paraplatin | COMPLETED | PHASE2 | 2005-06 | 2009-05 | 2009-03 |
| NCT00197106 | Treatment Of Symptomatic Asthma In Children | COMPLETED | PHASE4 | 2005-06 | 2008-10 | 2008-10 |
| NCT00380133 | Study of SB681323 and Prednisolone on Biomarkers in COPD (Chronic Obstructive Pulmonary Disease) Patients | COMPLETED | PHASE1 | 2005-06 | 2006-04 | 2006-04 |
| NCT00123890 | Screening Protocol To Determine Eligibility For Studies Of The Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 | TERMINATED | PHASE3 | 2005-06 | 2005-10 | 2005-10 |
| NCT00306995 | Safety Study of Pandemic Candidate Influenza Vaccines in the Elderly Population | COMPLETED | PHASE2 | 2005-05-11 | 2006-07-04 | 2006-07-04 |
| NCT00583362 | A Continuation Trial for Subjects With Systemic Lupus Erythematosus That Have Completed Protocol LBSL02 | COMPLETED | PHASE2 | 2005-05-04 | 2016-02-23 | 2016-02-23 |
| NCT00455923 | SERETIDE Vs FLIXOTIDE In Mild Persistent Asthma (GINAII) | COMPLETED | PHASE4 | 2005-05-03 | 2007-07-31 | 2007-07-31 |
| NCT00120900 | Evaluation of GW406381 in Treating Adults With Osteoarthritis Of The Knee | COMPLETED | PHASE3 | 2005-05 | 2007-09 | 2007-09 |
| NCT00225823 | Study In Adults And Adolescents With Seasonal Allergic Rhinitis. | COMPLETED | PHASE3 | 2005-05 | 2005-08 | 2005-08 |
| NCT00127023 | Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases | COMPLETED | PHASE3 | 2005-05 | 2005-11 | |
| NCT00126997 | Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases | COMPLETED | PHASE4 | 2005-05 | 2005-11 | 2005-11 |
| NCT00419809 | SB-681323-Methotrexate Interaction Study | COMPLETED | PHASE1 | 2005-05 | 2005-12 | 2005-12 |
| NCT00347009 | Adefovir Dipivoxil For The Treatment Of Patients With Chronic Hepatitis B Related Advanced Fibrosis Or Cirrhosis | COMPLETED | PHASE4 | 2005-05 | 2009-09 | 2009-09 |
| NCT00111800 | A New Oral Treatment For Type II Diabetes Mellitus | COMPLETED | PHASE2 | 2005-04-28 | 2006-07-21 | 2006-07-01 |
| NCT00134719 | Hib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate Vaccines | COMPLETED | PHASE2 | 2005-04-11 | 2007-02-21 | 2006-07-24 |
| NCT00111787 | Study Of Lapatinib In Combination With Paclitaxel In The Treatment Of Newly Diagnosed Inflammatory Breast Cancer | COMPLETED | PHASE2 | 2005-04-11 | 2006-11-01 | 2006-11-01 |
| NCT00327990 | Evaluation Of Missed Osteoporosis Diagnoses, And Preference Between Once Monthly Ibandronate And Once Weekly Alendronate | COMPLETED | PHASE4 | 2005-04 | 2006-12 | 2006-12 |
| NCT00375765 | Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer | COMPLETED | PHASE4 | 2005-04 | 2007-07 | 2007-07 |
| NCT00133874 | Topical SB-275833 Ointment, 1% For The Treatment Of Impetigo | COMPLETED | PHASE3 | 2005-04 | 2005-09 | 2005-09 |
| NCT00323622 | Long-Term Follow-up of Children for a 2-Year Period to Confirm the Safety and Immunogenicity of GSK 257049 Vaccine | COMPLETED | PHASE2 | 2005-04 | 2007-05 | 2007-05 |
| NCT00133848 | Treatment Of Impetigo With Topical SB-275833 Ointment, 1% Versus Topical Placebo Ointment | COMPLETED | PHASE3 | 2005-04 | 2006-01 | |
| NCT00109486 | Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal Spray | COMPLETED | PHASE3 | 2005-04 | 2005-11 | 2005-11 |
| NCT00118729 | Study In Adolescent And Adult Subjects 12 Years Of Age And Older With Seasonal Allergic Rhinitis To Assess Onset of Action | COMPLETED | PHASE3 | 2005-04 | 2005-08 | 2005-08 |
| NCT00110799 | SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C | COMPLETED | PHASE2 | 2005-04 | 2006-11 | 2006-10 |
| NCT00348361 | Exploration Of Key Targets And Biomarkers Involved In An Allergic Response In Subjects With Allergic Rhinitis (Hay Fever) | COMPLETED | PHASE1 | 2005-04 | | |
| NCT00158769 | A Study To Compare The Effects Of The Infusion Of A Sepsis Drug Between Healthy Adults And Adults With Damaged Livers | COMPLETED | PHASE1 | 2005-03-31 | 2005-10-26 | 2005-10-26 |
| NCT00116844 | VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive Subjects. VALTREX® Tablet is a Trademark of GlaxoSmithKline Group of Companies. | COMPLETED | PHASE4 | 2005-03-29 | 2006-01-10 | 2006-01-10 |
| NCT00196976 | Safety & Immunogenicity of 1 Dose of GSK134612 in Children 12-14 Months and 3-5 Years Old | COMPLETED | PHASE2 | 2005-03-24 | 2006-03-03 | 2006-03-01 |
| NCT00742131 | A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally to Subjects With Solid Tumors | COMPLETED | PHASE1 | 2005-03-17 | 2011-08-29 | 2008-05-13 |
| NCT00263666 | A Study of Safety, Reactogenicity and Immunogenicity of HRV Vaccine in HIV Infected Infants in South Africa | COMPLETED | PHASE2 | 2005-03-16 | 2008-02-13 | 2008-02-07 |
| NCT00140738 | Safety and Immunogenicity Study of the New dHER2 Vaccine to Treat HER2-positive Metastatic Breast Cancer | COMPLETED | PHASE1 | 2005-03-10 | 2009-09-29 | 2008-09-29 |
| NCT00231413 | Human Papilloma Virus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Bio's Novel HPV Vaccine. | COMPLETED | PHASE2 | 2005-03-04 | 2006-03-27 | 2006-03-27 |
| NCT00148928 | Safety & Activity of P501-AS15 Vaccine as a First-line Treatment for Patients With Hormone-sensitive Prostate Cancer Who Show Rising PSA | COMPLETED | PHASE1 | 2005-03-01 | 2006-11-07 | 2006-11-07 |
| NCT00169507 | Study of Immunological Memory Induced in Children by a Full 4 Dose Vaccination Schedule of 11 Valent Pneumococcal Conjugate Vaccine by Giving 1 Dose of Aventis Pasteur's 23-valent Pneumococcal Polysaccharide Vaccine (Pneumo 23) | COMPLETED | PHASE3 | 2005-03 | 2005-04 | 2005-04 |
| NCT00169585 | Levofloxacin For The Management Of Patients With Abnormal Prostate Specific Antigen (PSA) | COMPLETED | PHASE3 | 2005-03 | 2007-04 | 2007-04 |
| NCT00169455 | Assess the Immunogenicity of the Human Rotavirus (HRV) Vaccine After Reconstitution Without Buffering Agent; & Evaluate the Immunogenicity, Reactogenicity & Safety of the Vaccine After Storage for 7 d at 37°C Following 2 Doses in Healthy Infants | COMPLETED | PHASE3 | 2005-03 | 2005-12 | 2005-12 |
| NCT00369993 | Spacer Comparison In Adult Asthmatics | COMPLETED | PHASE2 | 2005-03 | 2005-05 | 2005-05 |
| NCT00197158 | Comparison of Monodose and Multidose Presentations of GSK Biologicals' Hepatitis B Vaccine in Terms of Immune Response | COMPLETED | PHASE4 | 2005-03 | 2005-12 | 2005-12 |
| NCT00196963 | Evaluate 4 Different Formulations of Meningococcal Serogroups A, C, W-135, Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 15-19 Yrs | COMPLETED | PHASE2 | 2005-03 | 2005-07 | 2005-07 |
| NCT00107757 | Seasonal Allergic Rhinitis In Pediatric Subjects | COMPLETED | PHASE3 | 2005-03 | 2005-11 | |
| NCT00263653 | Safety, Reactogenicity & Immunogenicity Study to Evaluate a Booster Dose of GSK Biologicals' Hib-MenC Given With Priorix™ in Toddlers (13-14 m) Primed With 3 Doses of Hib and MenC-CRM197 | COMPLETED | PHASE3 | 2005-03 | 2005-09 | 2005-03 |
| NCT00105950 | Study Of Lapatinib In Patients With Relapsed Or Refractory Inflammatory Breast Cancer | COMPLETED | PHASE2 | 2005-03 | 2010-05 | 2007-09 |
| NCT00169416 | Evaluation Of Valaciclovir In Patients With Chickenpox | COMPLETED | PHASE3 | 2005-03 | 2005-08 | 2005-08 |
| NCT00316173 | Second-Line Therapy Study For Potentially Platinum-Sensitive Relapsed Ovarian Cancer | COMPLETED | PHASE2 | 2005-03 | 2009-03 | 2009-01 |
| NCT00144833 | Open Label Study of 908/RTV in Combination With Other PIs for the Treatment of Multi PI-Experienced HIV Subjects | TERMINATED | PHASE3 | 2005-03 | | |
| NCT00363740 | Study of GW685698X In Patients With Seasonal Allergic Rhinitis | COMPLETED | PHASE3 | 2005-02-19 | 2005-04-13 | 2005-04-01 |
| NCT00169442 | Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in Infants | COMPLETED | PHASE3 | 2005-02-10 | 2006-03-10 | 2006-03-01 |
| NCT00102726 | SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy | COMPLETED | PHASE2 | 2005-02 | 2007-02 | 2007-02 |
| NCT00108914 | Perennial Allergic Rhinitis Study In Pediatric Subjects | COMPLETED | PHASE3 | 2005-02 | 2005-11 | 2005-11 |
| NCT00274690 | Post-Operative Nausea And Vomiting Study In Female Patients | COMPLETED | PHASE2 | 2005-02 | 2005-08 | 2005-08 |
| NCT00116883 | A Study Of GW685698X For The Treatment Of Perennial Allergic Rhinitis In Pediatrics | COMPLETED | PHASE3 | 2005-02 | 2005-07 | 2005-07 |
| NCT00258700 | Primary & Booster Immunogenicity Study of GSK Biologicals' Hib-MenC Versus a Licensed Men-C Vaccine | COMPLETED | PHASE3 | 2005-02 | 2006-07 | 2006-07 |
| NCT00102739 | SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP) | COMPLETED | PHASE2 | 2005-02 | 2007-01 | 2007-01 |
| NCT00291928 | HuMax-CD20 in Active Rheumatoid Arthritis, Phase I/II | COMPLETED | PHASE2 | 2005-02 | 2007-09 | 2007-09 |
| NCT00269126 | Clinical Evaluation Of GW815SF For Chronic Obstructive Pulmonary Disease (Chronic Bronchitis, Emphysema) | COMPLETED | PHASE3 | 2005-02 | 2005-08 | 2005-08 |
| NCT00169572 | Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy | COMPLETED | PHASE2 | 2005-02 | | |
| NCT00481182 | Co-Administration Of Fosamprenavir With Methadone: A Drug Interaction Study. | COMPLETED | PHASE1 | 2005-02 | | |
| NCT00269087 | GW815SF For Chronic Obstructive Pulmonary Disease (Chronic Bronchitis, Emphysema) | COMPLETED | PHASE3 | 2005-01-28 | 2006-10-25 | 2006-10-01 |
| NCT00364442 | Repeat Dose Study of Fluticasone Propionate/Salmeterol Versus Fluticasone Propionate + Salmeterol In Asthmatics | COMPLETED | PHASE1 | 2005-01-28 | 2005-04-13 | 2005-04-13 |
| NCT00419237 | Investigating The Pharmacokinetics Of An Inhaled Dose Of A New Corticosteroid In Patients With Impaired Liver Function | COMPLETED | PHASE1 | 2005-01-13 | 2005-04-15 | 2005-04-15 |
| NCT00449436 | Study To Evaluate Long Term Maintenance With TRIZIVIR After Boosted Protease Inhibitor (PI) Or Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) In HIV-1 Infected Adults | COMPLETED | PHASE4 | 2005-01-10 | 2007-12-13 | 2007-12-12 |
| NCT00148941 | Immune Response and Safety Comparison of 3 Lots of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP + IPV Vaccines | COMPLETED | PHASE3 | 2005-01-06 | 2006-12-04 | 2006-11-01 |
| NCT00358371 | Bioavailability Of Flucloxacillin Capsules (250 mg and 500 mg) | COMPLETED | PHASE1 | 2005-01-06 | 2005-02-08 | 2005-02-08 |
| NCT00158795 | Assess Safety & Reactogenicity of GSK Biologicals' Hib Vaccine Co-administered With or Without Chinese DTPw Vaccine | COMPLETED | PHASE4 | 2005-01 | 2005-07 | 2005-07 |
| NCT01389479 | Study to Evaluate the Safety, Tolerance and Immunogenicity of Fluviral™ in Healthy Adults | COMPLETED | PHASE3 | 2005-01 | 2005-05 | 2005-05 |
| NCT00158808 | Immune Memory Foll Pry Vaccination With DTPw-HBV/Hib Vaccine Formulation; Immuno & Reacto of Booster Dose at 15-18 Mths | COMPLETED | PHASE2 | 2005-01 | 2005-04 | 2005-04 |
| NCT00116831 | Rosiglitazone Versus a Sulfonylurea On Progression Of Atherosclerosis In Patients With Heart Disease And Type 2 Diabetes | COMPLETED | PHASE3 | 2005-01 | 2008-08 | 2008-08 |
| NCT00256880 | Pazopanib (GW786034) In Subjects With Relapsed Or Refractory Multiple Myeloma | COMPLETED | PHASE2 | 2005-01 | 2005-12 | |
| NCT00108082 | The CLEVER Study - Coreg And Left Ventricular Mass Regression | COMPLETED | PHASE3 | 2005-01 | 2008-08 | 2008-08 |
| NCT00116818 | A Study of GW685698X for the Treatment Of Perennial Allergic Rhinitis in Adolescents and Adults | COMPLETED | PHASE3 | 2005-01 | 2005-05 | 2005-05 |
| NCT00225862 | A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS) | COMPLETED | PHASE3 | 2005-01 | 2005-12 | |
| NCT00103454 | A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR). | COMPLETED | PHASE3 | 2005-01 | 2005-05 | 2005-05 |
| NCT00354874 | Investigation Of A New Medication (GW642444) In Asthmatic Patients | COMPLETED | PHASE2 | 2005-01 | 2005-06 | 2005-06 |
| NCT00400855 | Study on the Effects of an AMP Challenge on Asthmatic Patients Following Treatment With Fluticasone Propionate | COMPLETED | PHASE2 | 2005-01 | 2005-08 | 2005-08 |
| NCT01205165 | An Open Label, Multi Centre Phase IV Study of Adefovir Dipivoxil in Korean Patients With Chronic Hepatitis B (CHB) | COMPLETED | PHASE4 | 2004-12-17 | 2006-04-28 | 2006-04-28 |
| NCT00135512 | Study Of 323U66 SR In Major Depressive Disorder | COMPLETED | PHASE2 | 2004-12-01 | 2007-05-28 | 2007-05-28 |
| NCT00160394 | Comparison of Duac® Gel And Differin® Gel in Mild to Moderate Acne Vulgaris | COMPLETED | PHASE4 | 2004-12 | 2005-08 | 2005-08 |
| NCT00114049 | Dental Pain (Following Third Molar Tooth Extraction) Study | COMPLETED | PHASE3 | 2004-12 | 2005-04 | 2005-04 |
| NCT00600990 | Study Of An NK-1 Anti-Emetic Medication For The Prevention Of Post-Operative Nausea And Vomiting In Female Patients | COMPLETED | PHASE2 | 2004-12 | 2006-07 | 2006-07 |
| NCT00115492 | Advair® DISKUS® Versus Serevent® DISKUS® For Chronic Obstructive Pulmonary Disease Exacerbations | COMPLETED | PHASE4 | 2004-12 | 2007-06 | 2007-06 |
| NCT00104416 | Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) Seizures | COMPLETED | PHASE3 | 2004-12 | 2008-07 | 2008-07 |
| NCT00115622 | Study In Adults And Adolescents With Seasonal Allergic Rhinitis | COMPLETED | PHASE3 | 2004-12 | 2005-01 | 2005-01 |
| NCT00103727 | Study Of Talnetant Versus Placebo And Risperidone In Schizophrenia | COMPLETED | PHASE2 | 2004-12 | 2005-10 | 2005-10 |
| NCT00104403 | Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy | COMPLETED | PHASE2 | 2004-12 | 2006-01 | 2006-01 |
| NCT00300963 | Effect Of Talnetant Versus Risperidone Versus Placebo On Psychotic Symptoms In Schizophrenic Patients | COMPLETED | PHASE2 | 2004-12 | 2005-10 | 2005-10 |
| NCT00334568 | Effects Of Rosiglitazone (Extended Release Tablets) On Cerebral Glucose Utilisation And Cognition Alzheimers Disease | TERMINATED | PHASE2 | 2004-12 | 2007-07 | 2007-07 |
| NCT00343135 | AUGMENTIN 1gm In Skin And Soft Tissue Infection | COMPLETED | PHASE4 | 2004-12 | 2005-03 | 2005-03 |
| NCT00097409 | Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer | COMPLETED | PHASE2 | 2004-12 | 2007-05 | 2007-05 |
| NCT00457171 | GI-270384 Study In Patients With Mild To Moderate Ulcerative Colitis | TERMINATED | PHASE1 | 2004-12 | | |
| NCT00273013 | Study With GW274150 In Patients With Mild Asthma | COMPLETED | PHASE1 | 2004-11-15 | 2005-10-28 | 2005-10-28 |
| NCT00107718 | Anti-Tumor Activity Of SB-485232 In Patients With Previously Untreated Metastatic Melanoma | COMPLETED | PHASE2 | 2004-11-15 | 2006-05-19 | 2006-05-19 |
| NCT00273026 | Study In Asthma Control | TERMINATED | PHASE4 | 2004-11-08 | 2006-03-28 | |
| NCT00315744 | Viapaed Study In Children And Adolescents With Asthma | COMPLETED | PHASE4 | 2004-11-04 | 2007-04-12 | 2007-04-12 |
| NCT00325156 | Assess the Safety & Reactogenicity of DTPa-IPV/Hib Vaccine Administered at 3, 4, 5 & 18 Mths of Age, in Healthy Infants | COMPLETED | PHASE4 | 2004-11-02 | 2007-08-23 | 2007-08-23 |
| NCT00144872 | LAMICTAL (Lamotrigine) For The Treatment Of Absence Seizures | COMPLETED | PHASE1 | 2004-11-01 | 2006-04-22 | 2006-04-22 |
| NCT00102765 | Study Of Asthma In Patients Of African Descent | COMPLETED | PHASE4 | 2004-11 | 2007-04 | 2007-04 |
| NCT00289718 | Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Month Schedule | COMPLETED | PHASE3 | 2004-11-01 | 2005-03-02 | 2005-03-02 |
| NCT00103922 | Study In Subjects With COPD (Chronic Obstructive Pulmonary Disease) | COMPLETED | PHASE3 | 2004-11 | 2007-01 | 2007-01 |
| NCT00379600 | The Anti-Inflammatory And Metabolic Effects Of Rosiglitazone In Subjects With Rheumatoid Arthritis | COMPLETED | PHASE2 | 2004-11 | 2006-12 | 2006-12 |
| NCT00343707 | PET (Positron Emission Tomography)/Public Speaking Study With A Combination Of 2 Medications In Social Anxiety Patients | COMPLETED | PHASE2 | 2004-11 | 2005-11 | 2005-11 |
| NCT00289770 | Long-term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Mth Schedule in Healthy Adults | COMPLETED | PHASE3 | 2004-11-01 | 2004-12-20 | 2004-12-20 |
| NCT00256893 | Fibromyalgia Study In Adults | COMPLETED | PHASE2 | 2004-11 | 2005-07 | |
| NCT00323050 | Study of a Booster Dose of Hib-MenC Conjugate Vaccine vs Infanrix Hexa When Given to 14 Month Old Subjects | COMPLETED | PHASE3 | 2004-11 | 2005-03 | 2005-03 |
| NCT00403962 | A Combination Therapy In Patients With Social Anxiety Disorder | COMPLETED | PHASE2 | 2004-11 | 2005-08 | |
| NCT00328965 | Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In Korea | COMPLETED | PHASE4 | 2004-11 | 2006-05 | 2006-05 |
| NCT00343941 | Tucaresol As Add-On To HAART (Highly Active Antiretroviral Therapy) In Chronic HIV-1 Infected Adults | COMPLETED | PHASE2 | 2004-11 | | |
| NCT00119171 | Ispinesib In Combination With Capecitabine In Patients With Solid Tumors | COMPLETED | PHASE1 | 2004-11 | | |
| NCT00136578 | Ispinesib In Combination With Carboplatin In Patients With Solid Tumors | COMPLETED | PHASE1 | 2004-10-20 | 2006-10-25 | 2006-10-25 |
| NCT00196937 | Human Papilloma Virus (HPV) Vaccine Immunogenicity and Safety Trial in Young and Adult Women With GSK Biologicals' HPV-16/18 | COMPLETED | PHASE3 | 2004-10-07 | 2005-12-15 | 2005-12-15 |
| NCT00259935 | A Study To Determine If Two Different Versions Of Topotecan Have The Same Potency In Patients With Advanced Solid Tumors | COMPLETED | PHASE1 | 2004-10-04 | 2007-07-05 | 2007-07-05 |
| NCT00102882 | Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate | COMPLETED | PHASE4 | 2004-10 | 2007-01 | 2007-01 |
| NCT00169481 | A Study in Children With Different Formulations of GSK Biologicals' 11 Valent Pneumococcal Conjugate Vaccine | COMPLETED | PHASE2 | 2004-10 | 2005-05 | 2005-05 |
| NCT00108095 | A Study To Evaluate An NK-1 Antiemetic For The Prevention Of Post Operative Nausea And Vomiting | COMPLETED | PHASE2 | 2004-10 | 2005-08 | 2005-08 |
| NCT00113165 | Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures | COMPLETED | PHASE3 | 2004-10 | 2007-07 | 2007-07 |
| NCT00268983 | Comparison Of Rituximab Versus Tositumomab and Iodine I 131 Tositumomab (BEXXAR® Therapeutic Regimen) For Patients With Relapsed Follicular Non-Hodgkins Lymphoma | COMPLETED | PHASE3 | 2004-10 | 2013-06 | 2009-09 |
| NCT00144911 | ADVAIR® DISKUS® Inhaler (Fluticasone Propionate/Salmeterol) Versus SEREVENT® DISKUS® Inhaler (Salmeterol) For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations. ADVAIR® DISKUS® Inhaler and SEREVENT® DISKUS® Inhaler Are Trademarks of the GSK Group of Companies. | COMPLETED | PHASE4 | 2004-10 | 2006-12 | 2006-12 |
| NCT00317122 | Assess the Immune Response Following Primary Vaccination With GSK Biologicals' Tritanrix™-HepB/Hib-MenAC vs Tritanrix™-HepB/Hiberix™ Given at 6,10 & 14 Wks of Age to Infants Who Received Hepatitis B Vaccine at Birth | COMPLETED | PHASE3 | 2004-10 | 2005-07 | 2005-07 |
| NCT00102492 | Study Of GW679769 In Major Depressive Disorder | COMPLETED | PHASE2 | 2004-10 | 2006-09 | 2006-09 |
| NCT00101985 | Eight-Weeks Of Treatment With Talnetant In Subjects With Irritable Bowel Syndrome (IBS) | COMPLETED | PHASE2 | 2004-10 | 2005-07 | 2005-07 |
| NCT00101946 | Nine-Weeks Treatment With 683699 In Subjects With Moderately-To-Severely Active Crohn's Disease | COMPLETED | PHASE2 | 2004-10 | 2006-07 | 2006-07 |
| NCT00367055 | Rosiglitazone-Metformin Combination Versus Metformin-Sulfonylurea Combination On Beta-Cell Function In Type 2 Diabetes | COMPLETED | PHASE4 | 2004-10 | 2008-10 | 2008-10 |
| NCT00093314 | HuMax-CD20 in Chronic Lymphocytic Leukemia | WITHDRAWN | PHASE1, PHASE2 | 2004-10 | 2007-01 | 2007-01 |
| NCT00097370 | Open-Label Extension Of Intravenous Mepolizumab In Patients With Hypereosinophilic Syndrome | TERMINATED | PHASE3 | 2004-09-30 | 2010-09-29 | 2010-09-29 |
| NCT00158782 | Study Of Safety And Tolerability Of GW786034 Given With Lapatinib In Cancer Patients | COMPLETED | PHASE1 | 2004-09-28 | 2007-08-21 | 2007-08-21 |
| NCT00089986 | GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In Adults | COMPLETED | PHASE2 | 2004-09-01 | 2007-04-15 | 2007-04-01 |
| NCT00316160 | Sexual Functioning Study With Antidepressants | COMPLETED | PHASE4 | 2004-09 | 2005-05 | 2005-05 |
| NCT00140686 | To Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants in Co-administration With Specific Childhood Vaccines | COMPLETED | PHASE3 | 2004-09 | 2006-08 | 2006-08 |
| NCT00144846 | Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children | COMPLETED | PHASE3 | 2004-09 | 2006-02 | 2006-02 |
| NCT00169494 | Human Papilloma Virus Vaccine Consistency and Non-inferiority Trial in Young Adult Women With GSK Bio HPV-16/18 | COMPLETED | PHASE3 | 2004-09 | 2005-07 | 2005-07 |
| NCT00354666 | Single Doses GSK159797 On Patient Safety And Lung Function In Patients With Mild To Moderate Asthma | COMPLETED | PHASE2 | 2004-09 | 2004-12 | |
| NCT00097331 | Three Months Treatment With SB683699 In Patients With Relapsing Multiple Sclerosis | COMPLETED | PHASE2 | 2004-09 | 2006-07 | 2006-07 |
| NCT01750827 | A Study to Assess the Effect of SB 659032 on Platelet Function | COMPLETED | PHASE1 | 2004-09 | 2004-11 | 2004-11 |
| NCT01571661 | A First-time-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Doses of GSK189075A in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus | COMPLETED | PHASE1 | 2004-09 | 2005-01 | 2005-01 |
| NCT00725439 | An Open Label Trial to Assess the Safety and Efficacy of Oral R115866 in the Treatment Facial Acne | COMPLETED | PHASE2 | 2004-09 | 2007-12 | 2005-07 |
| NCT00197093 | In-Patient Study In Schizophrenic Patients | COMPLETED | PHASE1 | 2004-09 | | |
| NCT00158873 | Pharmaco-Economic Study Of Ultiva In Intensive Care Unit(ICU)Subjects | COMPLETED | PHASE4 | 2004-09 | | |
| NCT00092274 | Study of HuMax-CD20, a New Drug to Treat Early Stage Non-Hodgkin´s Follicular Lymphoma | WITHDRAWN | PHASE1, PHASE2 | 2004-09 | 2005-01 | 2005-01 |
| NCT00169533 | Rollover Study Of Lapatinib In Cancer Patients | COMPLETED | PHASE1 | 2004-08-19 | 2009-05-05 | 2009-05-05 |
| NCT00158899 | GW501516 In Subjects Who Have Low Level Of High-Density Lipoprotein Cholesterol | COMPLETED | PHASE2 | 2004-08 | 2006-06 | 2006-06 |
| NCT00129129 | Comparison of GSKBiologicals' Hib-MenCY-TT Vaccine vs Licensed Hib Conjugate or Meningococcal Vaccine | COMPLETED | PHASE2 | 2004-08-01 | 2006-03-29 | 2005-09-15 |
| NCT00317161 | Immunogenicity & Safety Study of a Vaccine Against Meningitis in Infants (2,4,6 Months) After a Hepatitis B Birth Dose. | COMPLETED | PHASE3 | 2004-08 | 2005-04 | 2005-04 |
| NCT00354042 | Effects Of Repeat Inhaled Doses Of GW597901X On Patient Safety And Lung Function In Asthmatic Subjects | COMPLETED | PHASE1 | 2004-08 | | |
| NCT00650871 | A Study to Evaluate the Effects of GW679769 on Sleep and Cognitive Function in Subjects With Primary Insomnia | COMPLETED | PHASE2 | 2004-07-30 | 2005-08-30 | 2005-08-30 |
| NCT00291889 | Safety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02 in Healthy PPD-negative Adults. | COMPLETED | PHASE1 | 2004-07 | 2005-05 | 2005-05 |
| NCT00289796 | Assess Feasibility of an Acellular Pertussis Vaccine (Pa) Given Soon After Birth, Followed by 3-dose Primary Vaccination With the DTPa-HBV-IPV/Hib Vaccine | COMPLETED | PHASE2 | 2004-07 | 2006-12 | 2006-04 |
| NCT00406211 | Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine | COMPLETED | PHASE3 | 2004-07 | 2004-12 | 2004-12 |
| NCT00094367 | A Study Comparing Safety Of Abacavir And Lamivudine Administered Once-Daily As A Single Tablet Versus The Same Drugs Administered Twice-Daily As Separate Tablets (ALOHA Study) | COMPLETED | PHASE3 | 2004-07 | 2005-10 | 2005-10 |
| NCT00128661 | Vaccine To Prevent Cervical Intraepithelial Neoplasia or Cervical Cancer in Younger Healthy Participants | COMPLETED | PHASE3 | 2004-06-30 | 2010-12-31 | 2010-12-31 |
| NCT00462956 | GW572016 In Patients With Advanced Or Metastatic Breast Cancer | COMPLETED | PHASE1 | 2004-06-30 | 2006-12-20 | 2006-12-20 |
| NCT00089973 | Study Of Ispinesib In Subjects With Breast Cancer | COMPLETED | PHASE2 | 2004-06-30 | 2006-08-25 | 2006-08-25 |
| NCT00359190 | Pharmacokinetics And Pharmacodynamics Of Lapatinib In Two Dosing Regimens In Treatment-naive Patients With Breast Cancer | COMPLETED | PHASE1 | 2004-06-29 | 2008-01-09 | 2008-01-09 |
| NCT00158860 | A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies. | COMPLETED | PHASE4 | 2004-06-21 | 2006-07-26 | 2006-07-26 |
| NCT00317187 | Safety Study of a Vaccine Against Meningitis in Infants (2,4 & 6 Months Age) After a Birth Dose of Hepatitis B. | COMPLETED | PHASE3 | 2004-06-08 | 2005-01-16 | 2005-01-16 |
| NCT00196924 | Human Papilloma Virus Vaccine Safety and Immunogenicity Trial in Young Adolescent Women With GSK Bio HPV-16/18. | COMPLETED | PHASE3 | 2004-06 | 2006-03 | 2006-03 |
| NCT00089999 | Lapatinib In Chemotherapy-Naive Or Metastatic Breast Cancer | COMPLETED | PHASE2 | 2004-06 | 2008-03 | 2008-03 |
| NCT00384306 | Effects Of Oral Prednisolone On Bone Metabolism In Patients With Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE1 | 2004-06 | 2006-01 | 2006-01 |
| NCT00093288 | Major Depressive Disorder In The Elderly | COMPLETED | PHASE3 | 2004-06 | 2005-10 | 2005-10 |
| NCT00169520 | SB-715992 In Combination With Docetaxel In Patients With Solid Tumors | COMPLETED | PHASE1 | 2004-06 | | |
| NCT00088673 | Evaluation of 3APS in Patients With Mild to Moderate Alzheimer's Disease | UNKNOWN | PHASE3 | 2004-06 | | |
| NCT00265148 | Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease | COMPLETED | PHASE2 | 2004-05-18 | 2008-07-10 | 2008-07-10 |
| NCT00122681 | Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18 | COMPLETED | PHASE3 | 2004-05-06 | 2009-11-26 | 2006-11-03 |
| NCT01476059 | Pediatric Study to Evaluate Treatment of Persistent Moderate or Severe Asthma With the Association Fluticasone 250 mcg/Dose and Salmeterol 50 mcg/Dose - ADERE PROJECT | COMPLETED | PHASE4 | 2004-05 | 2004-12 | 2004-12 |
| NCT00197119 | Long-Term Follow-Up Studies at Year 6, 7, 8, 9, 10: 2 Formulations of Combined Hepatitis A/B Vaccine Compared in Subjects Aged 12-15 Years | COMPLETED | PHASE3 | 2004-05 | 2004-06 | 2004-06 |
| NCT00086593 | Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophrenia | COMPLETED | PHASE3 | 2004-05 | 2005-07 | 2005-07 |
| NCT00290303 | Assess if Immune Response of GSK Biologicals' Tritanrix™-HepB/Hib-MenAC Given Without or With Hepatitis B Vaccine at Birth is at Least as Good as Tritanrix™-HepB/Hiberix™ Without Hepatitis B Vaccine at Birth, When Given to Healthy Infants | COMPLETED | PHASE3 | 2004-05 | 2005-03 | 2005-03 |
| NCT00085943 | KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks | COMPLETED | PHASE3 | 2004-05 | | |
| NCT00328939 | ARIXTRA Local Study For Registration In China. | COMPLETED | PHASE3 | 2004-05 | | |
| NCT00355342 | Bone Mineral Density Study In Patients With Chronic Obstructive Pulmonary Disease. DISKUS® Inhaler is a Trademark of the GSK Group of Companies. | COMPLETED | PHASE4 | 2004-04-28 | 2007-09-06 | 2007-09-06 |
| NCT00082394 | A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV | COMPLETED | PHASE4 | 2004-04-26 | 2006-03-01 | 2006-03-01 |
| NCT00343915 | Immuno & Safety Study of GSK Biologicals' Thio or Preservative Free Hepatitis B Vaccine in Subjects Aged 11-15 Yrs | COMPLETED | PHASE3 | 2004-04-21 | 2008-01-10 | 2008-01-10 |
| NCT00224484 | Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old | COMPLETED | PHASE3 | 2004-04-07 | 2007-07-24 | 2007-07-24 |
| NCT00240565 | Tositumomab And Iodine I 131-Tositumomab In Patients With Relapsed Indolent Non-Hodgkin's Lymphoma | COMPLETED | PHASE2 | 2004-04 | 2011-09 | 2007-02 |
| NCT00136513 | SB-743921 In Patients With Solid Tumors | COMPLETED | PHASE1 | 2004-04 | | |
| NCT00085904 | Dose-Escalating Study Of SB-485232 Administered Intravenously Every 28 Days To Adults With Solid Tumors Or Lymphomas | COMPLETED | PHASE1 | 2004-04 | | |
| NCT00725348 | An Open-Label, Multi-Center Trial in the Treatment of Subjects With Moderate to Severe Plaque Type Psoriasis | COMPLETED | PHASE2 | 2004-04 | 2006-12 | 2005-03 |
| NCT00090077 | Monotherapy Versus Placebo Over 7 Days-Non-Nucleoside Reverse Transcriptase Inhibitor-Experienced HIV1 Infected Adults | COMPLETED | PHASE1 | 2004-04 | | |
| NCT00086658 | Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES) | COMPLETED | PHASE3 | 2004-03-23 | 2006-05-01 | 2006-05-01 |
| NCT00197067 | A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Candidate Vaccines RTS,S/AS02D (0.5 mL Dose) and RTS,S/AS02A (0.25 mL Dose) Administered IM According to a 0, 1, 2 Month Vaccination Schedule in Children Aged 3 to 5 Years Living in a Malaria-endemic Region of Mozambique. | COMPLETED | PHASE1 | 2004-03-15 | 2005-04-26 | 2005-04-26 |
| NCT00079911 | A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected Persons | TERMINATED | PHASE4 | 2004-03-12 | 2004-10-15 | 2004-10-15 |
| NCT00078572 | Capecitabine (XELODA) With Or Without Lapatinib (GW572016) For Women With Refractory Advanced or Metastatic Breast Cancer | COMPLETED | PHASE3 | 2004-03 | 2010-02 | 2006-04 |
| NCT00289744 | Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,6 Month Schedule | COMPLETED | PHASE3 | 2004-02-16 | 2009-04-15 | 2009-04-15 |
| NCT00632736 | An Open-label Continuation Study Evaluating the Long-term Safety of Extended Release Ropinirole XL (Formerly CR) in Parkinson''s Disease | COMPLETED | PHASE3 | 2004-02 | 2010-03 | 2010-03 |
| NCT00359112 | AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 Diabetes | COMPLETED | PHASE3 | 2004-02 | | |
| NCT00307528 | Safety and Efficacy Study of Investigational Pneumococcal Vaccine in Elderly Population | COMPLETED | PHASE2 | 2004-01-20 | 2005-03-30 | 2005-03-30 |
| NCT00291876 | Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine Injected According to a 0, 12-month Schedule | COMPLETED | PHASE4 | 2004-01-01 | 2013-03-01 | 2013-03-01 |
| NCT00289757 | Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine, Injected According to 0, 6-month Schedule | COMPLETED | PHASE4 | 2004-01-01 | 2013-03-01 | 2013-03-01 |
| NCT00075270 | Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast Cancer | COMPLETED | PHASE3 | 2004-01 | 2012-03 | 2006-10 |
| NCT00480649 | Successful Control and Clinical Effectiveness Of SERETIDE(Salmeterol/Fluticasone Propionate) Study In Asthma.(SUCCESS) | COMPLETED | PHASE4 | 2004-01 | 2005-09 | 2005-09 |
| NCT00327353 | Influence Of Different Airflow Resistances On Drug Effect Of 50μg Salmeterol And 6 μg Formoterol | COMPLETED | PHASE4 | 2004-01 | | |
| NCT00730795 | Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine Given to PPD-Negative Adults | COMPLETED | PHASE1 | 2004-01 | | 2004-12 |
| NCT00118716 | A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise | COMPLETED | PHASE4 | 2003-12-23 | 2006-04-23 | 2006-04-01 |
| NCT00317135 | Safety Study of a Vaccine Against Meningitis in Infants ( 2,4 & 6 Months Age) After a Birth Dose of Hepatitis B. | COMPLETED | PHASE3 | 2003-12-11 | 2004-10-23 | 2004-10-23 |
| NCT00325143 | Safety of DTPa-IPV/Hib & DTPa-HBV-IPV/Hib, Followed by DTPa-IPV/Hib Vaccine in Infants Who Received Hepatitis B Vaccine | COMPLETED | PHASE3 | 2003-12-01 | 2007-02-01 | 2007-02-01 |
| NCT00363727 | Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's | COMPLETED | PHASE3 | 2003-12 | 2006-01 | 2006-01 |
| NCT00197210 | A Study to Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants | COMPLETED | PHASE3 | 2003-12 | 2007-07 | 2007-07 |
| NCT00139347 | Study of 2 Doses of HRV Vaccine Given Concomitantly With Routine EPI Vaccinations Including OPV in Healthy Infants | COMPLETED | PHASE3 | 2003-12 | 2007-03 | 2007-03 |
| NCT00224471 | Study to Compare Safety and Immunogenicity of Commercial Scale Consistency Lots of Herpes Simplex Vaccine | COMPLETED | PHASE3 | 2003-12 | 2006-01 | 2005-09 |
| NCT00118690 | A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise | COMPLETED | PHASE4 | 2003-12 | 2005-12 | 2005-12 |
| NCT01045590 | Glibenclamide (Dose to be Titrated From Starting Dose of 5mg om) Plus Rosiglitazone 4mg om (Increased to 8mg om After 6 Months) and vs Glibenclamide (Dose to be Titrated With Starting Dose of 5mg om) Plus Placebo, Administered to Patients With Type 2 Diabetes Mellitus | COMPLETED | PHASE4 | 2003-12 | 2006-02 | 2006-02 |
| NCT00085813 | Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer | COMPLETED | PHASE2 | 2003-12 | 2005-10 | 2005-10 |
| NCT00289731 | Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B Vacc | COMPLETED | PHASE4 | 2003-11-24 | 2004-12-21 | 2004-12-21 |
| NCT00197236 | Immunogenicity and Safety of Havrix™ Co-Administered With a Diphtheria, Tetanus and Pertussis and a Haemophilus b Vaccine in Children Aged 15 Months | COMPLETED | PHASE3 | 2003-11-11 | 2007-12-03 | 2007-12-03 |
| NCT00073008 | A Study Of Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung Cancer | TERMINATED | PHASE2 | 2003-11 | 2008-07 | 2008-07 |
| NCT00549146 | Treatment Of Partial Reversible Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE3 | 2003-11 | 2006-04 | 2006-04 |
| NCT00090103 | Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment | COMPLETED | PHASE3 | 2003-11 | 2009-04 | 2009-04 |
| NCT00120848 | Follow-up Study of GSK Biologicals' Human Papilloma Virus (HPV) Vaccine to Prevent Cervical Infection in Young Adults | COMPLETED | PHASE2 | 2003-11 | 2007-07 | 2007-07 |
| NCT00197184 | Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the Combined Hepatitis A and B Vaccine Were Compared | COMPLETED | PHASE3 | 2003-11-01 | 2004-03-10 | 2004-03-10 |
| NCT00263679 | Assessment of GSK Biologicals' Tdap Candidate Vaccine Administered as a Booster (6th Dose) in Terms of Immunogenicity and Safety to Children and Adolescents Previously Vaccinated With Five Doses of an Acellular Pertussis-containing Vaccine. | COMPLETED | PHASE3 | 2003-11 | 2004-10 | 2004-05 |
| NCT00274677 | Depression And Bipolar Disorder | COMPLETED | PHASE3 | 2003-11 | 2005-08 | 2005-08 |
| NCT00422955 | Fluid Retention in Rosiglitazone Treated Subjects With Autonomic Neuropathy. | COMPLETED | PHASE3 | 2003-11 | 2005-10 | 2005-10 |
| NCT00062686 | GW572016 For Treatment Of Refractory Metastatic Breast Cancer | COMPLETED | PHASE2 | 2003-11 | 2005-02 | 2005-02 |
| NCT00169559 | Dyslipidemia Study Investigating The Increase In "Good Cholesterol" | COMPLETED | PHASE2 | 2003-11 | 2005-04 | 2005-04 |
| NCT00067951 | A Study To Evaluate The Safety And Efficacy Of An Investigational Diabetes Drug In Poorly Controlled Type II Diabetics | COMPLETED | PHASE3 | 2003-10-17 | 2004-11-30 | 2004-11-01 |
| NCT00499707 | Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes Subjects | COMPLETED | PHASE3 | 2003-10-08 | 2004-12-16 | 2004-12-01 |
| NCT00197015 | Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in Children | COMPLETED | PHASE3 | 2003-10-06 | 2009-06-09 | 2009-06-09 |
| NCT00750360 | Study to Monitor the Safety and Reactogenicity of Fluarix™ in Korean Subjects Aged > 6 Months of Age. | COMPLETED | PHASE4 | 2003-10-03 | 2007-12-28 | 2007-12-01 |
| NCT00240500 | Follow-up Study 16-20 Years After Primary Vaccination Against Hepatitis B of Newborns From HBeAg+ & HBsAg+ Mothers | COMPLETED | PHASE4 | 2003-10 | 2007-11 | 2007-11 |
| NCT00240526 | LT F-up Study 16-20 Yrs After Vaccine Dose of Hepatitis B With/Without HBIg in Newborns to HBeAg+ Mothers | COMPLETED | PHASE4 | 2003-10 | 2010-03 | 2010-03 |
| NCT00240539 | Long Term Follow-Up Study 16-20 Years After Hepatitis B Vaccination in Newborns of Mothers Who Were Seropositive for Hepatitis B Envelope Antigen (HBeAg) & Hepatitis B Surface Antigen (HBsAg) | COMPLETED | PHASE4 | 2003-10 | 2008-07 | 2008-07 |
| NCT00062790 | Effect Of Dutasteride On Intraprostatic Dihydrotestosterone (DHT) Levels | COMPLETED | PHASE4 | 2003-10 | 2005-07 | |
| NCT00731393 | Immuno & Reacto of TF Trivalent Influenza Split Vaccine 2003/04 or of Std Formulation Influsplit SSW®/Fluarix™ 2003/04 | COMPLETED | PHASE3 | 2003-10 | 2004-08 | 2004-08 |
| NCT01457547 | Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination Course | COMPLETED | PHASE4 | 2003-10 | 2005-05 | 2005-05 |
| NCT00069836 | Study Of AVANDAMET® With Or Without Insulin In Type II Diabetes Mellitus Patients. AVANDAMET® is a Registered Trademark of the GSK Group of Companies. | COMPLETED | PHASE3 | 2003-10 | 2004-11 | 2004-11 |
| NCT01767402 | Study to Evaluate Safety, Reactogenicity and Immunogenicity of the Pneumococcal Protein PhtD Vaccine in Healthy Adults | COMPLETED | PHASE1 | 2003-10 | 2004-11 | 2004-11 |
| NCT00307008 | Study to Evaluate the Response Rate to the Licensed Pneumovax 23™ in Elderly Population. | COMPLETED | PHASE2 | 2003-10 | 2005-02 | 2005-02 |
| NCT00352963 | Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age). | COMPLETED | PHASE3 | 2003-09-30 | 2004-07-16 | |
| NCT00069459 | Seasonal Affective Depression (SAD) Study | COMPLETED | PHASE1 | 2003-09-23 | 2004-06-03 | 2004-06-03 |
| NCT01855711 | Safety and Efficacy Study of GR68755 (Alosetron Hydrochloride) to Treat Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS) | COMPLETED | PHASE2 | 2003-09-18 | 2005-05-10 | 2005-05-10 |
| NCT00197002 | Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Pneumococcal Vaccine in Healthy Children 15 m of Age | COMPLETED | PHASE3 | 2003-09-11 | 2006-01-16 | 2006-01-16 |
| NCT00792623 | Immunogenicity and Safety of GSK Biologicals' Live Attenuated Varicella Vaccine (VARILRIXTM). | COMPLETED | PHASE2 | 2003-09-08 | 2007-09-10 | 2007-09-10 |
| NCT01499446 | A Study of GW685698X 100mcg Administered Once Daily Either in the Morning or the Evening and GW685698X 250mcg Administered Once Daily in the Evening Via DISKHALER for 28 Days in Subjects With Persistent Bronchial Asthma. | COMPLETED | PHASE2 | 2003-09 | 2004-03 | 2004-03 |
| NCT00197171 | Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B Vaccine | COMPLETED | PHASE3 | 2003-09 | 2003-12 | 2003-12 |
| NCT00196950 | Study to Evaluate Meningococcal Serogroups A,C,W-135,Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 18-25 Years | COMPLETED | PHASE2 | 2003-09 | 2003-10 | 2003-10 |
| NCT00383903 | Evaluate Safety & Immunogenicity of 2 or 3 Doses of GSK HRV Vaccine in Healthy Infants in South Africa | COMPLETED | PHASE2 | 2003-09 | 2004-09 | 2004-09 |
| NCT00950794 | Study of Salmeterol (SN408D) for Adult Asthma | COMPLETED | PHASE4 | 2003-09 | 2005-02 | 2005-02 |
| NCT00279032 | GW406381 In Patients With Peripheral Nerve Injury | COMPLETED | PHASE1 | 2003-09 | | |
| NCT00065182 | Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer | COMPLETED | PHASE2 | 2003-08-14 | 2007-08-30 | 2007-08-30 |
| NCT00140673 | A Study to Test 2 Doses of the HRV Vaccine in Healthy Infants. | COMPLETED | PHASE3 | 2003-08-05 | 2005-10-20 | |
| NCT00363857 | A Clinical Research Study Testing Ropinirole Treatment for Restless Legs Syndrome | COMPLETED | PHASE3 | 2003-08 | 2004-05 | 2004-05 |
| NCT00064428 | OASIS-6 : The Safety and Efficacy of Fondaparinux Versus Control Therapy in Patients With ST Segment Elevation Acute Myocardial Infarction | COMPLETED | PHASE3 | 2003-08 | 2006-02 | 2006-02 |
| NCT01061541 | Immunogenicity, Safety & Reactogenicity of GSK Vaccine Tritanrix™-HepB/Hib2.5 Compared to GSK Vaccine Tritanrix™-HepB/Hiberix™ | COMPLETED | PHASE2 | 2003-08 | 2004-08 | 2004-01 |
| NCT00757770 | Assessment of Clinical Consistency of Three Production Lots of GSK Biologicals' HRV Vaccine | COMPLETED | PHASE3 | 2003-08 | 2004-01 | 2004-01 |
| NCT00067938 | Bipolar Study in Adults at Least 18 Years of Age | COMPLETED | PHASE4 | 2003-08 | 2004-08 | 2004-08 |
| NCT00071747 | Clinical Study Of Schizophrenia in Both Men and Women | COMPLETED | PHASE3 | 2003-08 | 2005-01 | |
| NCT00969072 | Extension Study of GI198745 to Treat Benign Prostatic Hyperplasia | COMPLETED | PHASE2 | 2003-08 | 2005-02 | 2005-02 |
| NCT00197041 | A Study to Evaluate the Safety, Immunogenicity and Efficacy of GlaxoSmithKline (GSK) Biologicals' Candidate Malaria Vaccine RTS,S/AS02A, When Administered to Children Aged 1 to 4 Years Living in a Malaria-endemic Region of Mozambique. | COMPLETED | PHASE2 | 2003-07 | 2005-04 | 2005-04 |
| NCT00317174 | A Study to Assess Antibody Persistence, Boostability & Safety in Previously Primed Subjects. | COMPLETED | PHASE2 | 2003-07 | 2004-04 | |
| NCT00241605 | AVANDAMET Versus Metformin For Type 2 Diabetes Mellitus | COMPLETED | PHASE4 | 2003-06-25 | 2005-12-16 | 2005-12-01 |
| NCT00064467 | Lethargic Depression Study | COMPLETED | PHASE3 | 2003-06 | 2005-05 | 2005-05 |
| NCT00381472 | Investigational Parkinson's Disease In Patients Not Well Controlled On L-dopa | COMPLETED | PHASE3 | 2003-06 | 2004-12 | |
| NCT00361959 | SERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE4 | 2003-06 | 2006-02 | 2006-02 |
| NCT00519467 | Safety and Efficacy Dose of Artesunate Used in Combination With LAPDAP Treatment of Uncomplicated Falciparum Malaria | COMPLETED | PHASE2 | 2003-06 | 2005-02 | 2005-02 |
| NCT00067444 | Depression Study In Elderly Patients | COMPLETED | PHASE3 | 2003-06 | 2005-01 | 2005-01 |
| NCT00067561 | Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy | COMPLETED | PHASE3 | 2003-06 | 2005-01 | 2005-01 |
| NCT00067457 | Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy | COMPLETED | PHASE3 | 2003-06 | 2005-12 | 2005-12 |
| NCT00544271 | Immunogenicity, Antibody Persistence and Safety of GSK Biologicals' DTPa (INFANRIX) and dTpa (BOOSTRIX) Vaccines. | TERMINATED | PHASE4 | 2003-05 | 2004-01 | |
| NCT00135525 | Study Of Generalized Anxiety Disorder | COMPLETED | PHASE2 | 2003-05 | 2006-05 | 2005-10 |
| NCT00148902 | Effects Of GW572016 In Combination With Docetaxel (TAXOTERE) | COMPLETED | PHASE1 | 2003-04-28 | 2006-01-21 | 2006-01-21 |
| NCT00139815 | Michelangelo - Oasis 5 | COMPLETED | PHASE3 | 2003-04 | 2005-12 | 2005-12 |
| NCT01294605 | Immunogenicity and Reactogenicity Study of BoostrixTM (dTpa) and Boostrix-IPV (dTpa-IPV) | COMPLETED | PHASE4 | 2003-04 | 2004-09 | 2004-09 |
| NCT00062894 | Study of Untreated or Transformed Follicular Non-Hodgkin's Lymphoma With Fission-Derived Iodine I 131 Tositumomab | COMPLETED | PHASE1, PHASE2 | 2003-04 | 2007-04 | |
| NCT00315731 | A Study Of Pharmacokinetics, Whole Body And Organ Dosimetry, And Biodistribution Of Fission-Derived Iodine I 131 Tositumomab (BEXXAR®) For Patients With Previously Untreated Or Relapsed Follicular Or Transformed Non-Hodgkin's Lymphoma | COMPLETED | PHASE1 | 2003-03-31 | 2013-06-30 | 2006-12-04 |
| NCT00058526 | A Dose-escalation Vaccine Trial in HER2-overexpressing Patients With High-risk Breast Cancer | COMPLETED | PHASE1 | 2003-03-20 | 2006-09-06 | 2006-09-06 |
| NCT00127855 | Dose Ranging Study of Combined Haemophilus Influenzae Type B-Meningococcal Serogroups CY (Hib-MenCY-TT) Vaccine | COMPLETED | PHASE2 | 2003-03-01 | 2004-02-12 | 2004-02-01 |
| NCT00129116 | 3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of Age | COMPLETED | PHASE2 | 2003-03-01 | 2003-12-16 | 2003-12-01 |
| NCT00056407 | "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk | COMPLETED | PHASE3 | 2003-03 | 2009-04 | 2009-01 |
| NCT00057226 | An 8 Week Study Of Adults Diagnosed With Major Depressive Disorder | COMPLETED | PHASE2 | 2003-03 | 2004-04 | 2004-04 |
| NCT00057213 | An 8 Week Study Of Depression In Adults Diagnosed With Major Depressive Disorder | COMPLETED | PHASE2 | 2003-03 | 2007-04 | 2007-04 |
| NCT00057239 | An 8 Week Depression Study In Adults Diagnosed With Major Depressive Disorder | COMPLETED | PHASE2 | 2003-03 | 2004-05 | 2004-05 |
| NCT00056277 | Bipolar Disorder Study for Men and Women | COMPLETED | PHASE3 | 2003-02-27 | 2005-12-14 | 2005-08-01 |
| NCT00920543 | GSK BHR Study (Sont) | COMPLETED | PHASE4 | 2003-02 | 2004-10 | 2004-10 |
| NCT00053638 | A New Tablet Containing Two FDA-Approved Drugs In HIV-Infected Patients Who Have Not Received Prior Therapy | COMPLETED | PHASE3 | 2003-02 | 2004-10 | 2004-10 |
| NCT00056238 | Cerebril™ in Patients With Lobar Hemorrhage Related to Cerebral Amyloid Angiopathy | COMPLETED | PHASE2 | 2003-02 | | |
| NCT00297206 | A Safety And Tolerability Study Of Valaciclovir Oral Suspension In Infants And Children | COMPLETED | PHASE1 | 2003-01-25 | 2007-02-28 | 2007-02-28 |
| NCT00057330 | HerpeVac Trial for Young Women | COMPLETED | PHASE3 | 2003-01-14 | 2009-08-22 | 2009-08-22 |
| NCT01916720 | Study to Determine the Effect of 14 Days Dosing With Darapladib (SB-480848) on Carotid Plague Composition in Patients With Planned Carotid Endarterectomy | COMPLETED | PHASE2 | 2003-01 | 2003-07 | 2003-07 |
| NCT00135564 | Study to Evaluate GlaxoSmithKline (GSK) Biologicals' MenC-TT and Hib-MenC-TT or Meningitec™ in Healthy Toddlers | COMPLETED | PHASE2 | 2003-01 | 2003-07 | 2003-07 |
| NCT00169546 | Study In Airway Physiology In Children SERETIDE DISKUS ® Inhlaer and FLIXOTIDE® Inhaler Are Trademarks of GSK Group of Companies. | COMPLETED | PHASE4 | 2003-01 | 2005-12 | 2005-12 |
| NCT01324362 | GSK BHR Study (Sont - Second Study) | COMPLETED | PHASE4 | 2003-01 | 2004-10 | 2004-10 |
| NCT00051272 | Effects Of Antidepressants On Sexual Functioning In Adults | COMPLETED | PHASE3 | 2003-01 | 2004-06 | 2004-06 |
| NCT00051259 | Effects of Antidepressants on Sexual Functioning | COMPLETED | PHASE3 | 2003-01 | 2004-06 | 2004-06 |
| NCT00085878 | Dose-Escalation Study Of SB-485232 Administered As Daily Subcutaneous Injections In Adults With Solid Tumors | COMPLETED | PHASE1 | 2003-01 | | |
| NCT00344513 | Organized Program To Initiate Lifesaving Treatment In Hospitalized Patients With Heart Failure (OPTIMIZE-HF) | COMPLETED | PHASE4 | 2002-12-16 | 2005-06-30 | |
| NCT00370591 | Study Of Airway Physiology In Adults. SERETIDE DISKUS® Inhaler and FLIXOTIDE® Inhaler Are Trademarks of GSK Croup of Companies. | COMPLETED | PHASE4 | 2002-12 | 2004-04 | 2004-04 |
| NCT00061308 | Second-line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian, Fallopian, Or Peritoneal Cancer | COMPLETED | PHASE2 | 2002-12 | | 2004-09 |
| NCT00857675 | A Efficacy and Safety Study of Adefovir Dipivoxil to Treat Chinese Patients With HBeAg+ve Chronic Hepatitis B | COMPLETED | PHASE3 | 2002-12 | 2008-03 | 2008-03 |
| NCT00048204 | A Study Of A New Medicine (GW597599B) For The Treatment Of Major Depressive Disorder | COMPLETED | PHASE2 | 2002-11-04 | 2003-09-30 | 2003-09-30 |
| NCT00479739 | CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE® Inhaler With An Adjustable Maintenance Dose Of SYMBICORT® Inhaler. SERETIDE® Inhaler is a Trademark of GSK Group of Companies. SYMBICORT® Inhaler is a Trademark of Astra Zeneca. | COMPLETED | PHASE4 | 2002-11 | 2004-07 | 2004-07 |
| NCT00109330 | A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td Vaccine | COMPLETED | PHASE3 | 2002-11 | 2004-04 | 2004-04 |
| NCT00263692 | Comparison of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP and IPV Separately Administered Vaccines in Terms of Immune Response and Safety | COMPLETED | PHASE2 | 2002-11 | 2004-09 | 2004-09 |
| NCT00376454 | The Study of GW493838, an Adenosine A1 Agonist, in Peripheral Neuropathic Pain | COMPLETED | PHASE2 | 2002-11 | 2003-06 | 2003-06 |
| NCT00453778 | A Study To Investigate The Effect Of Inhaled Fluticasone Propionate On The Bronchial Responsiveness To Leukotriene D4 In Asthmatics Patients | COMPLETED | PHASE4 | 2002-11 | 2004-05 | 2004-05 |
| NCT00291967 | Assess Immune Response Following Primary Vaccination With Tritanrix™-HepB Vaccine Mixed With 3 Formulations of Hib-MenAC Vaccine to Infants | COMPLETED | PHASE2 | 2002-11 | | |
| NCT00049946 | Schizophrenia Study In Adults | COMPLETED | PHASE2 | 2002-10 | 2003-04 | 2003-04 |
| NCT00197132 | Study In Patients With Insulin Resistance | COMPLETED | PHASE3 | 2002-10 | 2003-08 | 2003-08 |
| NCT00306696 | Examining the Effect of Different Diuretics on Fluid Retention in Diabetics Treated With Rosiglitazone. | COMPLETED | PHASE4 | 2002-10 | 2004-01 | |
| NCT00268177 | Airway Inflammation In Patients With Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE3 | 2002-10 | 2003-12 | |
| NCT00051103 | Oral Drug Study In Women With Refractory Metastatic Breast Cancer After First-line or Second-line Herceptin. | COMPLETED | PHASE2 | 2002-10 | 2005-06 | 2005-06 |
| NCT00048360 | Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults | COMPLETED | PHASE3 | 2002-10 | 2003-06 | 2003-06 |
| NCT00049972 | Major Depressive Disorder Study In Adults | COMPLETED | PHASE4 | 2002-09 | 2003-09 | 2003-09 |
| NCT00046241 | Prevention of Seasonal Affective Disorder | COMPLETED | PHASE3 | 2002-09 | 2003-06 | 2003-06 |
| NCT00231387 | Rosiglitazone And Plaque Study for Type 2 Diabetes Mellitus | COMPLETED | PHASE3 | 2002-09 | 2005-05 | 2005-05 |
| NCT00329225 | Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin | COMPLETED | PHASE4 | 2002-09 | 2004-04 | 2004-04 |
| NCT00046449 | Prevention of Seasonal Affective Disorder | COMPLETED | PHASE3 | 2002-09 | 2003-06 | 2003-06 |
| NCT00044343 | GW572016, An Oral Drug For Colorectal Cancer Patients Having Prior Therapy With 5-FU Plus CPT-11 And/Or Oxaliplatin | COMPLETED | PHASE2 | 2002-09 | 2003-10 | 2003-10 |
| NCT00731029 | Reacto & Immunogenicity of TF Formulation of Influsplit SSW® 2002/03 v/s Std Formulation of Influsplit SSW® 2002/03 | COMPLETED | PHASE3 | 2002-09 | | 2003-04 |
| NCT00224510 | A Study To Investigate The Antidepressant Effect Of Lamotrigine In Patients With Bipolar Disorder Using Lithium | COMPLETED | PHASE3 | 2002-08 | 2006-09 | 2006-09 |
| NCT00320359 | Topotecan Plus Cisplatin Versus Etoposide Plus Cisplatin In 1st Line Extensive Disease Small Cell Lung Cancer | COMPLETED | PHASE3 | 2002-08 | 2007-02 | 2007-02 |
| NCT00043862 | The Study Of An Oral Drug Called A Radiation Sensitizer In Patients With Newly Diagnosed Small Cell Lung Cancer (SCLC) | COMPLETED | PHASE2 | 2002-08 | | 2005-11 |
| NCT00137917 | Immunogenicity & Safety Study of a Meningococcal Serogroup B Vaccine Given in a 3 Dose Schedule to Healthy Adolescents Aged 12-18 Yrs | COMPLETED | PHASE2 | 2002-07 | 2003-06 | 2003-06 |
| NCT00046332 | A Study Comparing 4 Doses Of GW810781 Versus Placebo In HIV-Infected Patients | COMPLETED | PHASE2 | 2002-06 | 2003-01 | 2003-01 |
| NCT00290355 | Study to Test the Efficacy of the Vaccine GSK 249553 in Treating Non-small-cell Lung Cancer After Tumour Removal by Surgery | COMPLETED | PHASE2 | 2002-05-28 | 2011-07-19 | 2011-07-19 |
| NCT00044460 | Efficacy and Safety In Poorly Controlled Type 2 Diabetics | COMPLETED | PHASE4 | 2002-05 | 2003-04-10 | 2003-04-10 |
| NCT00197249 | Comparative Study in Healthy Adults Aged 18-50 Yrs Administered With Hepatyrix or Havrix+Typherix or Tiphim Vi, to Compare Reactogenicity & Immunogenicity | COMPLETED | PHASE3 | 2002-05 | 2005-11 | 2003-06 |
| NCT00306644 | Effect Of Rosiglitazone On Carotid Intima Media Thickness In Patients With Insulin Resistance Syndrome And/Or Type 2 Diabetes | COMPLETED | PHASE4 | 2002-05 | 2004-11 | 2004-11 |
| NCT00839397 | BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder | COMPLETED | PHASE3 | 2002-05 | 2005-06 | 2004-11 |
| NCT00650104 | Long-term Extension Study Evaluating Extended Release Ropinirole XL (Formerly Referred to as Ropinirole CR) in Patients Who Already Completed Either Study 167 or 164 | COMPLETED | PHASE3 | 2002-05 | 2009-03 | 2009-03 |
| NCT00383591 | Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years | COMPLETED | PHASE3 | 2002-03 | 2004-01 | |
| NCT00135486 | Study to Evaluate GlaxoSmithKline (GSK) Biologicals' MenC-TT Vaccine and Hib-MenC-TT Vaccine in Infants | COMPLETED | PHASE2 | 2002-03 | 2003-01 | 2003-01 |
| NCT00043914 | Measurement Of Serum Levels Of Two Antiepileptic Drugs During Conversion In Patients With Epilepsy | COMPLETED | PHASE4 | 2002-01-14 | 2003-01-29 | 2003-01-29 |
| NCT00041509 | ThromboEmbolism Prevention Efficacy and Safety Trial (TEMPEST) | COMPLETED | PHASE2 | 2002-01 | 2003-05 | 2003-05 |
| NCT01277705 | Comparison of GSK Biologicals' Reduced Antigen Diphtheria and Tetanus Toxoids and Acellular Pertussis- Inactivated Poliovirus Vaccine, to BoostrixTM and Inactivated Poliovirus Vaccine Administered Separately and With Revaxis® | COMPLETED | PHASE3 | 2002-01 | 2002-04 | 2002-04 |
| NCT00043888 | Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR | COMPLETED | PHASE3 | 2002-01 | 2003-05 | 2003-05 |
| NCT00158886 | Oral Topotecan As A Radiosensitizing Agent In Rectal Cancer | TERMINATED | PHASE1 | 2001-11-08 | 2006-08-11 | 2006-08-11 |
| NCT00346892 | To Evaluate 2 Doses of GSK Biologicals' Oral Live Attenuated Human HRV Vaccine Co-administered With Either OPV or IPV | COMPLETED | PHASE2 | 2001-11 | | 2003-03 |
| NCT00920959 | Advair Pediatric Once-Daily | COMPLETED | PHASE3 | 2001-11 | 2004-01 | 2004-01 |
| NCT00038961 | A Study to Evaluate the Efficacy and Safety of Fondaparinux Sodium When Used With Intermittent Pneumatic Compression to Prevent Venous Thromboembolic (IPC) Versus IPC Alone for the Prevention of Venous Thromboembolic Events in Subjects at Increased Risk Undergoing Major Abdominal Surgery (APOLLO). | COMPLETED | PHASE3 | 2001-11 | 2004-10 | 2004-10 |
| NCT00041496 | Prevention Of Recurrence Of Atrial Fibrillation | COMPLETED | PHASE2 | 2001-11 | 2003-12 | 2003-12 |
| NCT00049998 | Oral Topotecan Versus Intravenous Docetaxel In Pretreated, Advanced Non-Small Cell Lung Cancer | COMPLETED | PHASE3 | 2001-10 | | 2004-04 |
| NCT00035334 | Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis | COMPLETED | PHASE2, PHASE3 | 2001-10 | 2004-12 | |
| NCT00046111 | A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid Tumors | COMPLETED | PHASE1 | 2001-09 | 2004-04 | 2004-04 |
| NCT00366366 | To Evaluate Immunogenicity & Safety of GSK Bio's DTPa-HBV-IPV/Hib (Mixed Vaccine) and DTPa-IPV/Hib + HBV Vaccines | COMPLETED | PHASE3 | 2001-09 | 2002-09 | 2002-09 |
| NCT00992992 | Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell Lymphoma | COMPLETED | PHASE2 | 2001-06-28 | 2013-06-30 | 2013-06-30 |
| NCT00501020 | Comparison of the Efficacy and Tolerability of the Addition of AVANDIA to Submaximal Doses of Metformin | COMPLETED | PHASE4 | 2001-06-05 | 2003-02-13 | 2003-02-13 |
| NCT00060931 | Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And Hypertension | COMPLETED | PHASE4 | 2001-06 | 2004-04 | 2004-04 |
| NCT00060918 | Glycemic Control Of Carvedilol Versus Metoprolol In Patients With Type II Diabetes Mellitus And Hypertension | COMPLETED | PHASE4 | 2001-06 | 2004-04 | 2004-04 |
| NCT00385320 | Evaluate Protective Efficacy of Diff Strengths of Human Rotavirus Vaccine After Admn of 2 Doses to Infants Aged 2 Months | COMPLETED | PHASE2 | 2001-05-31 | 2003-04-30 | 2003-04-30 |
| NCT00025727 | Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure | UNKNOWN | PHASE3 | 2001-05 | | |
| NCT00379769 | RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes | COMPLETED | PHASE3 | 2001-04 | 2008-12 | 2008-12 |
| NCT00043927 | Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults | COMPLETED | PHASE3 | 2001-04 | | 2004-01 |
| NCT00011895 | Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs | UNKNOWN | PHASE4 | 2001-02 | | |
| NCT00689741 | Efficacy Study of HPV-16/18 Vaccine (GSK 580299) to Prevent HPV-16 and/or -18 Cervical Infection in Young Healthy Women | COMPLETED | PHASE2 | 2001-01 | 2003-04 | 2003-04 |
| NCT00880477 | Immunogenicity and Safety of Primary and Booster Vaccination With DTPa-HBV-IPV/Hib Vaccine | COMPLETED | PHASE3 | 2001-01 | 2002-11 | 2002-11 |
| NCT00429481 | Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine at Different Viral Concentrations in Healthy Infants | COMPLETED | PHASE2 | 2001-01 | 2003-04 | 2003-04 |
| NCT00043901 | Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug | COMPLETED | PHASE4 | 2000-12-01 | 2005-03-01 | 2003-11-01 |
| NCT00729001 | Study of Two Doses of GSK Biologicals' Live Attenuated HRV Vaccine (Two Different Formulations) in Healthy Infants. | COMPLETED | PHASE2 | 2000-11 | 2002-09 | 2002-09 |
| NCT00388440 | Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore. | COMPLETED | PHASE4 | 2000-11 | 2001-04 | 2001-04 |
| NCT00276276 | Active Symptom Control Alone Or In Combination With Oral Topotecan In Patients With Relapsed Resistant Small Cell Lung Cancer | COMPLETED | PHASE3 | 2000-11 | | |
| NCT00119743 | A Efficacy Against Otitis Media in Children With 11 Valent Pneumococcal Vaccine | TERMINATED | PHASE3 | 2000-10 | 2004-06 | 2004-06 |
| NCT00693615 | Safety and Immunogenicity Study of MEDI-517 (GSK 580299) With or Without Adjuvant in Healthy Adult Females | COMPLETED | PHASE2 | 2000-10 | 2005-01 | 2005-01 |
| NCT00044278 | Pediatric Epilepsy Study in Subjects 1-24 Months | COMPLETED | PHASE2 | 2000-09 | 2006-06 | 2006-06 |
| NCT00268216 | Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2000-09 | 2005-11 | 2005-11 |
| NCT00879827 | Immunogenicity and Reactogenicity of GSK Bio DTPa-HBV-IPV and Hib Vaccines When Coadministered to Healthy Infants | COMPLETED | PHASE3 | 2000-09 | 2001-05 | 2001-05 |
| NCT00697866 | Consistency of 3 Consecutive Lots of a Novel HBV Vaccine With Single-blind Safety Evaluation Using Engerix™-B as Control | COMPLETED | PHASE3 | 2000-08 | | 2001-02 |
| NCT00425737 | Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine in Healthy Infants | COMPLETED | PHASE2 | 2000-08 | 2001-07 | 2001-07 |
| NCT00333723 | AVANDIA With Glyburide In African American And Hispanic Patients With Type 2 Diabetes Not Controlled by Glyburide Alone | COMPLETED | PHASE4 | 2000-07-28 | 2003-01-06 | 2003-01-06 |
| NCT01868035 | Iodine-131 Anti-B1 Antibody Consolidation for Patients With Non-Hodgkin's Lymphoma Following First-line CHOP | COMPLETED | PHASE2 | 2000-05 | 2012-10 | 2012-10 |
| NCT00043875 | Pediatric Epilepsy Trial in Subjects 1-24 Months | COMPLETED | PHASE2 | 2000-05 | 2003-11 | 2003-11 |
| NCT00500955 | Rosiglitazone on Microalbuminuria in Type 2 Diabetics | COMPLETED | PHASE3 | 2000-04 | 2004-06 | |
| NCT00140725 | Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV) | COMPLETED | PHASE3 | 2000-04 | | |
| NCT00508833 | Safety and Efficacy of SmithKline Beecham (GlaxoSmithKline [GSK]) Biologicals' Candidate Adjuvanted Vaccines (287615) | COMPLETED | PHASE1, PHASE2 | 2000-03 | | |
| NCT01663714 | Open Label Multicenter Study of CVP Followed by Iodine-131 Anti-B1 Antibody for Subjects With Untreated Low-Grade Non Hodgkin's Lymphoma. | COMPLETED | PHASE2 | 2000-02 | 2012-02 | 2012-02 |
| NCT01457560 | Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio Vaccine | COMPLETED | PHASE3 | 2000-02 | 2001-04 | 2001-04 |
| NCT00279045 | Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide | COMPLETED | PHASE3 | 2000-01-03 | 2006-06-19 | 2006-06-01 |
| NCT00697554 | Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Pre-liver Transplant Patients 18 Years of Age | COMPLETED | PHASE3 | 2000-01 | | 2002-05 |
| NCT00383227 | Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years | COMPLETED | PHASE3 | 1999-12 | 2000-11 | 2000-11 |
| NCT00383383 | Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years | COMPLETED | PHASE3 | 1999-12 | | |
| NCT00698061 | Immunogenicity and Safety of an Adjuvanted HBV Vaccine Compared to Engerix™-B, in a Non-responder Population ≥ 15y | COMPLETED | PHASE3 | 1999-11 | 2001-05 | 2000-09 |
| NCT00158834 | Pediatric Asthma Study Using Stepwise Treatment With Two Food And Drug Administration Approved Asthma Medications | COMPLETED | PHASE3 | 1999-11 | | |
| NCT00693966 | Dose-Comparison Study to Evaluate the Safety and Immunogenicity of MEDI-517 (GSK 580299) in Healthy Adult Females | COMPLETED | PHASE2 | 1999-10 | 2004-09 | 2004-09 |
| NCT00992758 | Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Non Hodgkin's Lymphoma (NHL) Patients With Greater Than 25% Bone Marrow Involvement | COMPLETED | PHASE1 | 1999-05-28 | 2012-06-07 | 2012-06-07 |
| NCT00697749 | Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Healthy Volunteers Positive for the HLA-DQ2 Genotype | COMPLETED | PHASE3 | 1999-04 | 2000-01 | 2000-01 |
| NCT00696917 | Safety and Immunogenicity of 3 Lots of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Volunteers ≥ 15y | COMPLETED | PHASE3 | 1999-04 | | 2000-02 |
| NCT01457508 | Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered Separately | COMPLETED | PHASE3 | 1999-01 | 2000-03 | 2000-03 |
| NCT00697853 | Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine (2 Doses), and of Engerix™-B (3 Doses) in Healthy Adults | COMPLETED | PHASE2 | 1998-11 | | 1999-07 |
| NCT01457495 | Immunogenicity and Safety of DTPa-HBV-IPV/Hib Compared to DTPa-IPV/Hib and HBV Administered Concomitantly | COMPLETED | PHASE2 | 1998-09 | 1999-09 | 1999-09 |
| NCT00268203 | Expanded Access Study Of BEXXAR® For Low Grade And Transformed Low-Grade Non-Hodgkin's Lymphoma | COMPLETED | PHASE2 | 1998-09 | 2013-02 | 2000-03 |
| NCT01573000 | A Randomized Study of Iodine-131 Anti-b1 Antibody Versus Anti-b1 Antibody in Chemotherapy-relapsed/Refractory Low-grade or Transformed Low-grade Non-Hodgkin's Lymphoma (NHL) | COMPLETED | PHASE2 | 1998-09 | 2010-04 | 2001-04 |
| NCT00933335 | Study of Safety and Efficacy of a Sequential Regimen Consisting of Three Cycles of Fludarabine Followed by Tositumomab and Iodine I 131 Tositumomab | COMPLETED | PHASE2 | 1998-08 | 2010-08 | 2009-12 |
| NCT00996593 | Study of Iodine-131 Anti-B1 Antibody for Patients With Non Hodgkin's Lymphoma Who Have Previously Received Rituximab | COMPLETED | PHASE2 | 1998-07 | 2009-08 | 2001-04 |
| NCT00950755 | Study of Iodine 131 Anti B1 Antibody for 1st or 2nd Relapsed Indolent B-Cell Lymphomas or B-Cell Lymphomas That Have Transformed to a More Aggressive Histology | COMPLETED | PHASE2 | 1998-06 | 2011-04 | 2011-04 |
| NCT00938041 | Retreatment of Patients With Non-Hodgkin's Lymphoma Who Have Previously Responded to Iodine-131 Anti B1 Antibody | COMPLETED | PHASE2 | 1998-04 | 2013-06 | 2003-05 |
| NCT00697775 | Safety and Immunogenicity of GSK Bio's Candidate HBV-MPL Vaccines Compared to Engerix™-B, in Healthy Adolescents | COMPLETED | PHASE2 | 1998-03 | | 1999-05 |
| NCT01262924 | Study of Reduced-antigen-content Acellular Pertussis Vaccine and Diphtheria-Tetanus-Acellular Pertussis Vaccine | COMPLETED | PHASE3 | 1997-10 | 1998-12 | 1998-12 |
| NCT01267058 | Booster Study of Combined Diphtheria-tetanus-acellular Pertussis Vaccine in Healthy Adults | COMPLETED | PHASE3 | 1997-09 | 1998-02 | 1998-02 |
| NCT00696891 | Study Comparing Immunogenicity, Reactogenicity and Safety of GSK Bios' HBV-MPL Vaccine With That of Engerix™-B in Adults | COMPLETED | PHASE3 | 1997-06 | | 1999-05 |
| NCT00698906 | Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 19-40 y | COMPLETED | PHASE2 | 1997-06 | | 1998-02 |
| NCT00697931 | Immunogenicity and Reactogenicity of MPL Adjuvanted Recombinant Hepatitis B- Vaccine and Engerix™-B in Adult Non-Responders | COMPLETED | PHASE3 | 1997-05 | 1998-06 | 1998-06 |
| NCT00698555 | Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 18-40 y | COMPLETED | PHASE2 | 1997-03 | | 1998-05 |
| NCT00697216 | Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Adults (15-40 Yrs). | COMPLETED | PHASE3 | 1997-03 | | 1999-03 |
| NCT00989664 | Pivotal Study of Iodine I 131 Tositumomab for Chemotherapy-refractory Low-grade or Transformed Low-grade B-cell Non-Hodgkin's Lymphoma | COMPLETED | PHASE2 | 1996-11 | 2008-09 | 2004-01 |
| NCT00698568 | Safety Evaluation of Herpes Simplex Candidate Vaccine (gD2t) With Adjuvant in HSV Seropositive / Seronegative Subjects | COMPLETED | PHASE3 | 1996-10 | 1999-04 | 1999-04 |
| NCT00996996 | Iodine-131 Anti-B1 Antibody (Tositumomab and Iodine I 131 Tositumomab) for Previously Untreated, Advanced-stage, Low Grade Non-Hodgkin's Lymphoma | COMPLETED | PHASE2 | 1996-06 | 2011-10 | 1999-03 |
| NCT00699764 | Safety of a Herpes Simplex Candidate Vaccine (gD2t) With MPL and Its Efficacy to Prevent Genital Herpes Disease | COMPLETED | PHASE3 | 1996-03 | 1999-10 | 1999-10 |
| NCT01224821 | Dosimetry/Validation Study of 131Iodine-Anti B1 (Murine) Radioimmunotherapy for Chemotherapy Refractory Low Grade B Cell Lymphomas and Low Grade Lymphomas That Have Transformed to Higher Grade Histologies | COMPLETED | PHASE2 | 1995-12 | 2008-05 | 1997-11 |
| NCT00698490 | Humoral and Cellular Immune Response of Herpes Simplex (gD) Candidate Vaccines From 2 Different Cell Lines | COMPLETED | PHASE1, PHASE2 | 1995-08 | 1997-01 | 1997-01 |
| NCT00697840 | Safety, Immunogenicity and Reactogenicity of Recombinant Hepatitis B Vaccine (Adjuvanted & New Formulation) and Engerix™-B | COMPLETED | PHASE3 | 1995-06 | 1996-01 | 1996-01 |
| NCT00698087 | Comparison of Safety, Immuno- and Reactogenicity of MPL-Adjuvanted Recombinant Hepatitis B Vaccine to That of Engerix™-B | COMPLETED | PHASE3 | 1995-01 | 1996-02 | 1996-02 |
| NCT00697242 | Comparison of Immuno, Reacto and Safety of Recombinant Hepatitis B Vaccine With or Without MPL in Healthy Older Adults | COMPLETED | PHASE3 | 1994-01 | 1995-11 | 1995-11 |
| NCT00697970 | Evaluation of Immunogenicity and Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine | COMPLETED | PHASE3 | 1993-11 | 1995-04 | 1995-04 |
| NCT00697125 | Immunogenicity & Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine With Different Adjuvants | COMPLETED | PHASE2 | 1993-06 | 1994-07 | 1994-07 |
| NCT00697567 | Evaluation of Immunogenicity, Reactogenicity and Safety of Herpes Simplex (gD) Candidate Vaccine With/Without Adjuvant | COMPLETED | PHASE2 | 1992-09 | 1997-12 | 1997-12 |
| NCT00697229 | Immunogenicity & Reactogenicity of HBV-MPL Vaccine and Engerix™-B in Healthy Adults Following 2 Different Schedules | COMPLETED | PHASE2 | 1992-09 | 1998-12 | 1996-05 |
| NCT00698893 | Evaluation of Safety of Candidate gD Vaccine, With or Without MPL in Healthy Herpes Simplex Virus-positive Adults | COMPLETED | PHASE1 | 1992-05-01 | 1992-07-01 | 1992-07-01 |
| NCT00699231 | Evaluation of Immunogenicity, Reactogenicity and Safety of HBV-MPL Vaccine vs Engerix™-B, in Haemodialysis Patients | COMPLETED | PHASE1 | 1992-02 | 1992-12 | 1992-12 |
| NCT01536561 | Study of Radiolabeled Monoclonal Antibody Anti-B1 for the Treatment of B-Cell Lymphomas and Extended Study to Determine the Safety and Efficacy of Coulter Clone® 131Iodine-B1 Radioimmunotherapy of Advanced Non-Hodgkin's Lymphoma | COMPLETED | PHASE1 | 1990-04-24 | 2009-10-16 | 1997-07-02 |